[
  {
    "page": 2,
    "content": "ITI Treatment Guide\nVolume 8\n2"
  },
  {
    "page": 3,
    "content": "ITI\nTreatment\nGuide\nVolume 8\nBiological and Hardware Complications in Implant\nDentistry\nEditors:\nD. Wismeijer, D. Buser, S. Chen\nAuthors:\nU. Brägger, L. J. A. Heitz-Mayfield\n3"
  },
  {
    "page": 4,
    "content": "Quintessence Publishing Co, Ltd\nBerlin, Chicago, London, Tokyo, Barcelona, Beijing,\nIstanbul, Milan, Moscow, New Delhi, Paris, Prague,\nSão Paulo, Seoul, Singapore, Warsaw\n4"
  },
  {
    "page": 5,
    "content": "German National Library CIP Data\nThe German National Library has listed this publication\nin\nthe\nGerman\nNational\nBibliography.\nDetailed\nbibliographical data are available at http://dnb.ddb.de.\n© 2015 Quintessence Publishing Co, Ltd\nIfenpfad 2–4, 12107 Berlin, Germany\nwww.quintessenz.de\nAll rights reserved. This book or any part thereof may\nnot be reproduced, stored in a retrieval system, or\ntransmitted in any form or by any means, whether\nelectronic, mechanical, photocopying, or otherwise,\nwithout prior written permission of the publisher.\nIllustrations:\nUte Drewes, CH-Basel,\nwww.drewes.ch\nCopyediting:\nTriacom Dental, D-Barendorf,\nwww.dental.triacom.com\nGraphic concept:\nWirz Corporate AG, CH-Zürich\nProduction:\nJuliane Richter, D-Berlin\nPrinting:\nBosch-Druck GmbH, D-Landshut,\nwww.bosch-druck.de\n5"
  },
  {
    "page": 6,
    "content": "ISBN:\n978-3-86867-282-4 (ebook)\n978-3-86867-240-4 (print)\nThe materials offered in the ITI Treatment Guide are for educational\npurposes only and intended as a step-by-step guide to treatment of\na particular case and patient situation. These recommendations are\nbased on conclusions of the ITI Consensus Conferences and, as\nsuch,\nin\nline\nwith\nthe\nITI\ntreatment\nphilosophy.\nThese\nrecommendations, nevertheless, represent the opinions of the\nauthors. Neither the ITI nor the authors, editors and publishers\nmake any representation or warranty for the completeness or\naccuracy of the published materials and as a consequence do not\naccept any liability for damages (including, without limitation, direct,\nindirect, special, consequential or incidental damages or loss of\nprofits) caused by the use of the information contained in the ITI\nTreatment Guide. The information contained in the ITI Treatment\nGuide cannot replace an individual assessment by a clinician, and\nits use for the treatment of patients is therefore in the sole\nresponsibility of the clinician.\nThe inclusion of or reference to a particular product, method,\ntechnique or material relating to such products, methods, or\ntechniques in the ITI Treatment Guide does not represent a\nrecommendation or an endorsement of the values, features, or\nclaims made by its respective manufacturers.\nAll rights reserved. In particular, the materials published in the ITI\nTreatment Guide are protected by copyright. Any reproduction,\neither in whole or in part, without the publisher’s prior written\nconsent is prohibited. The information contained in the published\n6"
  },
  {
    "page": 7,
    "content": "materials can itself be protected by other intellectual property rights.\nSuch information may not be used without the prior written consent\nof the respective intellectual property right owner.\nSome of the manufacturer and product names referred to in this\npublication may be registered trademarks or proprietary names,\neven though specific reference to this fact is not made. Therefore,\nthe appearance of a name without designation as proprietary is not\nto be construed as a representation by the publisher that it is in the\npublic domain.\nThe tooth identification system used in this ITI Treatment Guide is\nthat of the FDI World Dental Federation.\n7"
  },
  {
    "page": 8,
    "content": "The ITI Mission is …\n“… to promote and disseminate knowledge on all\naspects\nof\nimplant\ndentistry\nand\nrelated\ntissue\nregeneration through education and research to the\nbenefit of the patient.”\n8"
  },
  {
    "page": 9,
    "content": "Preface\nWhile implant dentistry today is well documented\nand\ndemonstrates\npredictable\noutcomes,\na\nsignificant proportion of patients still experience\ncomplications. It is therefore a must for all\npractitioners to know the causes of implant-related\ncomplications and how to avoid and manage them.\nVolume 8 of the ITI Treatment Guide series\nprovides clinicians with the latest evidence-based\ninformation\non the origins and treatment\nof\nbiological as well as technical and mechanical\ncomplications.\nAn\nup-to-date\nanalysis\nof\nthe\ncurrent\nevidence\nis\nbased\nin\npart\non\nthe\nproceedings of the 4th ITI Consensus Conference\nheld in Stuttgart in 2008 and the 5th ITI Consensus\nConference held in Bern in 2013, as well as on a\nreview of the current literature. The diagnosis and\ntreatment of biological and technical complications\nare examined closely in 16 clinical cases presented\nby clinicians from all over the world.\nThe mission of the ITI “… to promote and\ndisseminate knowledge on all aspects of implant\ndentistry to the benefit of the patient” as always\nprovides\nthe\nbackground\nagainst\nwhich\nthis\nvolume of the ITI Treatment Guide series has been\nwritten.\n9"
  },
  {
    "page": 10,
    "content": "10"
  },
  {
    "page": 11,
    "content": "Acknowledgment\nWe would like to thank Dr. Kati Benthaus of the ITI\nHeadquarters for her invaluable assistance in the\npreparation of this volume of the Treatment Guide\nseries. We would also like to express our gratitude to\nMs. Juliane Richter (Quintessence Publishing) for\ntypesetting\nand\nfor\ncoordinating\nthe\nproduction\nworkflow, Mr. Per N. Döhler (Triacom Dental) for his\nediting support, and Ms. Ute Drewes for her excellent\nillustrations. We also acknowledge continuing support\nfrom Institut Straumann AG, ITI’s corporate partner.\n11"
  },
  {
    "page": 12,
    "content": "Editors and Authors\nEditors:\nDaniel Wismeijer\nDDS, PhD, Professor\nHead, Section of Implantology and Prosthetic Dentistry\nDepartment of Oral Function and Restorative Dentistry\nAcademic Centre for Dentistry Amsterdam (ACTA)\nGustav Mahlerlaan 3004\n1066 EA Amsterdam, Netherlands\nE-mail: d.wismeijer@acta.nl\nDaniel Buser\nDDS, Dr med dent\nProfessor and Chair\nDepartment of Oral Surgery and Stomatology\nUniversity of Bern, School of Dental Medicine\nFreiburgstrasse 7\n3010 Bern, Switzerland\n12"
  },
  {
    "page": 13,
    "content": "E-mail: daniel.buser@zmk.unibe.ch\nStephen Chen\nMDSc, PhD\nClinical Associate Professor\nSchool of Dental Science\nUniversity of Melbourne\n720 Swanston Street\nMelbourne VIC 3010, Australia\nE-mail: schen@balwynperio.com.au\nAuthors:\nUrs Brägger\nDr med dent\nProfessor and Chair\nDepartment\nof\nReconstructive\nDentistry\nand\nGerodontology\nUniversity of Bern, School of Dental Medicine\nFreiburgstrasse 7\n3010 Bern, Switzerland\n13"
  },
  {
    "page": 14,
    "content": "E-mail: urs.braegger@zmk.unibe.ch\nLisa J. A. Heitz-Mayfield\nBDS, MDSc, PhD\nProfessor\nInternational Research Collaborative\nUniversity of Western Australia\nNedlands, WA 6009, Australia\nE-mail: heitz.mayfield@iinet.net.au\n14"
  },
  {
    "page": 15,
    "content": "Contributors\nBilal Al-Nawas\nDr med, Dr med dent, Professor\nJohannes Gutenberg-University\nMedical Center\nDepartment of Oral and Maxillofacial Surgery\nAugustusplatz 2\n55131 Mainz, Germany\nE-mail: al-nawas@mkg.klinik.uni-mainz.de\nUrs C Belser\nDMD, Dr med dent, Professor\nDepartment of Oral Surgery and Stomatology\nDepartment\nof\nReconstructive\nDentistry\nand\nGerodontology\nUniversity of Bern, School of Dental Medicine\nFreiburgstrasse 7\n3010 Bern, Switzerland\n15"
  },
  {
    "page": 16,
    "content": "E-mail: urs.belser@unige.ch\nMichael M. Bornstein\nDr med dent, Associate Professor\nHead, Section of Oral Radiology and Stomatology\nDepartment of Oral Surgery and Stomatology\nUniversity of Bern, School of Dental Medicine\nFreiburgstrasse 7\n3010 Bern, Switzerland\nE-mail: michael.bornstein@zmk.unibe.ch\nUrs Braegger\nDr med dent\nProfessor and Chair\nDepartment\nof\nReconstructive\nDentistry\nand\nGerodontology\nUniversity of Bern, School of Dental Medicine\nFreiburgstrasse 7\n3010 Bern, Switzerland\nE-mail: urs.braegger@zmk.unibe.ch\n16"
  },
  {
    "page": 17,
    "content": "Daniel Buser\nDDS, Dr med dent\nProfessor and Chair\nDepartment of Oral Surgery and Stomatology\nUniversity of Bern, School of Dental Medicine\nFreiburgstrasse 7\n3010 Bern, Switzerland\nE-mail: daniel.buser@zmk.unibe.ch\nAgnieszka Frydrych\nBDSc(Hons), MDSc, FRACDS(Oral Med), FOMAA\nAssociate Professor (Oral Medicine)\nUniversity of Western Australia\n17 Monash Avenue\nNedlands, WA 6009, Australia\nE-mail: agnieszka.frydrych@uwa.edu.au\nAlexandros Grous\nDr med, Dr med dent\n17"
  },
  {
    "page": 18,
    "content": "Grous Dental Clinic\n2 Vasileos Alexandrou Street\n11634 Athens, Greece\nE-mail: alex@grousdental.com\nLisa J. A. Heitz-Mayfield\nBDS, MDSc, PhD\nProfessor\nInternational Research Collaborative\nUniversity of Western Australia\nNedlands, WA 6009, Australia\nE-mail: heitz.mayfield@iinet.net.au\nStefan Hicklin\nDr med dent, Senior Lecturer\nDepartment\nof\nReconstructive\nDentistry\nand\nGerodontology\nUniversity of Bern, School of Dental Medicine\nFreiburgstrasse 7\n3010 Bern, Switzerland\n18"
  },
  {
    "page": 19,
    "content": "E-mail: stefan.hicklin@zmk.unibe.ch\nTim Joda\nDr med dent, MSc, Senior Lecturer\nDepartment\nof\nReconstructive\nDentistry\nand\nGerodontology\nUniversity of Bern, School of Dental Medicine\nFreiburgstrasse 7\n3010 Bern, Switzerland\nE-mail: tim.joda@zmk.unibe.ch\nJanice Kan\nBDSc(Hons), DCD Pros\nPerth Prosthodontics\nSuite 3, Southbank Central\n38 Meadowvale Ave\nSouth Perth WA 6151, Australia\nE-mail: dr.jkan@perthpros.com.au\nDaan Kruger\nDDS, MSc Oral Implantology\n19"
  },
  {
    "page": 20,
    "content": "Section of Implantology and Prosthetic Dentistry\nDepartment of Oral Function and Restorative Dentistry\nAcademic Centre for Dentistry Amsterdam (ACTA)\nGustav Mahlerlaan 3004\n1066 EA Amsterdam, Netherlands\nE-mail: d.y.kruger@acta.nl\nPeer W. Kämmerer\nDr med, Dr med dent\nUniversity of Rostock\nDepartment of Oral and Maxillofacial Surgery\nSchillingallee 35\n18057 Rostock, Germany\nE-mail: peer.kaemmerer@uni-rostock.de\nTomas Linkevičius\nDDS, Dip Pros, PhD, Associate Professor\nInstitute of Odontology,\nFaculty of Medicine, Vilnius University\n20"
  },
  {
    "page": 21,
    "content": "Žalgirio 115/117\nLT-08217 Vilnius, Lithuania\nE-mail: linktomo@gmail.com\nMaximilian Moergel\nDr med, Dr med dent\nJohannes Gutenberg-University\nMedical Center\nDepartment of Oral and Maxillofacial Surgery\nAugustusplatz 2\n55131 Mainz, Germany\nE-mail: maximilian.moergel@unimedizin-mainz.de\nAndrea Mombelli\nDr med dent, Professor\nUniversité de Genève\nSection de Médecine Dentaire\nDivision de Physiopathologie Buccale et Parodontie\nRue Barthélemy-Menn 19\n21"
  },
  {
    "page": 22,
    "content": "1205 Genève, Switzerland\nE-mail: andrea.mombelli@unige.ch\nJoris Muris\nDDS\nDepartment of Material Science\nAcademic Centre for Dentistry Amsterdam (ACTA)\nUniversity\nof\nAmsterdam\nand\nVU\nUniversity\nAmsterdam\nGustav Mahlerlaan 3004\n1066 EA Amsterdam, Netherlands\nE-mail: j.muris@acta.nl\nGiovanni E. Salvi\nDr med dent, Professor\nDepartment of Periodontology\nUniversity of Bern, School of Dental Medicine\nFreiburgstrasse 7\n3010 Bern, Switzerland\nE-mail: giovanni.salvi@zmk.unibe.ch\n22"
  },
  {
    "page": 23,
    "content": "Bruno Schmid\nDr med dent\nPrivate Office\nBayweg 3\n3123 Belp, Switzerland\nE-mail: info@brunoschmid.ch\nSandro Tettamanti\nDr med dent\nDepartment\nof\nReconstructive\nDentistry\nand\nGerodontology\nUniversity of Bern, School of Dental Medicine\nFreiburgstrasse 7\n3010 Bern, Switzerland\nE-mail: tettamanti@hispeed.ch\nHans-Peter Weber\nDMD, Dr med dent\nProfessor and Chair\nDepartment of Prosthodontics and Operative Dentistry\n23"
  },
  {
    "page": 24,
    "content": "Tufts University, School of Dental Medicine\nOne Kneeland Street, Rm. 220\nBoston, MA 02111\nUnited States of America\nE-mail: hp.weber@tufts.edu\nPhilipp Wick\nDr med dent\nWeststrasse 4\n3005 Bern, Switzerland\nE-mail: philipp.wick@gmx.ch\nDaniel Wismeijer\nDDS, PhD, Professor\nHead, Section of Implantology and Prosthetic Dentistry\nDepartment of Oral Function and Restorative Dentistry\nAcademic Centre for Dentistry Amsterdam (ACTA)\nGustav Mahlerlaan 3004\n1066 EA Amsterdam, Netherlands\n24"
  },
  {
    "page": 25,
    "content": "E-mail: d.wismeijer@acta.nl\n25"
  },
  {
    "page": 26,
    "content": "Table of Contents\n1\nIntroduction\nL. J. A. Heitz-Mayfield, U. Brägger\n2\nLiterature Review\nL. J. A. Heitz-Mayfield, U. Brägger\n2.1 Statements and Recommendations Obtained from\nthe 4th and 5th ITI Consensus Conferences\n2.1.1 Proceedings of the 4th ITI Consensus Conference\n2008\n2.1.2 Proceedings of the 5th ITI Consensus Conference\n2013\n2.2 Literature Review: Biological Complications\nL. J. A. Heitz-Mayfield\n2.3 Literature Review: Hardware Complications and\nFailures\nU. Brägger\n2.3.1 Mechanical and Technical Risks\n26"
  },
  {
    "page": 27,
    "content": "2.3.2 Effect of Improved Components on Complications\nand Failure Rates\n2.3.3 Complication and Failure Rates with Cemented\nversus Screw-retained Reconstructions\n2.3.4 Complication and Failure Rates with Metal versus\nCeramic Abutments\n2.3.5 State of the Art of CAD/CAM-assisted Production\nof Implant-supported Reconstructions\n2.3.6 Overdentures\n2.3.7 Survival Rates of Reconstructions Obtained from\nSystematic Reviews\n3\nEtiology\nand\nRisk\nFactors:\nBiological\nComplications\nL. J. A. Heitz-Mayfield\n3.1 Peri-implant Infections\n3.1.1 Peri-implant Biofilms\n3.1.2 Risk Factors for Peri-implant Infection\n3.1.3 Hardware Complications Presenting as Biological\nComplications\n3.2 Non-plaque-related Biological Complications\n27"
  },
  {
    "page": 28,
    "content": "3.2.1 Complete Loss of Osseointegration and Occlusal\nOverload\n3.2.2 Other Theories for the Etiology of Loss of\nOsseointegration\n3.2.3 Non-plaque-related Oral Mucosal Disorders\n4\nEtiology and Origin of Hardware Complications\nU. Brägger\n4.1 Materials and Interfaces\n4.2 Absorption of Kinetic Energy and Biomechanical\nRisks\n4.3 Hardware-related Complications and Failures\n4.3.1 Implant Body\n4.3.2 Implant Body/Abutment Interface\n4.3.3 Abutment Screw\n4.3.4 Abutment Body\n4.3.5 Retention of Superstructures: Screw-retained and\nCemented\n4.3.6 Closure Screws, Healing Abutments, Mucosa\nFormers\n28"
  },
  {
    "page": 29,
    "content": "4.3.7 Attachment System for Overdentures\n4.3.8 Mesostructures\n4.3.9 Reconstruction\n5\nManagement of Biological Complications\nL. J. A. Heitz-Mayfield\n5.1 Treatment of Peri-implant Mucositis\n5.2 Treatment of Peri-implantitis\n5.2.1 Pre-treatment Phase\n5.2.2 Non-surgical Debridement\n5.2.3 Early Reassessment\n5.2.4 Surgical Intervention\n5.2.5 Immediate Postsurgical Care\n5.2.6 Maintenance\n5.2.7 Implant Removal\n5.2.8 Concluding Remarks\n5.3 Non-plaque-related Biological Complications\n6\nManagement of Hardware Complications\n29"
  },
  {
    "page": 30,
    "content": "U. Brägger\n6.1 Hardware Complications\n6.1.1 Fracture and Loss of Implants\n6.1.2 Unfavorable Three-dimensional Position of the\nPlatform\n6.1.3 Complications Related to Abutments\n6.1.4 Complications Related to Abutment Screws\n6.1.5 Complications Related to Retention\n6.1.6 Complications Related to Healing Abutments\n6.1.7 Complications\nRelated\nto\nSystems\nfor\nOverdentures\n6.2 Superstructure-related Complications\n6.2.1 Denture Teeth and Acrylic\n6.2.2 Wear and Attrition\n6.2.3 Ceramic Chipping\n6.3 Iatrogenic Reasons\n7\nPrevention of Biological Complications\nL. J. A. Heitz-Mayfield\n30"
  },
  {
    "page": 31,
    "content": "7.1 Prevention of Peri-implant Infections\n7.1.1 Treatment Planning\n7.1.2 Preparation of the Patient\n7.1.3 Preparation of the Recipient Site\n7.1.4 Implant Placement\n7.1.5 Prosthesis Design\n7.1.6 Supportive Care\n7.1.7 Diagnostic Monitoring of the Peri-implant Tissues\n7.1.8 Frequency of Recall\n7.2 Prevention of Loss of Osseointegration Due to\nOcclusal Overload\n7.3 Prevention of Non-plaque-related Oral Mucosal\nDisorders\n7.4 Concluding Remarks\n8\nPrevention of Hardware Complications\nU. Brägger\n8.1 Prevention\nof\nComplications\nRelated\nto\nComponents and Reconstructions\n8.1.1 Implant Body\n31"
  },
  {
    "page": 32,
    "content": "8.1.2 Implant/Abutment Connection\n8.1.3 Abutment Body and Abutment Screw\n8.1.4 Third-party Components\n8.1.5 Retention: Screw-retained and Cemented\n8.1.6 Closure\nScrew,\nHealing\nAbutment,\nMucosa\nFormers\n8.1.7 Attachment Systems for Overdentures\n8.1.8 Mesostructures\n8.1.9 Superstructures\n8.2 Risk Management\n9\nClinical Case Presentations\nBiological Complications\n9.1.1 Iatrogenic Complications Managed by Replacing\nProsthetic Components: Non-surgical Approach\nB. Schmid\n9.1.2 Peri-implantitis Treated with Access-Flap Surgery\nL. J. A. Heitz-Mayfield\n9.1.3 Excess\nCement\nResulting\nin\nPeri-implant\nInfection Presenting as a Draining Sinus Tract\n32"
  },
  {
    "page": 33,
    "content": "T. Linkevičius\n9.1.4 Peri-implantitis Modified by Submucosal Excess\nof Cement: Regenerative Peri-implantitis Therapy and\nSix-year Follow-up\nG. E. Salvi\n9.1.5 Peri-implantitis Treated by an Antimicrobial and\nRegenerative Approach\nA. Mombelli, P. Wick\n9.1.6 Recurrent Peri-implantitis Leading to Implant\nRemoval\nL. J. A. Heitz-Mayfield\nBiological Complications (Other than Infections)\n9.2.1 Removal of a Malpositioned Implant and Direct\nNew Implant Placement with Simultaneous Contour\nAugmentation using GBR\nD. Buser, U. Belser\n9.2.2 Oral Lichen Planus Associated with the Peri-\nimplant Mucosa\nA. Frydrych\n9.2.3 Peri-implant Carcinoma\n33"
  },
  {
    "page": 34,
    "content": "M. Moergel, P. W. Kämmerer, B. Al-Nawas\n9.2.4 Peripheral Giant-cell Granuloma Associated with\nPeri-implant Tissues\nM. M. Bornstein\n9.2.5 Peri-implantitis\nResulting\nin\nBisphosphonate-\nrelated Osteonecrosis of the Jaw\nM. M. Bornstein\n9.2.6 Metal Allergy\nD. Wismeijer, D. Kruger, J. Muris\nHardware Complications\n9.3.1 Management of a Fractured Implant Supporting a\nScrew-retained Metal-ceramic Restoration\nH. P. Weber, A. Grous\n9.3.2 Retreatment of a Patient with Multiple Biological\nand Technical Complications and Failures\nS. Hicklin, S. Tettamanti, U. Brägger\n9.3.3 Management of a Technical Complication Caused\nby a Fractured Zirconia Abutment\nT. Joda, U. Brägger\n34"
  },
  {
    "page": 35,
    "content": "9.3.4 Repeated Acrylic Fractures on a Mandibular\nFixed\nFull-arch\nImplant-supported\nMetal/Acrylic\nProsthesis\nJ. Kan\n10 Etiology, Management, and Prevention of Hardware\nComplications with Implant-supported Reconstructions\nU. Brägger, S. Hicklin\n11 Conclusions\nL. J. A. Heitz-Mayfield, U. Brägger\n12 References\n35"
  },
  {
    "page": 36,
    "content": "36"
  },
  {
    "page": 37,
    "content": "1 Introduction\nL. J. A. Heitz-Mayfield, U. Brägger\nThe\nreplacement\nof\nmissing\nteeth\nwith\nimplant-\nsupported prostheses is a well-documented, predictable\ntreatment method. High five- and ten-year survival rates\nof\nboth\nthe\nimplants\nand\nthe\nimplant-supported\nprostheses\nhave\nbeen\nreported\n(Pjetursson\nand\ncoworkers 2014). However, both the clinician and\npatient should be aware that a significant percentage of\npatients treated with dental implants will experience a\ncomplication requiring a dental visit within the first 5\nyears. Given the steady growth in the number of\nimplants placed and restored over recent years, the\nnumber of complications may also be expected to\nincrease\nin\nthe\nfuture.\nTherefore,\nthe\ndiagnosis,\nmanagement,\nand\nprevention\nof\nimplant-related\ncomplications are important issues to consider as a part\nof everyday practice.\nComplications may be categorized as biological or\nhardware-related.\nBiological\ncomplications\nare\nassociated\nwith\nthe\nsurrounding peri-implant tissues (peri-implant mucosa\nor bone).\nHardware complications may be associated with the\nimplant or with the prosthetic components. Following\n37"
  },
  {
    "page": 38,
    "content": "the definitions by Salvi and Brägger (2009), a technical\ncomplication is defined as a complication that affects\nthe laboratory-fabricated components of the prosthesis,\nwhile a mechanical complication is one associated with\nthe\nmanufacturer-fabricated\ncomponents.\nThus,\nhardware complications include both technical and\nmechanical complications, as well as other types of\ncomplications, for example fracture of the luting cement\nor loss of the occlusally screw-retained restoration.\nFurthermore, complications may be classified as minor\n(those that can be rectified at chairside with minimal\nintervention and minimal cost) or major (those that\nrequire\nnumerous\nvisits\nor\nare\nassociated\nwith\nconsiderable cost). Major complications may result in\neither implant loss, or failure of the prosthesis, or both.\nCompromised esthetics may be a consequence of either\nbiological or hardware complications.\nThe present Volume 8 of the ITI Treatment Guide\nseries addresses etiology, management, and prevention\nof biological and hardware complications that occur\nfollowing successful osseointegration, with the implant\nin function. Biological complications described in this\nvolume\ninclude\ncomplete\nloss\nof\nosseointegration\n(implant failure); peri-implant infections (peri-implant\nmucositis and peri-implantitis); bisphosphonate-related\nosteonecrosis of the jaw (BRONJ) in relation to\nosseointegrated\ndental\nimplants;\nperi-implant\noral\nmucosal disorders; material allergies; and carcinomas/\ntumors.\n38"
  },
  {
    "page": 39,
    "content": "Hardware complications outlined in this volume include\nimplant fracture; abutment or screw fracture; abutment\nor screw loosening; prosthesis framework fracture;\nprosthesis veneering material fracture; loss of the\nocclusally screw-retained restoration; and—in the case\nof cemented prostheses—fracture of the luting cement\n(loss of retention). Reasons for ill-fitting restoration\nmargins are also discussed, as well as complications\narising\nfrom\ninsufficient\nspace\nfor\nrestorative\ncomponents due to inadequate treatment planning.\nWhile various complications may appear similar in their\nclinical presentation, the clinician must be able to make\nthe correct diagnosis and understand the underlying\ncause of the complication in order to implement the\nappropriate\ntreatment\nstrategy.\nFurthermore,\nsome\nhardware complications, such as an abutment-screw\nfracture or prosthesis-screw loosening, may present\nclinically as a biological complication (e.g. a draining\nsinus). For the successful management of both hardware\nand biological complications, an accurate diagnosis and\nevaluation of the cause of the complication is therefore\nthe first important step.\nIn this treatment guide, step-by-step procedures for the\nmanagement of various complications are outlined and\nillustrated\nby\nindividual\ncase\ndescriptions.\nThe\nimportant topic of how to prevent complications is also\ndiscussed in detail.\nVolume 8 of the ITI Treatment Guide series aims to\nprovide the clinical and laboratory team with valuable\ninformation concerning the etiology and risk factors,\n39"
  },
  {
    "page": 40,
    "content": "management and prevention of biological and hardware\ncomplications occurring after the implant has been\nrestored.\n40"
  },
  {
    "page": 41,
    "content": "2.1 Statements and Recommendations Obtained from\nthe 4th and 5th ITI Consensus Conferences\n2.1.1 Proceedings of the 4th ITI Consensus Conference\n2008\nInternational\nJournal\nof\nOral\nand\nMaxillofacial\nImplants\n2009,\nVol.\n24\n(Supplement):\nConsensus\nstatements\nand\nrecommended\nclinical\nprocedures\nregarding risk factors in implant therapy (Cochran and\ncoworkers 2009)\nIntroductory remarks\nThe group was asked to address the available evidence\nfor potential risk factors in implant therapy. The authors\nwere requested to prepare narrative reviews using a\nsystematic approach, and were provided with general\ntopics rather than specific research questions. The four\nreviews presented for discussion within the group\naddressed: (1) systemic conditions and treatments as\nrisks\nfor\nimplant\ntherapy,\n(2)\nhistory\nof\ntreated\nperiodontitis and smoking as risks for implant therapy,\n(3) mechanical and technical risks in implant therapy,\nand (4) local risk factors for implant therapy. The\ngroup’s participants critically reviewed each of the\nreview\npapers\nproduced\nby\nits\nmembers,\nand\namendments were made following thorough discussion.\nSystemic conditions and treatments\n41"
  },
  {
    "page": 42,
    "content": "Clinical recommendations\nWith respect to systemic conditions and treatments as\nrisk\nfactors\nfor\nimplant\ntherapy,\nthe\nfollowing\nrecommendations can be made:\n•\nA thorough medical history is essential to identify\npotential systemic risks.\n•\nRisks for implant failure and risks for medical\ncomplications should be differentiated and evaluated. In\nsome instances, conditions and their treatments may\npose increased risks for implant failure, whereas the\nrisk for the patient may be minimal. As an example,\nthere are no data to support withholding implant\ntreatment for patients with diabetes or osteoporosis.\nHowever, these patients need to be informed of the\npossibility of implant complications.\n•\nWhere there is a potential risk of a medical\ncomplication—for example, osteonecrosis of the jaw in\npatients\ntaking\noral\nbisphosphonates\nand\npatients\nundergoing radiotherapy—the option of implant therapy\nshould be chosen restrictively, and the patient should be\ninformed specifically, taking into account the current\nlevel of uncertainty with regard to the consequences.\nFor patients with a life-threatening systemic disease,\nimplant placement should be postponed until the\npatient’s\nmedical\ncondition\nis\nstabilized\nand\nhas\nimproved.\nHistory of treated periodontitis and smoking\n42"
  },
  {
    "page": 43,
    "content": "Clinical recommendations\nWith respect to a history of treated periodontitis and\nsmoking, the following recommendations can be made:\n•\nHistory of treated periodontitis. A history of treated\nperiodontitis is not a contraindication for implant\nplacement. However, patients with a history of treated\nperiodontitis should be informed of an increased risk of\nimplant failure and peri-implantitis. Patients with a\nhistory of periodontitis should receive individualized\nperiodontal maintenance and regular monitoring of peri-\nimplant tissue conditions.\n•\nSmoking. Smoking is not a contraindication for\nimplant\nplacement.\nHowever,\npatients\nshould\nbe\ninformed that the survival and success rates are lower in\nsmokers. Heavy smokers should be informed that they\nare at greater risk of implant failure and loss of\nmarginal bone. Patients who smoke should be informed\nthat there is an increased risk of implant failure when\nsinus augmentation procedures are used.\n•\nHistory\nof\ntreated\nperiodontitis\nand\nsmoking\ncombined. Patients who smoke and have a history of\ntreated periodontitis should be informed that they have\nan increased risk of implant failure and peri-implant\nbone loss.\nMechanical and technical risks\nClinical recommendations\n43"
  },
  {
    "page": 44,
    "content": "With\nrespect\nto\nmechanical/technical\nrisks,\nthe\nfollowing recommendations can be made:\n•\nIn\ngeneral,\nimplant\nreconstructions\nshould\nbe\nplanned to minimize mechanical/technical risks.\n•\nPatients receiving implant therapy should receive\nregular maintenance care in order to detect mechanical/\ntechnical complications early, particularly in patients\nwith overdentures.\n•\nBoth\ncemented\nand\nscrew-retained\nimplant-\nsupported reconstructions can be recommended.\n•\nPatients should be evaluated for bruxism.\nLocal risk factors\nClinical recommendations\nWith respect to local risk factors, the following\nrecommendation can be made:\n•\nSpecial care should be taken in selection of implant\ndiameter and design in areas with limited interdental\nspace.\n2.1.2 Proceedings of the 5th ITI Consensus Conference\n2013\nInternational\nJournal\nof\nOral\nand\nMaxillofacial\nImplants\n2014,\nVol.\n29\n(Supplement):\nConsensus\nstatements and clinical recommendations for prevention\n44"
  },
  {
    "page": 45,
    "content": "and management of biologic and technical implant\ncomplications (Heitz-Mayfield and coworkers 2014)\nIntroductory remarks\nImplant treatment is highly successful, as documented\nin a wealth of scientific literature. However, patients\nand clinicians should expect to see complications within\ntheir daily practice. The aim of the papers presented by\nthis\ngroup\nwas\nto\naddress\nthe\nprevention\nand\nmanagement of technical and biologic complications in\norder to make recommendations both for clinical\npractice and future research. Three topics were chosen\nwithin the field of complications of implant treatment,\nand these addressed prevention and therapy of peri-\nimplant\ndisease\nand\nprevention\nof\ntechnical\ncomplications.\nThree systematic reviews were conducted and formed\nthe basis for discussion of working group 5. The\ndiscussions led to the development of statements and\nrecommendations determined by group consensus based\non the findings of the systematic reviews. These were\nthen presented and accepted following modifications as\nnecessary at plenary sessions.\nEffects\nof\nanti-infective\npreventive\nmeasures\non\nbiologic implant complications and implant loss\nConsensus statements\nThe aim of the review by Salvi and Zitzmann (2014)\nwas to systematically appraise whether anti-infective\n45"
  },
  {
    "page": 46,
    "content": "protocols are effective in preventing biologic implant\ncomplications and implant loss after a mean observation\nperiod of at least ten years following delivery of the\nprosthesis. Out of fifteen included studies, only one\ncomparative study assessed the effects of adherence to\nsupportive periodontal therapy (SPT) on the occurrence\nof biological complications and implant loss. In view of\nthe lack of randomized trails, observational studies\nincluding adherence and lack of adherence to SPT were\nconsidered valuable in order to estimate the effects of\nSPT on implant longevity and the occurrence of\nbiological complications.\n•\nOverall, the outcomes of this systematic review\nindicated that high long-term survival and success rates\nof dental implants can be achieved in partially and fully\nedentulous patients adhering to supportive periodontal\ntherapy (SPT).\n•\nLong-term implant survival and success rates are\nlower in patients with a history of periodontal disease\nadhering to SPT compared with those without a history\nof periodontal disease.\n•\nThe findings of this systematic review indicate that\npre-existing peri-implant mucositis in conjunction with\nlack of adherence to SPT was associated with a higher\nincidence of peri-implantitis.\nTreatment guidelines\nPreventive measures before implant placement\n46"
  },
  {
    "page": 47,
    "content": "•\nResidual periodontal pockets are a risk for peri-\nimplant disease and implant loss. Therefore, completion\nof active periodontal therapy aiming for elimination of\nresidual pockets with bleeding on probing should\nprecede\nimplant\nplacement\nin\nperiodontally\ncompromised patients.\n•\nIn cases of residual probing depths (PD) ≥5 mm\nwith concomitant bleeding on probing, full-mouth\nplaque scores > 20%, and associated risk factors, re-\ntreatment\nand\nperiodontal\nreevaluation\nare\nrecommended before implant placement.\n•\nIn subjects diagnosed with aggressive periodontitis,\nan SPT program with shorter intervals is a prerequisite.\n•\nDuring implant treatment planning, factors to be\nconsidered that may result in biological complications\ninclude: insufficient keratinized mucosa and bone\nvolume at the implant recipient site, implant proximity,\nthree-dimensional implant position, and design and\ncleansability of the prosthesis. Alternative restorative\nsolutions should be considered according to a patient’s\nindividual circumstances.\nPreventive measures after implant placement\n•\nAll\noral\nhealthcare\nproviders,\nincluding\nundergraduate students, should be trained to recognize\nclinical signs of peri-implant pathology and maintain or\nreestablish peri-implant health.\n47"
  },
  {
    "page": 48,
    "content": "•\nAfter delivery of the definitive implant-supported\nprosthesis,\nclinical\nand\nradiographic\nbaseline\nmeasurements should be established.\n•\nDuring SPT, an update of medical and dental history\nand a clinical inspection of the implant-supported\nprosthesis including the evaluation of iatrogenic factors\n(e.g. cement remnants, misfit of prosthesis, implant\nproximity with insufficient access for interproximal oral\nhygiene) should constitute the basis of a proper\ndiagnostic process.\n•\nRegular diagnostic monitoring of the peri-implant\ntissues includes assessment of presence of plaque,\nprobing\ndepth\n(PD),\nbleeding\non\ngentle\nprobing\n(approx. 0.25 N), and/or suppuration.\n•\nChanges in PD from a fixed landmark should be\nassessed\nregularly\nand\ncompared\nto\nprevious\nexaminations.\n•\nIn the presence of clinical signs of disease, an\nappropriate radiograph is indicated in order to detect\nradiographic bone-level changes compared to previous\nexaminations.\n•\nA diagnosis of peri-implant health is given in the\nabsence of clinical signs of inflammation. A recall\nfrequency of at least once per year is recommended\nunless systemic and/or local conditions require more\nfrequent intervals. In cases of peri-implant health,\nprofessional cleaning including reinforcement of self-\n48"
  },
  {
    "page": 49,
    "content": "performed oral hygiene is recommended as a preventive\nmeasure.\n•\nA diagnosis of peri-implant mucositis is given in the\npresence of individual clinical signs of soft tissue\ninflammation (e.g. redness, edema, suppuration) and\nbleeding on gentle probing. If mucositis is diagnosed, in\naddition\nto\nreinforcement\nof\nself-performed\noral\nhygiene, mechanical debridement with or without\nantiseptics (e.g. chlorhexidine) is delivered. The use of\nsystemic antibiotics for the treatment of peri-implant\nmucositis is not justified. Therapy of peri-implant\nmucositis should be considered as a preventive measure\nfor the onset of peri-implantitis.\n•\nA diagnosis of peri-implantitis is given in the\npresence of mucositis in conjunction with progressive\ncrestal bone loss. When peri-implantitis is diagnosed,\nearly\nimplementation\nof\nappropriate\ntherapy\nis\nrecommended to prevent further progression of the\ndisease.\nTherapy of peri-implantitis\nConsensus statements\nThe focused question for the review by Heitz-Mayfield\nand\nMombelli\n(2014)\nwas:\nIn\npatients\nwith\nosseointegrated\nimplants\ndiagnosed\nwith\nperi-\nimplantitis, how successful is treatment aimed at\nresolution of the disease?\n49"
  },
  {
    "page": 50,
    "content": "Currently, there is no standard of care for treating peri-\nimplantitis. Various clinical protocols for treating peri-\nimplantitis have been proposed, including mechanical\ndebridement, the use of antiseptics and local and\nsystemic\nantibiotics,\nas\nwell\nas\nsurgical\nand\nregenerative\nprocedures.\nIn\nview\nof\nthe\nlack\nof\ncomparable randomized controlled trials (RCTs), this\nreview has taken a broader approach to capture as many\nrelevant studies as possible, including randomized and\nobservational studies, but with consideration to the\nstrengths and limitations of the included research.\nThe ideal goal of the treatment of peri-implantitis would\nbe the resolution of disease, i.e. no suppuration or\nbleeding on probing, no further bone loss, and the re-\nestablishment and maintenance of healthy peri-implant\ntissues. A composite outcome to reflect this would\ninclude absence of peri-implant PD ≥5 mm with\nconcomitant bleeding on probing and no suppuration, in\naddition to no further bone loss. If these criteria are met,\nit can be assumed that no further intervention other than\nnonsurgical maintenance care would be required, and\nthe treatment outcome would therefore be regarded as\nsuccessful.\nUnfortunately\nthese\ndata\nwere\nrarely\nreported in the literature and therefore a compromise\ncomposite criterion for successful treatment outcome\nwas employed, i.e. implant survival with mean PD < 5\nmm and no further bone loss. Although there is no\nconsensus in the literature on whether a 5-mm peri-\nimplant PD alone represents health or disease, this\nthreshold was adopted for the purposes of the review.\nThis review was based on 33 studies reported in 43\npapers including case-series of at least 5 patients treated\n50"
  },
  {
    "page": 51,
    "content": "with the same protocol and comparative studies. No\nstudies were found comparing surgical and nonsurgical\nprotocols. Based on this literature, the following\nconclusions were drawn:\n1. The\ncase\ndefinition\nof\nperi-implantitis\nremains\nunclear and varies substantially between studies.\n2. There is a great variety of treatment protocols for\nboth nonsurgical and surgical treatment.\na. Nonsurgical therapy included: debridement with\nhand and powered instruments, air-powder abrasive\ndevices,\nlaser\ntreatment,\nand\nlocal\nand\nsystemic\nantimicrobial agents.\nb. Surgical\ntherapy\nincluded:\nelevation\nof\na\nmucoperiosteal flap and removal of granulation tissue\nto gain access to the implant and defect surfaces,\ndecontamination\nof\nthe\nimplant\nsurface\n(various\ntechniques)\nwith\nor\nwithout\nimplant\nsurface\nmodification. Some studies also evaluated resective\ntherapy or a variety of regenerative procedures. The\nmajority of the studies employed systemic antimicrobial\nadministration.\n3. The\nfollowing\nelements\nare\ncommon\nto\nmost\nprotocols for peri-implantitis therapy:\na. Pretreatment phase including establishment of good\noral hygiene.\n51"
  },
  {
    "page": 52,
    "content": "b. Anti-infective treatment including implant surface\ncleaning achieved by nonsurgical/surgical access.\nc. Supportive maintenance care.\n4. The\navailable\nevidence\ndoes\nnot\nallow\nrecommendation of specific treatment options for peri-\nimplantitis.\nHowever,\nimprovement\nof\nclinical\nparameters was reported for the majority of patients,\nalthough complete resolution according to a composite\nsuccess criterion was not usually achieved for all\npatients. Favorable short-term outcomes were reported\nin many studies; however, lack of disease resolution as\nwell as progression or recurrence of disease and implant\nloss, despite treatment, were also reported.\n5. Interpretation of the results of studies is complicated\nby unclear or high risk of bias, heterogeneity of study\ndesign, and difficulty of generalizing outcomes to\npractice settings due to frequent exclusion of patients\nwho smoke, those with poorly controlled diabetes, and\nother conditions that may affect clinical outcomes.\n6. There are no data investigating patient-reported\noutcomes and economic analysis of therapy.\n7. Peri-implantitis therapy was associated with soft-\ntissue recession, which was most evident following\nsurgical treatment. Postsurgery complications including\nmembrane exposure and infection were also reported.\nTreatment guidelines\n52"
  },
  {
    "page": 53,
    "content": "1. As peri-implantitis is an infection associated with the\npresence of a submucosal bacterial biofilm around\nimplants, the primary goal of therapy must be the\nresolution of the infection, which is achieved by the\ndisruption of the biofilm, the removal of calculus and/or\noverhanging restoration margins, and the prevention of\nrecurrence of the disease.\n2. It is important to try to establish if iatrogenic or other\nfactors have contributed to the infection, for example\nill-fitting or noncleansable overcontoured prostheses,\nmalpositioned implants, or foreign bodies such as\nimpression\nmaterial\nor\nexcess\nluting\ncement.\nNoniatrogenic factors may include impacted dental\nfloss.\n3. The\nfollowing\nsequence\nof\ntreatment\nof\nperi-\nimplantitis is normally recommended.\na. Pretreatment phase including:\ni. Thorough assessment and diagnosis.\nii. Reduction of risk factors for peri-implantitis; in\nparticular poor oral hygiene, prostheses that prevent\nadequate\naccess\nfor\nplaque\ncontrol,\ntobacco\nuse,\npresence of periodontal diseases, and systemic diseases\nthat may predispose to peri-implant disease.\niii. If required, prosthesis removal and adjustment/\nreplacement.\n53"
  },
  {
    "page": 54,
    "content": "b. Nonsurgical\ndebridement\nfocused\non\nmaximal\nremoval of biofilm, with or without antimicrobials.\nc. Early reassessment of peri-implant heath; normally\nwithin one to two months\nd. Surgical access if resolution of peri-implantitis has\nnot been achieved. This should include:\ni. Full-thickness mucoperiosteal flaps and removal of\ngranulation tissue to allow thorough cleaning of the\nimplant surface.\nii. Thorough surface decontamination of the implant\nand restorative components. The following techniques\nhave been proposed: locally applied chemicals, gauze\nsoaked\nwith\nsaline\nor\nantiseptics,\nhand-powered\ninstruments,\nair-powder\nabrasives,\nEr-YAG\nlasers,\nphotodynamic\ntherapy,\nand\nimplant\nsurface\nmodification. There is no evidence for the superiority of\nany one approach.\niii. Surgical therapy might also include regenerative or\nresective approaches:\n1. Regenerative approaches include filling of the\nintraosseous peri-implant defect with a bone substitute/\ngraft/bioactive substance with or without a resorbable\nbarrier membrane. Defect morphology for regeneration\nwould normally require a contained defect. Submerged\nhealing might reduce the risk of membrane exposure.\nRe-establishment\nof\nosseointegration\nfollowing\ntreatment has not been demonstrated in humans.\n54"
  },
  {
    "page": 55,
    "content": "2. Resective approaches include osseous recontouring\nwith apical positioning of the flap.\niv. Immediate\npostoperative\nanti-infective\nprotocol\nshould include daily chlorhexidine rinsing during the\nhealing period until mechanical oral hygiene can be\nresumed. In the absence of evidence comparing surgical\ntreatment\nwith\nor\nwithout\nantibiotics,\nperi-\nor\npostoperative systemic antibiotics are recommended in\nview of the aggressive nature of disease. Professional\nsupport of healing and plaque control will be needed\nduring this phase.\ne. Clinical monitoring should be performed on a\nregular\nbasis\nand\nsupplemented\nby\nappropriate\nradiographic\nevaluation\nas\nrequired.\nSupportive\nmaintenance\ntherapy\nincluding\nreinforcement\nof\neffective oral hygiene and professional biofilm removal\nshould be provided on a frequency determined by oral\nhealth and the risk profile, likely to be between every\nthree to six months.\n4. Surgical access is likely to be needed for the majority\nof deep lesions due to the difficulty of accessing the\nthreads and surfaces of the implant.\n5. The patient should be advised that:\na. Recession of the peri-implant mucosa should be\nexpected\nfollowing\nperi-implantitis\ntreatment,\nin\nparticular after surgical therapy.\n55"
  },
  {
    "page": 56,
    "content": "b. Progression or recurrence of disease might require\nadditional therapy or implant removal.\n6. The clinician should consider implant removal as a\ntreatment option. Factors influencing this decision may\ninclude the severity of the peri-implantitis lesion, the\nposition of the implant, the surrounding tissues, or when\nthe treatment outcomes are likely to be unsatisfactory.\n7. Referral to specialist care for non-responding peri-\nimplantitis should be considered.\n8. Regular\nassessment\nof\nperi-implant\nhealth\nis\nrecommended during SPT to identify disease at an early\nstage.\n9. Training of dental team professionals should include\ndiagnosis and management of peri-implant disease.\nSurvival rates of implant-supported fixed prostheses\nover the last decades\nConsensus statements\nThe systematic review by Pjetursson and coworkers\n(2014) was conducted to compare the survival and\ncomplication rates of implant-supported prostheses\npublished up to the year 2000 with those reported in\nstudies published after the year 2000. An association\nbetween period of publication and fixed implant-\nsupported prosthesis outcomes was found with higher\nsurvival rates and overall lower rates of mechanical and\ntechnical complication reported in more recent clinical\n56"
  },
  {
    "page": 57,
    "content": "studies. However, the incidence of reported technical\ncomplications is still high. The difference in survival\nrates are most evident for screw-retained prostheses,\nwhere the reported survival rate of 77.6% in the older\npublications was increased to 96.8% in the more recent\nones.\nTreatment Guidelines\nRisk of fracture—implants\n1. Implant fracture is a rare complication. To avoid\nimplant fracture it is recommended that clinicians\nconsider\nthe\nuse\nof\nappropriately\ndesigned\nand\nmanufactured implants with properly investigated and\ndocumented low fracture rates. Similarly, the clinician\nshould use implants manufactured from materials that\nhave been thoroughly investigated.\n2. The risk of implant fracture can be considered\nextremely low when:\na. The appropriate distribution, number, and diameter\nof implants are used.\nb. Implants are placed using a restoratively driven\nprotocol.\nc. Implants are combined with an adequately fitting\nprosthesis\nRisk of fracture and/or loosening—prosthetic screws\n57"
  },
  {
    "page": 58,
    "content": "Fracture of manufacturer screws made to specified\ntolerances\ncan\nbe\ninfluenced\nby\nthree\nfactors:\nmishandling, misfit, and occlusal forces.\n1. Mishandling: To reduce the risk of fracture of\nprosthetic screws, it is recommended that a clinician\nfollow the manufacturer’s instructions for use.\n2. Misfit: An inadequately fitting framework may be a\npredisposing factor to prosthetic screw fracture or\nloosening. It is recommended to prioritize evaluation of\nthe accuracy of the interface between the machined\nhead of the screw and its seating surface over the entire\narea of contact to reduce the risk of loosening and\nfracture.\n3. Occlusal forces, usually in the presence of other\npredisposing factors, misfit, and mishandling, may lead\nto prosthetic screw fracture or loosening.\nRisk of fracture and/or loosening—abutments\n1. It\nis\nrecommended\nthat\nthe\nclinician\ncarefully\nevaluate the differential etiology of screw loosening, as\nthe literature does not differentiate sufficiently between\nabutment or prosthetic screw loosening to conclude\nwhich type of screw is more likely to loosen.\n2. Metal abutment fracture is a rare complication.\nGreater caution is advised with ceramic abutments. It is\nrecommended\nthat\nthe\nspecific\nmaterial-based\nrequirements of ceramics should be respected when\nchoosing, designing, and handling these abutments.\n58"
  },
  {
    "page": 59,
    "content": "Risk of fracture of framework and/or veneering\nmaterials\n1. Currently framework fracture is a rare complication.\nThe choice of material, appropriate design, and method\nof fabrication are all factors in reducing the risk of\nframework fracture.\n2. To reduce the risk of fracturing the veneering\nmaterials,\nthe\nframework\nmust\nprovide\nadequate\nsupport for the veneering ceramic or resin in order to\navoid excessive thickness of the veneering material.\n3. When\nchoosing\nthe\nmaterial\nand\ndetermining\nframework design, it is recommended that the final\ncontour of the definitive prosthesis be visualized prior\nto framework fabrication.\n4. Scheduled regular maintenance appointments should\ninclude a careful occlusal review. It is recommended\nthat clinicians undertake any required adjustments to\nthe prosthesis, inclusive of meticulous polishing of\nworn ceramic surfaces, to reduce the risk of fracturing\nof the veneer material.\nQuality assurance\nIt is recommended that clinicians, technicians, and\nmanufacturers employ a tracking system for implants\nand restorative components. Clinicians should be aware\nthat not all implant systems have the same level of\ndocumentation. The clinician should be aware of the\norigin of the components used.\n59"
  },
  {
    "page": 60,
    "content": "2.2 Literature Review:\nBiological Complications\nL. J. A. Heitz-Mayfield\nIn earlier longitudinal studies reporting on outcomes of\nimplant-supported\nprostheses,\nthe\nfocus\nwas\npredominately\non\nimplant\nsurvival.\nIn\nmany\npublications, information regarding the occurrence and\nnature of both technical and biological complications\nassociated with the implant or the prosthesis was not\nreported (Berglundh and coworkers 2002).\nIn 2002, Berglundh and coworkers published the first\nsystematic\nreview\naddressing\nthe\nincidence\nof\nbiological\nand\ntechnical\ncomplications\nin\nimplant\ndentistry, reporting on prospective longitudinal studies\nof at least a five-year duration. They included 51 studies\nin a meta-analysis, and reported a higher incidence of\nsoft tissue complications for patients treated with\nimplants\nsupporting\noverdentures\nthan\nfor\nfixed\nprostheses. They found that most studies reported only\non implant loss, while biological complications were\nconsidered in only 40% to 60% of the studies and\ntechnical (hardware) complications in only 60% to 80%\nof the studies. The authors concluded that the incidence\nof biological and technical complications was likely\nunderestimated.\nFurthermore, where reported, biological complications\nassociated with osseointegrated dental implants were\ndescribed using a wide range of terms including;\nimplant loss, peri-implantitis, bone loss, soft-tissue\n60"
  },
  {
    "page": 61,
    "content": "hyperplasia,\nmucosal\novergrowth,\nand\nsoft-tissue\ncomplications. The inconsistencies in the terminology\nused have made it difficult to interpret data from these\nstudies relating to the incidence or prevalence of these\ncomplications.\nPjetursson and coworkers as well as other authors have\npublished a series of systematic reviews focusing on the\nsurvival and complication rates of implant-supported\nprostheses after an observation period of at least five\nyears (Pjetursson and coworkers 2004; Jung and\ncoworkers\n2008;\nAglietta\nand\ncoworkers\n2009;\nPjetursson\nand\ncoworkers\n2012;\nPjetursson\nand\ncoworkers 2014). These systematic reviews indicate\nthat hardware complications occur approximately three\nto\nfour\ntimes\nmore\nfrequently\nthan\nbiological\ncomplications.\nWhen\nevaluating\nimplant-supported\nfixed partial dentures, 8.6% (95% CI: 5.1%–14.1%) of\nthem had had a biological complication after five years\n(Pjetursson and coworkers 2004). Jung and coworkers\n(2008) evaluated the biological complication rate of\nimplant-supported single crowns in longitudinal studies\nwith a mean follow-up of five years and found a five-\nyear cumulative soft-tissue complication rate of 7.1%\n(95% CI: 4.4%–11.3%), and a five-year cumulative\ncomplication rate for implants with bone loss > 2 mm of\n5.2% (95% CI: 3.1%–8.6%). A systematic review\nanalyzing\nthe\nsurvival\nand\ncomplication\nrates\nof\nimplant-supported\nfixed\ndental\nprostheses\nwith\ncantilever extensions found the five year estimates for\nperi-implantitis\nwere\n5.4%\n(95%\nCI:\n2%–14.2%)\n(Aglietta and coworkers 2009).\n61"
  },
  {
    "page": 62,
    "content": "At the First European Workshop on Periodontology in\n1993, the terms peri-implant mucositis and peri-\nimplantitis were clearly defined. Peri-implant mucositis\nwas defined\nas inflammation\nof the peri-implant\nmucosa, and peri-implantitis as inflammation of the\nperi-implant mucosa in addition to loss of supporting\nbone\n(Albrektsson\nand\nIsidor\n1994).\nRecent\npublications have used these definitions, resulting in a\nclearer insight into the prevalence and incidence of\nthese biological complications.\nCross-sectional studies are valuable for determining the\nprevalence of biological complications in individuals\nwith implant-supported prostheses. In recent years, a\nnumber of these studies have been published with the\naim of determining the proportion of subjects within a\npopulation\nwith\nperi-implant\nmucositis\nand\nperi-\nimplantitis.\nMombelli and coworkers (2012) published a review\nfocused on the epidemiology of peri-implantitis. Based\non the data from 23 studies reporting information on the\npresence of signs of peri-implantitis in populations of at\nleast\n20\nimplant\ncases,\nthey\nsuggested\nthat\nthe\nprevalence of peri-implantitis is in the order of 10% of\nimplants and 20% of patients during a five- to ten-year\nperiod after implant placement.\nA subsequent systematic review and meta-analysis\nincluding 9 studies with 1,497 participants and 6,283\nimplants reported summary estimates of 63.4% of\nparticipants for the frequency of peri-implant mucositis\n62"
  },
  {
    "page": 63,
    "content": "and 18.8% of participants for the frequency of peri-\nimplantitis (Atieh and coworkers 2013).\nThere has, however, been great variation in reported\nprevalence data for peri-implantitis with some authors\nreporting a lower prevalence in the order of 1.8% - 10%\nof subjects over a ten-year period (Buser and coworkers\n2012; Cecchinato and coworkers 2013).\nOne of the difficulties in determining the prevalence of\nperi-implantitis is that authors use different bone-loss\nthresholds to define a case of peri-implantitis. One\nexample illustrating this is described in a study from\nThe University of Oslo, Norway, where a group of 109\nsubjects who had received dental implants between\n1990 and 2005 were clinically and radiographically\nexamined a mean of eight years after restoration of the\nimplants. The prevalence of peri-implantitis depended\non\nthe\nbone\nloss\nthresholds\nand\nprobing-depth\nthresholds used. The prevalence of peri-implantitis was:\n47.1% of subjects when defined as inflammation and\ndetectable bone loss; 20.1% of subjects when defined as\nbleeding on probing at peri-implant pockets ≥4 mm\nwith bone loss ≥2 mm; and 11.7% of subjects when\ndefined as bleeding on probing at peri-implant pockets\n≥4 mm with bone loss ≥3 mm (Koldsland and\ncoworkers 2010). Obviously, the prevalence of peri-\nimplantitis will depend on the thresholds and definition\nused. In addition the prevalence of peri-implantitis is\nalso\nlikely\nrelated\nto\nthe\nsubjects\nwithin\nthe\nconvenience sample examined. Factors including the\nskill of the treating clinician, the proportion of smokers\nor periodontal patients within the population, and the\n63"
  },
  {
    "page": 64,
    "content": "frequency and nature of the supportive care program\nwill have an impact on the prevalence of peri-implant\nmucositis and peri-implantitis.\nAs the use of dental implants increases worldwide, it is\nlikely that the prevalence of biological complications\nwill also increase. Clinicians need to be aware of the\nprocedures for management and prevention of these\ncomplications outlined in this Treatment Guide volume.\n2.3 Literature Review:\nHardware Complications and Failures\nU. Brägger\n2.3.1 Mechanical and Technical Risks\nA literature review was prepared for the ITI Consensus\nConference in Stuttgart to identify mechanical and\ntechnical risks for implant-supported reconstructions\n(Salvi and Brägger 2009). Ten conditions with a\npotential impact on the integrity of implant-supported\nreconstructions and their prosthetic components were\nidentified after searching the literature:\n•\nType of retentive elements supporting overdentures\n•\nPresence of cantilever extension(s)\n•\nCemented versus screw-retained reconstruction\n•\nAngled/angulated abutments\n64"
  },
  {
    "page": 65,
    "content": "•\nBruxism\n•\nCrown/implant ratio\n•\nLength of the superstructure\n•\nProsthetic materials\n•\nNumber of implants supporting a fixed dental\nprosthesis (FDP)\n•\nHistory of mechanical/technical complications\nA total of 35 clinical reports compared the events\nobserved over at least four years with or without these\npotential risk conditions.\nRegarding overdentures, it was found that, independent\nof the retention elements, patients required multiple\nprosthetic\nmaintenance.\nTechnical/mechanical\ncomplications\noccurred\nmore\nfrequently\nwith\nball\nretainers than with bars. Retention was perceived to be\nbetter with bars compared to ball retainers; the lowest\nretention was found for magnets. Metal frameworks\nwere recommended to reduce the observed rate of resin\nbody fractures where no framework was present.\nWhen short FDP with or without cantilevers were\nfollowed\nwithin\nthe\nsame\nstudy\npopulation,\nno\ndifference\nin\nthe\nrate\nof\ntechnical/mechanical\ncomplications\nwas\ndocumented.\nIn\none\nstudy,\ncantilevers exceeding 15 mm in length were associated\n65"
  },
  {
    "page": 66,
    "content": "with a high risk of framework fracture and, therefore,\nremakes of full-arch reconstructions.\nThe few studies that compared cemented and screw-\nretained crowns and short FDP did not indicate an\nincreased risk. Similarly, the available data did not\nindicate\nan\nincreased\nrisk\nfor\nreconstructions\non\nangulated versus straight abutments.\nAn unfavorable crown-to-root ratio has traditionally\nbeen perceived as a risk factor for implant loss. There\nwas, however, no evidence to be found in the literature\nthat the ratio of crown height versus osseointegrated\nimplant length would determine the incidence of\ncomplications\nor\nfailures.\nHowever,\nsmaller\nreconstructions were more prone to complications than\nextended\nones.\nReconstructions\nwith\nprevious\ncomplications\nor\nmultiple\ncomplications\ndid\ndemonstrate a higher risk for the definitive mechanical/\ntechnical failure, especially—and significantly more\nfrequently—in bruxers (patients with attrition). One\nstudy also reported more chipping on veneered titanium\nversus gold frameworks.\nOne of the main findings of this review was that the 10\nfactors examined did not affect the integration of the\nimplant or the crestal bone height.\nThe small number of papers included and the quality of\nthe data presentation available at the time did not allow\na pooled statistical analysis in terms of a meta-analysis.\n66"
  },
  {
    "page": 67,
    "content": "2.3.2 Effect of Improved Components on Complications\nand Failure Rates\nIn 2013, at the most recent ITI Consensus Conference\nheld in Bern, Switzerland, a major focus was on\nconsensus statements and recommendations for clinical\nprocedures\nregarding\nprosthetic\nmaterials\nand\nproduction processes.\nIt was assumed that the continuous improvement of\nprosthetic components would result in better survival\nand success rates for implant-supported reconstructions.\nOne way to assess any such improvement would be to\ncompare event rates reported in older and newer\npublications (Pjetursson and coworkers 2014)\nThe year 2000 was chosen as a cut-off, and results from\n31 older studies were compared to data from 108 more\nrecent studies. Estimated five-year survival rates for\ncemented reconstructions increased from 95.2% to\n97.9%, for screw-retained reconstructions from 77.6%\nto 96.8%.\nThe survival rates for implant-supported single crowns\nincreased from 92.6% to 97.2%, for FDP from 93.5% to\n96.4%.\nIn the older studies, annual rates for screw loosening\nranged from 0.79% to 6.08%. This means that after five\nyears, 3.9% to 26.2% of the reconstructions were\naffected. The more recent studies reported event rates\nbetween 0.62% and 2.29%, affecting between 3.6% and\n10.8% of the reconstructions at five years.\n67"
  },
  {
    "page": 68,
    "content": "Annual rates for abutment screw fractures ranged from\n0.16% to 0.44% (0.8%–2.2% at five years) in the older\npublications. This was reduced to 0% to 1.2% (0%\n–5.8% at five years) in the more recent studies.\nFractures of the veneering material ranged from 0.25%\nto 4.28% per year in the older studies but remained high\nat 0.64% to 5.82% per year in the more recent studies.\nThe rates for implant and framework fractures and for\nloss of retention did not change significantly.\nThe total incidence of technical complications reported\nranged from 2.32% to 10.46% per year in the older\nstudies and even higher, with 3.55% to 15.19%, in the\nmore recent studies.\nWhile the survival rates of the reconstructions were\nincreased\nand\nthe\nabutment-related\nfailures/\ncomplications\nwere\nreduced\nconsiderably,\nveneer\nchipping and total events seemed to have increased,\naccording to newer publications.\nThis could be explained by an increased awareness on\nthe part of clinical researchers for the need to report in\ndetail\nall\nevents\nrelated\nto\nthe\nquality\nof\nthe\nsuperstructure\nand\nthe\ncomponents\nrather\nthan\nconcentrating on implant survival and changes in bone\nlevel.\n2.3.3 Complication and Failure Rates with Cemented\nversus Screw-retained Reconstructions\n68"
  },
  {
    "page": 69,
    "content": "One of the systematic reviews prepared for the 2013 ITI\nConsensus\nConference\nfocused\non\nthe\nclinical\nperformance of screw-retained versus cemented fixed\nimplant-supported\nreconstructions\n(Wittneben\nand\nMillen 2014). A thorough search identified 4,324 titles\nof\npublications.\nUltimately,\n73\npublications\nwere\nincluded for analysis. The number of publications and\nthe quality of the data presentation allowed a pooled\nanalysis\nand\na\nrandom-effect\nPoisson\nregression\nanalysis when several studies were summarized.\nEstimated failure rates and the weights of all included\nstudies\nrelated\nto\ncemented\nand\nscrew-retained\nreconstructions\nwere\npresented\nbased\non\n5,858\nreconstructions observed over a mean observation\nperiod of 5.4 years.\nOf these, 59% were screw-retained, while 41% were\ncemented. Grouping into single crowns, shorter FDP,\nand full-arch FDP did not reveal any significant\ndifference in failure rates between cemented and screw-\nretained reconstructions.\nWhen the material was considered, the cemented all-\nceramic crowns revealed higher failure rates than metal-\nceramic crowns. A similar difference was not found for\nthe screw-retained implant crowns.\nTechnical complications as a whole occurred more\nfrequently with cemented reconstructions than with\nscrew-retained reconstructions. “Loss of retention” and\n“screw\nloosening”\nas\nseparate\nevents\nwere\nalso\nsignificantly\nmore\nfrequent\nwith\ncemented\n69"
  },
  {
    "page": 70,
    "content": "reconstructions, while “ceramic chipping” was more\nfrequent in the screw-retained ones.\nAs far as biological complications are concerned, the\npresence of fistulas/suppuration\n*\nwas\nmore\nfrequently\nobserved\nwith\ncemented\nrestorations.\nOverall,\nbiological\nevents\nwere\nsignificantly more frequent with cemented prostheses.\n2.3.4 Complication and Failure Rates with Metal versus\nCeramic Abutments\nA third systematic review focused specifically on the\nsurvival and success rates of abutments (Zembic and\ncoworkers 2014). The search returned 24 publications\n(1996–2012) for data extraction.\nThree\nrandomized\nclinical\ntrials\npresented\ndata\ncomparing zirconia versus titanium, alumina versus\ntitanium, and titanium versus gold abutments.\nComponents from eight commercially available implant\nsystems were involved, with external and internal\nconnections.\nHowever, of the total 2,186 abutments analyzed, only\n134 were ceramic abutments. The mean observation\nperiod was 5.5 years.\nThe quality of the data presentation and the number of\npublications allowed the pooled calculation of event\nrates per 100 objects per year. Ceramic abutments\nsurvived at 97.5% at five years; metal abutments, at\n70"
  },
  {
    "page": 71,
    "content": "97.6%. The estimated rate of mechanical complications\nwas 8.9% for ceramic abutments and 12.0% for metal\nabutments.\nThe percentage of technical complications was 1.3\ntimes higher for implants with external connections.\nEight studies also reported on incorrect fit affecting 1\nceramic and 19 metal abutments (20 out of 2,186\nimplant-abutment connections).\n2.3.5 State of the Art of CAD/CAM-assisted Production\nof Implant-supported Reconstructions\nThe fourth systematic review covered the available\nevidence to support the use of computer-aided design/\ncomputer-aided\nmanufacturing\n(CAD/CAM)\ntechnology for the production of custom prosthetic\ncomponents and frameworks (bars) (Kapos and Evans\n2014). Of the seventeen publications included, two\nreported on CAD/CAM crowns, six on implant CAD/\nCAM abutments, and nine on implant-supported CAD/\nCAM frameworks.\nThe short-term survival rates were high for CAD/CAM\nsingle crowns, with no failure reported in one study\nwith 24 crowns and only 1 out of 75 crowns that had to\nbe remade in another study.\nThe short-term survival of CAD/CAM individualized\nabutments was also high, with no failed abutments in\nfour studies and 1 out of 58 and 3 out of 40 abutment\nfailures in two other studies.\n71"
  },
  {
    "page": 72,
    "content": "The\ndata\non\nCAD/CAM\nframeworks\nincluded\nobservation times between 24 and 120 months. One\nstudy reported 5 out of 26 framework failures; another\nstudy reported 2 out of 67 framework failures. A third\nstudy reported 5 out of 66 framework failures. No\nfailures were reported in four studies; one study did not\ncomment on prosthetic survival.\nIn addition to the failures, a rather high incidence of\nchipping\nwas\nreported\nfor\nat\nleast\nfour\nstudies\nconsidering\ncomplications,\nwhereas\nfour\nstudies\nreported no technical complications and one study\nfocused on bars only.\nIn summary, this implies that the availability of CAD/\nCAM technology has not eliminated the risks for\nhardware-related complications.\n2.3.6 Overdentures\nSeveral systematic reviews have explored the prosthetic\nmaintenance needs for implant-supported overdentures.\nThe most frequent hardware-related problems reported\nare associated with the activation or replacement of\npatrix-matrix components, as well as maintenance\nrequired for the overdenture or restorations in the\nopposing jaw.\nA time-dependent analysis of reported maintenance\nwith\nimplant-supported\noverdentures\nresulted\nin\ncontinuous rates for the maxilla and the mandible\n72"
  },
  {
    "page": 73,
    "content": "during year 1, between years 1 and 5, and after year 5\n(Cehreli and coworkers 2010).\nIt was also found that the type of the attachment system\ndid not have an effect on the prosthetic outcome with\nthe overdenture (Cehreli and coworkers 2010).\nThis review was based on 49 clinical studies and listed\nhardware-related events including: patrix loosening;\npatrix activation; patrix replacement; patrix fracture;\ndislodged, worn or loose matrix or housing; matrix\nactivation; matrix replacement; matrix fracture; fracture\nof the implant-supported overdenture; fracture of the\nacrylic above a patrix; fractured denture teeth; relining\nof\nimplant\noverdentures;\nfabrication\nof\na\nnew\noverdenture.\nThe evaluation of pooled data from several clinical\nstudies yields weak conclusions. When analyzing the\ndata, it becomes obvious that there is always a range of\nobserved\ncomplication\nrates.\nTherefore,\nfewer\ncomplications did occur in some patient groups, and the\nprocedures and components yielding the best outcomes\nshould be identified and applied.\nA significant piece of information is that the inclination\nof\nthe\nimplants\nhad\nan\nadverse\ninfluence\non\nprosthodontic maintenance. Not least for the prevention\nof\noverdenture-related\ncomplications,\nprosthetically\ndriven implant placement is needed (Walton and\ncoworkers 2001).\n73"
  },
  {
    "page": 74,
    "content": "Whereas\nthe\nreported\nsurvival\nrates\nof\nimplant-\nsupported overdentures are very high, a substantial\nnumber of maintenance visits are required and time\nneeds to be invested during the years following the\ninsertion of overdentures.\nA regular maintenance schedule is recommended for\nearly detection of component wear, so that the affected\ncomponents can be replaced before extensive repairs\nare needed.\n2.3.7 Survival Rates of Reconstructions Obtained from\nSystematic Reviews\nNumerous systematic reviews have focused on the\nestimated survival and success rates expected with\ndifferent types of reconstructions.\nThe event rates per 100 reconstructions per year were\nretrieved from observed events and extrapolated to five\nor ten years’ exposure.\nThese estimated event rates were the basis for statistical\ncomparisons of the outcomes with various types of\nreconstructions.\nIn Figure 1, the expected prostheses survival rates of\nvarious tooth or implant-supported reconstructions were\nmarked graphically, based on the systematic reviews by\nAglietta and coworkers 2009, Harder and coworkers\n2009,\nHeydecke\nand\ncoworkers\n2012,\nJung\nand\ncoworkers 2008, Jung and coworkers 2012, Koller and\ncoworkers\n2011,\nLulic\nand\ncoworkers\n2007,\n74"
  },
  {
    "page": 75,
    "content": "Sunnegardh\nand\ncoworkers\n2012,\nPjetursson\nand\ncoworkers\n2004,\nPjetursson\nand\ncoworkers\n2007,\nPjetursson\nand\ncoworkers\n2008,\nPjetursson\nand\ncoworkers 2012, Rohlin and coworkers 2012, Romanos\nand coworkers 2012, Romeo and coworkers 2012,\nSailer and coworkers 2007, Sailer and coworkers 2012,\nSalinas and coworkers 2010, Schley and coworkers\n2010, Stavropolou and coworkers 2007, Tan and\ncoworkers 2004, van Heuman and coworkers 2009,\nWasseman\nand\ncoworkers\n2006,\nWittneben\nand\ncoworkers 2009, and Zurdo and coworkers 2009.\nFig 1 Survival rates of prostheses, obtained from\nsystematic reviews reporting on expected failure rates\nwith various types of tooth- and/or implant-supported\nreconstructions.\nThe overview demonstrates that failure rates increase\nwith time. Differences between the reconstructions can\nbe observed after only a brief exposure; and the range\n75"
  },
  {
    "page": 76,
    "content": "of the estimated failure rates increases drastically after\nlonger exposure periods.\nOne would like most patients to be found in the upper\nright corner of the graph; reality, however, tells a\ndifferent story.\nPatients, treatment providers, and insurance companies\nwill have to accept the fact that the incidence of\nprosthetic failures and complications is increasing. The\nsteepness of the progress depends on the type of\nreconstruction and is associated with patient-related and\nother risk factors.\nIt is therefore important to avoid and control as many\nrisk factors as possible during the treatment planning\nphase as well as during the production and insertion of\nimplant-supported reconstructions and their regular\nprophylactic maintenance.\nEvidence-based analyses of the literature as presented\nin this volume of the ITI Treatment Guide therefore\nhave a direct impact on clinical practice and feed\nknowledge into the clinical process.\n* In this book, to acknowledge the geographic usage of\nthe terms “fistula” and “draining sinus,” the authors and\ncontributors use both nomenclature based on the\nAmerical\nAssociation\nof\nEndodontists’\n(AAE)\ndefinitions and on the ITI’s Glossary of Oral and\nMaxillofacial Implants (ISBN-13: 978-3-938947-00-5).\n76"
  },
  {
    "page": 77,
    "content": "Nomenclature based on the American Association of\nEndodontists (AAE) definitions: Fistula: An abnormal\ncommunication pathway between two internal organs or\nfrom one epithelial-lined surface to another epithelial-\nlined surface; not a sinus tract. Sinus tract: A pathway\nfrom an enclosed area of infection to an epithelial\nsurface; the opening or stoma may be intraoral or\nextraoral and represents an orifice through which\npressure\nis\ndischarged;\nusually\ndisappears\nspontaneously with elimination of the causative factor\nby endodontic treatment.\nNomenclature based on the Glossary of Oral and\nMaxillofacial Implants: Fistula: Abnormal connection\nbetween two anatomic cavities or an anatomic cavity\nand the external body surface. They can form as a result\nof trauma, infection, or inflammation.\n77"
  },
  {
    "page": 78,
    "content": "2 Literature Review\nL. J. A. Heitz-Mayfield, U. Brägger\n78"
  },
  {
    "page": 79,
    "content": "3.1 Peri-implant Infections\nIn health, the peri-implant soft tissue forms a collar\naround the implant/abutment (or implant/prosthesis)\njunction. The peri-implant soft tissue consists of an\nepithelial component (keratinized oral epithelium and\nnon-keratinized\njunctional\nepithelium)\nand\na\nconnective-tissue component (Fig 1). The epithelium is\nseparated from the peri-implant marginal bone by\napproximately 1–1.5 mm of connective tissue. The\ncoronoapical dimension of the junctional epithelium is\napproximately\n2\nmm;\nhowever,\nthis\nmay\nvary\ndepending on factors including the depth of implant\nplacement, the soft-tissue phenotype, and the type of\nimplant-abutment connection. When the peri-implant\nmucosa is healthy there are no clinical signs of\ninflammation (i.e. no bleeding on gentle probing).\nFig 1 Schematic diagram illustrating a bone level\nimplant and the surrounding peri-implant tissues. (a)\n79"
  },
  {
    "page": 80,
    "content": "Epithelium (keratinized and non-keratinized barrier\nepithelium). (b) Connective tissue, (c) Marginal bone\ncrest.\n(d)\nImplant/prosthesis\njunction:\n(Left)\nPeri-\nimplant health. (Right) Peri-implant mucositis.\nFig 2 Schematic diagram of peri-implantitis (marginal\nbone loss and clinical signs of inflammation).\nOnce exposed to the oral cavity, microorganisms\nrapidly colonize the transmucosal part of the implant/\nabutment. In health, there is equilibrium between the\nbacterial challenge and the host response. The peri-\nimplant soft tissue may be considered as a barrier that\nprotects the zone of osseointegration from factors\nreleased from bacterial plaque and the oral cavity.\nPeri-implant infections (also referred to as peri-implant\ndiseases) are caused when an imbalance between the\nbacterial biofilm challenge and the host defense occurs,\nresulting in an inflammatory process.\n80"
  },
  {
    "page": 81,
    "content": "When there are clinical signs of inflammation of the\nperi-implant mucosa (bleeding on gentle probing, 0.25\nN) without the loss of supporting bone, the definition is\nperi-implant mucositis (Zitzmann and Berglundh 2008)\n(Fig 1).\nWhen there are clinical signs of inflammation (bleeding\non gentle probing, 0.25 N) in addition to loss of\nsupporting\nbone\nthe\ndefinition\nis\nperi-implantitis\n(Zitzmann and Berglundh 2008) (Fig 2).\nIn the case of peri-implantitis, probing depths greater\nthan 5 mm with suppuration and/or bleeding on probing\nare frequently present (Figs 3a-b).\nRecession of the peri-implant mucosa may also be\nassociated with peri-implant infections (Fig 4).\nFig 3a An implant diagnosed with peri-implantitis.\nDeep probing depth of 8 mm and suppuration on\nprobing.\n81"
  },
  {
    "page": 82,
    "content": "Fig 3b Periapical radiograph showing peri-implant bone\nloss associated with the same implant as in Fig 3a with\nthe\nprosthesis\nin\nplace.\nThe\nmarginal\nbone\nis\napproximately at the level of the eighth thread.\n82"
  },
  {
    "page": 83,
    "content": "Fig 4 Two implants diagnosed with peri-implantitis.\nRecession of the peri-implant mucosa and biofilm\nformation on the exposed implant threads.\n83"
  },
  {
    "page": 84,
    "content": "Fig 5 Plaque and calculus on the lingual surface of an\nimplant-supported prosthesis in the mandible, resulting\nin clinical signs of inflammation and peri-implant\nmucositis.\nFig 6 Calculus and biofilm at the implants at sites 41\nand 31, both of which are affected by peri-implantitis.\n3.1.1 Peri-implant Biofilms\n84"
  },
  {
    "page": 85,
    "content": "The\ncause-and-effect\nrelationship\nbetween\nbiofilm\nformation at implants and peri-implant mucositis has\nbeen clearly demonstrated in humans (Pontoriero and\ncoworkers 1994; Zitzmann and coworkers 2001; Salvi\nand coworkers 2012). In these studies, when oral\nhygiene was discontinued in order to allow undisturbed\nplaque accumulation, clinical signs of peri-implant\ninflammation (bleeding on probing) appeared after a\nfew days and resolved when oral hygiene was reinstated\n(Salvi and coworkers 2012).\nThe composition of peri-implant biofilms associated\nwith this inflammation, which may lead to further peri-\nimplant infection in a susceptible host, is influenced by\nthe local environment and is very similar to the\nmicrobiota on the remaining teeth in partially dentate\nsubjects. Therefore, subjects with untreated periodontal\ndisease, residual deep periodontal pockets, and/or poor\noral hygiene are at greater risk for the development of\nperi-implantitis (Costa and coworkers 2012; Heitz-\nMayfield and Huynh-Ba 2009; Ferreira and coworkers\n2006) (Figs 5 and 6).\nBiofilms associated with peri-implant infection (peri-\nimplant mucositis and peri-implantitis) have been\nstudied\nextensively\nusing\nvarious\nmicrobiological\ntechniques. The majority of studies has found the\ncomposition of the submucosal microbiota to be similar\nto that found in chronic periodontitis, with a mixed\nanaerobic\ninfection\ndominated\nby\nGram-negative\nbacteria. Some studies, however, have found high\nnumbers\nof\nother\nmicroorganisms\nnot\ncommonly\nassociated with periodontal disease, including enteric\n85"
  },
  {
    "page": 86,
    "content": "rods and yeasts, or microorganisms associated with\nextraoral\ninfections\nsuch\nas\nstaphylococci\n(Staphylococcus\naureus\nand\nStaphylococcus\nepidermidis)\nor\npeptostreptococci\n(Leonhardt\nand\ncoworkers 2003; Fürst and coworkers 2007; Persson\nand coworkers 2010). The microbiota associated with\nperi-implant mucositis appear to be similar to those\nassociated\nwith\nperi-implantitis\n(Máximo\nand\ncoworkers\n2009;\nCasado\nand\ncoworkers\n2011),\nsuggesting that supramucosal plaque formation and the\ndevelopment\nof\nperi-implant\nmucositis\nare\nthe\nprecursors to peri-implantitis.\nFig 7 Peri-implant infection (peri-implant mucositis)\nassociated with non-keratinized peri-implant mucosa,\ncaused by impaction of a food particle.\n86"
  },
  {
    "page": 87,
    "content": "Fig 8 Peri-implantitis associated with the middle\nimplant,\nwhere\nthe\nperi-implant\nmucosa\nis\nnon-\nkeratinized and movable.\n3.1.2 Risk Factors for Peri-implant Infection\nInadequate plaque control\nPoor oral hygiene or any factor that prevents adequate\nplaque control around implants can be considered a risk\nfor peri-implant infection (Ferreira and coworkers\n2006).\nInadequate width of keratinized peri-implant mucosa\nAn inadequate width of attached keratinized peri-\nimplant mucosa has been found to be associated with an\nincreased risk of peri-implant infection in some studies\n(Schrott and coworkers 2009; Lin and coworkers 2013;\nBrito and coworkers 2014). It is suggested that the lack\nof keratinized mucosa may compromise the ability to\n87"
  },
  {
    "page": 88,
    "content": "maintain an adequate plaque control. Furthermore,\nimpaction of food particles or foreign bodies may\noccur, causing an infection (Figs 7 and 8).\nFig 9 An implant placed too close to the adjacent tooth\nresulting in peri-implant infection.\nIatrogenic risk factors\nSurgical phase. Surgical-phase iatrogenic risk factors\nassociated\nwith\nperi-implant\ninfection\ninclude\nmalpositioned\nimplants\nand\ninadequate\ngrafting\ntechniques. Implants placed too close together, or too\nclose to neighboring teeth, do not allow adequate space\nfor oral hygiene procedures and plaque control (Fig 9)\n(Abi Nader and coworkers 2014).\nImplants\nshould\nbe\nplaced\nin\na\ncorrect\nthree-\ndimensional position with sufficient bone volume\n(minimum of 1 mm) surrounding the endosseous\nportion of the implant. If the implant is malpositioned\n88"
  },
  {
    "page": 89,
    "content": "and the endosseous portion of the implant is not\ncompletely surrounded by an adequate volume of bone,\nthe implant surface may become contaminated with a\nbiofilm, leading to infection and progressive peri-\nimplant bone loss.\nSimilarly, if bone augmentation procedures at the time\nof implant placement are unsuccessful and result in\nincomplete osseointegration of the implant, the implant\nsurface will be more easily contaminated with a biofilm\nif the peri-implant soft-tissue barrier is compromised\n(Fig 10).\nFig 10 Cone-beam CT scan. Absence of a facial bony\nwall at the implant, resulting from an unsuccessful bone\naugmentation procedure. Management of this case is\ndescribed in Chapter 9, case 9.2.1.\n89"
  },
  {
    "page": 90,
    "content": "90"
  },
  {
    "page": 91,
    "content": "Figs 11a-c An implant-supported prosthesis with poor\naccess for cleansability. Plaque and calculus formation\nare seen in this case diagnosed with peri-implantitis. (a)\nLingual\nview.\n(b)\nBuccal\nview.\n(c)\nPeriapical\nradiograph illustrating peri-implant bone loss at both\nimplants.\n91"
  },
  {
    "page": 92,
    "content": "Fig 12a Peri-implant mucositis caused by an inadequate\nfit of the screw-retained crown at site 22.\nFig 12b Periapical radiograph of the case illustrated in\nFig 12a.. Inadequate fit of the screw-retained crown at\nsite 22.\nProsthetic phase. Iatrogenic risk factors for peri-\nimplant infection include inadequate prosthesis design,\npoor fit, inadequate seating, or excess luting cement.\nOvercontoured or poorly designed implant-supported\nprostheses that prevent adequate access for oral hygiene\nprocedures may lead to peri-implant infection in\nsusceptible individuals (Figs 11a-c). The association\nbetween implant-supported prostheses with inadequate\naccess for oral hygiene and peri-implantitis has been\nclearly demonstrated (Serino and Ström 2009).\n92"
  },
  {
    "page": 93,
    "content": "Fig 13a Peri-implant infection caused by inadequate\nseating of the cemented crown at site 12.\nFig 13b Radiograph. Inadequate seating of the implant\ncrown at site 12.\n93"
  },
  {
    "page": 94,
    "content": "Fig 14a Periapical radiograph. Excess luting cement\nfollowing crown cementation and associated peri-\nimplant marginal bone loss at site 21.\n94"
  },
  {
    "page": 95,
    "content": "Fig 14b A draining sinus (arrow) on the facial peri-\nimplant mucosa and a deep peri-implant pocket with\nbleeding on probing at site 21.\nOther iatrogenic factors including inadequate fit of the\nabutment or prosthesis (Figs 12a-b), incorrect seating of\na cemented prosthesis (Figs 13a-b), or the presence of\nsubmucosal excess luting cement (Figs 14a-b) may also\ncause bacterial accumulation and result in clinical\ninflammation and peri-implant infection.\nImplant surface as a risk factor for peri-implant\ninfection\nWhile\nthere\nis\nno\nevidence\nthat\nthe\nsurface\ncharacteristics of a properly placed and integrated\nimplant influence the initiation of peri-implantitis, it has\nbeen documented that rough surface implants (e.g.\ntitanium plasma-sprayed, TPS) are more likely to\ndevelop\nperi-implantitis\nthan\nmicro-rough\nimplant\nsurfaces if the implant surface becomes exposed to the\noral\nenvironment\n(Lang\nand\nBerglundh\n2011).\nHowever, once initiated, the progression of peri-implant\ninfection and progression of bone loss may be related to\nhost susceptibility as well as to the implant surface\ncharacteristics.\nCase\nreports\nindicate\nthat\nhydroxyapatite-coated\nimplants with a thick coating, are likely to develop peri-\nimplantitis leading to implant loss if the hydroxyapatite\ncoating detaches (Piatelli and coworkers 1995).\n95"
  },
  {
    "page": 96,
    "content": "Systemic conditions as potential risk factors for peri-\nimplant infection\nCigarette smoking may increase the risk for peri-\nimplant infection (Lindquist and coworkers 1997;\nHeitz-Mayfield and Huynh-Ba 2009). Smoking is a risk\nfactor for general health and oral health and has a\nchronic effect on many aspects of the inflammatory and\nimmune systems. The deleterious effects of smoking\ninclude impaired wound healing, reduced collagen\nproduction,\nimpaired\nfibroblast\nfunction,\nreduced\nperipheral circulation, and compromised function of\nneutrophils and macrophages (Palmer and coworkers\n2005).\nThe\nbiological\nprocesses\ninvolved\nin\nosseointegration and the maintenance of peri-implant\nbone levels are likely affected by tobacco smoking,\nproviding an explanation for the lower implant survival\nand success rates reported in smokers (Clementini and\ncoworkers 2014; Chen and coworkers 2013; Vervaeke\nand coworkers 2013).\nDiabetes mellitus is associated with various systemic\ncomplications,\nincluding\nretinopathy,\nnephropathy,\nneuropathy, micro- and macrovascular disturbances,\nand impaired wound healing. In the oral cavity,\nxerostomia, caries, and periodontitis have been linked\nto diabetes mellitus. The increased susceptibility to\nperiodontitis is thought to be due to a negative influence\nof diabetes on the inflammatory mechanisms resulting\nin a deregulated host defense, impaired wound healing,\nand microvascular problems (Graves and coworkers\n2006).\n96"
  },
  {
    "page": 97,
    "content": "Studies\nevaluating\nimplant-related\nbiological\ncomplications in patients with diabetes are scarce, and\nthe\ninfluence\nof\nglycemic\ncontrol\nhas\nnot\nbeen\nevaluated.\nNevertheless,\none survey of 212 non-\nsmoking subjects with 578 implants found that the 29\nindividuals\nwith\ndiabetes\nmellitus\nhad\na\nhigher\nprevalence\nof\nperi-implantitis\ncompared\nto\nthose\nwithout diabetes (Ferreira and coworkers 2006).\n3.1.3 Hardware Complications Presenting as Biological\nComplications\nThe presence of a draining sinus may be observed\nclinically when there is a peri-implant infection that\ndrains through the peri-implant mucosa. A draining\nsinus may be associated with peri-implant mucositis or\nperi-implantitis, and its primary cause may either be\nbiological (plaque-related) (Figs 15a-b) or hardware-\nrelated (Figs 16a-d). Hardware complications may\ninclude a loose abutment or screw, abutment or screw\nfracture, incorrect prosthesis seating, or—in the case of\na cement-retained prosthesis—the presence of excess\nluting cement (Fig 14a-b). Hence, a careful assessment\ninvolving a clinical and radiographic evaluation is\nrequired to make an accurate diagnosis.\n97"
  },
  {
    "page": 98,
    "content": "Fig 15a Peri-implantitis at site 12 with a draining sinus\n(arrow) associated with significant bone loss.\n98"
  },
  {
    "page": 99,
    "content": "Fig\n15b\nPeriapical\nradiograph.\nBone\nloss\nto\napproximately the third thread (arrow) of the implant at\nsite 12.\nFig 16a A draining sinus and swelling on the facial\nmucosa at the screw-retained implant crown at site 21.\n99"
  },
  {
    "page": 100,
    "content": "Fig 16b Periapical radiograph of the screw-retained\nimplant crown at site 21. There is no marginal bone\nloss.\n100"
  },
  {
    "page": 101,
    "content": "Figs 16c-d The initiating factor associated with this\ninfection was found to be a loose abutment screw. In\naddition, there had been a technical error during the\nfabrication of the crown, resulting in a visible gap\nbetween the crown and the abutment where bacteria\ncould accumulate.\n3.2 Non-plaque-related Biological Complications\n3.2.1 Complete Loss of Osseointegration and Occlusal\nOverload\nThere are case reports describing complete loss of\nosseointegration\n(implant\nfailure)\nwhere\nocclusal\noverload is presumed to be the cause. In these cases,\nthere are usually no signs of peri-implant infection\nreported, and a radiograph shows a narrow radiolucent\narea surrounding the entire endosseous portion of the\nimplant (Figs 17a-d). This is in contrast to the\n101"
  },
  {
    "page": 102,
    "content": "radiographic bone-loss pattern of progressive crestal\nbone loss observed in peri-implantitis induced by the\nbiofilm-related inflammatory response.\nFig 17a A removable partial upper prosthesis with\ncombined rigid support (telescope crown at implant 23)\nand non-rigid support (clasps at teeth 14, 15, 27). The\ncombination of rigid and non-rigid support over a\nperiod of eight years may have resulted in occlusal\noverload of the rigid implant retainer and a loss of\nosseointegration.\n102"
  },
  {
    "page": 103,
    "content": "Fig 17b Implant 23 with shallow probing depths and no\nclinical signs of infection. The patient had noticed\nimplant mobility for two days.\nFig\n17c\nPeriapical\nradiograph.\nImplant\nwith\na\nradiolucent\narea\naround\nthe\nentire\narea\nof\nthe\nendosseous part of the implant.\n103"
  },
  {
    "page": 104,
    "content": "Fig 17d The implant has completely lost integration.\nCase courtesy of Professor Nicola Zitzmann.\nFig 18 Erosive oral lichen planus associated with the\nperi-implant mucosa. Management of oral lichen planus\nis presented in Chapter 9.2.2.\n104"
  },
  {
    "page": 105,
    "content": "Fig 19 Squamous cell carcinoma associated with a\ndental implant. The Management of this case is\ndescribed in Chapter 9.2.3.\nIn a case series published by Piattelli and coworkers\n(2003), 51 implants were retrieved due to mobility over\na five-year period and examined histologically. Almost\nall of the implants had been inserted in posterior\n(premolar-molar)\nregions\nof\nboth\njaws.\nIn\nall\nspecimens, there was the presence of a 600- to\n1,100-µm thick connective tissue between implants and\nsurrounding bone. In every case, the surrounding bone\nwas compact and highly mineralized and no bacteria\nwere found in the most coronal portion of the implants.\nA scarce inflammatory cell infiltrate was present in the\nconnective tissue of some specimens. In about 10% of\nspecimens, the epithelium tended to surround the\nperimeter of the implant. These histologic findings are\nconsistent with the hypothesis that late failures of\nosseointegrated\nimplants\ncan\nbe\ncaused\nby\na\ncombination of poor bone quality, mechanical trauma to\n105"
  },
  {
    "page": 106,
    "content": "bone, and overloading. It is suggested that the load has\nexceeded the capacity of the host bone, and hence\nosseointegration is completely lost. Patients who report\nparafunctional habits such as bruxism or clenching may\nbe\nat\ngreater\nrisk\nfor\nthis\ntype\nof\nbiological\ncomplication.\n3.2.2 Other Theories for the Etiology of Loss of\nOsseointegration\nOther explanations proposed by some authors for the\netiology of peri-implant marginal bone loss and loss of\nintegration\ninclude\n“a\nforeign\nbody\nreaction”\n(Albrektsson and coworkers 2013). There is, however,\ncurrently no cohesive scientific evidence to support this\ntheory.\n3.2.3 Non-plaque-related Oral Mucosal Disorders\nOral mucosal disorders found in the oral cavity may\nalso affect the peri-implant mucosa. These conditions\nshould be distinguished from peri-implant infection,\nwhich may have a similar clinical appearance, and a\nthorough history and biopsy is usually required to make\nthe correct diagnosis.\nOral lichen planus\nOral lichen planus (OLP) is a common inflammatory\nmucocutaneous disease that frequently manifests itself\nintraorally and may present on peri-implant mucosa.\nOLP can appear in many forms, the most significant\nbeing the erosive lichen planus (Fig 18). OLP may\n106"
  },
  {
    "page": 107,
    "content": "sometimes\nresemble\nother\nchronic\nmucosal\ninflammatory diseases hence a biopsy is essential to\nensure accurate diagnosis (Parashar 2011). Recent\nstudies have concluded that OLP is not a risk factor for\nperi-implantitis and that implants do not influence\nmanifestations of OLP (López-Jornet and coworkers\n2014).\nCarcinomas/tumors\nWhile their incidence is rare, carcinomas may occur\naround dental implants and usually present as an\nexophytic mass (Fig 19). A recent literature search\nidentified 25 reported cases of peri-implant carcinoma\nand one sarcoma (Moergel and coworkers 2014). Eight\nof the patients reported alcohol/tobacco consumption.\nIn most of the reported cases, patients exhibited risk\nfactors for possible malignant transformation: previous\ncarcinoma (n = 12), lichen (n = 4), irradiation (n = 3),\nand leukoplakia (n = 3).\n107"
  },
  {
    "page": 108,
    "content": "Fig 20 Peripheral giant-cell granuloma associated with\nan implant at site 32. The management of this case is\ndescribed in Chapter 9.2.4.\nPeripheral giant-cell granuloma\nAnother infrequent biological complication that may\noccur around a dental implant is the peripheral giant-\ncell granuloma (PGCG). The PGCG is a benign reactive\nexophytic lesion of unknown etiology. Although it is\nthe most common giant-cell lesion of the jaws, there\nhave been only 12 published case reports in association\nwith implants (Galindo-Moreno and coworkers 2013).\nThe clinical appearance is usually that of an exophytic\nmulti-lobed lesion surrounded by pink-reddish tissue\n(Fig 20). A biopsy and histological examination are\nrequired to confirm the diagnosis.\n108"
  },
  {
    "page": 109,
    "content": "Fig 21 Periapical radiograph. Implant with BRONJ. The\nmanagement of this case is described in Chapter 9.2.5.\nImplant-associated\nbisphosphonate-related\nosteonecrosis of the jaw\nBisphosphonate-related\nosteonecrosis\nof\nthe\njaw\n(BRONJ) associated with dental implants is a rare\nbiological complication (Fig 21). The risk of BRONJ\nappears to be much lower when the drug is taken orally\nthan when it is administered intravenously, but appears\nto increase with the duration of bisphosphonate therapy.\nSuccessfully osseointegrated implants that later develop\nosteonecrosis around the implant after bisphosphonate\nadministration have been reported in the literature\n(Kwon\nand\ncoworkers\n2012;\nLópez-Cedrún\nand\ncoworkers 2013). Histological features of these lesions\nshow necrotic bone with empty lacunae infiltrated by\ninflammatory cells and bacterial colonies. Three types\nof bone destruction pattern may be observed: (1)\ncomplete necrosis of the bone around the implant\n(frozen type), (2) extensive osteolysis around the\nimplant with or without sequestra (osteolytic type), and\n(3) sequestration of bone with an implant maintaining\ndirect\nimplant-bone\ncontact\n(en-bloc\nsequestration\ntype). En-bloc sequestration of bone with the implant\nmight be one of the characteristics of implant-related\nBRONJ that differs from peri-implantitis-induced bone\ndestruction (Kwon and coworkers 2012).\n109"
  },
  {
    "page": 110,
    "content": "Fig 22 Suspected metal allergy to the non-titanium\nhealing abutments. The Management of this case is\ndescribed in Chapter 9.2.6.\nMetal allergies\nHypersensitivity reactions to metals used in implant-\nsupported\nprostheses\nhave\nbeen\nreported,\nwith\nsymptoms such as dermal inflammatory reactions\n(facial eczema, dermatitis, and rashes) and mucosal\nhyperplasia (Fig 22). Allergic responses to titanium\nhave also been reported in a few studies, although the\nsignificance of titanium as the cause of allergic\nreactions remains unproven (Javed and coworkers\n2013). Thus, in rare circumstances and for some\npatients, the use of certain metals may result in an\nallergy. Cutaneous allergy tests are required to confirm\nthe diagnosis (Sicilia and coworkers 2008; Javed and\ncoworkers 2013).\n110"
  },
  {
    "page": 111,
    "content": "3 Etiology and Risk Factors: Biological Complications\nL. J. A. Heitz-Mayfield\n111"
  },
  {
    "page": 112,
    "content": "4.1 Materials and Interfaces\nSeveral options exist when retaining a superstructure\nwith implants. Consequently, the number of interfaces\ninvolved in the load transfer differs as well. Removable\nprostheses function via various attachment systems such\nas spherical attachments, a bar system, or LOCATOR®\nabutments (Zest Anchors, LLC, Escondido, California,\nUSA). A screw retained crown or FDP can be fixed\nwith occlusal screws clamping the superstructure via\nabutments onto the implants. The abutment may also be\nconstructed as part of the crown, and a direct fixation\ninto/onto the implant via an abutment screw can be\nprovided. Cemented crowns or FDPs are retained via\nabutments that are connected to the implants. Instead of\ncementing in the oral cavity, a superstructure can also\nbe bonded to a base that is tightened into/onto an\nimplant as a one-piece reconstruction.\nFigures\n1\na-f\nillustrate\nthe\nvarious\noptions\nfor\nsuprastructure\nretention\nand\nclearly\nreveals\nthe\npotentially\nincreasing\nsusceptibility\nfor\nhardware\ncomplications\nwith\nthe\nrising\ncomplexity\nof\nthe\nconstruction.\nThe superstructures are either cemented or screw-\nretained.\nThe\nscrew-retained\nreconstructions\nmay\nrequire separate abutments or may be manufactured in\none piece. The newer option with a bonding base is\nshown as well (Fig 1c).\n112"
  },
  {
    "page": 113,
    "content": "A\nstatic\nrepresentation\nof\nan\nimplant-supported\nreconstruction/abutment complex already leaves the\nclinician with the notion that the reliability of the\nprocessed materials and the maintenance of a tight\ninterface over many years of function is challenging.\nThis impression becomes even more striking when\nthese complexes are visualized during function, i.e.\nsimulated in a fatigue test.\nThe materials’ physical/mechanical properties have to\nwithstand compressive, tensile, and torsional forces\nalong\naxial\nand\nlateral\nvectors,\nwith\nchanging\namplitudes and peaks (e.g. during trauma).\nEvery\nmaterial\nchosen\nfor\nimplants,\nabutments,\nabutment screws, copings, occlusal screws, male/female\ncomponents\nof\nattachment\nsystems,\nframeworks,\nveneers, and denture teeth exhibits its own physical\nproperties when exposed to forces; these include:\n•\nHardness (resistance to compression)\n•\nModule of elasticity (resistance to tension)\n•\nCohesive strength (resistance to a single intense\nload)\n•\nFatigue (microscopic cracks appearing on repeated\nloading create and extend fissures until catastrophic\nfailure occurs)\n•\nYield strength or overload (the point at which a\nmaterial starts to deform permanently)\n113"
  },
  {
    "page": 114,
    "content": "By ISO-standardized testing, properties of the material\nsuch as its ultimate tensile or compressive strength can\nbe assessed, compared, and modified.\nManufacturers\ndevoted\nto\nquality\nalso\ntest\nnew\ncomponents by means of finite-element analyses as well\nas cyclic loading.\nIn addition to the choice of material per se, the\ndimensions of the components should not exceed\ncertain critical values in order to withstand forces. For\nexample, the occlusal screw of a reduced-diameter\nimplant/reconstruction complex needs to be optimized\nto survive long-term exposure to function. In addition to\nthe linear dimensions, the shape of the object, such as\nthe cross-section of a component, is also crucial. The\nheight and width and the diameter of rectangular,\nelliptic, round, or hollow cylindrical cross-sections of\nreconstructions greatly affect deflection and stress\nunder load. When designing components and dental\nlaboratory work, general physical laws have to be\nrespected to minimize hardware complications (Wiskott\n2011).\nFigures 1a-f allow a view into the “innards” of the\nreconstruction/abutment/implant complex that is usually\ninvisible\nto\nthe\nclinician.\nNext\nto\nthe\nmaterial\nproperties,\nthe\nmost\nimportant\nsurvival\nfactor\nis\ninterface stability. At least eight interfaces are present:\n•\nImplant bore/abutment screw\n•\nImplant/abutment base\n114"
  },
  {
    "page": 115,
    "content": "•\nAbutment/abutment screw head\n•\nAbutment/reconstruction (coping; cement interface)\n•\nAbutment bore/occlusal screw\n•\nOcclusal screw head/reconstruction\n•\nReconstruction /abutment or implant platform\n•\nAdditional interfaces with mesostructures\nThe design of the mating interfaces will modify the\nclamping effect at these interfaces (flat vs. conical\nsurfaces). Peak force concentrating at specific points\nshould be avoided, as well as edges, ledges, and\nnotches. The physical characteristics of the mating\ninterfaces should be adapted, e.g. to obtain a predictable\nfailure mode for an abutment screw. Wear due to\ndifferences\nin\nhardness\nand\nto\ninterposed\nrough\nparticles may weaken the clamping effect.\nAnother issue is the precision of the components; they\nmust be of consistent quality and subject to stringent\nquality management. The accepted tolerance—e.g. with\nregard to rotation between the abutment and the internal\nimplant interface—is a typical measure of production\nquality standards.\nIn addition to interfaces held together by the clamping\neffect, some interfaces involve an adhesive connection\nbetween a veneering material and a framework. As\nmentioned in the literature review, the weakest link in\n115"
  },
  {
    "page": 116,
    "content": "most of today’s dental reconstructions is cohesive and\nadhesive failure at the framework-veneer interface.\nFig 1a Tissue-level implant with a screw-retained\ncrown and an abutment for screw fixation.\n116"
  },
  {
    "page": 117,
    "content": "Fig 1b Bone-level implant with a ceramic abutment and\na cemented separate crown.\n117"
  },
  {
    "page": 118,
    "content": "Fig 1c Bonding base on a tissue-level implant.\n118"
  },
  {
    "page": 119,
    "content": "Fig 1d Mucosa former on a bone-level implant.\n119"
  },
  {
    "page": 120,
    "content": "Fig 1e LOCATOR® abutment on a bone-level implant.\nFig 1f Spherical attachment on a tissue-level implant.\nFigs 1a-f Examples of implant/abutment/reconstruction\ncomplexes associated with tissue-level implants, bone-\nlevel\nimplants,\nabutments\nfor\ncementation,\nscrew\nretention, healing abutments, attachment systems. (1)\nImplant body; (2) Implant body/abutment interface; (3)\nAbutment screw; (4) Abutment body; (5) Retention:\ncemented or screw-retained; (6) Closure screw, healing\nabutment,\nmucosa\nformer;\n(7)\nAttachment\nfor\noverdentures;\n(8)\nMesostructure\n(not\nshown);\n(9)\nReconstruction.\n4.2 Absorption of Kinetic Energy and Biomechanical\nRisks\n120"
  },
  {
    "page": 121,
    "content": "During\nintraoral\nfunction,\nimplant-supported\nreconstructions are exposed to forces that can be\ngrouped according to intensity, frequency, direction,\nmaterial composition, contact area, shape of the acting/\nreacting masses, and the presence and quality of\nintermediate structures.\nIntensity. Chewing forces during biting and mastication\nhave been found to range between 108 and 174 N\n(Helkimo\nand\ncoworkers\n1977),\n93\nand\n368\nN\n(Haraldson and coworkers 1979), and 161 and 299 N\n(Lujan-Climent and coworkers 2008) in the incisor\nregion. Measured by surface electromyography, the\nmaximal biting forces in the molar region ranged\nbetween 446 and 1,220 N (Ferrario and coworkers\n2004). During active phases of bruxism, extreme\nsportive activity, spasms, or trauma, still higher forces\nmay be expected.\nReconstructive and component materials, veneering\nmaterial combinations, and screws clamping abutments\nor reconstructions onto/into implants have to withstand\nthese intensive stress peaks in order not to cause\ncomplications or failures. Excessive peak forces or\ncontinous repeated jiggling may even compromise\nosseointegration; however, there is no clear evidence\nfor the effect of overload in the etiology of loss of\nosseointegration. Critical bending moments describe the\nforce needed to cause permanent deformation and/or\nrupture of a material or combination of materials.\n121"
  },
  {
    "page": 122,
    "content": "Frequency. Daily tooth contact during physiologic\nfunction has been estimated to last for a few minutes.\nUnder stress or during parafunction, these phases may\nbe prolonged. The risk of damage is higher the longer\nthe exposure exists. The total exposure is responsible\nfor the wear, loosening, or fracture due to fatigue.\nDirection. The notion that axial forces are less prone to\ninflicting damage than non-axial forces is generally\naccepted in reconstructive and implant dentistry. While\nthe effect on bone loss of non-axial loading has not\nbeen confirmed by scientific evidence, the resulting\nshear forces may be associated with ceramic chipping\nand\ncountertorque,\nresulting\nin\nscrew\nloosening.\nUnidirectional and multidirectional forces may have\ndetrimental consequences for the affected materials.\nContact area. A mass in motion hitting an object, or a\nmass pressed onto another object with force, will result\nin deformation, depending on the size and shape of the\ncontact area distributing the forces to a point or to a flat\nor irregular surface. The force (action) will trigger a\nreaction of equal magnitude. If the object (the implant-\nsupported reconstruction) cannot move and convert the\nforce into kinetic energy, the force has to be absorbed.\nThis is described by the material’s coefficient of elastic\ndeformation. Elasticity and flexibility describe the\ncapacity of an object to absorb force. If the materials in\na\ncombination\ndo\nnot\nhave\nthe\nsame\nelastic\ndeformation, stress builds within the object, potentially\ncausing e.g. ceramic chipping.\n122"
  },
  {
    "page": 123,
    "content": "If the object cannot move or deform, the force will be\npropagated to the weakest element and result in\ndamage: deformation, breakage, cracks, opening of\ninterfaces. Loosened screw joints are acute events; wear\nor microcracks are chronic effects.\nForces may affect the implant material, any prosthetic\ncomponents such as abutments or screws, as well as the\nmaterials of the superstructures. In addition, any\nconnections (interfaces) between implants, components,\nand the superstructure may be loosened. Forces may act\ndirectly on the contact area, but distant areas may also\nbe affected through deformation of the materials due to\nleverage.\nThe physical characteristics of interposed particles\nwhile polishing, during grinding, cutting, or caused by\nattrition promote the deterioration of the materials.\nBiomechanics.\nDuring\nmastication,\nproprioception\ncoordinates chewing motions and chewing forces.\nProprioception with implants is reduced by about a\nfactor 10 compared to vital teeth (Hämmerle and\ncoworkers 1995).\nTo what extent this might be responsible for the higher\nrate\nof\nceramic\nchipping\nin\nmetal-ceramic\nreconstructions on implants compared to teeth is not\nclear.\nAt least for the mixed tooth-implant-supported FDP, no\nprotective mechanism exists; more frequent failures and\n123"
  },
  {
    "page": 124,
    "content": "complications have been reported with this type of\nreconstruction (Lang and coworkers 2004).\nThe biomechanical conditions in the oral cavity induce\naging, which affects the deterioration of materials.\nExposure to saliva, food, and drink, with temperature\nand pH changes, the exposure to bacterial biofilm, the\nanaerobic environment, and tissue-secretion products\nleaking into the interfaces may also induce corrosion,\nattrition, and material degradation. Function against\nopposing\nhard\nnatural\nor\nartificial\nmaterials\nand\ninterposed particles cause wear.\nSimilar\ntypes\nof\nexposure\nmay\nalso\ninclude\ninterventions\nsuch\nas\noral\nhygiene,\nprofessional\nmaintenance procedures, or manipulation by dentists/\ntechnicians\naltering\nthe\nintegrity\nof\nsurfaces\nand\nmaterials.\nScaling,\npolishing,\ninstrumentation\nwith\nultrasonic tips, grinding, adjustments, retightening,\nchanging components, the use of chemical agents—all\nthese may have an effect on the structures; they are\nmeant to prevent damage, but they also carry with them\na certain risk of triggering microcracks as initial lesions.\n4.3 Hardware-related Complications and Failures\nTable 1 in Chapter 10, page 190 lists the site of origin\nof hardware-related complications and failures, the key\nparameters involved, the management and prevention of\nsuch events, starting with the implant and proceeding to\nthe reconstruction (bottom-up).\n124"
  },
  {
    "page": 125,
    "content": "4.3.1 Implant Body\nMost documented oral implants are made of grade IV\ntitanium. Implants vary in body design, threads, neck\ndesign,\nplatform,\nconnection,\napex,\nlength,\nand\ndiameter. They may be placed with the platform at bone\nlevel or near the mucosal level. Rough surfaces and\nimproved\nchemical\nsurface\ncharacteristics\nprovide\nfaster healing and more attractive loading protocols.\nSmall-diameter implants may increase the risk of\nimplant fracture (Zinsli and coworkers 2004; Allum and\ncoworkers\n2008),\nwhile,\nfor\nexample,\nalmost\nno\ninstances of implant fractures have been reported with\nregular-diameter implants.\nThe implant body has to withstand the axial and lateral\nforces\nwith\neffective\namplitudes\nduring\nfunction.\nParafunction\nand\npossible\npeak\nloads,\ne.g.\nin\nencountering unexpectedly hard food particles or in\ntrauma, may result in excessive stress. The physical\nproperties of the implant material should guarantee a\ncertain\nflexibility\nand\nresistance\nto\npermanent\ndeformation. The load is transferred to the bone around\nthe osseointegrated implant.\nThe three-dimensional position of the implant platform\nis crucial for the successful construction of an esthetic\nand functional reconstruction. The position ultimately\ndetermines whether prefabricated components can be\nused or if custom components need to be fabricated.\nThe position of the platform defines whether screw\nretention is possible or if angulation is needed.\n125"
  },
  {
    "page": 126,
    "content": "Space requirements for components and superstructures\nin all dimensions must be respected together with\nanatomical\nand\nsurgical\nlimitations.\nUnfavorable\nplatform positions will cause biologically unacceptable\nconnections between the superstructure and abutments/\nimplants in terms of oral hygiene as well as diagnostic\nand maintenance procedures. Finally, the esthetic result\nwill largely depend on the correct platform position.\n4.3.2 Implant Body/Abutment Interface\nA wide variety of matching interface designs exists for\nthe connection between an implant and an abutment.\nThe connections may be grouped according to external,\ninternal\nconnections,\none-piece\nor\ntwo-piece\nconfigurations, butt joint vs. morse taper connection.\nThe\nnumber\nof\nsurfaces\n(hexagon/octagon,\nthree\ngrooves, multiple parallel flat surfaces) and the shapes\nof the “notches” may vary.\n4.3.3 Abutment Screw\nMost abutments are tightened with a torque-control\ndevice to a recommended value between 28 and 35\nNcm.\nSome\nabutments\nemploy\nfriction\nfit,\nusing\nlow\ntemperatures for seating, which results in an expanding\nabutment volume at body temperature.\nWhile many complication and failures were related to\nnon-optimal connection characteristics during the early\n126"
  },
  {
    "page": 127,
    "content": "phases of implant dentistry, the newer components\nexhibit a lower incidence of abutment loosening or\nfractures (Theoharidou and coworkers 2008).\nFrom a biomechanical point of view, maintaining the\nfriction between the threads of the abutment screw and\nthe bore of the implant interface remains a challenge.\nRegarding the interfaces between zirconia and titanium,\nthe tribological effect on the connection (wear) has been\nstudied to a limited extent (Stimmelmayr and coworkers\n2012).\n4.3.4 Abutment Body\nAn abutment portfolio must satisfy almost any clinical\ndemand for cementation or screw retention of crowns\nand FDP, and with a variety of attachments for\noverdentures. Gold, titanium, and ceramic abutments\nwith\ntheir\ninherent\nmechanical\nand\nbiological\ncharacteristics are available.\nThe physical integrity of the abutments is crucial for the\nlong-term stability of the superstructure. A modular\ndesign allows exchanging a used or fractured abutment\nwithout the need for a remake of the superstructure.\nThis can be achieved by features for interchangeable\nrepositioning and predetermined breaking points for\nuncomplicated removal of fractured components.\nThe superstructure can be either cemented or screw-\nretained onto an abutment that is itself screw-retained\non the implant. An alternative fixation can be achieved\n127"
  },
  {
    "page": 128,
    "content": "via direct screw retention of a superstructure on an\nimplant.\nThe stability of the connecting interfaces is essential for\nthe function of the superstructure. If loosening occurs,\nretightening a screw is only possible if the abutment\nscrew or occlusal screw is accessible. This may be\nreadily achieved by removing the screw-access closure\nif the head of the screw had been protected with an\neasily removable material (e.g. Teflon) (Moráguez and\nBelser 2010).\nScrew retention may also be provided by abutments for\ntransversal screw retention or by short angulated\nabutments with features for screw retention.\nCAD/CAM abutments\nMost implant systems offer a wide range of abutments\nto cover a large percentage of all prosthetic indications.\nGreat progress has also been made in the area of custom\nabutments. CAD/CAM production can be regarded as\nthe solution for cases not restorable with standard\nprefabricated abutments—or it can be regarded as the\nstandard modality, e.g. for esthetic ceramic crowns\n(Kapos and Evans 2014).\n4.3.5 Retention of Superstructures: Screw-retained and\nCemented\nThe main advantage of screw-retained crowns is easier\nand\nmore\npredictable\nretrievability\ncompared\nto\ncemented superstructures. In case of technical or\n128"
  },
  {
    "page": 129,
    "content": "biological complications, controlled removal may offer\nclinical advantages.\nScrew-retained reconstructions can also be fabricated\nwith\nprecision\ncopings;\nseveral\nin-vitro\nstudies\ndemonstrated\ngreater\nprecision\nfor\nscrew-retained\ncompared to cemented superstructures (Keith and\ncoworkers 1999; Tosches and coworkers 2009).\nScrew-retained superstructures may favor the growth of\npotentially pathogenic bacteria. This is expressed by an\nunpleasant\nsmell\nwhile\nretrieving\nscrew-retained\nreconstructions. Bacterial samples obtained at and\nunderneath such superstructures have revealed the\npresence of anaerobic bacteria and a flora resembling\nthe\nflora\nfrom\nperiodontal\npockets\n(Keller\nand\ncoworkers\n1998).\nChlorhexidine\ngel\nor\nsimilar\ndisinfectant substances have been administered to\nminimize the growth of anaerobic bacteria provoking\nbad\nbreath.\nDue\nto\nthe\nfast\nclearance\nof\nthese\nsubstances, a limited long-term effect can be expected.\nThe occlusal screw is the smallest component in the\ncomplex. The dimension and design of the screw head,\nthe shank and the thread pitch and the material\ninfluence its mechanical characteristics, e.g. the torque\nthat can be applied, the torque needed to remove the\nsuperstructure, as well as resistance and elasticity.\nSakaguchi and Borgersen (1993, 1995) have described\nthe\ncomplex\nrelationships\nassociated\nwith\na\nsuperstructure secured with an occlusal screw on an\nabutment torqued into an implant. While pressing the\n129"
  },
  {
    "page": 130,
    "content": "superstructure tightly with the crown margin onto the\nbase of the abutment or the implant, the clamping force\nmay reduce the pressure connecting the abutment head\nand the abutment base, which is a potential reason for\nabutment-screw loosening. This may be avoided by\nchoosing a one-piece reconstruction with engaging or\nnon-engaging connections screwed onto an internal\nconnection.\nThe\nultimate\nproof\nof\nstability\nachieved\nwith\na\ncomponent or combination of designs/materials lies in\nthe long-term use in patients. Exposure to the oral\nenvironment and safe handling of the components\nduring\nfabrication\nand\nmaintenance\nultimately\ndetermine\nthe successful\nfunction\nof an implant/\nsuperstructure complex.\nAbutment height, abutment axes (straight or angulated),\nand conicity determine whether a superstructure can be\ncemented. In multiple-unit reconstructions, a lack of\nparallelism must be corrected for. A threshold limit of 4\nmm for abutment height is recommended if cementation\nis planned (Misch and coworkers 2006).\nAntirotational features such as grooves or flat surfaces\nare required for single-unit reconstructions. Neither\nparallel surfaces nor undercuts are acceptable for\nmultiple-unit reconstructions.\nThe space needed for the cement may be anticipated\nand considered in the analogue/coping components.\n130"
  },
  {
    "page": 131,
    "content": "While adhesive technology has reduced the minimal\ndentin abutment height required for cementation for\nsingle crowns and onlays, the choice of the cement\naffects the retention of implant superstructures only\nminimally.\nRoughening the abutment surfaces may increase the\nretention minimally.\nCements\nhave\nbeen\ndeveloped\nfor\nseating\nreconstructions on teeth. There is no consensus as to\nwhich cement should be used when and exactly how it\nshould\nbe\napplied.\nIncreasing\nconcern\nis\nbeing\nexpressed with regard to cement residue associated with\nsevere infection in tissues around abutments and\nimplants.\nA brush technique while applying cement may be\npreferable to uncontrolled filling of the crown. Pushing\ndown the crown with excess cement may open up the\nsoft-tissue collar, and the cement flow may reach deep\ndown into the connective tissue (Wadhwani and Chung\n2013). Cement residue may react chemically and could\nevoke foreign-body reactions similar to impression\nmaterial injected into the tissue around teeth (O’Leary\nand coworkers 1973; Ree 2001). Similar to calculus,\ncement residue may facilitate plaque accumulation and\nbiofilm growth. In addition, cement residue is difficult\nto detect and remove.\nCrown margins reaching the implant shoulder or\nmargins ending on abutments require perfect precision.\nIll-fitting reconstructions should not be accepted. They\n131"
  },
  {
    "page": 132,
    "content": "reflect transfer errors and problems with occlusal\nadjustment. They function as niches for bacteria and\ncause\nbiological\ncomplications,\nespecially\nwhen\ncombined\nwith\ncement\nresidue.\nIn\naddition,\noral\nhygiene\nprocedures\nsuch\nas\nflossing\ncannot\nbe\nperformed properly.\n4.3.6 Closure Screws, Healing Abutments, Mucosa\nFormers\nAfter the surgical procedure, the access to the implant\nplatform and connection can be closed in a variety of\nways.\nFor submerged healing, a small and short cover screw is\npreferable. A slightly higher cover screw may assist in\npositioning and stabilizing a membrane. Wider and\nhigher healing caps and mucosa formers may then be\nchosen for a semi-submerged or transmucosal healing\nperiod.\nHealing caps can be exchanged to a more suitable\ndesign during second-stage surgery or be replaced with\nprovisionals; the latter are mainly used for the final\ntissue-management stage, following the concept of\ndynamic\ncompression\n(Wittneben\nand\ncoworkers\n2013a).\nComplications originating with these components are\nrelated to tissue overgrowth, impinging soft and hard\ntissue\n(i.e.\ngraft\nparticles),\ndamage/wear\nto\nthe\nscrewdriver insert, or the use of corroded, non-original,\nnon-pristine components.\n132"
  },
  {
    "page": 133,
    "content": "4.3.7 Attachment System for Overdentures\nThe quality of life of edentulous patients can be\nradically improved with dental implants (Wismeijer and\ncoworkers 1995; Timmerman and coworkers 2004). An\nabundance of prosthetic components exists on the\nmarket to improve denture retention (Osman and\ncoworkers 2012). The components should be resistant\nto large forces and, if the retentive force is diminished,\nactivation or replacement by new components should be\nstraightforward. A small retention area is responsible\nfor securing the function of a full-arch reconstruction,\nresulting in concentrated stress and wear. It is therefore\nnot surprising that the maintenance requirements for\noverdentures in both jaws are considerable, irrespective\nof the attachment system used and irrespective of the\nnumber of implants supporting the overdenture.\n4.3.8 Mesostructures\nEach additional interface and material combination\nrepresents an additional risk factor. It seems logical to\nprefer a one-piece resistant reconstruction that can be\nattached to the implant with one abutment screw. This\nleaves the complex with the lowest risk for hardware-\nrelated complications.\nDue to limiting anatomical conditions or unfavorable\ndivergent axes and space requirements, the regular\nrange of abutments and attachment systems for fixed\nand removable reconstructions may not be sufficient to\nprovide a reasonable reconstruction. In such instances, a\nmesostructure fabricated manually or via CAD/CAM\n133"
  },
  {
    "page": 134,
    "content": "connected to an abutment may provide the necessary\nmodifications\nto\nsupport\na\nsuperstructure.\nThese\nsometimes\nvery\nsophisticated,\nbut\nbulky\nimplant/\nreconstruction complexes result in additional hardware-\nrelated risks.\n4.3.9 Reconstruction\nIn\ngeneral,\nimplant-supported\nsuperstructures\nare\nfabricated and designed similarly to tooth-supported\nreconstructions. Any differences are related to the\nconnection to the implant, the different biomechanical\ncharacteristics of implants and abutment teeth, and the\nspace required for the connection to the implant.\nTo restore a functional dentition after the loss of teeth\nand surrounding tissues, various occlusal concepts have\nbeen advocated for practical reasons. These concepts\nwere originally derived from the natural dentition and\napplied in conventional prosthodontics.\nThe desire of patients to chew comfortably can be met\nby\nvarious\nocclusal\nconcepts\nand\nsimple\nbite-\nregistration methods. Occlusal factors and details of\nocclusion seem to be of minor importance for the\noutcome of implant-supported reconstructions (Carlsson\n2009).\nLooking for information related to parafunction and\noverloading, excessive forces, etc., Hsu and coworkers\n(2012) found 15 clinical reports in which associations\nwith marginal bone loss, damage to resin or ceramic\nveneers, attachment systems, denture base fractures,\n134"
  },
  {
    "page": 135,
    "content": "component fractures, loosening, or even implant failure\nwere reported, especially in cases with parafunction.\nWhile the biological limit for overload and its effect on\ncrestal bone levels is unknown (Chang and coworkers\n2013), the effect of stress and fatigue on prosthetic\nmaterials obviously require considerable maintenance\n(Papaspyridakos and coworkers 2012).\nSound comprehensive prosthetic-care concepts need to\nbe applied along with surgical skills as a basis for\nsuccessful prosthetic laboratory work. The choice of\ncomponents,\nmaterials,\nmaterial\ncombinations,\nand\nproduction\nprocesses\nmeeting\nhigh\nclinical\nand\nlaboratory standards will result in a reconstruction/\nabutment/implant complex with a good chance for long-\nterm survival. In addition, risk mitigation involves a\nplan how to proceed in the event of a complication or\nfailure.\n135"
  },
  {
    "page": 136,
    "content": "4 Etiology and Origin of Hardware Complications\nU. Brägger\n136"
  },
  {
    "page": 137,
    "content": "5.1 Treatment of Peri-implant Mucositis\nTherapy of peri-implant mucositis should be considered\nas a preventive measure for the onset of peri-implantitis\n(Salvi and Zitzmann 2014). Treatment of peri-implant\nmucositis includes a thorough removal of the supra- and\nsubmucosal peri-implant biofilm in combination with\nreinforcement of self-performed oral hygiene. Non-\nsurgical mechanical removal of calculus and biofilm\ncan be performed using a range of instruments,\nincluding hand curettes and ultrasonic devices with\nplastic, carbon-fiber, or titanium tips. Peri-implant\nbiofilms\ncan\nalso\nbe\nremoved\nusing\nair-abrasive\ndevices, Erbium-YAG lasers, photodynamic therapy, or\nrubber polishing cups. The clinician should choose a\nmethod that minimizes damage to the surface of the\ntransmucosal\nparts\nof\nthe\nprosthesis\nor\nimplant.\nAntiseptics such as chlorhexidine solution or gel can\nalso be recommended as an adjunct to mechanical\ncleaning.\nImportantly, if contributing factors such as an ill-fitting\nor overcontoured prosthesis, a loose abutment or screw,\nor the presence of a foreign body are identified, these\nmust be corrected in order to achieve a satisfactory\ntreatment outcome.\nPeri-implant mucositis is considered to be a reversible\ncondition, as was demonstrated in an experimental\nhuman study where clinical signs of peri-implant\n137"
  },
  {
    "page": 138,
    "content": "inflammation (bleeding on probing) resolved when oral\nhygiene was reinstated after a period of three weeks of\nundisturbed plaque accumulation (Salvi and coworkers\n2012).\nStudies evaluating various treatment protocols using a\nvariety of antiseptic agents and toothpastes have shown\nsignificant clinical improvements with a reduction in\nbleeding on probing, and probing depths following\ntreatment (Figs 1a-c and 2a-b).\nHowever, in these studies complete resolution of the\nperi-implant mucositis in all cases is infrequently\nreported.\nThe\nlocation\nof\nthe\nimplant-supported\nrestoration\nmargin\nmay\ninfluence\nthe\ntreatment\nresponse. This was shown in a clinical study where\nimplants diagnosed with peri-implant mucositis with\nsubmucosal restoration margins had less favorable\ntreatment outcomes compared to those with equi- or\nsupramucosal margins (Heitz-Mayfield and coworkers\n2011).\nThe use of systemic antibiotics for the treatment of peri-\nimplant mucositis is not justified (Hallström and\ncoworkers 2012).\n138"
  },
  {
    "page": 139,
    "content": "Fig 1a Peri-implant mucositis at implant site 11.\nBleeding on probing caused by inadequate oral hygiene\nresulting in plaque accumulation and inflammation.\n139"
  },
  {
    "page": 140,
    "content": "Fig 1b Periapical radiograph. No marginal bone loss at\nsites 11 and 12, confirming the diagnosis of peri-\nimplant mucositis.\nFig 1c Resolution of the of peri-implant mucositis at\nsite 11 (no bleeding on probing) four weeks following\nnon-surgical debridement and oral hygiene instructions\n(flossing and brushing).\n140"
  },
  {
    "page": 141,
    "content": "Fig 2a Implant at site 35 diagnosed with peri-implant\nmucositis caused by an impacted food particle. Swelling\nand redness of the peri-implant mucosa. There was also\nbleeding on probing.\nFig\n2b\nResolution\nof\nthe\nperi-implant\nmucositis\nfollowing debridement, oral hygiene instructions and\napplication of chlorhexidine solution twice daily for one\nweek.\n5.2 Treatment of Peri-implantitis\nOnce a patient is diagnosed with peri-implantitis, it is\nimportant to implement an anti-infective treatment\nprotocol. If left untreated, it is likely that there will be\nprogression of bone loss and possible eventual loss of\nthe implant.\n141"
  },
  {
    "page": 142,
    "content": "The primary goal of peri-implantitis treatment should\nbe to establish healthy peri-implant tissues. A cause-\nrelated\ntreatment\napproach\nis\nrequired,\naimed\nat\nresolution of the infection and the prevention of disease\nprogression. Secondary goals may include peri-implant\nbone regeneration and fill of the intrabony defect.\nThere are many different peri-implantitis treatment\napproaches reported in the literature; however, it is not\nyet known which is the most effective (Esposito and\ncoworkers 2012).\nA recent systematic review prepared for the 5th ITI\nConsensus Conference identified a number of study\nprotocols where successful treatment outcomes were\nachieved in the majority of patients at twelve months\n(Heitz-Mayfield and Mombelli 2014). This systematic\nreview also found that, while favorable short-term\noutcomes were documented in many studies, a lack of\ndisease resolution as well as progression and recurrence\nof the disease and implant loss despite treatment were\nalso reported (Heitz-Mayfield and Mombelli 2014).\nThe following sequence of treatment is recommended,\nbased on similarities in the treatment approaches\nbetween studies included in this systematic review\n(Heitz-Mayfield and coworkers 2014):\n5.2.1 Pre-treatment Phase\n142"
  },
  {
    "page": 143,
    "content": "•\nAssessment of the peri-implant soft tissues, bone\nlevels and the prosthesis in order to make a diagnosis\nand to establish the cause of the infection.\nA correctly aligned radiograph showing the marginal\nbone levels should be made and clinical probing\nmeasurements recorded. This will give an indication of\nthe severity of the bone loss, and allow identification of\nany hardware or technical complication that may\nmanifest itself as a biological complication, for example\nan inadequate fit of prosthetic components. In addition,\nobtaining previous radiographic records from the time\nof the prosthesis insertion will allow a comparison with\nthe current marginal bone levels.\n•\nReduction\nof\nrisk\nfactors\nfor\nperi-implant\ninfection—in particular poor oral hygiene, inadequate\nprosthesis design, tobacco use, presence of periodontal\ndiseases and systemic diseases that may predispose to\nperi-implant infection.\nTreatment may include:\n– Smoking cessation counseling\n– Periodontal therapy in partially dentate patients\nwith the presence of pockets greater than 5 mm, with\nconcomitant bleeding on probing\n– Individual oral hygiene instructions\n143"
  },
  {
    "page": 144,
    "content": "•\nIf the prosthesis is screw-retained, it may have to be\nremoved to assess the prosthetic components or modify\nthe prosthesis’ contours. Removal may also improve\naccess\nto\nthe\nimplant\nsurface\nfor\nsubsequent\ndebridement.\n5.2.2 Non-surgical Debridement\nNon-surgical debridement should be aimed at the\nremoval of calculus and biofilm supramucosally, and on\nthe contaminated implant surface if accessible (Figs 3\nand 6a-b). This can be achieved using a range of\ninstruments including curettes or ultrasonic instruments\nwith carbon-fiber or plastic tips (Fig 3), air-abrasive\ndevices using sodium bicarbonate or glycine powder\n(Fig 4), Er:YAG lasers, or photodynamic therapy.\nDue to the topography of the implant and the limited\naccess to the implant surface, care should be taken\nusing instruments submucosally in deep pockets to\navoid breakage of the instrument, or damage to the\nsurrounding tissues.\nAntiseptics (e.g. chlorhexidine), local antimicrobials\n(e.g. minocycline-HCL microspheres) (Figs 5a-b), or\nsystemic antimicrobials may be used in conjunction\nwith the non-surgical debridement. The severity of the\nperi-implantitis lesion appears to play a role in the\nsuccess of non-surgical therapy, with a more favorable\ntreatment outcome at implants without advanced bone\nloss and without deep peri-implant probing depths.\n144"
  },
  {
    "page": 145,
    "content": "Fig 3 Removing calculus and biofilm using a titanium\ncurette from an implant with peri-implantitis.\n145"
  },
  {
    "page": 146,
    "content": "Fig 4 Non-surgical debridement using an air-abrasive\ndevice (glycine powder). The flexible tip of the air-\nabrasive\ndevice\nis\nplaced\napproximately\n3\nmm\nsubmucosally.\n146"
  },
  {
    "page": 147,
    "content": "Figs\n5a-b\nApplying\na\nlocal\nantimicrobial\nagent\n(minocycline\nmicrospheres)\nfollowing\nnon-surgical\ndebridement using a titanium curette for the treatment\nof peri-implantitis at site 15.\nFig 6a Calculus and biofilm formation on the implants\nat sites 41 and 31, which had been diagnosed with peri-\nimplantitis. Inflamed peri-implant mucosa. Labial view.\n147"
  },
  {
    "page": 148,
    "content": "Fig 6b Clinical photograph illustrating calculus and\nbiofilm formation on the implants at sites 41 and 31.\nThe implant-supported crowns are splinted and screw-\nretained. Lingual view.\n148"
  },
  {
    "page": 149,
    "content": "Figs 7a-b Resolution of the peri-implant infection at the\nimplants shown in Figs 6a-b following non-surgical\ndebridement using a titanium curette, administration of\nsystemic antimicrobials for seven days, and improved\noral hygiene. Peri-implant mucosal recession following\ntreatment. (a) Labial view. (b) Lingual view.\n5.2.3 Early Reassessment\nIf a successful treatment outcome is achieved within\napproximately one to two months following non-\nsurgical management, the patient should be provided\nwith regular supportive care and monitoring (Figs 7a-b).\nIf resolution of the infection is not achieved, i.e. there is\npersistent suppuration or deep probing depths with\nbleeding on probing, further active therapy—usually\ninvolving surgical access—should follow.\n5.2.4 Surgical Intervention\n149"
  },
  {
    "page": 150,
    "content": "Surgical\nprotocols\nmay\ninvolve\nan\nopen\nflap\ndebridement approach, a regenerative approach, or a\nresective approach.\nAll surgical protocols include the elevation of a full-\nthickness mucoperiosteal flap, followed by the removal\nof the peri-implant inflammatory granulation tissue\nenabling\naccess\nto\nthe\nimplant\nsurface\nfor\ndecontamination (Fig 8).\nFig 8 Clinical photograph illustrating intra-surgical\nimplant surface decontamination using a titanium brush\n(TiBrush; Institut Straumann AG, Basel, Switzerland),\nin a surgical handpiece, which oscillates in a clockwise/\ncounterclockwise\ndirection\n(900\noscillations\nper\nminute). Sterile saline solution (NaCl) is used for\nirrigation and cooling.\n150"
  },
  {
    "page": 151,
    "content": "Implant surface decontamination protocols are many\nand varied and may include the use of:\n•\nHand instruments with plastic, carbon-fiber, or\ntitanium tips\n•\nUltrasonic devices\n•\nTitanium brushes\n•\nAir-abrasive devices using sodium bicarbonate or\nglycine powder\n•\nEr:YAG, CO2 or Nd:YAG laser\n•\nPhotodynamic therapy\n•\nirrigation and/or rubbing of the implant surface using\nchemical agents such as hydrogen peroxide, phosphoric\nacid,\nsterile\nsaline,\nchlorhexidine,\nor\nethylenediamenetetraacetic acid (EDTA)\n•\nCarbide or diamond bur to modify the implant\nsurface (also described as implantoplasty)\nOpen-flap debridement. Elevation of a full-thickness\nmucoperiosteal flap, which frequently includes vertical\nreleasing incisions, enables access to the implant\nsurface for decontamination (Figs 9a-b and 10). When\nthe peri-implant bone defect has no intraosseous\ncomponent, this technique is the most suitable (Figs\n13a,d). A reduction in probing depths, bleeding on\n151"
  },
  {
    "page": 152,
    "content": "probing, and recession of the peri-implant mucosa are\nexpected outcomes following this treatment modality.\nRegenerative surgical protocol. A regenerative surgical\napproach aims to regenerate the peri-implant defect and\nmay be applied when an intraosseous defect component\nis present. Following implant-surface decontamination,\nthe intraosseous component of the peri-implant defect is\nfilled with a graft material that may also be covered\nwith a barrier membrane (Figs 11 and 12a-f).\nVarious graft materials including autogenous bone,\nallogeneic decalcified freeze-dried bone, xenogeneic\nbone\nmineral,\nphytogenic\ncalcium\ncarbonate,\nhydroxyapatite, or beta-tricalcium phosphate have been\ndocumented in an attempt to regenerate peri-implant\ndefects. In some protocols, non-resorbable membranes\nof\nexpanded\npolytetrafluoroethylene\n(ePTFE)\nor\nresorbable collagen or else synthetic membranes have\nbeen used to cover the graft material (Fig 11). The use\nof biologically active agents such as growth factors or\nenamel matrix derivatives may also be considered when\nregeneration of the peri-implant defect is the goal of\ntreatment. Healing following a regenerative approach\nmay be either submerged—if the prosthesis can be\nremoved—or transmucosal.\n152"
  },
  {
    "page": 153,
    "content": "Fig\n9a\nSchematic\ndiagram.\nElevation\nof\na\nfull\nmucoperiosteal flap to enable access to the implant\nsurface for biofilm removal using a titanium curette.\nFig 9b Schematic diagram. Positioning of the flap\nmargins following implant surface decontamination.\n153"
  },
  {
    "page": 154,
    "content": "Fig 10 Full mucoperiosteal flap raised with vertical\nreleasing incisions to enable adequate access to implant\n22 for surface decontamination.\n154"
  },
  {
    "page": 155,
    "content": "Fig 11 Schematic diagram. Intrabony peri-implant\ndefect filled with bone-graft material and covered with\na barrier membrane. The flap margins are approximated\nto allow transmucosal healing.\nFig 12a Circumferential three-wall intrabony peri-\nimplant defect at site 11 following flap elevation and\nremoval of the inflammatory granulation tissue.\n155"
  },
  {
    "page": 156,
    "content": "Fig\n12b\nThe\nsame\nintrabony\ndefect\nfilled\nwith\ndeproteinized particulate bovine bone mineral (Bio-\nOss®, Geistlich, Wolhusen, Switzerland).\nFig 12c A resorbable collagen barrier membrane (Bio-\nGide®) covering the graft material.\n156"
  },
  {
    "page": 157,
    "content": "Fig 12d After positioning of the flap margins and\nsuturing.\nFig\n12e\nFive\nyears\nafter\nregenerative\nsurgical\nmanagement of the peri-implantitis at site 11. The\npatient was seen for regular maintenance care. The peri-\nimplant tissue is healthy.\n157"
  },
  {
    "page": 158,
    "content": "Fig\n12f\nPeri-implant\nradiograph\nfive\nyears\nafter\nregenerative surgical treatment of peri-implantitis at site\n11. Stable marginal bone levels.\nDefect\nmorphology\nmay\ninfluence\nthe\ntreatment\noutcome for regenerative procedures. A three-wall\ncontained\ncircumferential\ndefect\nwill\nhave\nmore\nregenerative potential than a two-wall intraosseous\ndefect where one bone wall is missing (Figs 12a-f and\n13a-d).\nThe addition of a connective-tissue graft, with the aim\nof minimizing soft-tissue recession, has also been\ndocumented in a case series including 10 patients\n(Schwarz and coworkers 2014).\n158"
  },
  {
    "page": 159,
    "content": "159"
  },
  {
    "page": 160,
    "content": "Figs 13a-d Schematic diagrams illustrating various peri-\nimplant defect configurations. (a) Peri-implant defect\nwith loss of the buccal bone wall and no intraosseous\ndefect component. (b) Peri-implant defect with loss of\nthe buccal bone wall and a two-wall intraosseous\ndefect. (c) Peri-implant defect with a circumferential\nintraosseous defect. This defect configuration is most\nsuitable\nfor\nregeneration.\n(d)\nVertical\nbone\nloss\n160"
  },
  {
    "page": 161,
    "content": "resulting in a peri-implant defect with no intraosseous\ncomponent.\nFig\n14a\nSchematic\ndiagram.\nResective\nsurgical\napproach to peri-implantitis treatment. Removal of\nalveolar\nbone\npeaks\nto\nallow\nimplant\nsurface\ndecontamination.\n161"
  },
  {
    "page": 162,
    "content": "Fig 14b Schematic diagram. The flap margins are\nrepositioned apically once the bone has been removed\nand the implant surface has been decontaminated. This\nusually results in part of the implant surface becoming\nsupramucosal.\nResective\nsurgical\nprotocol.\nA\nresective\nsurgical\napproach is aimed at pocket reduction and involves the\nremoval of the alveolar bone peaks surrounding the\nperi-implant defect. Once the implant surface has been\ndecontaminated, the flap is positioned apically resulting\nin significant soft-tissue recession and exposure of the\nimplant surface (Figs 14 a-b and 15).\nFig 15 Clinical situation after a resective surgical\napproach.\nIntra-surgical modification of the implant surface, using\ncarbide or diamond polishing burs, in an attempt to\nsmooth the implant surface, or remove implant threads,\nmay also be made when a resective surgical protocol is\n162"
  },
  {
    "page": 163,
    "content": "chosen. This implant surface modification is commonly\nreferred to as implantoplasty. While the effect of this\nsurface modification on the implant diameter has not\nbeen thoroughly investigated, it has been shown that it\nmay compromise the strength of the implant, resulting\nin an increased risk of implant fracture (Chan and\ncoworkers 2013).\n163"
  },
  {
    "page": 164,
    "content": "Figs 16a-b Application of chlorhexidine solution with a\npostsurgical soft brush.\n5.2.5 Immediate Postsurgical Care\nPostsurgical\ncare\nshould\nenable\nadequate\nbiofilm\ncontrol by daily rinsing with chlorhexidine solution\nduring the early healing period, when oral hygiene\nprocedures are not possible. The use of a postsurgical\nsoft toothbrush, specifically designed to apply the\nchlorhexidine to the site, may also be beneficial in the\nfirst weeks following surgery (Heitz and coworkers\n2004) (Figs 16a-b). Systemic antimicrobials in the\npostoperative care phase are frequently used and are\nrecommended.\nGiven the aggressive nature of the peri-implantitis\nlesion and the accumulation of periodontal pathogens in\ndeep peri-implant pockets, the rationale for the use of\nsystemic antimicrobials is to suppress the microbial\nload and specific periodontal/peri-implant pathogens.\nHowever, there are currently no randomized controlled\ntrials evaluating the effect of systemic antimicrobials\nfor peri-implantitis treatment. Possible side effects of\nsystemic antimicrobials should be discussed with the\npatient prior to administration.\n5.2.6 Maintenance\nAn important phase of the peri-implantitis treatment\nprotocol\ninvolves\nthe\nprovision\nof\nindividualized\nmaintenance care. Regular monitoring, oral hygiene\nreinforcement, and professional supra-mucosal biofilm\n164"
  },
  {
    "page": 165,
    "content": "removal are required to avoid reinfection or the\nrecurrence of peri-implantitis (Fig 17).\nThe frequency of maintenance care will depend upon\nthe risk assessment for each patient related to patient-\nrelated risk factors, such as smoking habits, periodontal\nstatus, diabetes, and oral hygiene, and local risk factors,\nsuch as access for biofilm removal.\nFig 17 Maintenance care using an air-abrasive device\nwith glycine powder at site 41 six months following\nsurgical treatment for peri-implantitis.\n5.2.7 Implant Removal\nIn some patients, despite treatment, persistent or\nrecurrent infection occurs requiring removal of the\nimplant. Furthermore, when advanced bone loss has\noccurred,\nor\nwhen\ntreatment\nwill\nresult\nin\na\ncompromised esthetic outcome, the patient may choose\n165"
  },
  {
    "page": 166,
    "content": "to have the implant removed rather than undergo peri-\nimplantitis treatment.\nThe implant should be removed, where possible, in a\nconservative manner avoiding additional damage to\nneighboring structures and preserving as much bone as\npossible. Today, the preferred method for implant\nremoval, where possible, is to use an implant-retrieval\ndevice. Many implant manufacturers have a specific\ntool that can be used to remove the implant by reversing\nit at high torque. The prosthesis and abutment should\nfirst be removed and the implant retrieval device\ninserted counterclockwise into the internal aspect of the\nimplant (Fig 18a). A ratchet is then attached to the\nretrieval device and torque is applied to the implant,\ntypically counterclockwise, until the osseointegration is\nbroken and the implant can be removed (Fig 18b).\n166"
  },
  {
    "page": 167,
    "content": "Fig 18a Schematic diagram. Implant retrieval device\ninserted counterclockwise into the internal aspect of the\nimplant to be removed.\nFig\n18b\nCounterclockwise\ntorque\nto\nremove\nthe\nimplant.\n167"
  },
  {
    "page": 168,
    "content": "Figs 19a-b Five implants in the mandible. The implant\nsupported-fixed prosthesis has been removed to allow a\nthorough examination. (a) Buccal view. (b) Lingual\nview.\n168"
  },
  {
    "page": 169,
    "content": "Fig 19c Cone beam CT scan showing severe bone loss\nat the middle implant, extending to within 1 mm of the\napex.\nFig 19d The middle implant, which was removed using\nan implant-retrieval device.\n169"
  },
  {
    "page": 170,
    "content": "Fig 19e Following treatment (surgical access flap and\nimplant surface decontamination) of the remaining 4\nimplants,\nwhich\nalso\nshowed\nperi-implantitis,\nthe\nimplant-supported\nprosthesis\nwas\nmodified\nand\nreconnected. Supportive peri-implant maintenance care\nwas provided every four months.\nIn the few cases where an implant-removal device\ncannot be used, for example due to a fracture or\nsplitting\nof\nthe\nimplant,\ncareful\nremoval\nof\nthe\nsurrounding bone using a piezoelectric device or bur,\nfollowed by removal of the implant using forceps is\npossible.\nWhere bone removal is necessary, care should be taken\nto preserve the palatal bone wall in the maxilla and the\nlingual bone wall in the mandible so that further\nimplant placement or bone augmentation procedures\ncan be facilitated.\n170"
  },
  {
    "page": 171,
    "content": "While the use of a trephine bur to remove implants has\nbeen described in the literature and is shown in Chapter\n9.3.1, this method should be avoided if possible, as it\nmay result in excessive bone removal.\nAdequate\nradiographs\nto assess\nproximity\nof the\nimplant to neighboring structures should be obtained\nprior\nto\nimplant\nremoval\nin\norder\nto\navoid\ncomplications.\nConsideration must also be given to the replacement of\nthe lost implant. In some instances, modification and re-\nconnection of the existing prosthesis may be possible\n(Figs 19a-e), while in other instances placement of a\nnew implant and fabrication of a new prosthesis will be\nrequired.\nBone\naugmentation\nprocedures\nmay\nbe\nnecessary to enable an adequate bone volume for\nfurther implant placement. In some cases, an alternative\nsolution such as a removable partial prosthesis may be\nthe preferred option.\n5.2.8 Concluding Remarks\nUntil further evidence is available to distinguish the\nrelative effectiveness of the various protocols, the\nclinician should choose the most appropriate treatment\nmethod according to the needs of the individual case.\nThe relative costs as well as the effectiveness of\nprocedures/materials\nshould\nbe\nconsidered\nand\ndiscussed with the patient. Some studies have described\nelaborate protocols combining numerous materials and\ntechniques, which means the costs of treatment increase\nwith no clear advantage in treatment outcome.\n171"
  },
  {
    "page": 172,
    "content": "Healing following treatment of peri-implantitis (and\nperi-implant mucositis) usually results in peri-implant\nmucosal recession, which may result in a compromised\nesthetic outcome. The possibility of adverse events such\nas soft-tissue recession or recurrent infection should\ntherefore\nbe\ndiscussed\nwith\nthe\npatient\nprior\nto\ntreatment.\n5.3 Non-plaque-related Biological Complications\nManagement\nof\nnon-plaque-related\nbiological\ncomplications such as oral lichen planus (Chapter\n9.2.2), peripheral giant-cell granuloma (Chapter 9.2.4),\nor carcinoma (Chapter 9.2.3) involves taking a thorough\nmedical\nhistory\nand\nan\nappropriate\nbiopsy\nfor\nhistopathologic evaluation in order to make a definitive\ndiagnosis. Referral to an oral-medicine specialist or an\noral and maxillofacial surgeon is recommended for\nassessment and appropriate treatment. Examples of the\ntreatment\nof\nvarious\nnon-plaque-related\nbiological\ncomplications are outlined in the case reports in Chapter\n9. While such complications are rare, the consequences\nmay be severe and the clinician must be familiar with\ntheir\nclinical\npresentation\nin\norder\nto\navoid\nmisdiagnoses and inappropriate treatment.\n172"
  },
  {
    "page": 173,
    "content": "5 Management of Biological Complications\nL. J. A. Heitz-Mayfield\n173"
  },
  {
    "page": 174,
    "content": "6.1 Hardware Complications\n6.1.1 Fracture and Loss of Implants\nWhen implants fracture and the decision is made to\nreplace the implant in the same position, steps need to\nbe taken to retrieve the part of the implant that remains\nembedded in the bone. The following cases illustrate\nsome of the management issues associated with loss of\nimplants due to implant fracture.\nA reduced-diameter regular-neck tissue-level implant at\nsite 13 had been placed in a thin ridge to avoid a GBR\nprocedure and to offer a less costly solution. After five\nyears, the patient complained about a mobile implant\ncrown (Figs 1a-f). A fracture line was visible on the\nperiapical radiograph at the level of a vertical bony\ndefect. The crown could be removed completely,\ntogether with the neck portion of the implant. Three\nweeks later, the mucosa had completely overgrown the\nnow submerged implant fragment.\nA mucoperiosteal flap was raised so the fractured\nimplant could be removed. Since the implant platform\nwas\nlost,\nthe\nexplantation\nset\nand\ncorresponding\ntrephine could not be used (ten Bruggenkate and\ncoworkers 1994).\n174"
  },
  {
    "page": 175,
    "content": "Fig 1a Radiograph obtained after the patient had\ncomplained about a mobile implant crown. A vertical\nbone defect reached the level of the abutment screw. A\nfracture line was visible.\n175"
  },
  {
    "page": 176,
    "content": "Fig 1b Ruptured coronal part of a reduced-diameter\nregular-neck tissue-level implant together with the\ncemented crown.\n176"
  },
  {
    "page": 177,
    "content": "Fig 1c After removal of the fractured coronal part, soft\ntissue had grown over the implant fragment within a\nfew weeks.\nFig 1d The remaining implant fragment had to be\nremoved by separating it from the surrounding bone\nwith small drills. This resulted in a large bone defect on\nthe buccal aspect.\n177"
  },
  {
    "page": 178,
    "content": "Fig 1e A new tissue level implant with a regular-neck\ndesign but with a standard diameter (4.1 mm) was\nplaced. This intervention required considerable bone\naugmentation.\n178"
  },
  {
    "page": 179,
    "content": "Fig 1f After cementation of the new crown, a tissue\ndefect remains, despite augmentation procedures.\nThe\nstill\nosseointegrated\nimplant\nfragment\nwas\ntherefore separated from the surrounding bone with\ndrills and removed towards the buccal side.\nLater, a GBR procedure was performed and a new\nimplant (Regular Neck, diameter 4.1 mm; Institut\nStraumann AG, Basel, Switzerland) was placed. The\nnew metal-ceramic\ncrown and associated surgical\nprocedures were offered to the patient free of charge.\nThe implant fragment had to be removed before a new\nimplant could be placed. This was associated with\nadditional\nsurgical\nand\nprosthetic\ninterventions,\nmorbidity, discomfort and considerable costs; legal\nconsequences may also ensue.\nIn the mid-seventies, Schroeder and coworkers (1988)\ntreated\npatients\nwith\nfree-end\nsituations\nat\nthe\nUniversity\nof\nBern,\nSwitzerland\nusing\nan\nearlier\ngeneration of Straumann dental implants, the so-called\nbasket-type implants.\nFor the case presented in Figures 2a-e and 3a-i, this had\nbeen the only alternative to a removable partial denture.\nThe implants were placed in the molar area and often\nsplinted to natural teeth. The patient had originally\nreceived metal-ceramic FDP (i35-x-i37 and i47-x-x-44).\nThe FDP were cemented on the abutment teeth with\nzinc-phosphate\ncement\nbut\nscrew-retained\non\nthe\n179"
  },
  {
    "page": 180,
    "content": "implants. This concept keeps available options open in\ncase the retention is lost on the more mobile abutment\nof the FDP. After the loss of the hollow-cylinder\nimplant 35, a new FDP was fabricated (34-x-x-i37).\nAfter the loss of tooth 34, the one-piece implant 37\nfractured. It was decided to leave the well-integrated\nbasket-cylinder\nimplant\nin\nplace.\nThe\nmorbidity\nassociated with the removal of the large fragment in this\nmandibular molar region was considered too high.\nTwo\nimplants\n(Regular\nNeck,\ndiameter\n4.1\nmm;\nStraumann) were then placed at sites 34 and 35; a\ncantilever FDP (i34-i35-x) now ensured function in this\nquadrant.\nFig 2a Three-unit metal-ceramic FDP (i35-x-i37) on\nhollow-cylinder and basket implants as delivered (July\n1985).\n180"
  },
  {
    "page": 181,
    "content": "Fig 2b The radiograph of June 1994 shows the mesial\nimplant missing; a new FDP (34-x-x-i37) is present.\nFig 2c In the periapical radiograph with a gutta-percha\npoint in January 2002, the endodontically treated tooth\n34 with its post-and-core seems to be hopeless. The\ntooth was extracted and the FDP was separated mesially\nof implant 37.\n181"
  },
  {
    "page": 182,
    "content": "Fig 2d The distal abutment had failed because of an\nimplant fracture. The radiograph of January 2007 shows\na new FDP (i34-i35-x). The fragment of implant 37\nremains integrated in the bone.\n182"
  },
  {
    "page": 183,
    "content": "Fig 2e The coronal part of the implant ruptured at the\nbase to the basket construction.\nFor the same patient as in Figures 2a-e, the failure of a\nmixed tooth/implant-supported FDP (i47-x-x-44) is\ndocumented.\nThe original FDP was delivered in July 1985. After\neight years, loss of retention was noticed at the natural\nabutment. The tooth was endodontically treated and a\npost-and-core adapted underneath the retrievable FDP.\nThe original reconstruction could be maintained until\nthe abutment tooth was extracted.\nLater, a new implant was placed at site 44. The old\nbasket-type implant was then splinted with a synOcta®\nRegular Neck (RN) implant (Straumann). (The original\naluminum impression posts were still available from the\nmanufacturer.)\nThis patient is a typical example of a case with multiple\ncomplications\nand\nfailures.\nIn\nthe\nmaxilla,\nthe\nreconstructions exhibited loss of retention, caries, and\nother problems. At present, the maxilla is restored with\nan overdenture supported by implants 15 and 13 and\nnatural teeth 23 and 25.\n183"
  },
  {
    "page": 184,
    "content": "Fig 3a Periapical radiograph of a FDP (i47-x-x-44;\nsame patient as in Fig 1) delivered in July 1985.\n184"
  },
  {
    "page": 185,
    "content": "Fig 3b In November 1993, a loss of retention was\nobserved\nat\nthe\ntooth\nabutment.\nTooth\n44\nwas\nendodontically treated and received a post-and-core.\nFig 3c The repaired FDP a week later.\nFig 3d In November 1997, it was decided to remove the\nperiapically infected tooth 44.\n185"
  },
  {
    "page": 186,
    "content": "Fig 3e A regular-neck standard-diameter implant was\nplaced at site 44 in April 1998.\nFig 3f Occlusal view of the one-piece basket-type\nimplant 47 with the prosthetic post for screw retention\nand the synOcta® abutment 44.\n186"
  },
  {
    "page": 187,
    "content": "Fig 3g Impression taking with the old but still available\nimpression post for the basket-type implant as well as\nwith the synOcta® open-tray impression post (at that\ntime not yet color-coded).\nFig 3h Control radiograph of the FDP (i47-x-x-i44)\ncombining an old- and a new-generation implant.\n187"
  },
  {
    "page": 188,
    "content": "Fig\n3i\nPanoramic\nradiograph\nobtained\nafter\nreconstruction of the maxilla with an overdenture with\nfour spherical attachments on implants 14 and 12 and\nnatural teeth 23 and 24 (December 2012).\n6.1.2 Unfavorable Three-dimensional Position of the\nPlatform\nWhen implants are placed without a properly designed\nprosthodontically driven treatment plan, this can result\nin an unfavorable three-dimensional position of the\nimplant platforms relative to each other (with multiple\nimplants) and adjacent teeth. The following cases\nillustrate the problem of implant malposition and the\nmanagement issues that arise.\nInterference with standard prosthetic procedures. In\nthe following clinical situation, the three-dimensional\npositions\nof\nthe\nimplants\ninterfere\nwith\nstandard\nprosthetic\nprocedures.\nThe\nextruded\nmandibular\nanteriors almost touch the palatal papilla. Regular-neck\n188"
  },
  {
    "page": 189,
    "content": "tissue-level implants were placed at sites 13, 11, 21, and\n23. There is not enough space for a regular connection\nto implants 11 and 21 (Figs 4a-f).\nThe patient received a long-term provisional (i13-x-\ni11-i21-x-i23)\nand\nwas\nscheduled\nfor\northodontic\ntreatment in the mandible after extraction of tooth 31 to\nprovide\nspace\nfor\nthe\nprosthetic\ncomponents.\nA\nreduction of the lower anteriors by preparation, crown\nlengthening, composite, or veneers was discussed as an\nalternative.\nDistances not respected. In this clinical case, two\nimplants had been placed at sites 46 and 47. The choice\nof implant platform (two regular-neck tissue-level\nimplants) and the distances from the adjacent teeth, as\nwell as the position of the implant platform in relation\nto the cementoenamel junction of tooth 48, resulted in a\nsituation that created reconstructive problems (Figs\n5a-b).\nThe distances do not favor a three-unit FDP, while the\nreconstruction on implant 47 cannot be given an\noptimized emergence profile.\nThe patient had already worn several reconstructions of\ndifferent designs but rejected all of them due to food\nimpaction.\nThe\nfinal\nversion\nuses\ntwo\nlong-term\ntemporary crowns, which leave an intentional gap.\n189"
  },
  {
    "page": 190,
    "content": "Fig 4a Frontal view illustrating the limited space\nbetween the tissue level implants at sites 13, 11, 21, 23.\nThe patient has a deep bite and the mandibular anteriors\nseem to be extruded towards the opposing jaw.\nFig 4b The laboratory-made long-term provisional\n(i13-x-i11-i21-x-i23) is directly screw-retained on the\nimplants. The lower incisors come close to the occlusal\nscrews at sites 11 and 21.\n190"
  },
  {
    "page": 191,
    "content": "Fig 4c The inserted long-term provisional will be used\nto manipulate the soft tissues for improved emergence\nprofiles, papilla formation, and phonetics. The patient\nwill also undergo orthodontic therapy with intrusion of\nthe lower incisors, of which one will be extracted. This\nwill create more space for the components required for\nthe\nocclusally\nscrew-retained\nFDP\non\ntissue-level\nimplants in the maxilla.\n191"
  },
  {
    "page": 192,
    "content": "Figs 4d-f Radiographs of the implants at sites 13, 11,\n21, and 23 with the long-term provisional in place. The\nimprovised connections of the temporary abutments are\nvisible.\nFig 5a Unfavorable distances between implants and\nbetween implants and adjacent teeth. As a compromise,\ntwo long-term provisional crowns were fabricated with\na gap to test if food impaction could be reduced\ncompared to the different crown and FDP designs the\npatient had previously tried.\n192"
  },
  {
    "page": 193,
    "content": "Fig 5b The emergence profile of the molar crown was\nunfavorable due to the small implant platform; it was\npositioned too far coronally, and the distance between\nthe implant and the molar was too great.\nAxes not respected. The two implants 11 and 21 had be\nen placed in combination with a GBR procedure (Figs\n6a-i). However, they were positioned too far facially\nand with unfavorable implant axes. Since facially bone\nwas still present, a soft-tissue grafting procedure was\nperformed to provide an adequate tissue seal. Long-\nterm provisionals achieved an acceptable esthetic result.\nThe long-term stability of the facially bone plate is at\nrisk.\n193"
  },
  {
    "page": 194,
    "content": "Fig 6a Implants 11 and 21, ready to be restored.\nFig 6b The implants were placed too far labially.\n194"
  },
  {
    "page": 195,
    "content": "Fig 6c The axes of the two implants were tilted too far\nlabially.\nFig 6d Poor result with the first set of provisionals.\n195"
  },
  {
    "page": 196,
    "content": "Fig 6e Soft-tissue graft to improve the condition of the\nmucosa.\nFig 6f First wax-up.\n196"
  },
  {
    "page": 197,
    "content": "Fig 6g CARES® abutments (Straumann) with labial\naccess channels.\nFig 6h Second wax-up with the CARES® abutments.\n197"
  },
  {
    "page": 198,
    "content": "Fig 6i Definitive crowns.\n6.1.3 Complications Related to Abutments\nHardware complications can occur at the level of the\nabutments, as illustrated in the following case.\nAbutment fracture. A 65-year-old patient received two\nimplant-supported fixed reconstructions (x-i16-i15-x-\ni13-x-i11 and x-i22-x-x-i25-i26) (Figs 7a-e).\nThe screws of the FDP in the first quadrant loosened\nrepeatedly. Merely retightening the occlusal screw did\nnot stabilize the situation. The FDP was removed\ncompletely and the abutments were controlled and\nretorqued. It was then noted that the base of one of the\nabutments had fractured from the rest of the component.\nThe synOcta® abutments (Straumann) are fabricated\nfrom three components: a base, the abutment, and the\nabutment screw. In this instance the “laser suture” had\n198"
  },
  {
    "page": 199,
    "content": "broken. A new corresponding abutment was inserted\nand torqued to 35 Ncm, and the FDP was now stable for\nten years. The occlusion and articulation were checked\nand the patient was advised to wear the existing\nprotective splint regularly.\nFig 7a After removal of the FDP (x-i22-x-x-i25-i26),\nwhose occlusal screw of the FDP loosened repeatedly.\nThe coronal part of the synOcta® abutment on implant\n25 had fractured from its base and could be removed.\n199"
  },
  {
    "page": 200,
    "content": "Fig 7b The abutment screw was removed with the base\nof the abutment.\nFig 7c The synOcta® connection was free of fragments.\nA pristine abutment could be inserted.\n200"
  },
  {
    "page": 201,
    "content": "Fig\n7d\nThe\nFDP\nwere\nreseated\nafter\ncontrolled\ntorqueing of all the abutments (35 Ncm) and occlusal\nscrews (15 Ncm).\nFig 7e The patient was motivated to wear a protective\nnightguard.\n201"
  },
  {
    "page": 202,
    "content": "Fig 8a The implant crown with the solid abutment had\nfractured in a bicycle accident. The broken abutment\ncomponent could be removed by the emergency dentist\nwith a probe. A healing screw had been inserted.\nFig 8b A matching new solid abutment was chosen and\nscrewed in place at 35 Ncm.\n202"
  },
  {
    "page": 203,
    "content": "Fig 8c The—still intact—metal-ceramic crown could be\nreused but had to be adapted in the area of the groove\nand the flat surface of the abutment.\n203"
  },
  {
    "page": 204,
    "content": "Fig 8d The abutment was shaped to match the old\ncrown.\nFig 8e Fit Checker (GC, Tokyo, Japan) was used to\nevaluate the amount of reduction required.\nFractured abutment due to trauma. A 60-year-old\npatient had received a metal-ceramic crown cemented\non a solid abutment. She had lost the crown in a bicycle\naccident and injured her lip. After emergency treatment\nand healing of the lip wound, she was examined to\ninvestigate the options of a remake or repair of the\ncrown (Figs 8a-e).\nThe remaining fragment of the solid abutment could be\nremoved\nmanually.\nA\ncorresponding\nnew\nsolid\nabutment was inserted at 35 Ncm of torque. The shape\nof the abutment was adapted to the inside of the crown.\nFit Checker (GC Corporation, Tokyo, Japan) was used\nto\nindicate\nand\nguide\nthe\namount\nof\nmaterial\nremovalrequired.\n204"
  },
  {
    "page": 205,
    "content": "The interior aspect of the crown (the “groove part”) had\nto be adjusted because the old Bonefit® implants\n(Straumann) provided no stop position. The internal\nround conical connection did not allow the exact\nreplacement of a torqued abutment (as there was no\nindex). The abutment and crown could be adjusted to a\nsatisfactory level of marginal fit and good retention for\ncementation. The crown was cemented with a glass-\nionomer cement.\n6.1.4 Complications Related to Abutment Screws\nSeveral problems arising from the screws connecting\nthe abutment to the implant may be encountered in\nclinical practice.\nDamage to abutment-screw insert. A 70-year-old\npatient was referred for removal of an abutment with a\nnon-engaging abutment screw. The dentist had decided\nto remake a metal-ceramic crown after severe ceramic\nchipping, but the abutment screw could not be removed;\nobviously, the insert had been damaged. A stainless-\nsteel drill from the service set was used to drill directly\ninto the head of the abutment screw. These drills are\napplied at low speed with ample irrigation (Fig s 9a-f).\nThe extraction bolt could then be inserted into the\ncavity. The threads engaged the lateral walls of the\ndrilled access canal so that the ratchet could pry the\nabutment loose. A healing abutment was inserted after\ncareful rinsing of the connection area, and the patient\nwas referred back for the fabrication of the planned new\ncrown.\n205"
  },
  {
    "page": 206,
    "content": "Fig 9a SynOcta® abutment (Straumann) surrounded by\nexcessive soft tissue that had overgrown the implant\nshoulder. The abutment screw was filled with debris.\nFig 9b The head of the abutment screw was damaged,\nso that the screwdriver did not engage. Steel drills from\nthe service set were used to drill through the head of the\nabutment screw.\n206"
  },
  {
    "page": 207,
    "content": "Fig 9c Ample irrigation was necessary to avoid\noverheating the surrounding tissue.\nFig 9d An access opening about 3 mm in depth was\nprepared.\n207"
  },
  {
    "page": 208,
    "content": "Fig 9e The extraction bolt (6°) was first turned into the\ncomponent manually until it caught. The torque was\napplied with the ratchet set at the “unscrew” level.\nFig 9f The removed synOcta® abutment.\n208"
  },
  {
    "page": 209,
    "content": "Fig 10a Components of the service set applied for the\nguided removal of fractured abutment screws in a bone-\nlevel implant: thread-removal tools, drilling guides,\nmilling cutters, drills, and taps.\n209"
  },
  {
    "page": 210,
    "content": "Fig 10b The metal-ceramic crown 23 had loosened\nrepeatedly. A torque of more than 35 Ncm was applied,\nwhich resulted in fracture of the abutment screw.\n210"
  },
  {
    "page": 211,
    "content": "Fig 10c Application of a thread-removal tool as a first\nattempt for easy retrieval of the fractured component.\n211"
  },
  {
    "page": 212,
    "content": "Fig 10d The fragment could not be removed in this\nmanner.\n212"
  },
  {
    "page": 213,
    "content": "Fig 10e Positioning of the drilling guide.\n213"
  },
  {
    "page": 214,
    "content": "Fig 10f With the milling cutters (left-hand cutting),\nfragments were removed down to the base of the\nabutment.\nFractured screw of a gold abutment. To restore a\nmissing canine at site 23, a metal-ceramic crown was\nconstructed\non\na\nbone-level\nimplant.\nA\ncontrol\nradiograph was taken with the impression post in place.\nThe patient appeared repeatedly as an emergency\npatient due to screw loosening. The one-piece crown\nwas finally torqued to more than 35 Ncm; as a\nconsequence, the abutment screw fractured with a\nfragment remaining in the CrossFit® connection. The\nradiograph with the impression post showed that no\nclose fit was present; obviously, the impression post for\na narrow CrossFit connection had been used. The\ntechnician had therefore used the wrong implant analog\nand the wrong gold coping.\nAs could be expected, the CrossFit® (Straumann)\nconnection of the final crown was not good either, as\nthe walls did not match—which explained the repeated\nloosening. After applying the service set for bone-level\nimplants and components, the fractured segment could\nbe removed under controlled conditions (Figs 10a-m).\nFollowing rinsing, the correct RC impression post was\nused and a well-fitting crown was fabricated. No more\nscrew loosening occurred with the new crown.\n214"
  },
  {
    "page": 215,
    "content": "Fig 10g The stop on the drilling guide prevented\noverinstrumentation.\n215"
  },
  {
    "page": 216,
    "content": "Fig 10h Changeover to the steel drills (left-hand\ncutting)\nFig 10i Final drill guided by the precision instrument to\nremove the fragment.\n216"
  },
  {
    "page": 217,
    "content": "Fig 10j The necessary depth was reached with the final\ntap. The remaining particles were removed completely\nfrom the bore in the implant.\nFigs 10k-m The radiographs finally revealed the cause\nof the failure: an incorrect impression post—narrow\nCrossFit® instead of regular CrossFit®—had been\nused. As a consequence, the lab used the wrong implant\n217"
  },
  {
    "page": 218,
    "content": "analog and a gold abutment that was too small, so the\nCrossFit®\nconnection\nwas\nnot\nfunctional.\nThe\ncorresponding gaps can be seen in the first two\nradiographs (arrow), whereas no gap is present with the\nnew regular CrossFit® impression post.\nRemoval of an abutment screw. In a 35-year-old\npatient, tooth 11 had to be replaced with an implant\ncrown due to trauma. A Regular CrossFit® RC\n(Straumann)\nbone-level\nimplant\nwas\nplaced\nin\ncombination with a GBR procedure.The patient wore a\nlong-term provisional crown for four months to adapt\nthe soft-tissue profile and to optimize the papilla\nconfiguration using the dynamic compression technique\n(Wittnebenand coworkers 2013b). During delivery of\nthe\ndefinitive\none-piece\nCARES®zirconia\ncrown\n(Straumann), the abutment screw fractured at about 30\nNcm. The base of the abutment screw remained in the\nRC connection (Figs 11a-v).\nThe position of the crown had changedafter the fracture.\nDespite the fractured component, the provisional crown\ncould still be used to maintain the soft-tissue contour.\n218"
  },
  {
    "page": 219,
    "content": "Fig 11a A veneered zirconia CARES® crown was\nready for delivery. During torqueing to 35 Ncm, the\nabutment screw fractured at about 30 Ncm.\nFig 11b The crown could not be returned to its position.\n219"
  },
  {
    "page": 220,
    "content": "Fig 11c The fractured abutment screw with the flat head\nbase for ceramic crowns. The apical portion had\nremained in the implant.\nThe patient was scheduled for an open-end session, and\nthe service set was ordered and prepared together with\nthe components for the bone-level supplement. The\nprovisional crown was removed. The tools of the\nservice set were used according to the instruction\nmanual\nunder\ngood\nergonomic\nand\nillumination\nconditions.\nA first attempt to unscrew the fractured part with the\nthread-removal tool was unsuccessful, so the drilling\nguide was inserted into the implant. The configuration\nof the RC connection allowed accurate positioning. The\nwings of the device were secured on the neighboring\nteeth. The milling cutters and the drills were applied in\ndue order, with manual tapping at low speed and ample\ncooling.\n220"
  },
  {
    "page": 221,
    "content": "The\nmost\nimportant\nprerequisite\nfor\ncorrect\ninstrumentation is parallelization with the implant axis.\nMisalignment can lead to immediate fracture of the\ndrills.\nThe cutting effect was evident, with the metal particles\ntransported coronally and remaining on the drills. The\nsite was rinsed repeatedly. The correct depth was\nindicated on the instruments. Taps 1, 2, and 3 were\napplied, centered by the drilling guides. Silicon oil\nhelped ease the tapping process. After another rinse, the\nCrossFit® connection was tested for undisturbed access\nwith a new abutment screw.\nThe final fit and correct position was verified with the\ndefinitive crown. The abutment screw was torqued in\nplace, keeping the screwdriver parallel and away from\nthe ceramic walls of the access hole and correctly\npressed onto the screw head. The access hole was then\nclosed with Teflon and light-curing silicone.\nAfter one month, the site demonstrated a tight fit and\ncorrect position, and a complete papilla had formed.\nThe access hole was closed with Teflon and a\ncomposite filling. A control radiograph confirmed the\ncorrect seating of the crown in the connection.\nThe fragment visible in the radiograph was removed\nsuccessfully.\n221"
  },
  {
    "page": 222,
    "content": "Fig 11d Unscrewing attempt using the thread-removal\ntool.\n222"
  },
  {
    "page": 223,
    "content": "Fig 11e The fragment would not move.\n223"
  },
  {
    "page": 224,
    "content": "Fig 11f Steel drills and the drilling guide.\nFig 11g Secure position of the drilling guide.\n224"
  },
  {
    "page": 225,
    "content": "Fig 11h Drilling parallel to the long axis of the implant.\n225"
  },
  {
    "page": 226,
    "content": "Fig 11i Ample cooling is required, less than 200 rpm,\nleft-hand drilling.\nFig 11j Drill cutting through the fragment. Loose\nparticles need to be rinsed out.\n226"
  },
  {
    "page": 227,
    "content": "Fig 11k This tap broke due to deviation from the long\naxis.\n227"
  },
  {
    "page": 228,
    "content": "Fig 11l The first tap reaching the bottom of the\nCrossFit® connection.\n228"
  },
  {
    "page": 229,
    "content": "Fig 11m A positioning screw was used to check the\nregular function of the screw retention.\n229"
  },
  {
    "page": 230,
    "content": "Fig 11n The connection was rinsed carefully.\n230"
  },
  {
    "page": 231,
    "content": "Fig 11o Final tap with the guidance instrument.\nFig 11p Drills and taps used to rescue the crown and\nimplant. The drills needed to be replaced (single use\nonly).\nFig 11q The original position of the CARES® crown\nwas restored.\n231"
  },
  {
    "page": 232,
    "content": "Fig 11r The one-piece CARES® crown with a zirconia\nframework and direct veneering.\nFig 11s Smile, lateral view.\n232"
  },
  {
    "page": 233,
    "content": "Fig 11t Smile, frontal view.\nFigs 11u-v Periapical radiographs with the zirconia\nfragment and the final crown in situ.\n6.1.5 Complications Related to Retention\nBetween the prosthetic components of an implant\nsystem and the matching screw-retained prosthesis there\n233"
  },
  {
    "page": 234,
    "content": "are always voids. A completely tight fit would make the\nhandling of the components impracticable. A certain\namount\nof\ntolerance\nis\nbuilt\ninto\nall\ninterfaces.\nTherespective areas are exposed to leakage. In an\nanaerobic environment, microbial plaque can develop\nand\nwill\nbe\nprotected\nfrom\nany\nattempts\nat\nmechanicalcleaning or antiseptic rinses. The following\ntwo clinical cases are characterized by considerable\nplaque deposits in the abutment region (Figs 12 and 13).\nThesame bacteria may also be responsible for bad\nbreath and may cause infection of the adjacent tissues.\nFig 12 Plaque deposits uncovered on removal of a\ntransversally screw-retained crown.\n234"
  },
  {
    "page": 235,
    "content": "Fig 13 Abutment overgrown with plaque deposits. The\nsurrounding tissue is chronically inflamed.\nScrew loosening with possible fistula formation. A\n67-year-old patient received a bone-level implant. A\nlong-term provisional was provided to create an optimal\nemergence profile. The patient then went on vacation\nfor two months; during the final week the patient had\nrealized that the temporary crown became mobile. She\ndid not see an emergency dentist abroad, and during\nthat short time, a fistula developed that originated from\nthe connection area of the mobile temporary abutment\n(Figs 14a-e).\n235"
  },
  {
    "page": 236,
    "content": "Fig 14a A long-term temporary crown was installed for\nthe conditioning of the emergence profile.\nFig\n14b\nA\nfavorable\nresult\nwith\nno\nsigns\nof\ninflammation was achieved.\n236"
  },
  {
    "page": 237,
    "content": "Fig 14c During the vacation, the provisional crown\nbecame mobile and a fistula developed.\nFig 14d After removal of the temporary crown. The\nmucosa was inflamed and a small fistula is visible.\n237"
  },
  {
    "page": 238,
    "content": "Fig 14e Definitive crown inserted at 35 Ncm with stable\nconditions.\nCement excess. In a 45-year-old patient, a missing\nlateral incisor was replaced with an implant-supported\ncrown. A tissue-level implant was placed fairly deeply,\nwith the implant shoulder at the bone crest. The metal-\nceramic\ncrown\nwas\ncemented\nwith\nglass-ionomer\ncement. The control radiograph revealed excess cement\npressed into the tissues. The patient was scheduled for a\nsurgical intervention the following day to remove the\ncement particles (Figs 15a-d).\n238"
  },
  {
    "page": 239,
    "content": "Fig 15a Control radiograph after cementation of a\nmetal-ceramic crown on a tissue-level implant at site\n12.\n239"
  },
  {
    "page": 240,
    "content": "Fig 15b The patient was scheduled for an open-flap\nprocedure the following day. The cement particles had\nbeen pushed into the connective tissue and underneath\nthe periosteum.\n240"
  },
  {
    "page": 241,
    "content": "Fig 15c One year after the surgical intervention.\nFig 15d Control radiograph. No more particles are\nvisible.\nUpon flap elevation, the white particles pressed in\nunderneath the periosteum were evident. After careful\nremoval and rinsing, sutures were placed. A clinical\nexamination at one year revealed neither recession nor\nsigns of infection at the site. The radiograph showed no\nbone damage.\nRetrievability of cemented crowns. The safest way to\nremove a cemented reconstruction is to break the\ncement seal. The superstructure can be clamped with a\nforceps with rubber-protected jaws. A pulsing device to\nbreak the cement seal may be helpful (CORONAflex®;\n241"
  },
  {
    "page": 242,
    "content": "KaVo, Biberach, Germany). The force applied with the\nmobile abutment screw remaining in the bore must not\ndamage the implant connection. If the cement seal\ncannot be broken, the crown must be cut down to the\ndepth of the cement seal between the crown and the\nabutment.\nIn metal-ceramic reconstructions, the ceramic veneer\ncan be prepared with a rough diamond followed by a\nsteel drill. In zirconia frameworks, a special spiral-\nshaped diamond seems to be efficient (JOTA service\nset; Jota, Rüthi, Switzerland).\nCutting should remove the superstructure and provide\naccess to the abutment screw. If the screwdriver\nengages at this point, the abutment can be completely\nremoved. If the regular screwdriver does not engage\nbecause of prior damage to the head of the abutment\nscrew, the service set from the respective implant\nmanufacturer will be needed.\nIn the case shown here (Figs 16a-c), implants 46 and 45\nhad been restored with splinted metal-ceramic double\ncrowns on solid abutments, and cemented with a glass-\nionomer\ncement.\nAfter\nsix\nmonths,\nthe\npatient\ncomplained about ceramic chipping that led to food\nimpaction.\nAttempts\nto\nremove\nthe\ndouble\ncrown\nwith\nthe\nCORONAflex were unsuccessful. The dentist was\nadvised to separate the crown with diamond burs for the\nceramic\nand\nwith\nstainless\nsteel\ndrills\nfor\nthe\nframework.\n242"
  },
  {
    "page": 243,
    "content": "Apparently,\nthe\nborderbetween\nthe\nframework,\ncementum, and abutment had been missed, so the\ncutting had damaged the solid abutment with the insert\nfor the screwdriver. Thus for the removal of the\nnon-retrievable solid abutment the service set had to be\nused for detorqueing the abutment in a controlled way.\nFig 16a A metal-ceramic double crown was inserted on\nimplants 45 and 46. Chipping in the ridge region\noccurred after one year.\n243"
  },
  {
    "page": 244,
    "content": "Fig 16b The crowns, which had been cemented with a\nglass-ionomer cement, could not be removed even with\nthe CORONAflex system. The crowns were therefore\ncut. During cutting, the insert for the screwdriver in the\nsolid abutment of the distal implant was damaged.\n244"
  },
  {
    "page": 245,
    "content": "Fig 16c A conical extraction bolt was applied after\ndrilling an access hole into the solid abutment with the\nsteel drills. Ratchet and bolts with 6° conicity.\nRepeated loosening of an occlusal screw. A 67-year-\nold patient had received a LOCATOR® overdenture in\nthe maxilla and a metal-ceramic crown on a wide-neck\nimplant at site 46 and a cantilever FDP (x-i36) at site\n36, also on a Wide Neck (WN) implant and a synOcta®\nabutment (both Straumann) torqued to 35 Ncm. The\nseparate framework on implant 36 was made using a\ngold coping. The final reconstruction was tightened to\n15 Ncm as recommended by the manufacturer.\nThe patient experienced repeated screw loosening at\nsite 36.\nIt was decided to take a new impression and to\nconstruct the new framework with a gold abutment. The\nnew FDP was a one-piece reconstruction tightened to\n35 Ncm. It is expected that the biomechanical risk for\nscrew loosening has been reduced (Figs 17a-p).\n245"
  },
  {
    "page": 246,
    "content": "Fig 17a Frontal view after insertion of a LOCATOR®-\nretained overdenture in the maxilla as well as an\nimplant-supported crown at site 46 and a cantilever\nFDP at site 36 (x-i36).\nFig 17b Lateral view of the two-unit FDP.\n246"
  },
  {
    "page": 247,
    "content": "Fig 17c The FDP was transocclusally screw-retained.\nFig 17d Radiograph of site 46.\n247"
  },
  {
    "page": 248,
    "content": "Fig 17e Control radiograph of site 36.\nFig 17f The cantilever FDP at site 36 was designed with\na separate synOcta® abutment for screw retention;\ntherefore, the retention is based on two screws.\n248"
  },
  {
    "page": 249,
    "content": "Fig 17g Screw loosening at site 36 had occurred several\ntimes.\nFig 17h A new impression was taken and a healing\nabutment inserted.\n249"
  },
  {
    "page": 250,
    "content": "Fig 17i The two-unit FDP was designed in one piece\nwith only one abutment screw.\nFig 17j Patient smile.\n250"
  },
  {
    "page": 251,
    "content": "Fig 17k Frontal view.\nFig 17l Lateral view.\n251"
  },
  {
    "page": 252,
    "content": "Fig 17m Lateral view.\nFig 17n Occlusal view of the palate-free overdenture.\n252"
  },
  {
    "page": 253,
    "content": "Fig 17o Occlusal view after closing the access holes\nwith a composite restorative material.\nFig 17p One-piece reconstruction made with a gold\nabutment to reduce the number of interfaces.\nNon-retrievable occlusal screw. If the head of the\nocclusal screw is damaged, it may be non-retrievable. In\nthis clinical case, the patient had already received\n253"
  },
  {
    "page": 254,
    "content": "implants in the late 1980s. Due to unresolvable\nendodontic problems with remaining anterior maxillary\nteeth, a new treatment plan included the removal of\nthese teeth and the placement of additional implants.\nThis required the removal of the first generation of\nfixed reconstructions. The existing implants in the\nmaxilla could be used to support a cross-arch cantilever\ndenture.\nThe attempt to remove the transocclusally screw-\nretained FDP turned out to be complicated (Figs 18a-e).\nDue to attrition, the head of the occlusal screw did not\nengage the screwdriver. The drills of the service set\nwere therefore used to drill directly into the screw head.\nAfter enlargement and drilling to a depth of 3 mm, the\nextraction bolt was activated with the ratchet after the\nFDP had been segmented with diamond disks and cut\nback to allow rotation. Upon application of torque, the\nentire complex consisting of occlusal screw, crown, and\nabutment came loose in one piece.\nThe old implants could subsequently be splinted with\nthe new ones and a new reconstruction fabricated.\n254"
  },
  {
    "page": 255,
    "content": "Fig 18a The patient had already received implants in the\nlate 1980s. A new treatment plan required the removal\nof the first generation of fixed reconstructions. As a\nresult of attrition and the coronal position of the screw\nheads, the crosshead had worn away completely in one\nof the occlusal screws.\n255"
  },
  {
    "page": 256,
    "content": "Fig 18b Using the spiral drills and the extraction bolt,\nthe entire superstructure was removed.\n256"
  },
  {
    "page": 257,
    "content": "Fig 18c The FDP had to be segmented to allow\nunscrewing.\n257"
  },
  {
    "page": 258,
    "content": "Fig 18d After many years in function, the occlusal\nscrew, crown, and abutment were fused and came out in\none piece.\nFig 18e Following placement of additional implants, the\nmaxilla was restored with a full-arch screw-retained\nFDP with denture teeth and an acrylic veneer.\n6.1.6 Complications Related to Healing Abutments\nThe following examples illustrate some of the problems\nthat may be encountered with healing abutments.\nDamage to the insert of a healing abutment. A patient\nwith a non-retrievable implant component was referred\nwith a request to remove the healing abutment from\nimplant 33 (Figs 19a-c).\n258"
  },
  {
    "page": 259,
    "content": "Fig 19a The two implants were ready for impression-\ntaking. Deposits were present in the SCS part. The\nscrewdriver did not engage, so the healing abutment\ncould not be removed.\nFig 19b After preparing an access hole in the healing\nabutment, an extraction bolt was tightened manually.\n259"
  },
  {
    "page": 260,
    "content": "Fig 19c With the ratchet set to “unscrew,” the blocked\ncomponent was removed.\nThe patient had been scheduled for impressions in a\nprivate\npractice.\nThe\nconnection\nbetween\nthe\nscrewdriver\nand\nthe\nhealing\nabutment\nhad\nbeen\ndamaged.\nA first attempt consisted in the removal of the deposits\nin the insert of the healing abutment. The connection\nwas damaged considerably, and no detorquing force\ncould be applied with a screwdriver. Therefore, a\n1.6-mm drill from the service set was used to prepare a\ncentral access hole in the healing abutment. At a depth\nof about 3 to 4 mm, the 6° extraction bolt was screwed\ninto the hole counterclockwise. On activating the torque\nratchet, the healing abutment was removed. After\ncareful cleaning, a new healing abutment was tightened\nmanually on the implant, and the patient was referred\nback to the private dentist.\n260"
  },
  {
    "page": 261,
    "content": "Removal of a blocked healing abutment. A 53-year-old\npatient had had a 4.1-mm-diameter regular CrossFit®\nimplant (Straumann) placed at site 15 at a private\npractice. A healing abutment was connected to the\nimplant.\nThe dentist prepared to take an impression of the\nimplant,\nbut\nthe\nhealing\nabutment\ncould\nnot\nbe\nremoved. The dentist ordered the special service set\nfrom the implant manufacturer, but attempts to reverse\ntorque of the healing abutment were unsuccessful\ndespite the fact that an access hole had been drilled and\nan extraction bolt applied.\nThe patient was then referred. The retrieval of the\nblocked healing abutment was challenging because the\noriginal screw-access hole had been damaged during\nthe initial attempts. The corresponding screwdriver no\nlonger engaged the implant component (Figs 20a-e).\nGiven the damage to the original screw-access hole in\nthe healing abutment, the hole was enlarged with a\nspecial drill from the manufacturer’s service set.\nContinuous irrigation was required to reduce the heat in\nthe implant body. The drilling speed was limited to a\nmaximum of 200 rpm. Under these conditions, the\nsharp edges of the drills were able to engage the healing\nabutment. After preparing the new access hole, the\nextraction bolt from the service set was connected and\nthe torque ratchet activated. Remarkably, the healing\nabutment still would not loosen at a reverse torque of\napproximately 50 Ncm.\n261"
  },
  {
    "page": 262,
    "content": "Fig 20a The initial attempt by the restorative dentist to\nrescue the blocked healing abutment was unsuccessful.\nFig 20b The access bore was widened for easier\napplication of the torque.\n262"
  },
  {
    "page": 263,
    "content": "Fig 20c A longer extraction bolt was provided, but the\npatient reacted to torques greater than 40 Ncm as he felt\npain in the bone.\nFig 20d CO2 was applied for two minutes with the\napplicator for vitality testing.\nThe access hole was further enlarged and reverse torque\nwas again applied with the extraction bolt, whereupon\n263"
  },
  {
    "page": 264,
    "content": "the patient began to feel pain at the implant site. The\nreverse torque required was thought to be so intense\nthat damage to the implant connection or the bone-to-\nimplant interface was possible, so the blocked healing\nabutment was cooled twice for 60 seconds with dry ice\n(CO2) on the buccal and palatal aspects. The dry ice\nwas obtained from a pressurized CO2 cylinder and\nplaced in a hollow removable carrier encased in a pencil\nstick. The interval between the first and second cooling\nwas 30 seconds. The patient was not anesthetized\nduring\nCO2\napplication,\nbut\ndid\nnot\nreport\nany\nsensitivity or pain.\nThe cooling effect reduced the preload between the\nCrossFit® connection of the implant and the conical\nnon-retrievable healing abutment. The approach of\ncreating an access hole for the application of reverse\ntorque via the extraction bolt, in combination with the\nnovel cryogenic effect, led to the successful removal of\nthe non-retrievable abutment. Neither the critical bone-\nto-implant interface nor the internal implant-thread\ngeometry was damaged. Upon removal of the healing\nabutment, it became obvious that the axis of the initial\nbore drilled by the restorative dentist did not correspond\nto the long axis of the implant. This might have\nprevented the success of the purely mechanical reverse-\ntorque\nattempts.\nThe\ncombined\ncryomechanical\nprocedure saved the implant, which was successfully\nrestored as planned by the restorative dentist. (Case:\nJoda and coworkers 2013.)\n264"
  },
  {
    "page": 265,
    "content": "Fig 20e After applying CO2 to the healing abutment and\nthe connection area, the component could be retrieved\nwith less torque.\n6.1.7 Complications\nRelated\nto\nSystems\nfor\nOverdentures\nDamage to the bar and sleeve. A 70-year-old patient\nhad received a bar overdenture in the undergraduate\ncourse at the University of Bern, Switzerland.\nThe overdenture required repeated repairs due to\ndamage to the bar and sleeve.\nIt\nwas\ndecided\nto\nchange\nthe\nbar\ndesign\nto\na\nLOCATOR® overdenture design. The synOcta® 1.5\n(Straumann) TO abutments were removed and replaced\nwith LOCATOR® (Zest Anchors LLC, Escondido,\nCalifornia, USA) abutments. One of the abutments\ncould not be removed with the screwdriver. Application\nof the stainless-steel drill followed by the extraction\n265"
  },
  {
    "page": 266,
    "content": "bolt and the ratchet resulted in carefully controlled\nremoval of the blocked abutment (Figs 21a-d).\nFig 21a A bruxism patient had fractured teeth and\nreconstructions several times. The bar components of an\noverdenture also fractured on a later occasion. The four\nsynOcta® abutments were replaced with LOCATOR®\nabutments. Three abutments could be removed using\nthe regular screwdriver and ratchet. To remove the\nfourth abutment, the drills and extraction bolt from the\nservice set were needed.\n266"
  },
  {
    "page": 267,
    "content": "Fig 21b Impressions of the LOCATOR® abutments\nwere obtained using the housings with the protective\ninserts.\n267"
  },
  {
    "page": 268,
    "content": "Fig 21c Final overdenture modified from a bar design to\na LOCATOR® overdenture design.\nFig 21d Occlusal view of the four LOCATOR®\nabutments.\nWhen the final LOCATOR® abutment had been\ntightened, an impression was taken with the metal\nhousings, and the overdenture was rebased/modified.\nFractured\nLOCATOR®abutment.\nA\nLOCATOR®\nabutment\nscrew\nhad\nfractured,\nwith\na\nfragment\nremaining in the implant. On counterclockwise drilling\ninto the center of the fragment with the stainless-steel\ndrill, the fragment loosened and could be removed (Figs\n22a-c). Very careful handling is recommended to avoid\naspiration\nin\nthese\ncases.\nAfter\nrinsing,\na\nnew\nLOCATOR® abutment was inserted and torqued to 35\nNcm. The overdenture could be returned to function\nimmediately.\n268"
  },
  {
    "page": 269,
    "content": "Fig 22a This LOCATOR®-supported partial denture no\nlonger functioned well because one of the abutments\nwas broken.\nFig 22b The top of the LOCATOR® abutment was torn\noff. The abutment screw was removed using the drills\nfrom the service set.\n269"
  },
  {
    "page": 270,
    "content": "Fig 22c With the new abutment, the overdenture was\nagain functional.\nWear\nof\nattachment\nsystems\nfor\noverdentures.\nAttachment systems for the retention of overdentures\nare exposed to wear. A patient presented with a partially\nedentulous mandible and extreme wear of the few\nremaining anterior teeth (Figs 23a-e). The patient did\nnot\nwear\nher\nremovable\npartial\ndenture,\nso\nthe\nfunctional and parafunctional forces were concentrated\nin the anterior region.\n270"
  },
  {
    "page": 271,
    "content": "Fig 23a The patient had received a LOCATOR®\noverdenture supported by implants 14, 13, 11, 21, and\n23.\nFig 23b Signs of severe attrition of the few remaining\nmandibular anteriors. The patient did not wear her\npartial denture.\n271"
  },
  {
    "page": 272,
    "content": "Fig 23c The LOCATOR® abutments showed signs of\nsevere wear; the retentive areas were damaged.\nFig 23d The inserts in the overdenture were also heavily\nworn.\n272"
  },
  {
    "page": 273,
    "content": "Fig 23e All five LOCATOR® abutments were replaced,\nand new inserts were provided. This repair took place\nfive years after delivery of the overdenture.\nThe LOCATOR® abutments showed heavy wear, and\nthe inserts were degraded. The retentive mechanism\nwas dysfunctional. All the LOCATOR® abutments\nwere replaced after five years in function and new red\ninserts\nwere\npressed\ninto\nthe\nhousings.\nThis\nimmediately restored the retention of the overdenture.\n6.2 Superstructure-related Complications\n6.2.1 Denture Teeth and Acrylic\nFracture of denture teeth. The maxilla of this 55-year-\nold edentulous patient had been reconstructed with an\noverdenture on four implants. The mandible held a\nretrievable cantilever prosthesis on 6 implants, which\n273"
  },
  {
    "page": 274,
    "content": "replaced a large volume of missing tissue. Denture\ntooth 31 fractured at the base and was replaced (Figs\n24a-b).\nFig 24a Denture tooth 31 broken out from the acrylic\nbase.\nFig 24b The overdenture was repaired the same day.\n274"
  },
  {
    "page": 275,
    "content": "6.2.2 Wear and Attrition\nRepeated fracture of denture teeth and acrylic. This\n65-year-old patient had received a cantilever prosthesis\non\nfour\nimplants,\nwhich\nwas\nscrew-retained\nand\nveneered with acrylic. The patient experienced multiple\nfractures of the denture teeth and veneer (more than ten\ntimes). It was finally decided to change the prosthesis to\na LOCATOR® overdenture. After insertion of the\nLOCATOR® denture there were no more events related\nto acrylic or denture tooth fractures (Figs 25a-d).\nFig 25a The patient had received a bar-retained\nprosthesis in the maxilla and a screw-retained acrylic\nFDP in the mandible.\n275"
  },
  {
    "page": 276,
    "content": "Fig 25b Repeated denture-tooth and acrylic fractures\noccurred.\nFig 25c The FDP was changed to a LOCATOR®\ndevice.\n276"
  },
  {
    "page": 277,
    "content": "Fig\n25d\nThe\nLOCATOR®\nabutments\nwere\nwell\ndistributed. No more tooth fractures occurred.\nAttrition, bruxism, chipping. The patient had lost and\nfractured several teeth in an accident and was treated\nwith\ntooth-supported\nand\nimplant-supported\nreconstructions in December 2006. A Michigan splint\nwas provided to protect the reconstructions, since it was\nevident that the patient was a heavy bruxer.\nIn March 2012, the FDP (x-25-26) was redone due to\nmassive chipping. In November 2013, the patient again\npresented\nwith\nmassive\nchipping,\ndestroying\na\nsubstantial share of the ceramic veneer. The chipping in\nthe maxilla was temporarily accepted, but the implant-\nsupported FDP (i35-x-i37) was scheduled for a remake\nbecause of food impaction (Figs 26a-b).\n277"
  },
  {
    "page": 278,
    "content": "Fig 26a Occlusal view of an implant-supported FDP\n(i47-x-i45). The extensive chipping could be attributed\nto insufficient framework support.\n278"
  },
  {
    "page": 279,
    "content": "Fig 26b The patient was a severe bruxer. The lateral\nview demonstrates the extensive chipping.\nIn cases with chipping, it often becomes evident that the\nrequired framework support has not been provided.\n6.2.3 Ceramic Chipping\nIn this particular case, three fixed FDP supported by\nonly four implants in each jaw were inserted to\nrehabilitate this patient. He was a severe bruxer. Since\nhe refused to accept a removable appliance, a cost-\neffective fixed reconstruction was provided. Severe\nattrition affected the reconstructions. The esthetically\ndistracting loss of the veneer ceramic in the incisal\nregion of tooth 21 was repaired with a composite filling.\nIt is unclear how long this repair will survive. Since the\nFDP is retrievable, alternative repairs in the laboratory\nare envisioned if needed (Figs 27a-d).\n279"
  },
  {
    "page": 280,
    "content": "Fig 27a Maxillary and mandibular FDP on only four\nimplants had been inserted. The chipped veneer at site\n11 is distracting.\nFig 27b Heavy signs of wear in the maxilla.\nFig 27c Heavy signs of wear in the mandible.\n280"
  },
  {
    "page": 281,
    "content": "Fig 27d Repaired upper anterior region. The incisal\nedge was adhesively reshaped with composite.\n6.3 Iatrogenic Reasons\nIn this case, the patient had expected to benefit from a\nfull-mouth rehabilitation. The treatment included the\nplacement of implants in the posterior regions, since she\nhad lost her molars to advanced periodontal disease. All\nthe teeth were prepared for ceramic crowns (Figs\n28a-e).\nUnfortunately, essential quality requirements related to\nbiological principles (biologic width, access for oral\nhygiene, regular maintenance), esthetics (non-esthetic\nreconstructions), surgical management (early loss of an\nimplant), and function were not met.\n281"
  },
  {
    "page": 282,
    "content": "With respect to occlusion and articulation, the clinical\nviews demonstrate a non-functional situation. The\npatient could not close and had no posterior contacts.\nThe patient suffered from severe pain, day and night.\nAll\nthe\nreconstructive\nelements\nwill\nhave\nto\nbe\ndisassembled and the acute pain controlled using new\ntemporaries before a new rehabilitation can be created.\nThis\nwill\nhave\nconsiderable\nfinancial\nand\nlegal\nconsequences.\nFig 28a Smile line of a recent full-mouth rehabilitation.\nNote the inflamed gingival margins.\n282"
  },
  {
    "page": 283,
    "content": "Fig 28b The large anteriors are too long and touch the\nlower lip.\nFig 28c The patient could not close in the posterior\nregion. The occlusal planes of the lower and upper\nreconstructions did not match.\n283"
  },
  {
    "page": 284,
    "content": "Fig 28d Imprecise and overcontoured reconstructions,\nespecially in the anterior region.\nFig 28e Ill-fitting crowns resulted in crown/tooth\nfracture and endodontic emergencies.\n284"
  },
  {
    "page": 285,
    "content": "6 Management of Hardware Complications\nU. Brägger\n285"
  },
  {
    "page": 286,
    "content": "7.1 Prevention of Peri-implant Infections\nPrevention\nof\nbiological\ncomplications\ninvolves\nidentification\nand\nmanagement\nof\nmodifiable\nrisk\nfactors.\nThe\nfollowing\npatient-related\nfactors\nare\nassociated with an increased risk for peri-implant\ninfection:\n•\nPoor oral hygiene\n•\nTobacco smoking\n•\nHistory of treated periodontitis\n•\nPresence of periodontal pockets (≥5 mm with\nconcomitant bleeding on probing)\n•\nLack of supportive or maintenance care\n•\nDiabetes mellitus (has also been suggested as a risk\nfactor, although poor control of the diabetes may be of\ngreater importance)\nSite-related\nfactors\nassociated\nwith\nperi-implant\ninfection include:\n•\nInsufficient bone volume at the implant recipient site\n•\nIncorrect three dimensional implant position\n•\nProximity of implants/teeth\n286"
  },
  {
    "page": 287,
    "content": "•\nInsufficient\nwidth\nof\nkeratinized\nperi-implant\nmucosa\nFor patients presenting with multiple risk factors,\nplacement of implants should be delayed until all\nfactors have been addressed. For example, in a patient\nwith periodontitis with poor oral hygiene who smokes\n20 cigarettes per day, the risks are expected to be much\ngreater than in a patient who has only one risk factor\nsuch as tobacco smoking. Implant placement should\nonly be performed when the periodontal health is stable,\nthe patient’s oral hygiene has improved (full-mouth\nplaque score/FMPS less than 20%), and smoking\ncessation advice has been provided.\nThe following stages of the implant treatment process\nplay an important role in the prevention of future\nbiological complications:\n7.1.1 Treatment Planning\nAs part of the treatment planning stage, a careful\nassessment\nof\nthe\npatient’s\nrequirements\nand\nexpectations, a thorough medical and dental history,\nand a comprehensive clinical examination are required.\nThe use of a diagnostic wax-up, a radiographic stent,\nand appropriate radiographs are important in this\nplanning stage (Figs 1a-c). These steps will ensure that\npotential patient- or site-related risk factors for future\nbiological complications are identified and discussed\nwith the patient prior to treatment commencing.\n7.1.2 Preparation of the Patient\n287"
  },
  {
    "page": 288,
    "content": "In patients diagnosed with chronic or aggressive\nperiodontitis, completion of active periodontal therapy,\naiming for elimination of residual pockets with bleeding\non probing, should precede implant placement.\nIn patients with a history of treated periodontitis with\nresidual probing depths (PD) at least 5 mm with\nconcomitant bleeding on probing, FMPS of more than\n20% and associated risk factors, retreatment, and\nperiodontal\nreevaluation\nare\nrecommended\nbefore\nimplant placement. The increased risk for peri-implant\ninfection should be discussed with patients who have a\nhistory of periodontitis prior to implant treatment. A\nmaintenance care program with shorter intervals should\nbe planned for patients diagnosed with aggressive\nperiodontitis.\nTobacco smokers should be informed of their increased\nrisk\nof\nperi-implant\ninfection\nand\nprovided\nwith\nsmoking cessation advice.\n288"
  },
  {
    "page": 289,
    "content": "Fig 1a Diagnostic model of a maxillary anterior site.\nFig 1b Diagnostic wax-up.\n289"
  },
  {
    "page": 290,
    "content": "Fig 1c CT scan of a mandibular molar site with\nradiographic stent in situ.\nFig 2 Schematic diagram. Minimum orofacial width of\nthe bone required for implant placement in relation to\nthe implant diameter (d). In this diagram, the implant\nhas 1 mm of bone on the facial and palatal aspects.\n290"
  },
  {
    "page": 291,
    "content": "Fig 3a Limited keratinized mucosa available in the\nposterior mandible prior to implant placement.\nFig 3b Free gingival graft to increase the width of\nkeratinized mucosa.\nFig 3c After placement of the implants a band of\nkeratinized mucosa surrounds the implants, Images\ncourtesy of Dr. M. Roccuzzo.\n291"
  },
  {
    "page": 292,
    "content": "7.1.3 Preparation of the Recipient Site\nPreparation of the recipient site may involve hard- or\nsoft-tissue grafting procedures, to ensure an adequate\nvolume of bone and width of keratinized mucosa prior\nto implant placement. If bone augmentation is required,\na staged or simultaneous approach may be chosen\ndepending on the available bone volume for correct\nthree-dimensional implant positioning. A minimum of 1\nmm\nof\nbone\nsurrounding\nthe\nentire\nimplant\ncircumference\nis\nrequired\nto\navoid\nincomplete\nosseointegration of the implant, which may result in\nsubsequent\nbiological\ncomplications\n(Fig\n2).\nThe\nappropriate choice of the implant diameter is therefore\nimportant to prevent future biological complications.\nThe effect of the width of the keratinized mucosa on\nperi-implant health outcomes may be influenced by a\nnumber of factors, including the patient’s oral hygiene,\nand on the supportive post-implant therapy provided\n(Frisch and coworkers 2014). Nevertheless, a recent\nsystematic\nreview\naddressing\nthe\nnecessity\nof\nkeratinized mucosa for peri-implant health concluded\nthat an adequate zone of keratinized mucosa (approx. 2\nmm) is related to better peri-implant health (Brito and\ncoworkers\n2014).\nFurthermore,\nin\nthe\ncompletely\nedentulous mandible an insufficient band of keratinized\nmucosa (less than 6 mm) on the orofacial aspect was\nassociated\nwith\na\nhigher\nincidence\nof\nbiological\ncomplications in the first year following provision of\nfull-arch\nimplant-supported\nmandibular\nprostheses\n(Maló and coworkers 2013). Therefore, establishing an\nadequate band of keratinized tissue can be considered as\n292"
  },
  {
    "page": 293,
    "content": "a\npreventive\nmeasure\nfor\nfuture\nbiological\ncomplications (Figs 3a-c). Where keratinized mucosa is\nminimal\nor\nabsent,\nsoft-tissue\ngrafting\nmay\nbe\nperformed either prior to implant placement, at the time\nof second-stage surgery if submerged healing has\noccurred, or following restoration of the implant as a\npreventive measure.\nPreparation of the Implant recipient site may also\ninvolve orthodontic treatment to create the ideal space\nfor implant placement and subsequent restoration.\nOrthodontic tooth extrusion may also be considered in\nsituations where the crown has fractured subgingivally,\nin order to optimize the bone and soft-tissue volume at\nthe implant recipient site (Fig 4).\nFig 4 Extrusion of a fractured tooth to create a more\nfavorable recipient site.\n293"
  },
  {
    "page": 294,
    "content": "Fig 5a Schematic diagram. The green zone indicates the\nideal mesiodistal implant position; encroaching on the\nred zone would mean that the implant is too close to the\nadjacent teeth.\nFig 5b Ideal apicocoronal position.\n294"
  },
  {
    "page": 295,
    "content": "Fig 5c Ideal orofacial position.\n7.1.4 Implant Placement\nA\ncorrect\nsurgical\ntechnique\n(sufficient\ncooling,\nminimal\npressure,\nsharp\ndrills)\nduring\nosteotomy\npreparation is important (Buser et al. 2004) to prevent\noverheating of the alveolar bone, which would result in\nmarginal bone loss and incomplete osseointegration of\nthe implant.\nCorrect three-dimensional positioning of an implant is\nimportant to prevent risk of biological and esthetic\ncomplications (Figs 5a-c). Placement of implants too\nclose together (less than 3 mm between adjacent\nimplants), or too close to neighboring teeth (distance\nfrom implant platform to tooth less than 1.5 mm) may\nresult in insufficient access for adequate plaque control\nand subsequent peri-implant infection (Serino and\nStröm 2009; Abi Nader and coworkers 2014).\n295"
  },
  {
    "page": 296,
    "content": "Malpositioned implants may result in marginal bone\nloss, mucosal recession, and exposure of part of the\nimplant surface to the oral cavity, which enables a\nbiofilm to readily form on the endosseous portion of the\nimplant with the risk of peri-implant infection (Fig 6).\nFig 6 Schematic diagram. The implant body has been\nplaced too far facially, so that the implant shoulder also\nprojects too far facially. As a result, a portion of the\nfacial implant surface will not be surrounded by an\nadequate thickness of bone.\nThe use of a surgical template aids in the correct three-\ndimensional position for implant placement (Figs 7a-b).\n296"
  },
  {
    "page": 297,
    "content": "Fig 7a Acrylic surgical template with an osteotomy drill\nin position, facilitating an ideal position of the implant\nfor screw retention. Occlusal view.\n297"
  },
  {
    "page": 298,
    "content": "Fig 7b Acrylic surgical guide illustrating the distance\nfrom the zenith of the crown to the bone level. Buccal\nview.\n7.1.5 Prosthesis Design\nA correct design of the implant-supported prosthesis\nmay also prevent future biological complications. By\nensuring adequate access for cleaning, the risk for\nbiofilm\naccumulation\nand\nsubsequent\ninfection\nis\nminimized. The technician should provide sufficient\nspace for the use of oral hygiene aids between the\nmucosa and the fitting surface of the prosthesis, and\nbetween implants. Pontics and cantilevers should have\nhighly polished convex surfaces that can be easily\ncleaned (Figs 8a-d). There should be no rough or sharp\nedges that could tear or shred dental floss during oral-\nhygiene procedures (possibly resulting in a retained\nfloss remnant and subsequent infection). Avoiding\nexcessive ridge-lap designs and minimizing the palatal\nextension of prostheses may also facilitate cleansability\n(Abi Nader and coworkers 2014).\n298"
  },
  {
    "page": 299,
    "content": "Figs 8a-b Well-designed multi-unit implant-supported\nprosthesis with a highly polished ovate ceramic pontic.\nThe embrasure spaces provide sufficient access for\ndental\nfloss\nor\ninterdental\nbrushes.\nThese\ndesign\nprinciples facilitate plaque control.\n299"
  },
  {
    "page": 300,
    "content": "Figs\n8c-d\nWell-designed\nsingle\nimplant-supported\nprosthesis\nwith\na\nhighly\npolished\novate\nceramic\ncantilever. The notch can be easily located by the\npatient\nto\nguide\nin\ninserting\ndental\nfloss\nor\nan\ninterdental brush for plaque control. (Images courtesy\nof Mr. John Lucas, technician).\n300"
  },
  {
    "page": 301,
    "content": "The\ndesign\nand\nthe\nsubmucosal\ncontour\nof\nthe\nprosthesis\nwill\ninfluence\nthe\nperi-implant\ntissues.\nProsthesis design should also aim to establish good\nproximal contacts with contours that prevent food-\npacking in embrasure areas (Fig 9).\nFig 9 Single implant-supported crown, designed with\nbroad contacts and ideal embrasure spaces to avoid food\ntrapping.\nIf a cement-retained prosthesis is required and the\nimplant has been placed deeply, that the cement line\nmust not be deeper than 1.5 mm submucosally. This can\nbe achieved in a number of ways.\nSome implant systems provide a selection of stock\nabutments with cementation lines of varying heights.\nAlternatively, a custom abutment can be fabricated to\nplace the cement line in an ideal position. This will\nreduce the risk of a biological complication caused by\nretained excess luting cement (Figs 10a-b). Using a\n301"
  },
  {
    "page": 302,
    "content": "careful cementation technique will also reduce the risk\nfor submucosal excess luting cement. It has also been\nsuggested that excess cement might be more easily\nidentified on a radiograph if the luting cement used\nwere radiopaque.\nFig 10a Screw-retained custom abutment. This enables\nthe final crown to be cemented at a position (approx. 1\nmm submucosally) where the cement line can be\nmanaged minimizing the risk for excess luting cement.\n302"
  },
  {
    "page": 303,
    "content": "Fig 10b Crown seated on the custom abutment. (Images\ncourtesy of Mr. John Lucas, technician).\nAnother treatment option that can be considered when\nthe restoration margin is located more than 1.5 mm\nsubmucosally, and where direct screw retention is not\npossible due to the implant angulation, is screw\nretention using a transverse screw (Figs 11a-c).\n303"
  },
  {
    "page": 304,
    "content": "Fig 11a Custom gold abutment with transverse screw at\nsite 23.\nFig\n11b\nFinal\nprosthesis\nscrew-retained\nwith\na\ntransverse screw at site 23. Occlusal view.\nFig\n11c\nFinal\nprosthesis\nscrew-retained\nwith\na\ntransverse screw at site 23. Facial view.\n304"
  },
  {
    "page": 305,
    "content": "When fabricating provisional restorations on implants,\ngreat care must also be taken to avoid biological\ncomplications caused by rough submucosal surfaces or\nby the fracture of provisional restorative materials. Fig\n12 shows a peri-implant infection caused by a fragment\nof the provisional composite crown, which was lodged\nsubmucosally.\nFig 12a Peri-implant infection. The temporary crown at\nsite 11 has been removed. Redness and swelling at the\nfacial mucosa.\n305"
  },
  {
    "page": 306,
    "content": "Fig 12b Periapical radiograph. A dislodged fragment of\nthe provisional crown at site 11.\n306"
  },
  {
    "page": 307,
    "content": "Fig 12c Once the fragment (shown) was removed, the\ninfection resolved.\n7.1.6 Supportive Care\nRegular supportive care plays an important role in the\nprevention\nof\nperi-implant\ninfections\n(Costa\nand\ncoworkers 2012; Roccuzzo and coworkers 2012). An\nindividualized recall program should be discussed with\nthe patient as part of the treatment planning phase to\nprevent both biological and hardware complications.\nApproximately\none\nmonth\nafter\ndelivery\nof\nthe\ndefinitive implant-supported prosthesis, clinical and\nradiographic\nbaseline\nmeasurements\nshould\nbe\nestablished and recorded for future reference and\ncomparison. Probing depth measurements in relation to\n307"
  },
  {
    "page": 308,
    "content": "a fixed landmark should be recorded at four sites per\nimplant where possible.\nIndividualized\noral-hygiene\ninstructions\nshould\nbe\nprovided to ensure the patient is able to clean the\nprosthesis and maintain healthy peri-implant tissues.\nWith regard to the ideal oral hygiene regimen, there are\nvery few studies comparing different products and\ntechniques in patients with implants (Grusovin and\ncoworkers 2010). The use of interdental brushes or\ndental floss and an electric, sonic-powered, or manual\ntoothbrush is recommended to clean circumferentially\naround each implant (Swierkot and coworkers 2013;\nChongcharoen and coworkers 2012) (Fig 13). The\nclinician should be aware that manual dexterity varies\nbetween individuals and may change for an individual\nover time. A careful assessment of the patient’s ability\nand motivation to maintain adequate plaque control is\nrecommended.\n308"
  },
  {
    "page": 309,
    "content": "Fig 13 Thick green floss used to clean the implant\nabutments circumferentially.\nWhile there is limited evidence to recommend the\nroutine use of antiseptic mouthrinses to prevent of peri-\nimplant infections, a triclosan-based toothpaste seems\nto be more effective than a fluoride toothpaste in\npreventing\nperi-implant\nmucositis\n(Trombelli\nand\nFarina 2013).\nDuring\nsupportive\ncare,\nthe\nfollowing\nsteps\nare\nimportant:\n•\nUpdate of the medical and dental history\n•\nClinical\ninspection\nof\nthe\nimplant-supported\nprosthesis\n– Assessment of the occlusion\n–\nAssessment\nfor\nany\ncomponent-related\ncomplications such as material wear, chipping and\nfractures\n– Assessment of contact areas and embrasure areas,\n•\nClinical inspection of the peri-implant tissues\n– Plaque or calculus\n– Probing depths in relation to a fixed reference point\n– Bleeding or suppuration on gentle probing\n309"
  },
  {
    "page": 310,
    "content": "–\nMucosal\nabnormality\ne.g.\nredness,\nswelling,\ndraining sinus\n•\nClinical inspection of the remaining dentition and\nsoft tissue\n•\nProphylaxis or additional treatment as required\n•\nIndividualized instructions for oral hygiene\n•\nDetermination of the next recall interval\n7.1.7 Diagnostic Monitoring of the Peri-implant Tissues\nRegular diagnostic monitoring of the peri-implant\ntissues includes assessment of presence of plaque,\nprobing depths, bleeding on gentle probing (approx.\n0.25 N) or suppuration.\nChanges in probing depth from a fixed landmark should\nbe\nassessed\nregularly\nand\ncompared\nto\nprevious\nexaminations. In the presence of clinical signs of\ndisease, an appropriate radiograph is indicated in order\nto detect radiographic bone level changes compared to\nprevious examinations.\nPeri-implant health is diagnosed in the absence of\nclinical signs of inflammation. A recall frequency of at\nleast once yearly is recommended unless systemic or\nlocal conditions require more frequent intervals. In\ncases of peri-implant health, professional cleaning\nincluding\nreinforcement\nof\noral\nhygiene\nis\nrecommended as a preventive measure (Figs 14a-b).\n310"
  },
  {
    "page": 311,
    "content": "Fig\n14a\nImplant\nmonitoring\nat\na\nsupportive-care\nappointment using a periodontal probe with light\npressure. Healthy peri-implant tissues with a probing\ndepth of 3 mm and no bleeding on probing.\n311"
  },
  {
    "page": 312,
    "content": "Fig 14b Professional prophylaxis using a rubber cup\nand polishing paste at the supportive-care appointment.\nPeri-implant mucositis is diagnosed in the presence of\nindividual clinical signs of soft-tissue inflammation\n(e.g. redness, edema, suppuration) and bleeding on\ngentle probing. If peri-implant mucositis is diagnosed,\nin addition to reinforcement of oral hygiene, mechanical\ndebridement\nwith\nor\nwithout\nantiseptics\n(e.g.\nchlorhexidine)\nis\ndelivered.\nRe-evaluation\nshould\nfollow approximately six to eight weeks after this\ntreatment. The use of systemic antimicrobials is not\nrecommended\nfor\nthe\ntreatment\nof\nperi-implant\nmucositis. There is some evidence that the regular use\nof a toothpaste containing triclosan may reduce the\nclinical signs of inflammation in subjects with peri-\nimplant mucositis (Ramberg and coworkers 2009). The\n312"
  },
  {
    "page": 313,
    "content": "treatment\nof\nperi-implant\nmucositis\nshould\nbe\nconsidered as a preventive measure for the onset of\nperi-implantitis (Costa and coworkers 2012).\nPeri-implantitis is diagnosed in the presence of peri-\nimplant mucositis in conjunction with progressive\ncrestal bone loss. When peri-implantitis is diagnosed,\nearly implementation of an appropriate treatment is\nrecommended to prevent further progression of the\ndisease (see Chapter 5).\n7.1.8 Frequency of Recall\nThe frequency of recall is dependent on the patient’s\nrisk profile and willingness to attend. A risk-assessment\ntool may be used to guide the appropriate interval for\nsupportive care (Lang and Tonetti 2003). This tool\nrequires the evaluation of a number of factors and\ncalculates the risk for biological complications as either\nhigh, medium, or low providing the rationale for recall\nat three, six, or twelve months, respectively (Figs\n15a-c). This risk-assessment tool can be downloaded in\nseveral\nlanguages\nfrom\nthe\nUniversity\nof\nBern\n(www.perio-tools.com) (Lang and Tonetti 2003).\n313"
  },
  {
    "page": 314,
    "content": "314"
  },
  {
    "page": 315,
    "content": "Figs 15a-c Examples of (a) high, (b) medium, and (c)\nlow risk with recommended recall frequencies.\nThe factors taken into consideration include:\n•\nPatient age\n•\nNumber of teeth and implants present\n•\nNumber of missing teeth\n•\nNumber of bleeding positive sites\n•\nNumber of sites with a probing depth greater than 5\nmm\n•\nPeriodontal bone loss\n•\nTobacco smoking\n•\nSystemic conditions such as diabetes mellitus\n315"
  },
  {
    "page": 316,
    "content": "7.2 Prevention of Loss of Osseointegration Due to\nOcclusal Overload\nFor patients diagnosed with parafunctional habits such\nas clenching or bruxism, an occlusal nightguard is\nindicated\nto\nprevent\nbiological\nand\nhardware\ncomplications (Fig 16).\nFig 16 Maxillary acrylic occlusal nightguard to be worn\nat\nnight\nby\na\nbruxer\nwith\nan\nimplant-supported\nprosthesis.\nWhile there is limited evidence to suggest that a\nspecific\nocclusal\nscheme\nfor\nimplant-supported\nprostheses is superior, some general recommendations\nfor occlusal morphology include flat fossa and grooves\nfor wide freedom in centric occlusion, shallow occlusal\nanatomy, a narrow occlusal table, and reduced cusp\ninclination. A smaller (30% to 40%) occlusal table for\n316"
  },
  {
    "page": 317,
    "content": "molars as well as implant-protected occlusion has also\nbeen recommended (Yuan and Sukotjo 2013) (Table 1).\nTable 1 Occlusal scheme guidelines for implant-\nsupported prostheses, adapted from Yuan and Sukotjo\n2013.\nGeneral occlusal scheme\n•\nCentered contacts in maximum intercuspation\n(point centric or freedom in centric with 1–1.5 mm)\n•\nLight contact on firm occlusion with shimstock\n(8–30 µm) passing through\n•\nAnterior guidance with natural dentition\n•\nNo centric\nrelation—maximum\nintercuspation\ndiscrepancy\nImplant-supported fixed dental prosthesis (single\nunit)\n•\nAvoid excursive guidance\n•\nIncreased proximal contact\n317"
  },
  {
    "page": 318,
    "content": "Implant-supported fixed dental prosthesis (multiple\nunit)\n•\nAnterior section\n– Light contact in maximum intercuspation\n–\nFlat vertical and horizontal overlap and\nprotrusive guidance to reduce lateral forces\n–\nSelective\nexcursive\nguidance\nfor\nbest\nbiomechanical abutment distribution\n•\nPosterior section\n– Excursive guidance on well-supported anterior\nnatural teeth with posterior teeth disclusion in\neccentric movements\n–\nCanine\nprotected\nor\nmutually\nprotected\nocclusion if canine present\n–\nGroup function occlusal scheme if canine\nabsent or prosthesis replacing bilateral distal\nextension\n–\nOptimum\nabutment\nsupport\nfor\nworking\nguidance\n7.3 Prevention of Non-plaque-related Oral Mucosal\nDisorders\n318"
  },
  {
    "page": 319,
    "content": "A careful medical history taking and assessment of the\noral hard and soft tissues in the treatment-planning\nphase, prior to implant placement is important. While\nthe prevention of some non-plaque related biological\ncomplications might not be possible, if the patient is\nseen on a regular basis for supportive care, an early\ndiagnosis and appropriate management can be made. At\neach supportive care appointment, the medical history\nand current medications should be updated. The patient\nshould be referred for appropriate assessment and\nbiopsy if the diagnosis is unclear.\n7.4 Concluding Remarks\nIdentifying and reducing potential risk factors is an\neffective\npreventive\nstrategy\nfor\ncomplications\nin\nimplant dentistry. Of the complications presented in this\nITI Treatment Guide, many seem to be iatrogenic.\nAppropriate\nclinician\neducation,\ntraining,\nand\nexperience will reduce the overall risk of complications.\nFurthermore, a patient who has been informed of the\npotential for future complications prior to treatment\nmay be less likely to see an adverse event as a\ncomplication, but rather as part of supportive or\nmaintenance care. In other words, the worst type of\ncomplication\nmay\nbe\nthe\nunexpected\none—the\ncomplication\nthat\nwas\nnot\ndiscussed\nduring\nthe\ntreatment planning stage. The most difficult scenario to\nmanage might be when a patient has been told that the\n319"
  },
  {
    "page": 320,
    "content": "implant treatment will “last a lifetime” or that “implants\nare better than teeth.”\nTo reduce the risk of unexpected complications due to a\ncomponent or a technique, documentation of long-term\nsuccess rates is of paramount importance. Given the\nrapid development of new materials and techniques\nwithin the field of implant dentistry, it would be prudent\nto think carefully about the risks and benefits of “early\nadoption” before committing to the new and relatively\nuntested.\nThe incidence of biological and hardware complications\nhas been documented in numerous systematic reviews\n(Jung and coworkers 2008; Romeo and Storelli 2012;\nPjetursson\nand\ncoworkers\n2012;\nPjetursson\nand\ncoworkers 2014). From these reviews, it is apparent that\nthe incidence of hardware complications is much\ngreater than biological complications. The relevant\ninformation\nconcerning\nthe\nlikelihood\nof\npossible\ncomplications and the importance of regular monitoring\nand supportive care should be presented to the patient in\nthe treatment discussion phase of implant therapy.\n320"
  },
  {
    "page": 321,
    "content": "7 Prevention of Biological Complications\nL. J. A. Heitz-Mayfield\n321"
  },
  {
    "page": 322,
    "content": "8.1 Prevention\nof\nComplications\nRelated\nto\nComponents and Reconstructions\n8.1.1 Implant Body\nIn order to avoid permanent deformation or fracture of\nthe implant body, standard implant diameters and\nmaterials should be chosen that are optimized in terms\nof\nmaterial\ncharacteristics\nand\ndesign.\nReduced-\ndiameter implants may play an important role in narrow\nridges and narrow spaces. They provide easier and less\nexpensive\ntreatment\noptions\nand\nlower\nmorbidity\ncompared to GBR procedures (Sohrabi and coworkers\n2012). This also applies for short implants compared to\nsinus augmentation or nerve displacement procedures\n(Neldam and Pinholt 2012; Srinivasan and coworkers\n2012). There is no evidence yet that so-called mini-\nimplants\ncan\nbe\nrecommended\nfor\ndefinitive\nreconstructions (Bidra and Almas 2013).\nWhen the envelope of indications is stretched, however,\nit is advisable to choose materials with improved\nphysical\nproperties\nbut\nwith\nan\nequivalent\nosseointegrative surface. The search for additional\nindications for implant-supported reconstructions led to\nthe\ndevelopment\nof\nreduced-diameter\nimplants\nmanufactured\nfrom\na\ntitanium/zirconium\nalloy\n(Steinemann\n1998;\nGottlow\nand\ncoworkers\n2010;\nThoma and coworkers 2011).\n322"
  },
  {
    "page": 323,
    "content": "Ongoing clinical testing of mandibular overdenture\ncases with one reduced-diameter (3.3 mm) bone-level\nimplant made of grade IV titanium and one implant\nwith the same design but made of titanium/zirconium\nalloy\nhas\ndemonstrated\nvery\nsimilar\nclinical\nperformance\n(Al-Nawas\nand\ncoworkers\n2012).\nOsseointegration and stable tissue integration can be\nachieved with this new material while getting a chance\nof\nbetter\nbiomechanical\nperformance\nfor\nfixed\nreconstructions (Barter and coworkers 2012; Chiapasco\nand coworkers 2012). This improved material has been\nintegrated into a new set of implants by a leading\nmanufacturer.\nThe search for attractive materials in esthetically\ndemanding cases and for ways to avoid the use of\ndifferent materials in a reconstruction/abutment/implant\ncomplex led to the development of zirconia implants.\nThis material seems to osseointegrate in a manner\nsimilar to titanium implants (Gahlert and coworkers\n2009; Bormann and coworkers 2012) but its physical\nproperties\nare\ncompletely\ndifferent.\nThe\nclinical\napplication of reduced-diameter zirconia implants has\nso far been unsuccessful (Gahlert and coworkers 2012).\nIn addition, the one-piece implants in zirconia create\nunfavorable prosthetic conditions.\nThe design characteristics of the platform and neck\nregion\ninfluence\nthe\nload\ntransfer\nfrom\nthe\nreconstruction/abutment complex to the surrounding\ncrestal bone, and the neck surface is in direct contact\nwith the adjacent soft-tissue cuff. Attempts to improve\nthe hardware were made (conical connection designs,\n323"
  },
  {
    "page": 324,
    "content": "platform switching, surface alterations), all aiming to\nprovide the capacity to sustain and transfer the load and\nto interfere only minimally with the formation of a\nstable biologic width and crestal bone level.\nAny maintenance procedures such as oral hygiene or\nprofessional supportive therapy should not damage the\nimplant neck (or the abutment). This applies especially\nto the use of mechanical instruments, acids, abrasive\nsubstances, lasers, and the tips of ultrasonic devices.\nWhen performing aggressive interventions, such as\ncutting a non-retrievable cemented crown, caution is\nrequired not to damage the platform e.g. in tissue-level\nimplants.\nDamage unintentionally inflicted with a drill may be\nirreparable and will pose a problem for a precise fit of a\nfuture\nreconstruction.\nAn\nindividual\nconventional\nimpression can be required after smoothening the\naffected\nplatform\nwhen\na\nnew\nreconstruction\nis\ndelivered.\nIf the three-dimensional position of the implant body\n(axis and platform) is unfavorable relative to adjacent\nand opposing structures, the prosthetic procedures will\nbe more complex. The reconstruction may require\nesthetic, biological, or functional compromises—or the\nimplant may be even non-restorable. Prosthetically\ndriven implant planning and positioning is therefore\nmandatory. This includes the depth of the platform in\nrelation to adjacent teeth, adjacent implants, and the\nopposing jaw; the buccooral position of the platform(s);\nthe axis of the implant(s); and the relative positions of\n324"
  },
  {
    "page": 325,
    "content": "the platform and the planned reconstruction. This\napplies not only to fixed reconstructions but also to\noverdentures.\n8.1.2 Implant/Abutment Connection\nImproved connection designs have been developed to\nprevent hardware-related complications and failure, and\nthe\nloosening/fracture\nrate\nhas\nbeen\nreduced\nto\nacceptable levels (Theoharidou and coworkers 2008)\ncompared to when oral implants were first introduced.\nClinicians can avoid problems by careful handling of\nthe connection area, by creating an open access with\nhealing screws and mucosa formers, and by using long-\nterm\nprovisionals\nfor\nconditioning\nthe\nemergence\nprofile. Any foreign matter (tissue, graft particles,\nblood) should be rinsed off before connecting a\ncomponent.\nFinding the correct index position is very important.\nRadiographic controls of impression posts can assist in\nthis, as can transfer keys for angled or modified\nabutments.\nThe\nimpression\npost\nmust\nmatch\nthe\nimplant.\nThe abutment screw should not be pushed down into\nthe connection. Rather, the index of the abutment base\nshould first be found; only then is the abutment screw\nturned slowly and without tilting.\n325"
  },
  {
    "page": 326,
    "content": "In multi-unit reconstructions, it is advisable to activate\nthe screws alternatingly and in increments until the final\nseating is achieved with the torque ratchet.\nThe torque recommended by the manufacturer was\noptimized\nfor the\nrespective\nmaterial\nand design\ncombinations and must be respected.\n8.1.3 Abutment Body and Abutment Screw\nThe design of an abutment can determine where an\nabutment screw will fracture in case of excessive force\nonto the superstructure/implant complex—preferably in\nan area that provides good access and visibility. In these\ncases, the fragment can easily be removed with a probe\nand rotational movements. However, an abutment screw\nfragment may also be completely blocked in the\nconnection, or restricted access to a fragment may limit\nits controlled removal. The connection area should not\nbe damaged while removing fragments. The microscope\nmay provide a direct view of the area to help locate the\nproblem so the fragment can be removed with an\nendodontic explorer. Any drilling or retapping should\nonly be performed with a precise guide (from the\nmanufacturer’s service set).\nIt is a clinical reality that not only impression posts but\nalso\nabutment\nscrews\nmay\nbe\nunintentionally\nexchanged. This could happen at the laboratory or at\nchairside. For example, the use of an abutment screw\nwith a conical head base may result in fracture of a\nceramic abutment. The threads of the abutment screw\n326"
  },
  {
    "page": 327,
    "content": "must match the bore in the implant, so the use of\noriginal abutments is advisable.\nThe axis of the screwdriver has to be positioned along\nthe long axis of the implant/abutment to find the correct\ninsertion position. When tightening down a crown, the\ncontacts\nwith\nadjacent\nteeth\nor\nimplant-supported\ncrowns should not be so tight that they block the screw\nmovement, as otherwise a fracture in the ceramic\nveneer or damage to the bore/thread might occur. The\nabutment screw should not be forced downwards. The\ncorrect\nindex\nshould\nbe\nfirst\nlocated\nand\nthe\nreconstruction/abutment held in the insertion direction.\nThe head of the abutment screw must be protected,\npreferably\nwith\nTeflon,\nunderneath\na\nscrew-canal\nrestoration.\nWith respect to the correct handling of the components,\nit also seems important to provide the clinician/\ntechnician\nwith\nassistance\nrelated\nto\nlogistics,\ninformation on new products, instruction, training,\nlogical\n(e.g.\ncolor-coded)\nstep-by-step\nprocedures,\nexchangeable components, and, in case of problems,\nassistance in the form of a service set and a well-\norganized complaint system.\nThese issues relate not only to the implant and to\nprosthetic components but also to the auxiliary parts,\nsuch as impression posts, analogs, registration posts,\nand the screwdrivers and torque ratchets.\n8.1.4 Third-party Components\n327"
  },
  {
    "page": 328,
    "content": "The\nabutment\nbody\nmust\nmatch\nthe\nimplant\nconfiguration.\nNarrow,\nregular,\nand\nwide\ndesigns\nshould not be mixed; third-party abutments do not\nmatch the original connection precisely.\nEconomic pressure to produce and deliver implant-\nsupported reconstructions at a reduced price may lead to\nthe acceptance of alternative solutions involving third-\nparty abutments (i.e. abutments made by a different\nmanufacturer than the implant) available on the market.\nLimited access to equipment and halting investment in\nlaboratory equipment could also result in the selection\nof third-party abutments. The designs of screw joints\nsuch as those at the implant/abutment interfaces should\nbe\nmatched\ncarefully\nbecause\nthe\nbiomechanical\nproperties mainly depend on factors such as materials,\ntolerance, connection designs, and preload (Dixon and\ncoworkers 1995; Gratton and coworkers 2001; Khraisat\nand coworkers 2002; Meng and coworkers 2007; Lee\nand coworkers 2010).\nThe aims of a recent in-vitro study (Gigandetand\ncoworkers 2014) were:\n1.\nTo test the in-vitro mechanical resistance of three\noriginal implant/abutment interfaces and to compare\nthese original interfaces to two combinations of third-\nparty abutments and one of the original implants.\n2.\nTo test the influence of geometric discrepancies at\nthe interfaces between the implants and the original/\nthird-party abutments by assessing rotational misfit.\n328"
  },
  {
    "page": 329,
    "content": "3.\nTo assess and compare failure modes.\nSmall-diameter implants were chosen to test a high-risk\ncondition compared to implant/abutment connections of\nstandard dimensions. The null hypothesis was that there\nwould be no significant difference in the mechanical\ncharacteristics between the original and third-party\ninterfaces.\nThird-party abutments differed in the design of the\nconnecting surfaces, shape, dimensions, and material\nand had a higher rotational misfit. All these differences\nresulted in unexpected failures and may have had an\nadverse effect on clinical handling. More clinical\nstudies testing the failure and complication rates of\nreconstructions on original and third-party connections\nshould be performed; however, at this point it is\nrecommended to use abutments by the original implant\nmanufacturer when restoring implants.\nA recent clinical study related to the survival of\nalumina-reinforced zirconia abutments examined the\nlong-term risks associated with third-party interfaces\nbetween implants and abutments (Kim and coworkers\n2013). A total of 213 patients had received 611\nexternalhex implants and 328 fixed reconstructions.\nImplants from five manufacturers were placed. The\nceramic abutments, however, were produced by a single\nmanufacturer.\nPosterior\nsingle-unit\nreconstructions\n(n = 101) demonstrated an increased and clinically\nunacceptable rate of technical failures. The third-party\nabutments on the five implant systems were not stable\n329"
  },
  {
    "page": 330,
    "content": "enough to provide satisfactory function in the posterior\narea.\n8.1.5 Retention: Screw-retained and Cemented\nAs in conventional prosthodontics on natural teeth, a\nprecise marginal fit must be achieved on implant/\nabutment platforms. Therefore, the conventional and the\nnewer digital impression techniques, the production\nprocess at the laboratory or production center, and\nintraoral delivery must avoid the accumulation of errors\nthat lead to unacceptable gaps. A framework try-in\nhelps detect any need for corrections or remakes.\nOne-piece\nreconstructions\ndirectly\nscrew-connected\nwith the implant have major advantages. In two-part\nsystems,\nthe\nuse\nof\ncopings\nfor\nscrew-retained\nreconstructions results in more precise gaps compared\nto cemented reconstructions. It is also more predictable\nto\nproduce\na\n“precision\ngap”\nwith\nsingle-unit\nreconstructions. The gap width increases with the length\nof the reconstruction.\nTo prevent biological problems, cement gaps should be\navoided wherever possible; if required, they should be\nlocated\nas\nfar\ncoronally\nas\npossible.\nExtraoral\ncementation onto bonding bases is an alternative, since\nthe cementation process is controlled in the dental\nlaboratory and thereby submucosal cement residues are\navoided.\nA very thin layer of cement should be applied with a\nbrushing technique. The reconstruction must be seated\n330"
  },
  {
    "page": 331,
    "content": "slowly. Applying petroleum jelly on the outer aspect of\nthe crown may make cement removal easier. Residue\nmay be removed with Superfloss® dental floss (Oral-B,\nSchwalbach, Germany), dental floss with knots, or an\ninterdental brush. Cement residue is explored with a\nperiodontal probe and air jet to open the sulcus. The\ncontrol radiograph will not help detect all cement\nresidue. Signs of inflammation should be checked for\nduring the days/weeks after cementation. Even a\ntemporary cement such as Temp Bond (Kerr, Orange,\nCalifornia, USA) may be difficult to detect and remove\ncompletely. Controllable cementation protocols should\ntherefore be developed.\nThe prophylactic considerations for occlusal screws are\nsimilar to those for abutment screws. A correct original\nscrew must be applied. For screws from an unknown\nsystem, a matching screwdriver must be found. In the\nevent of screw loosening, the entire reconstruction with\nall the components have to be disassembled, cleaned,\nand retightened carefully, followed by checking the\nocclusion and articulation. Pristine screws have to be\nused in case of repeated loosening.\nScrewdrivers/ratchets must be applied correctly. The\ndental technician should provide a sufficiently wide\naccess for the screwdriver. The screwdriver must not be\npressed against any ceramic surface around the access\nhole in order not to cause cracks.\nThe access head of the screw must be protected,\npreferably\nwith\nTeflon\ntape.\nScrew-retained\nreconstructions offer the advantage of retrievability.\n331"
  },
  {
    "page": 332,
    "content": "They can be used to create emergence profiles and\npontic designs much more easily than the cemented\nones.\nPatients\nshould\nbe\ninstructed\nto\nreturn\nimmediately\nin\ncase\nof\nscrew\nloosening.\nThe\nreconstruction should be retightened as soon as possible\nto avoid additional damage such as screw fractures or\nceramic chipping.\nScrew-retained\nsuperstructures\nmay\nrequire\nan\ninordinate amount of maintenance if screws loosen\nrepeatedly. Reasons for this complication may include:\n•\nInsufficient framework fit\n•\nOcclusal interference\n•\nLoosening of the underlying abutments\n•\nDefective screw joint\n•\nNot enough torque due to incorrect handling or use\nof a worn ratchet\n•\nUse of a worn screw (e.g. the laboratory occlusal\nscrew)\nScrew loosening may be controlled by eliminating\npotential\nadverse\nfactors,\ncarefully\ncleaning\nthe\ncomponents, using a new occlusal screw, and applying\nthe correct torque.\nThe\nscrew\naccess\nplug\nshould\nhide\nthe\nusually\nunesthetic\naccess\nhole\nand\nprovide\na\ncontinuous\n332"
  },
  {
    "page": 333,
    "content": "functional surface. Removal should be easy, and\ndamage to the screw head should be avoided (Moráguez\nand Belser 2010).\nIf the screw head is located at or slightly underneath the\nocclusal surface, attrition may result in damaging of the\nscrewdriver insert.\nAbutments and frameworks must fit correctly. For\ncross-arch FDP, the Sheffield test should result in a\nstable seat/fit while tightening an occlusal screw.\nFrameworks should not get stuck as they are placed on\nabutments. As when changing a car tire, the screws are\nactivated incrementally, moving from one screw to the\nother. After a few minutes’ break, a second and final\nadjustment is made.\nBoth\ncemented\nand\nscrew-retained\nreconstructions\nshould be designed to allow optimal access for oral\nhygiene and to provide access for diagnostic procedures\nand professional maintenance.\nIt\nis\nnot\nadvisable\nto\nremove\nscrew-retained\nreconstructions at each recall appointment—this would\nbe impractical (time-consuming and expensive). Screw-\nretained reconstructions may, however, be removed if a\nclinical or radiographic examination indicates changes\nin the condition of the peri-implant tissues. In such\ninstances,\nretrievable\nreconstructions\nallow\ndirect\naccess to the implant platforms and the surrounding\ntissue, not least for interventions to treat infections. It is\nalso easier to repair screw-retained reconstructions in\ncase of hardware-related complications. Access for the\n333"
  },
  {
    "page": 334,
    "content": "treatment of biological complication is also much easier\nwith easily retrievable reconstructions.\n8.1.6 Closure\nScrew,\nHealing\nAbutment,\nMucosa\nFormers\nComplications can be avoided by choosing the most\nsuitable component in terms of height and width. It may\nalso\nbe\ndecided\nto\nreplace\na\ncomponent\nby\nan\nalternative one, e.g. after second-stage surgery.\nIn patients with a thin mucosal biotype, excessive\npressure may result in recession. Mucosa formers\nshould be torqued manually. Patients should perform\nchemical plaque control for about one week after\nsurgery, after which time mechanical cleaning is\nadvised, e.g. with an end-tufted brush.\nBefore applying the screwdriver, deposits such as hard\nfood residue or calculus must be removed with a probe.\nDetorqueing should be manual at first. With tight-fitting\ncomponents, care must be taken not to rotate the\nimplant. Increasing ISQ (Implant Stability Quotient)\nvalues are indicative of successful integration. The\nratchet should be positioned so the screwdriver is\nparallel\nto\nthe\nlong\naxis\nof\nthe\nimplant.\nStop\ndetorqueing immediately if the patient feels pain.\n8.1.7 Attachment Systems for Overdentures\nAttachment\ncomponents\nshould\nbe\nwear-resistant.\nComponents\nwith\neasy\nchairside\nactivation\nand\ncomponents that do not involve the laboratory for\n334"
  },
  {
    "page": 335,
    "content": "replacement are preferred. Space requirements should\nbe minimal.\nFor an optimal overdenture support, the implants should\nform an optimal support polygon and not be positioned\ntoo closely and with the implants/abutments at a similar\nvertical height. The axes of the implants should not\ndiverge too far. Overgrowing mucosa may inhibit the\nfunction of an attachment.\nFig 1a Heavy plaque deposits on a full-arch fixed\ndenture after removal. The patient had obviously not\nsucceeded in cleaning successfully underneath the\nreconstruction.\n335"
  },
  {
    "page": 336,
    "content": "Fig\n1b\nThe\ncorresponding\nocclusal\nview\nshows\naccumulated plaque around the implants and abutments.\nFig 2a The removable LOCATOR® overdenture (same\npatient) has been kept much cleaner.\n336"
  },
  {
    "page": 337,
    "content": "Fig 2b The peri-implant situation in the maxilla\nrevealed clean and healthy conditions.\nSome attachment systems may be difficult to keep\nfunctional in elderly patients who cannot remove food\nparticles from retentive areas. These patients may be\nbetter off with solitary attachments.\nBasic occlusion concepts apply to reduce stress/load/\nfatigue on attachment systems. Overdentures should be\nreinforced with metal frameworks. Again, prosthetically\ndriven implant placement is mandatory.\n8.1.8 Mesostructures\nMesostructures as described in the Glossary of Oral and\nMaxillofacial Implants are intermediate or middle\nsupporting framework connected to the infrastructure\nand\nproviding\nsupport\nand/or\nretention\nfor\nthe\nsuperstructure. They should be avoided by placing\nimplants in a correct position. Reconstructions should\n337"
  },
  {
    "page": 338,
    "content": "be as simple as possible. This can be achieved by\nplacing the implants in the correct position, thereby\navoiding bulky and uncleansable superstructures.\n8.1.9 Superstructures\nThe design of a reconstruction should not interfere with\noral hygiene. Some designs such as the cantilever\nextension prosthesis replacing large volumes of tissue\nmay be too bulky and prevent comfortable access for\nplaque control in large areas.\nThe following example demonstrates the situation after\nremoval of a superstructure before the recall at the\ndental hygienist (Figs 1a-b and 2a-b). The patient has\nworn the reconstruction for eight years. At every third\nrecall\nappointment,\nthe\nentire\nreconstruction\nwas\nremoved for better access for professional cleaning and\nultrasonic treatment of the denture. The opposing\nLOCATOR® overdenture was much more amenable to\noral hygiene.\nOn removal of the cross-arch extension prosthesis, it\nbecame evident that the patient was not capable of\ncleaning underneath the reconstruction, while at the\nupper\ndenture\nno\nobvious\nplaque\nformation\nwas\nobserved.\nWhen opting for a removable rather than a fixed\nreconstruction, easy access for plaque control is often a\nmajor decision factor.\n8.2 Risk Management\n338"
  },
  {
    "page": 339,
    "content": "Since the risks that affect the outcome of implant\ntreatment\nmay\narise\nfrom\nmany\nsources,\na\ncomprehensive\nrisk\nscheme\nis\nproposed\nhere.\nIt\nconsiders nine sources of risks, each of them with eight\npotential risk factors (Table 1). Evidence can be found\nin the literature for many of the factors associated with\nincreased risk. Most factors can be controlled by the\ndentist and the patient.\nTable 1 Risks that may negatively affect implant\ntreatment outcomes.\nRisk sources\nRisk factors\n1. Economic\nrisks\n1.\nLow\nGDP\n(gross\ndomestic\nproduct)\n2. Access to technology, know-how\n3. Social security\n4. Income loss\n5. Education, system\n6. Third-party payer\n339"
  },
  {
    "page": 340,
    "content": "7.\nMe-too\nproducts\n(similar\nor\nidentical to an established product\nwith no significant advantage over it)\n8.\nProfit-oriented\ntreatment\n(no\nsustainability)\n2. Provider-\nrelated risks\n1. Education, competence\n2. Access to technology\n3. Treatment concept\n4.\nSurgeon/prosthodontists/general\ndentist\n5. Logistics, assistance\n6. Collaboration with technician\n7. Prophylaxis, maintenance\n8. Ethics\n3. Patient-related\nrisks\n1. Health\n2. Mindset, education, willingness to\ncooperate\n340"
  },
  {
    "page": 341,
    "content": "3. Parafunction, bruxisms\n4. Periodontitis susceptibility\n5. Smoking\n6. Drugs\n7. Handicaps\n8. Risk for trauma\n4. Implant-/\ncomponent-\nrelated risks\n1. Implant material\n2. Implant surface\n3. Implant dimensions, design\n4. Connection\n5. Component materials\n6. Tolerances, precision\n7. Original component\n8. Tools\n341"
  },
  {
    "page": 342,
    "content": "5. Manufacturer-\nrelated risks\n1. Competence, experience\n2. Portfolio of products\n3. Quality control\n4. Evidence\n5. Service, complaint system\n6. Logistics\n7. Teaching, education\n8. Innovation\n6. Surgical risks\n1. General surgical risk\n2. Handling of bone, soft tissue,\nguided bone regeneration (GBR)\n3.\nComprehensive\nplanning\nwith\nperiodontal pretreatment\n4.\nProsthetically\ndriven\nimplant\nplacement\n5. Infection control, operatory\n342"
  },
  {
    "page": 343,
    "content": "6.\nComplexity\nof\ncase,\nself-\nassessment, limits\n7. Repeated interventions\n8. Postsurgical care\n7. Esthetic risks\n1. Correct platform position\n2.\nSoft-tissue\nmanagement/\nemergence profile\n3. Defects, missing volume, scars\n4. Papilla, large gaps\n5. Smile\n6. Thin mucosa\n7. White Esthetic Score (WES)\n8. Complications affecting esthetics,\nchipping\n8. Laboratory-\nrelated risks\n1. Education, competence\n2. Quality\n343"
  },
  {
    "page": 344,
    "content": "3. Logistics, support, availability\n4. Infection control\n5. Conventional production workflow\n6. Digital production workflow\n7. Art, ceramics\n8. Esthetics\n9. Superstructure-\nrelated risks\n1. Loading protocol\n2. Type of reconstruction\n3. Connection/fixation\n4. Occlusion\n5. Veneer\n6. Contour, access for cleaning\n7. Retrievability\n8. Wear, attrition, fatigue\nAs indicated in the overview of reported survival and\nsuccess rates with implant-supported reconstructions,\nhardware complications and failures do occur and are\n344"
  },
  {
    "page": 345,
    "content": "on a gradual increase. The steepness of the increase\ndepends on the type of reconstruction inserted and on\npatient, maintenance, and other risk factors.\nBy providing retrievability, repairs may be easier and\nmay postpone failure. Hardware-related failures and\ncomplications can be reduced by controlling the quality\nof the materials and the production process.\nFactors shown to be associated with increased failure/\ncomplication rates can be influenced and avoided. The\nrisk assessment should include multifactorial causes.\nA\nlthough associations between certain constellations and\nfailures/complications have been demonstrated, the real\ncause often cannot be ascertained, which is reflected in\nthe literature. Causative factors may include material\nspecifications,\ndimensions\nof\nframeworks/veneers,\nnumber of firing cycles, manipulation of components,\nuse of third-party components, and many more. This\ninformation is usually not given in the studies related to\nthis topic.\nNevertheless, the risk levels shown in Figures 3 and 4\nfor a supposed low-risk and a supposed high-risk\nindividual receiving a reconstruction reflects that the\ndecision-making process can in fact influence most of\nthe critical parameters.\n345"
  },
  {
    "page": 346,
    "content": "Fig 3 Example of a high-risk case.\nFig 4 Example of a low-risk case.\n346"
  },
  {
    "page": 347,
    "content": "8 Prevention of Hardware Complications\nU. Brägger\n347"
  },
  {
    "page": 348,
    "content": "348"
  },
  {
    "page": 349,
    "content": "9 Clinical Case Presentations\n9.1\nBiological Complications\n9.1.1 Iatrogenic Complications Managed by Replacing\nProsthetic Components: Non-surgical Approach\nB. Schmid\nA male patient had lost teeth 11 and 22 as a result of a\nbicycle accident at age 14. In his adolescent years, a\nremovable prosthesis had replaced the missing teeth. At\nage 21, the patient was referred by his dentist to the\nuniversity clinic for treatment of the missing teeth 11\nand 22 with implants. He was in good health and a non-\nsmoker. The absence of teeth 11 and 22 over many\nyears had led to significant atrophy of the alveolar\nridge, particularly at site 11. As a first step, the alveolar\nridge was augmented using a block graft to replace the\nlost bone. A Straumann SP implant (diameter 4.1 mm,\nlength\n12\nmm;\nInstitut\nStraumann\nAG,\nBasel,\nSwitzerland) and a Straumann Narrow Neck implant\n(length 10 mm) were inserted in the correct location and\naxial position at sites 11 and 22, respectively, six\nmonths later. After three months of healing and\nsubsequent reentry, the patient returned to the referring\ndentist to receive the prosthetic restoration. The patient\nwas seen again six months after the restoration had been\nplaced. The frontal view showed a high smile line, an\nirregular gingival profile, and a bluish-gray tinge to\nimplant crowns 11 and 22 compared to the natural\ndentition (Fig 1).\n349"
  },
  {
    "page": 350,
    "content": "Fig 1 Frontal view at baseline. High smile line with\nirregular gingival profile from implant crown 11 to\nnatural tooth 21.\nFig 2 Inflamed soft tissue at the buccal aspect of\nimplant crown 11 with fistula formation.\nUnder magnification, a slightly shorter incisal edge of\nimplant crown 11 as well as pronounced reddening\n350"
  },
  {
    "page": 351,
    "content": "accompanied by fistula formation at the buccal aspect\nof implant 11 (Fig 2) was observed. Crowns 11 and 22\nhad been cemented. The radiographs showed a distinct\ngap, particularly at implant 11, between the implant\nshoulder and the edge of the crown (Figs 3a-b).\n351"
  },
  {
    "page": 352,
    "content": "Figs 3a-b Implants 11 und 22 at baseline. (a) Distinct\ngap between the implant and the crown due to a\ncementing error at implant 11. (b) At implant 22, only a\nsmall cementing error is seen.\nAs the crowns had been cemented, strong compression\nresulted in cement residue being deposited in the soft\ntissue, which was responsible for the inflammation\n(mucositis) around the implant. If cement residue is\npresent,\nassociated\nbone\nloss\n(peri-implantitis)\nis\nfrequently the long-term result.\nFigures 3c-d show a case six years after cementation of\nan implant-supported anterior crown with bone loss due\nto peri-implantitis as well as cement residue around the\nNarrow Neck implant.\n352"
  },
  {
    "page": 353,
    "content": "Figs 3c-d (c) Radiograph of a Narrow Neck implant six\nyears after cementation of a crown. Cement residue is\nvisible on the mesial and distal aspects of the implant\n353"
  },
  {
    "page": 354,
    "content": "neck. (d) Intraoperatively, the cement residue causing\nthe inflammation and the bone defect are clearly visible.\nThe removal of cement residue in deeply subgingival\ncemented superstructures can be difficult (Korsch and\ncoworkers\n2013).\nThe\nITI\nConsensus\nStatements\nrecommend\nscrew-retained\nsuperstructures\nor\na\ncustomized mesostructures in cases where an implant\nshoulder is in a deep subgingival position (deeper than\n1.5 mm), in order to keep the cement within the sulcus\narea (Wismeijer and coworkers 2013). There are\nbasically two treatment approaches to iatrogenic peri-\nimplantitis caused by cement residue:\n•\nSurgical intervention to remove the cement residue\nunder (advantageous) visual control while leaving the\nexisting crown in place. Disadvantages include the\ndifficult surgical access and, as in this case, the fact that\nan inadequate crown will still be in place.\n•\nNon-surgical intervention to remove of the cement\nresidue after removing the existing restoration. An\nadvantage\nis\nthe\nopportunity\nto\nprepare\na\nnew,\nesthetically\nimproved,\nbetter\nfitting\ncrown.\nDisadvantages include the difficult removal of cement\nresidue with no visual control and the high costs\nassociated with a new implant crown.\nGiven the esthetically unsatisfactory result, the patient\ndecided to opt for a new restoration and non-surgical\nintervention. With permanent cement (in this case\nKetac™Cem, 3M AG, Rüschlikon, Switzerland), it is\ndifficult to remove individual crowns cemented in one\n354"
  },
  {
    "page": 355,
    "content": "piece. To avoid damaging the implant structure, it was\ndecided to dismantle the crown using a carbide drill.\nUnder local anesthesia, crowns 11 and 22 were slit open\non the buccal and palatal aspects and then removed.\nSome slight damage to the soft tissue at the subgingival\nedge of the crown was almost unavoidable (Fig 4). The\nabutments were unscrewed and removed (Fig 5). A\nperiodontal curette and a sharp scoop were used to\nremove the inflamed tissue and the cement residue\naround the implant. The sulcus was then rinsed with\nchlorhexidine digluconate (0.1%).\nFig 4 Removal of implant crown 11 using a carbide bur.\nTraces of the slitting at the buccal and palatal aspects.\n355"
  },
  {
    "page": 356,
    "content": "Fig 5 Occlusal view after removal of the abutment.\nClear signs of inflammation in the peri-implant soft\ntissue; the implant shoulder is not visible due to the\ninflamed soft tissue and the inadequate fit of the former\ncemented crown. Surprisingly, the dentist had cemented\nnot only the crowns but also the abutments (Fig 6). This\nviolates the implant manufacturer’s instructions.\n356"
  },
  {
    "page": 357,
    "content": "Fig 6 Removed SynOcta abutment, which had been\ninappropriately cemented.\nFig\n7\nOpen-tray\nimpression\nusing\nscrew-retained\ncopings\nfor\na\nnew\nscrew-retained\nsingle-tooth\nprovisional.\nFig\n8\nLaboratory-made,\nscrew-retained\ncomposite\nprovisional on implants 11 and 22. The great pressure\n357"
  },
  {
    "page": 358,
    "content": "on the soft tissue caused by the emergence profile\ndesigned by the technician is evidenced by visible\nischemia.\nFig 9 The provisionals were left in place for five\nmonths to give the soft tissue time to mature.\nAt the same appointment, an impression was taken at\nimplant level using screw-retained impression copings\n(Fig 7) to provide the patient with individual screw-\nretained provisionals on implants 11 and 22 and to\nproceed\nwith\nsoft-tissue\nconditioning.\nAfter\nthe\nimpression, long cylindrical healing caps were installed\nand the old removable prosthesis was worn for another\nweek,\nafter\nwhich\nthe\ncustom\nscrew-retained\nprovisionals were fitted on implants 11 and 22. The\npressure on the soft tissue to create the emergence\nprofile designed by the dental technician produced\nextensive initial ischemia (Fig 8). Often this step cannot\nbe carried out without local anesthesia, as the pressure\nexerted on the soft tissue is very painful for the patient.\n358"
  },
  {
    "page": 359,
    "content": "Fixed provisionals in the esthetic zone are often\nintended to shape and condition the soft tissue and\nallow the dentist time to discuss and define esthetic\nconsiderations with the patient.\nAfter five months of wearing the provisional, the soft\ntissue had matured (Fig 9). A new impression was taken\nfor the final restoration to transfer the emergence profile\ncreated to the laboratory. Using gold copings, the\ntechnician prepared two single screw-retained crowns\nfor implants 11 and 22.\nThe frontal view after treatment (Fig 10) showed that\nthe soft tissue was free of inflammation and presented a\nharmonious gingival profile. The radiographs document\nthe precise fit of the new screw-retained restorations\n(Figs 11a-b).\nFig 10 Definitive screw-retained metal-ceramic crowns.\nGood integration of the soft tissue and harmonious\ngingival profile.\n359"
  },
  {
    "page": 360,
    "content": "Figs 11a-b Radiographs of implants 11 (a) and 22 (b)\nafter treatment.\n360"
  },
  {
    "page": 361,
    "content": "The long-term follow-up ten years after insertion\nshowed stable soft tissue (Figs 12a-b) and new bone\nformation (Figs 12c-d) despite less than diligent oral\nhygiene.\n361"
  },
  {
    "page": 362,
    "content": "Figs 12a-d Ten years after delivery. (a, b) The patient’s\noral hygiene is inadequate, with plaque visible between\nthe teeth. (c, d) The radiographs show stable bone\nconditions.\n362"
  },
  {
    "page": 363,
    "content": "This case documents that deep subgingival cementation\ncan give rise to peri-implant infection of the soft tissue\nwith accompanying bone loss caused by uncontrolled\ncement residue. This fact has been documented by\nvarious studies (Linkevicius and coworkers 2011,\n2013). The ITI Consensus Statements recommend\nscrew-retained reconstructions in the anterior esthetic\nzone\nwhere\nthe\ncrown\nmargins\nare\nlocated\nsubgingivally, to avoid problems of this very sort.\nCementing superstructures (e.g. in the event of implant-\naxis problems) should limit the cementing area to the\nsulcus via mesostructures to facilitate removal of\ncement residue.\n363"
  },
  {
    "page": 364,
    "content": "9.1.2 Peri-implantitis Treated with Access-Flap Surgery\nL. J. A. Heitz-Mayfield\nA 27-year-old male was referred to the periodontist for\nassessment and management of implant site 41. The\nimplant had been placed nine years previously and\nrestored with a screw-retained single crown. The patient\nwas a cigarette smoker in good general health. He\nreported he had reduced his smoking habit from 25\ncigarettes per day to 15 cigarettes per day in the\nprevious six months.\nOn examination, there was calculus and plaque present\nat the lower anterior teeth and at implant site 41.\nLocalized attachment loss was observed at teeth 32 and\n42, with 2–3 mm of gingival recession. At implant site\n41, there were 8–9 mm probing depths with suppuration\nand bleeding on probing (Fig 1). The patient had\nhimself noted suppuration on finger pressure from\naround the implant. A periapical radiograph showed\nmarginal bone loss to between thread 6 and 7 of the\nimplant\n(Fig\n2).\nPrevious\nradiographs\nwere\nnot\navailable\nfor\ncomparison.\nA\ndiagnosis\nof\nperi-\nimplantitis was made.\n364"
  },
  {
    "page": 365,
    "content": "Fig 1 Implant site 41, with bleeding and suppuration on\nprobing.\nFig 2 Periapical radiograph. Marginal bone loss to\nbetween thread 6 and 7 of the implant.\n365"
  },
  {
    "page": 366,
    "content": "The patient was informed that there was severe bone\nloss around the implant and that one of the treatment\noptions to consider would be removal of the implant.\nThe patient was also informed that, when attempting to\ntreat and maintain the implant, surgical access would\nlikely be required considering the extent of bone loss\nand depth of the peri-implant pocket. He was also\ninformed that recession of the mucosal margin should\nbe expected following treatment. The patient opted to\ntry to maintain the implant for as long as possible.\nFig 3 The implant following elevation of a full-\nthickness mucoperiosteal flap prior to decontamination\nof the implant surface. Approximately eight threads of\nthe implant are exposed on the facial aspect of the\nimplant.\n366"
  },
  {
    "page": 367,
    "content": "Fig 4 Clinical photograph showing decontamination of\nthe implant surface using a titanium brush.\nFig 5 Implant site 41 after positioning the flap margins\nand suturing.\n367"
  },
  {
    "page": 368,
    "content": "Fig 6 Implant site 41 twelve months following surgical\ntreatment. Note the recession of the soft-tissue margin.\nFig 7 Regular supportive care. Air-powder abrasive\nwith glycine powder used to remove biofilm every three\nto four months.\n368"
  },
  {
    "page": 369,
    "content": "Fig 8 Periapical radiograph showing stable peri-implant\nmarginal bone levels twelve months after surgical\ntreatment. Marginal bone level between threads 6 and 7\nof the implant.\nNon-surgical treatment\nThe patient attended for one visit for non-surgical\ndebridement\nof\nhis\ndentition\nand\noral-hygiene\ninstructions. Information regarding smoking cessation\nwas\nalso\nprovided.\nAt\nthe\nimplant,\nnon-surgical\ndebridement was performed using titanium curettes.\nOral-hygiene\ninstructions\ndemonstrating\na\ncircumferential flossing technique at implant 41 were\nprovided. The periodontal and peri-implant tissues were\nre-evaluated at four weeks. An improvement in the\npatient’s plaque control was noted with a resolution of\n369"
  },
  {
    "page": 370,
    "content": "gingivitis. As expected, there was a persistent deep\nprobing depth at the implant, and surgical access was\nplanned for decontamination of the implant surface in\nconjunction with systemic antimicrobial treatment.\nSurgical\naccess\nflap\nand\nimplant-surface\ndecontamination\nFull-thickness facial and lingual mucoperiosteal flaps\nwere raised with vertical releasing incisions to gain\naccess to the defect associated with the implant. The\ninflammatory granulation tissue was removed, revealing\na circumferential bone defect with no buccal or lingual\nwalls (Fig 3). The defect was therefore considered\nunsuitable for a regenerative approach (bone-graft\nmaterial/barrier membrane). The implant surface was\ndecontaminated using a titanium brush in an oscillating\nhandpiece with copious irrigation with sterile saline\n(Fig 4).\nThe flaps were positioned and sutured (Fig 5) and\npostoperative instructions provided. Amoxicillin 500\nmg, three times a day, and metronidazole 400 mg, three\ntimes a day, were prescribed for seven days. The patient\nwas instructed to rinse with a chlorhexidine mouthrinse\ntwice daily for one minute for a period of four weeks.\nThe patient was warned of possible side effects\nfollowing systemic antimicrobials. The patient was seen\nfor suture removal ten days after surgery and for review\nat one and three months (Fig 6).\nThree-month re-evaluation\n370"
  },
  {
    "page": 371,
    "content": "Three months following surgical treatment, the peri-\nimplant infection had resolved (no suppuration or\nbleeding on probing and a reduction in probing depths\nto 5 mm). There was also 2 mm recession of the peri-\nimplant soft tissue margin. The patient was then seen on\na three-monthly basis for monitoring and supportive\ncare (Fig 7).\nTwelve-month re-evaluation\nTwelve months following surgical treatment, there were\nfurther improvements in the health of the peri-implant\nsoft tissues with probing depths of 3 mm, and no\nbleeding or suppuration on probing (Fig 6). No further\nbone loss was observed on the radiograph (Fig 8). The\npatient reported he had reduced his smoking habit but\ncontinued to smoke approximately 10 cigarettes per\nday.\nDiscussion\nThis case describes an anti-infective approach for the\nmanagement\nof\nperi-implantitis\nwith\na\nsuccessful\noutcome\nat\ntwelve\nmonths\n(Heitz-Mayfield\nand\ncoworkers 2012). Importantly, a strict postoperative and\nsupportive care protocol was followed. Regular (three-\nto four-monthly) visits will be required for future\nmonitoring and maintenance care for this patient.\n371"
  },
  {
    "page": 372,
    "content": "9.1.3 Excess\nCement\nResulting\nin\nPeri-implant\nInfection Presenting as a Draining Sinus Tract\nT. Linkevičius\nBiological complications caused by undetected cement\nresidue have been receiving much attention. Excess\ncement might be responsible not only for rapidly\ndeveloping of peri-implantitis, but also for delayed or\nchronic manifestations of the disease many years after\ncementation (Wilson 2009; Linkevicius and coworkers\n2013). In-vitro and clinical studies have shown that it is\nvery difficult or even impossible to completely clean up\nexcess cement at subgingival margins, so popular in\ncemented restorations (Agar and coworkers 1997;\nLinkevicius\nand\ncoworkers\n2011,\n2012).\nPossible\noutcomes of biological complications due to excess\ncement range from temporary inflammation of the peri-\nimplant soft tissues without any serious esthetic and\nfunctional consequences all the way to implant loss.\nThis report describes a case of peri-implantitis caused\nby residual cement; as well as the management and\nquite unusual resolution of the complication.\nThe patient presented in 2009 with a draining sinus\ntract, tenderness on chewing, and tissue contact above\nthe implant-supported restoration (Fig 1). The implant\nhad been restored approximately three years before.\n372"
  },
  {
    "page": 373,
    "content": "Fig 1 Draining sinus tract above an implant-supported\nrestoration.\nThe patient’s dental history showed that a two-piece\nimplant 3.5 mm in diameter and 12 mm in length\n(Internal System; BioHorizons, Birmingham, Alabama,\nUSA) had been placed and had successfully integrated.\nA\nstandard\nabutment\nsupported\na\nmetal-ceramic\nrestoration\ncemented\nwith\nglass-ionomer\ncement\nmodified with a resin luting agent (Fuji Plus; GC,\nTokyo,\nJapan).\nExcess\ncement\nwas\nremoved;\na\nradiographic examination did not show any residue. The\ntreatment was considered completed; the patient was\nsatisfied and did not request any consultation or\nintervention\nafter\nthe\ntreatment\nuntil\nthe\npresent\noccasion.\nProbing showed deep pockets up to 8 mm and profuse\nbleeding on probing (Fig 2). However, the general\ncondition of the periodontal tissue around other teeth\n373"
  },
  {
    "page": 374,
    "content": "was good; bleeding on probing and the plaque index of\nthe other teeth did not exceed 15%.\nFig 2 Bleeding on probing.\nThe radiographic examination showed severe crestal\nbone loss up to the third implant thread. The bone-loss\npattern was characteristic of peri-implantitis. No cement\nresidue was noted, and the bone level of the adjacent\nteeth indicated no periodontal involvement (Figs 3a-b).\nClinical and radiological evaluation yielded a diagnosis\nof chronic peri-implantitis.\n374"
  },
  {
    "page": 375,
    "content": "Figs 3a-b Radiographic examination with different\npositions of the holder.\n375"
  },
  {
    "page": 376,
    "content": "The initial treatment plan provided for removal of the\nrestoration and evaluation of the peri-implant tissues.\nThe occlusal surface of the restoration opened to gain\naccess to the abutment screw, which was loosened and\nthe restoration was removed. A large lump of cement\nresidue was found on the buccal side of the implant,\ninvisible on the radiograph (Figs 4a-b).\n376"
  },
  {
    "page": 377,
    "content": "Figs 4a-b (a) Previously undetected lump of cement\nresidue in the peri-implant sulcus. (b) Size of the\nundercut of the restoration; removed excess cement.\nAn\nextensive\nundercut\nwas\npresent\nbetween\nthe\ncementation margin on the standard abutment (lower\narrow) and the emergence profile of the restoration on\nthe buccal side (upper arrow) (Fig 4b), the side of the\nundercut where the cement residue was lodged in the\nperi-implant mucosa. The undercut can be described as\nthe distance between the cementation margin (where the\ncement was extruded) and the emergence profile of the\nrestoration.\nIt\nis\npossible\nthat\nmore\npronounced\nundercut results in an even greater risk of cement\nentrapments.\nThe cement residue was removed and the peri-implant\ntissues rinsed with copious amounts of chlorhexidine\n377"
  },
  {
    "page": 378,
    "content": "digluconate\n0.12%\nsolution\n(PerioAid;\nDentaid,\nBarcelona, Spain). There was an ulcer in the peri-\nimplant tissues where the cement residue had been (Fig\n5a). Chlorhexidine gel (PerioAid Gel; Dentaid) was\napplied\non\nthe\nhealing\nabutment,\nwhich\nwas\nreconnected to the implant (Figs 5b-c). The excess gel\nwas washed away. The patient was instructed to rinse\nthe infected site with chlorhexidine digluconate solution\ntwice a day for one week.\n378"
  },
  {
    "page": 379,
    "content": "Figs 5a-c (a) Peri-implant sulcus after removal of\nexcess cement. (b) Healing-abutment connection. (c)\nRadiographic verification.\n379"
  },
  {
    "page": 380,
    "content": "The patient returned one week after removal of the\nexcess\ncement.\nThe\ndraining\nsinus\ntract\nhad\ndisappeared. The patient did not report any tenderness\nat the site. Clinically, the soft tissues appeared healthy,\nwith restricted blushing of the gingiva at the former\nlocation of the draining sinus tract. The restoration was\nreconnected to the implant; the occlusal access was\nisolated with polytetrafluoroethylene tape and covered\nwith an adhesive composite resin (Fig 6). It was decided\nnot\nto\nuse\nany\nantibacterial\ndrugs\nor\nperform\nregenerative\ntreatment\nof\nthe\nperi-implantitis;\nthe\npatient was scheduled for recall visits every six months.\nFig 6 The sinus tract has healed.\nThe patient returned one year after removal of the\nexcess cement and did not have any complaints. A\nradiological examination showed bony remineralization\nat the previously infected implant site (Fig 7b). After\ntwo years, full regrowth of the crestal bone around the\nimplant was observed (Fig 7c). During this time, the\n380"
  },
  {
    "page": 381,
    "content": "patient had had his adjacent tooth replaced by an\nimplant.\n381"
  },
  {
    "page": 382,
    "content": "Figs 7a-c (a) Reference radiograph in 2009. (b) Partial\nremineralization of the bone defect in 2010. (c) Fully\nestablished bone level in 2012. Note that in the follow-\nup period, the premolar had also been replaced with an\nimplant supported crown.\nThe soft tissue was clinically healthy; the bone contours\nhad improved, although limited change in soft-tissue\ncolor remained (Fig 8).\n382"
  },
  {
    "page": 383,
    "content": "Fig 8 Clinical appearance of the implant-supported\nrestoration three years after treatment.\nDiscussion\nThe cement residue\nin this clinical case had obviously caused crestal bone\nresorption. After elimination of the residue, not only the\nhad the soft-tissue inflammation resolved, but bone\nremineralization had occurred as well. This can be\ncompared to the remineralization of alveolar bone\naround teeth. When infection has been successfully\ntreated and the irritants have been removed, the organic\nbone matrix is remineralized. Bone regeneration occurs\nin infrabony pockets in patients maintaining optimal\noral hygiene (Rosling and coworkers 1976). It can be\nspeculated that a similar process took place in this\nimplant case. The excess cement had behaved like\n“artificial\ncalculus,”\nwhich\npredisposed\nfor\nperi-\nimplantitis.\n383"
  },
  {
    "page": 384,
    "content": "A surgical intervention is probably not always required\nas part of cement-related peri-implantitis treatment.\nOnce\nthe\ncement\nresidue\nhas\nbeen\nremoved,\nremineralization of the crestal bone can occur.\n384"
  },
  {
    "page": 385,
    "content": "9.1.4 Peri-implantitis Modified by Submucosal Excess\nof Cement: Regenerative Peri-implantitis Therapy and\nSix-year Follow-up\nG. E. Salvi\nA 30-year-old female patient was referred to the\nDepartment of Periodontology of the University of\nBern, Switzerland, by a dentist in private practice.\nTooth 45 had been congenitally missing and had been\nreplaced with a titanium implant three years prior to the\nfirst visit at the Department of Periodontology. The\ntissue level implant had a diameter of 4.1 mm, a length\nof 12 mm, and a sandblasted and acid-etched (SLA)\nsurface (Straumann® Dental Implant System; Institut\nStraumann AG, Basel, Switzerland).\nThe metal-ceramic crown on implant 45 had been\ncemented permanently. Implant 45 had been diagnosed\nwith peri-implantitis by the referring dentist in the\ncourse of regular supportive care.\nThe non-smoking patient was systemically healthy and\nexhibited a high standard of plaque control.\nThe periapical radiograph of implant 45 (Fig 1)\nindicated that cement excess had not been removed\nbelow the implant shoulder mesially and distally of\nimplant 45 after delivery of the implant crown. The\ncrown had been cemented permanently and could not be\nremoved without being damaged. The patient’s chief\n385"
  },
  {
    "page": 386,
    "content": "complaint was to save the implant without removing the\ncrown for financial reasons.\nFig 1 Periapical radiograph.\nFigure 2 presents a clinical buccal view of the inflamed\nperi-implant mucosa at site 45 at the first examination.\nThe patient did not report any pain in the peri-implant\narea. Pocket probing depths (PPD) up to 9 mm with\nconcomitant bleeding on probing (BoP) and suppuration\nwere detected.\n386"
  },
  {
    "page": 387,
    "content": "Fig 2 Buccal view of the inflamed peri-implant mucosa.\nA treatment plan including a non-surgical and a surgical\nphase was presented to the patient. The non-surgical\nphase included mechanical submucosal debridement\nwith titanium curettes under local anesthesia to remove\ncement residue, followed by submucosal irrigation with\nchlorhexidine digluconate solution. The patient was\ninstructed in the daily use of interdental brushes in\nconjunction with chlorhexidine digluconate gel. A\nregenerative approach to the peri-implant defect was\nplanned, provided a contained defect configuration was\nconfirmed at the time of surgery.\nFigure 3 illustrates the application of a bone substitute\nto the peri-implant defect to support a barrier membrane\n(shown as the dark blue line).\n387"
  },
  {
    "page": 388,
    "content": "Fig 3 Application of bone substitute to the peri-implant\ndefect.\nFollowing elevation of a full-thickness mucoperiosteal\nflap and removal of the granulation tissue, a contained\ncircumferential bone defect could be assessed. The\nmarginal bone levels of the adjacent teeth, however, had\nnot been affected (Fig 4).\n388"
  },
  {
    "page": 389,
    "content": "Fig\n4\nIntraoperative\nview\nof\ndefect.\nUnaffected\nmarginal bone levels of the adjacent teeth.\nFigure 5 shows the peri-implant defect prior to the\nsurgical phase. The radiograph confirms that excess\ncement had been removed during the non-surgical\nphase.\n389"
  },
  {
    "page": 390,
    "content": "Fig 5 Baseline radiograph.\nAfter decontamination of the implant threads with\ncotton pellets soaked in chlorhexidine digluconate and\nsaline solutions, deproteinized bovine bone mineral\n(DBBM) particles (0.25–1 mm) (Bio-Oss®; Geistlich,\nWolhusen, Switzerland) were applied to the peri-\nimplant defect up to the transition line from the smooth\nto\nthe\nmicro-rough\nimplant\nsurface\n(Fig\n6).\nSubsequently, two layers of a bioabsorbable collagen\nmembrane (Bio-Gide®; Geistlich) were adapted around\nthe neck of the implant.\n390"
  },
  {
    "page": 391,
    "content": "Fig\n6\nIntraoperative\nview\nafter\nimplant\nsurface\ndecontamination showing a DBBM application.\nThe mucoperiosteal flap was sutured in place around\nthe neck of the implant, allowing for transmucosal\nhealing of the soft tissues (Fig 7).\nFig 7 After wound closure (transmucosal healing\nmode).\n391"
  },
  {
    "page": 392,
    "content": "A periapical radiograph taken immediately after surgery\nshows the fill of the peri-implant defect with DBBM\nparticles (Fig 8).\nFig 8 Postsurgical radiograph.\nThe patient was prescribed systemic antibiotics for five\ndays and was instructed to rinse with chlorhexidine\ndigluconate solution for four weeks after surgery. The\nnon-resorbable sutures were removed after one week;\nthe patient was instructed to gently brush the area with a\nsoft toothbrush and chlorhexidine digluconate gel in\naddition to the chlorhexidine rinse. The patient resumed\ninterproximal cleaning with an interdental brush and\nchlorhexidine gel six weeks after surgery.\n392"
  },
  {
    "page": 393,
    "content": "Following\nthe\nfinal\nevaluation\nof\nthe\ntreatment\noutcome, the patient was referred back to the private\ndental office for regular supportive care at six-month\nintervals.\nFigure 9 shows the clinical buccal view of implant 45\ntwo years after regenerative therapy of the peri-\nimplantitis defect. PPDs of 3 mm or less without BoP\nand suppuration could be assessed around implant 45.\nFig 9 Clinical situation two years after regenerative\ndefect therapy.\nThe periapical radiograph taken two years after surgery\nindicates a defect fill to the smooth implant neck (Fig\n10).\n393"
  },
  {
    "page": 394,
    "content": "Fig\n10\nPeriapical\nradiograph\ntwo\nyears\nafter\nregenerative defect therapy.\nFigure 11 shows a clinical buccal view of implant 45\nsix years after regenerative therapy. Redness and\nswelling of the peri-implant mucosa are absent. A band\nof keratinized tissue is present on both the buccal and\nlingual aspects of the implant crown. The lingual view\nof implant 45 six years after completion of therapy\nshows an absence of bacterial deposits around the\nimplant crown and the neighboring teeth. This confirms\nthe excellent level of plaque control by the patient (Fig\n12).\n394"
  },
  {
    "page": 395,
    "content": "Fig 11 Six years after regenerative therapy. Buccal\nview.\nFig 12 Six years after regenerative therapy. Lingual\nview.\nFigure 13 shows an occlusal view of the cemented\ncrown six years after regenerative therapy.\n395"
  },
  {
    "page": 396,
    "content": "Fig 13 Six years after regenerative therapy. Occlusal\nview. The periapical radiograph taken six years after\nregenerative therapy reveals a defect filled to the\nsmooth implant neck (Fig 14).\n396"
  },
  {
    "page": 397,
    "content": "Fig 14 Periapical radiograph six years after regenerative\ntherapy.\nDiscussion\nThe treatment of this patient started with the diagnosis\nof a modifying factor for peri-implantitis (i.e. the\npresence of submucosal excess cement) in the course of\nsupportive\ncare\nin\na\nprivate\ndental\noffice.\nThis\nhighlights the importance of regularly monitoring\nimplants during supportive care by clinical (i.e. peri-\nimplant probing, bleeding on probing, suppuration) and\nradiographic means (Salvi and Lang 2004; Salvi and\nZitzmann 2014).\nDuring the non-surgical therapy, submucosal cement\nexcess was removed mechanically by titanium curettes.\n397"
  },
  {
    "page": 398,
    "content": "Improvement of the peri-implant soft-tissue condition\nwas confirmed at re-evaluation (Wilson 2009). The\npresence of mucosal inflammation and residual PPDs of\n6 mm or more after non-surgical therapy indicated that\nthe peri-implantitis had not been resolved with non-\nsurgical\ndebridement\nin\nconjunction\nwith\nantimicrobials.\nElevation\nof\na\nfull-thickness\nmucoperiosteal flap, removal of granulation tissue and\nthorough implant-surface decontamination constituted\nthe first steps of the surgical access to the peri-implant\ndefect (Heitz-Mayfield and Mombelli 2014). Based on\nthe fact that a contained circumferential defect (with\nfour bony walls) was detected at time of surgery, a\nregenerative approach including the use of a bone\nsubstitute and a barrier membrane seemed justified\n(Heitz-Mayfield\nand\nMombelli\n2014).\nAlthough\nradiographs taken two and six years after regenerative\ntherapy\nshowed\na\nfilled\nperi-implant\ndefect,\nre-\nosseointegration of the previously contaminated implant\nsurface cannot be claimed due to a lack of histological\nproof (Persson et al. 2001).\n398"
  },
  {
    "page": 399,
    "content": "9.1.5 Peri-implantitis Treated by an Antimicrobial and\nRegenerative Approach\nA. Mombelli, P. Wick\nA 73-year-old woman was referred to the Division of\nPeriodontology (University of Geneva School of Dental\nMedicine) after repeated unsuccessful treatment of a\nperi-implant infection. She was systemically healthy\nand did not smoke. The patient’s history revealed that,\nthree years earlier, an immediate implant (Straumann\nTapered Effect RN 4.8/4.1; Institut Straumann AG,\nBasel, Switzerland) had been inserted to replace the\nupper right central incisor. A metal-ceramic crown had\nbeen delivered using an adhesive resin cement. One\nyear later, the patient had consulted another dentist due\nto discomfort in the soft tissues in the implant region.\nThere was a suppurating peri-implant pocket, 10 mm\ndeep. Peri-implant bone loss and excess luting cement\nwere seen on the radiograph. The situation was treated\nwith\nnon-surgical\ndebridement,\namoxicillin,\nand\nrepeated submucosal irrigation with a chlorhexidine\ndigluconate solution. The patient was referred after the\nsuppuration had persisted for several months.\nFigures 1 and 2 show the clinical and radiographic\nsituation at the time of referral. A visual inspection\nshowed only minimal inflammation (Fig 1). The teeth\nwere well maintained and periodontally healthy. Peri-\nimplant\nprobing\nrevealed\na\ndeep\npocket\n(8\nmm\nmesially, 8 mm mid-buccally, 9 mm distally, 5 mm\n399"
  },
  {
    "page": 400,
    "content": "palatally). There were suppuration and bleeding on\nprobing.\nFig 1 Minimal signs of inflammation. On the buccal\nside of implant 11, there is a deep pocket with bleeding\non probing and suppuration (8 mm mesially, 8 mm mid-\nbuccally, 9 mm distally, 5 mm palatally).\n400"
  },
  {
    "page": 401,
    "content": "Fig 2 Radiograph showing a peri-implant bone defect at\nimplant 11.\nA radiograph (Fig 2) showed a peri-implant bone\ndefect. Cement residues were not visible.\nA microbiological sample, taken by paper point from\nthe peri-implant pocket, was positive for six common\nanaerobic\nmicroorganisms\n(Porphyromonas\ngingivalis,\nTannerella\nforsythia,\nTreponema\ndenticola,\nParvimonas\nmicra,\nFusobacterium\nnucleatum, Campylobacter rectus), indicating the\npresence of a mixed anaerobic infection. The diagnosis\nwas peri-implantitis. The refractory state was assumed\nto be due to persisting bacterial deposits on the implant\nsurface.\nThe\ntreatment\nplan\ncalled\nfor\nopen-flap\n401"
  },
  {
    "page": 402,
    "content": "debridement and adjunctive systemic antimicrobial\ntherapy.\nPrior to the surgical intervention, the site was cleaned\nmechanically, the pocket was rinsed with chlorhexidine,\nand a prescription was made for 375 mg of amoxicillin\nand 500 mg of metronidazole three times per day for\nseven days, beginning one hour before surgery. An\nintrasulcular incision was extended from the mesial\naspect of the right canine to the mesial aspect of the left\nsecond incisor. No vertical releasing incisions were\nmade.\nA\nmucoperiosteal\nflap\nwas\nelevated\nand\ngranulation tissue was removed to expose the peri-\nimplant bone defect and the contaminated implant. A\nlarge piece of excess luting cement was detected on the\nbuccal aspect of the implant (Fig 3). The vestibular\nbony plate was missing in this area. In addition,\nextensive vertical loss of periodontal attachment and\nalveolar bone was seen on the neighboring lateral\nincisor, due to the close proximity of the implant to the\nroot of that tooth.\n402"
  },
  {
    "page": 403,
    "content": "Fig 3 Full-thickness flap exposing a piece of excess\nluting cement. Close proximity of the implant to the\nneighboring lateral incisor causing a vertical loss of\nperiodontal attachment and alveolar bone.\nThe cement residue was removed with an ultrasonic\nscaler, and the implant surface was carefully cleansed\n(Fig 4).\n403"
  },
  {
    "page": 404,
    "content": "Fig 4 The cement residue was removed and the implant\nsurface carefully cleansed.\nThe bone defect was filled with a xenogeneic bone\nsubstitute and covered with a collagen membrane (Fig\n5).\nFig 5 The bone defect was filled with a xenogeneic\nbone substitute and covered with a collagen membrane.\nPassive\nrepositioning\nwas\nachieved\nusing\nfour\nhorizontal mattress sutures. The wound was secured\nwith interrupted sutures (Fig 6). The patient rinsed with\n0.2% chlorhexidine digluconate twice a day for two\nweeks. The postsurgical phase was uneventful.\n404"
  },
  {
    "page": 405,
    "content": "Fig 6 Primary closure achieved with interrupted sutures.\nHorizontal mattress sutures for passive repositioning.\nFig 7 shows the situation at a follow-up examination,\none year after the surgical intervention. There were no\nmore clinical signs of infection. Peri-implant probing\nrevealed no depths above 5 mm and no suppuration. At\nthe buccodistal aspect of the implant, the margin of the\nperi-implant mucosa was positioned further apically\nthan before, but the implant itself was not exposed.\nThere was gingival recession mesial of the lateral\nincisor.\n405"
  },
  {
    "page": 406,
    "content": "Fig 7 One year after the surgical intervention.\nFig 8 shows the situation at the two-year follow-up. The\ngingival recession mesial of the lateral incisor is less\nprominent due to spontaneous partial leveling of the\ngingival margin.\nFig 8 Two-year follow-up.\n406"
  },
  {
    "page": 407,
    "content": "Discussion\nTwo aspects of this case merit closer attention: the\ndiagnosis and antimicrobial treatment approach and the\nimpact of the implant position on the outcome.\nBiofilm-associated infections are notoriously resistant\nto\nantimicrobial\ntherapy\nunless\nthe\nbiofilm\nis\nmechanically disrupted and the bulk of the bacterial\nmass is physically removed. We therefore assumed that\nthe refractory nature of this local purulent infection was\ndue to persisting biofilm on the deeper surface areas of\nthe implant.\nThis case is a good example of a peri-implant infection\ntriggered and sustained by the presence of a foreign\nbody. In this patient, a mixed anaerobic, biofilm-\nassociated infection had developed due to the presence\nof excess luting cement (Marsh and Devine 2011;\nMombelli and Décaillet 2011). Although suppuration\nand hard-tissue damage were caused by the bacterial\ninfection, antimicrobial agents alone could not resolve\nthe condition. In fact, cement residues had appeared on\nan earlier radiograph, and measures had been taken to\nremove them, but the full extent of the problem had not\nbeen recognized. Thus, this case also demonstrates the\nlimits of a clinical examination and conventional dental\nradiography with regard to a specific diagnosis.\nOverall,\nthe\noutcome\nof\nthe\ntreatment\naimed\nat\nremoving\nthe\ncause\nof\nthe\ninfection\nand\nthe\nreconstructing lost structures was good. The success at\nthe esthetic level was partial. Due to the close proximity\n407"
  },
  {
    "page": 408,
    "content": "of the implant to the lateral incisor, the infectious\nprocess had induced a loss of periodontal attachment on\nthe mesial aspect of the neighboring tooth. The result\nwas gingival recession and the loss of the papilla\nbetween the tooth and the implant. The implant itself\nwas not exposed. If the deep position of the implant\nprevented exposure, on the other hand, residual probing\ndepths of approximately 5 mm were the consequence\n(Gallucci and coworkers 2011).\nThe present case illustrates a specific difficulty when\npositioning immediate implants in sites where the\nalveolus of the extracted tooth is very close to a\nneighboring tooth.\n408"
  },
  {
    "page": 409,
    "content": "9.1.6 Recurrent Peri-implantitis Leading to Implant\nRemoval\nL. J. A. Heitz-Mayfield\nBackground\nA 65-year-old female patient was referred to the\nperiodontist for assessment and management of implant\nsite 12. Implant 12 had been placed ten years previously\nand restored with a cemented single crown. The patient\nwas a non-smoker in good general and periodontal\nhealth.\nOn examination there were 7 mm probing depths at\nimplant 12 with suppuration and bleeding on probing.\nThe patient was aware of the presence of pus but had no\ndiscomfort. A periapical radiograph showed marginal\nbone loss to approximately the third thread of the\nimplant (Fig 1). Previous radiographs obtained from the\nreferring\nclinician\nindicated\nthat\nthere\nhad\nbeen\nprogressive bone loss since the implant was restored. A\ndiagnosis of peri-implantitis was made.\n409"
  },
  {
    "page": 410,
    "content": "Fig 1 Periapical radiograph of implant 12 showing\nmarginal bone loss to the level of the third implant\nthread.\nFollowing non-surgical debridement and oral-hygiene\ninstructions demonstrating a circumferential flossing\ntechnique, the peri-implant tissues were reassessed at\nfour\nweeks.\nThere\nwas\npersistent\ninfection.\nAn\nappointment was made for open-flap debridement and\nimplant-surface decontamination in conjunction with\nsystemic antimicrobials. One month following surgical\ntreatment, the peri-implant infection had resolved (no\nsuppuration or bleeding on probing and a reduction in\nprobing depths to 5 mm). The patient was seen on a\nthree-monthly basis for monitoring and supportive care.\nProgressive bone loss\n410"
  },
  {
    "page": 411,
    "content": "Unfortunately, recurrent peri-implantitis was diagnosed\nat the eighteen-month follow-up. A radiograph taken to\nmonitor the marginal bone levels revealed additional\nbone loss, which had progressed to the level of the ninth\nthread of the implant (Fig 2). The implant was not\nmobile, and there were 5-mm probing depths with some\nbleeding on probing, with no suppuration (Fig 3).\nFollowing discussion with the patient, it was decided to\nremove the implant to avoid further bone loss and loss\nof attachment at the adjacent teeth.\nFig\n2\nPeriapical\nradiograph\nshowing\nprogressive\nmarginal bone loss to the level of the ninth thread of\nimplant 12 eighteen months following peri-implantitis\ntreatment.\n411"
  },
  {
    "page": 412,
    "content": "Fig 3 Implant 12 eighteen months after surgical\ntreatment of peri-implantitis. Probing depths were 5 mm\nwith bleeding on probing.\nA provisional partial denture was fabricated by the\npatient’s dentist and delivered to the periodontist prior\nto the implant-removal appointment. The cemented\ncrown and screw-retained abutment were removed (Fig\n4).\nFollowing\nlocal\nanesthesia,\nthe\nimplant\nwas\nremoved using an implant-retrieval tool (Nobel Biocare,\nZürich, Switzerland) (Figs 4 and 5).\n412"
  },
  {
    "page": 413,
    "content": "Fig 4 The sectioned implant crown (right), the screw\nretained abutment (center), and the implant (left).\nFig 5 Removal of the implant using an implant retrieval\ntool and ratchet (Nobel Biocare®).\nThe\nimplant-retrieval\ntool\nwas\ninserted\nin\na\ncounterclockwise direction into the internal part of the\nimplant. A ratchet was then attached to the retrieval tool\n413"
  },
  {
    "page": 414,
    "content": "and\ncounterclockwise\ntorque\napplied\nuntil\nthe\nosseointegration was lost. There was no flap raised and\nthe site was debrided and allowed to heal for a period of\nthree months.\nThe treatment options for replacement of the missing\ntooth were discussed with the patient. The patient\ndecided against additional surgical procedures and\nchose to replace the missing tooth with a tooth-\nsupported prosthesis.\nDiscussion\nThis case illustrates that despite anti-infective treatment\nof peri-implantitis, some implants in some patients may\nexperience recurrent infection and progressive bone\nloss. This possibility should be discussed with the\npatient prior to peri-implantitis therapy. This case also\ndescribes a conservative implant-removal approach\nusing an implant-retrieval tool without the use of\ntrephine drills.\n414"
  },
  {
    "page": 415,
    "content": "9.2\nBiological Complications (Other than Infections)\n9.2.1 Removal of a Malpositioned Implant and Direct\nNew Implant Placement with Simultaneous Contour\nAugmentation using GBR\nD. Buser, U. Belser\nA 35-year old female patient was referred to the\nDepartment of Oral Surgery and Stomatology at the\nUniversity of Bern, Switzerland, for examination of an\nimplant site that had exhibited clinical signs of slightly\ndelayed wound healing. In addition, the referring\nclinician found no evidence for a facial bone wall when\nshe raised a flap to gain access to the implant for\nabutment connection.\nFour months earlier, she had inserted a bone-level\nimplant in a single-tooth gap, where the lateral incisor\nhad been extracted due to a chronic periapical lesion on\nthe mesial aspect of the root (Fig 1). Implant placement\nwas combined with simultaneous bone augmentation\nusing deproteinized bovine bone mineral (DBBM, Bio-\nOss®;\nGeistlich,\nWolhusen,\nSwitzerland)\nand\na\ncollagen membrane (Bio-Gide®; Geistlich), followed\nby primary wound closure. The patient also provided\nthe postsurgical radiograph that displayed the implant\nwith a 3.5-mm healing cap (Fig 2).\n415"
  },
  {
    "page": 416,
    "content": "Fig 1 Initial periapical radiograph of the upper right\nlateral incisor demonstrating a periapical lesion. At that\npoint, the referring clinician had decided to extract the\ntooth and replace it with an implant. Excellent crestal\nbone levels are present at both adjacent teeth.\n416"
  },
  {
    "page": 417,
    "content": "Fig 2 Radiograph following placement of a reduced-\ndiameter bone-level implant and a healing cap 3.5 mm\nin length.\nThe clinical examination showed a single-tooth gap\nwith a missing lateral incisor in the right maxilla and a\nslight gingival recession at the distal aspect of the\ncentral incisor (Fig 3). The mucosa had healed without\nsigns of a fistula. We examined the implant site by\nthree-dimensional\n(3D)\ncone-beam\ncomputed\ntomography (CBCT) to assess the 3D anatomical\nsituation: The implant was inserted too far facially, and\nthere was no radiographic evidence of a facial bone\nwall (Figs 4a-b).\n417"
  },
  {
    "page": 418,
    "content": "Fig 3 First re-examination at our clinic showing the\nsingle-tooth\ngap\nwith\na\nsubmerged\nimplant.\nThe\nadjacent\ncentral\nincisor\nexhibited\nminor\ngingival\nrecession.\n418"
  },
  {
    "page": 419,
    "content": "Fig 4a Orofacial section of the CBCT demonstrating the\nabsence of a facial bone wall across the entire implant\nsurface.\nFig 4b Horizontal section of the CBCT indicating a\nfacial malposition of the implant and confirming the\nabsence of a facial bone wall.\nThe situation was discussed with the patient, and three\ntreatment options were presented. Each option included\nan\nopen-flap\nprocedure\nfor\nthe\nmost\nadequate\ntherapeutic choice to be determined intraoperatively.\n•\nOption\n1.\nLeaving\nthe\nimplant\nin\nplace\nand\nperforming a second augmentation procedure using\nGBR to generate a new facial bone wall.\n•\nOption 2. Removing the implant and inserting a new\nimplant in a correct 3D position, combined with a\nsimultaneous contour augmentation using GBR.\n•\nOption 3. Removing the implant and performing\nlocal ridge augmentation using GBR to allow placement\nof a new implant five months later.\n419"
  },
  {
    "page": 420,
    "content": "The\nsurgery\nwas\nperformed\nin\nlocal\nanesthesia\ncombined with sedative premedication. The site was\nopened with a triangular flap using a distal line-angle\nreleasing incision at the first premolar (Fig 5).\nFig 5 The implant site was opened with a triangular flap\nusing a vertical releasing incision distal to the first\npremolar.\nFollowing\nelevation\nof\na\nfull-thickness\nflap,\nthe\nosseointegrated implant was clearly visible; no facial\nbone wall was present (Fig 6). The occlusal view also\nconfirmed that the implant had been inserted too far\nfacially. The exposed implant surface was clearly\nlocated outside the alveolar ridge (Fig 7). Chances to\ngenerate a new facial bone wall on top of the exposed\nimplant surface were considered slim.\n420"
  },
  {
    "page": 421,
    "content": "Fig 6 A full-thickness flap was elevated and the implant\nsite exposed. The osseointegrated implant had no facial\nbone wall. A few remnants of DBBM particles became\nvisible at the bone surface lateral to the implant.\nFig\n7\nOcclusal\nview\ndocumenting\nthe\nfacial\nmalposition. The exposed implant surface was outside\nthe bony envelope. This required the implant to be\n421"
  },
  {
    "page": 422,
    "content": "removed and a new one inserted in a more favorable\norofacial position.\nIt was therefore decided to remove the implant with a\nspecial removal instrument and a hand ratchet (Fig 8).\nThis allowed the application of rotational torque to\nfracture the bone-implant interface and loosen the\nimplant (Fig 9). Following implant removal, the local\nanatomy was carefully checked, especially the crestal\nwidth at the mesial and distal aspect of the single-tooth\ngap (Fig 10).\nFig 8 A special removal instrument was inserted to\nfracture\nthe\nbone-implant\ninterface\nby\napplying\nrotational torque with a ratchet. With this technique, the\nimplant was easily loosened.\n422"
  },
  {
    "page": 423,
    "content": "Fig 9 The removed implant still attached to the removal\ninstrument.\nFig 10 After implant removal. The local bone anatomy\nallowed the placement of a new implant at the same\nsurgical appointment. The implant bed was prepared\nslightly further palatally.\n423"
  },
  {
    "page": 424,
    "content": "Since the crestal width was more than 6 mm, it was\ndecided to directly reinsert a new implant in the correct\n3D position and inclination. The implant bed was\nprepared and a standard-diameter bone-level implant\n(regular CrossFit RC 4.1 mm; Institut Straumann AG,\nBasel, Switzerland) featuring a hydrophilic surface\n(SLActive®) inserted into the palatal bone.\nThe implant achieved good primary stability. Following\ninsertion of a 2-mm healing cap, it became evident that\nthe facial bone defect had a favorable two-wall\nmorphology, as previously expected (Fig 11).\nFig 11 A standard-diameter bone-level implant (BLI\n4.1) was inserted in a correct 3D position, followed by\nplacement of a 2-mm healing cap. Two-wall defect\nmorphology on the facial aspect was a prerequisite for\nsuccessful contour augmentation.\nThe crater-like bone defect was augmented with two\nbone fillers: (1) a layer of autologous bone chips (Fig\n424"
  },
  {
    "page": 425,
    "content": "12)\nwas\nharvested\nlocally\nwithin\nthe\nsame\nflap\nconfinement using a bone scraper; and (2) a superficial\nlayer of DBBM particles to overcontour the local bone\nanatomy on the facial aspect (Figs 13 and 14). The bone\nfillers were covered by a non-crosslinked collagen\nmembrane (Bio-Gide®; Geistlich). The membrane was\napplied in a double-layer technique (Fig 15), and the\nsurgery completed by tension-free primary wound\nclosure (Fig 16). To achieve this, the flap had to be\nreleased at its base with an incision in the periosteum.\nThe postsurgical radiograph showed a well-positioned\nbone level implant (Fig 17).\nFig\n12\nLocally\nharvested\nautologous\nbone\nchips\ncovered the exposed implant surface on the facial\naspect.\nThese\nautograft\nchips\nwere\nexpected\nto\naccelerate bone formation in the defect area due to their\nfavorable osteogenic properties.\n425"
  },
  {
    "page": 426,
    "content": "Fig 13 A second layer of DBBM particles was applied\nto overcontour the alveolar crest on the facial aspect of\nthe implant.\nFig 14 Occlusal view of the overcontoured local\nanatomy. The low substitution rate of DBBM particles\nwas expected to contribute to the long-term stability of\nthe newly regenerated facial bone wall.\n426"
  },
  {
    "page": 427,
    "content": "Fig 15 The bone fillers were covered with a non-\ncrosslinked collagen membrane, which was applied\nusing a double-layer technique to prolong its barrier\nfunction and to enhance the stability of the membrane\nand the bone fillers underneath.\n427"
  },
  {
    "page": 428,
    "content": "Fig 16 The implant surgery was completed with a\ntension-free primary wound closure. An incision of the\nperiosteum was needed to release the flap sufficiently.\nFig 17 Post-surgical radiograph demonstrating the\nbone-level implant with its 2-mm healing cap.\n428"
  },
  {
    "page": 429,
    "content": "Fig 18 At eight weeks, the implant was well integrated.\nThe reentry procedure was performed using a punch\ntechnique without flap elevation.\n429"
  },
  {
    "page": 430,
    "content": "Fig 19 After the reopening procedure. The small 2-mm\nhealing cap was replaced by a 3.5-mm healing cap. The\nocclusal view confirmed the slightly palatal position of\nthe implant. The facial contour was now favorable for\nan esthetic outcome.\nTwo weeks later, an open-tray impression was taken\nwith an addition-curing silicon material using a custom\ntray in conjunction with a screw-retained impression\npost. At the dental laboratory, a directly screw-retained\nmetal-acrylic\nprovisional\ncrown\nbased\non\na\nprefabricated temporary titanium/PEEK coping was\nproduced and inserted at the next appointment (Fig 20).\nFig 20 At the time of insertion of a directly screw-\nretained provisional acrylic implant-supported crown\nbased\non\na\nprefabricated\ntitanium\nabutment,\nthe\nincreased cervical volume caused marked blanching of\nthe peri-implant mucosa before the restoration was\nfinally seated.\n430"
  },
  {
    "page": 431,
    "content": "The\nappropriate\ncervical\nemergence\nprofile\nwas\nfinalized at chairside to assure a harmonious contour of\nthe peri-implant mucosa, prevent persisting soft-tissue\nblanching, and provide adequate access for the patient’s\noral hygiene (Fig 21).\nFig 21 After the emergence profile of the restoration\nwas\nreduced\nat\nits\napical\naspect,\nthe\nblanching\ndisappeared and adequate interproximal space for oral\nhygiene was obtained.\nThree months after placement of the provisional crown,\nthe peri-implant soft tissues had matured, gaining\nsignificant volume in the embrasure areas (Fig 22). The\ncorresponding periapical radiograph confirmed stable\nosseointegration and minor crestal bone remodeling at\nthe distal aspect (Fig 23). At this stage, an alginate\nimpression of the upper jaw before removing the\ntemporary crown and a final elastomeric impression\nwere taken (Fig 24).\n431"
  },
  {
    "page": 432,
    "content": "Fig 22 Three months after insertion of the provisional\nmetal-acrylic crown. Conditioning and maturation of\nthe peri-implant soft tissue has yielded an esthetically\npleasing\noutcome.\nThe\nsoft-tissue\nvolume\nin\nthe\nembrasure areas is greatly increased.\n432"
  },
  {
    "page": 433,
    "content": "Fig 23 The corresponding periapical radiograph shows\nthe\nwell-integrated\nbone-level\nimplant\nand\nthe\nprovisional metal-acrylic crown. Some minimal crestal-\nbone resorption is present at the distal aspect.\nFig 24 At this stage, an open-tray impression was taken\nusing a polyvinyl siloxane elastomeric material.\nAfter mounting the master cast in a semi-adjustable\narticulator, sites 13, 12, and 11 were scanned to permit\nthe\non-screen\nvirtual\ndesigning\nof\nthe\nzirconia\ninfrastructure for the final implant crown replacing the\nmissing tooth 12. The data set was sent to the\nfabrication\ncenter\nby\ne-mail,\nwhere\nthe\nzirconia\ncomponent was milled (ETCON-CARES®; Institut\nStraumann AG, Basel, Switzerland). The zirconia\nframework, which provided uniform support for the\nveneering ceramic, was then built up to full anatomic\ncontour\nusing\ne.max\nZirPress\n(Ivoclar\nVivadent,\nSchaan, Liechtenstein), to which a thin layer of\nmanually stratified feldspathic ceramic was added on\n433"
  },
  {
    "page": 434,
    "content": "the facial aspect to provide maximum esthetics (Figs 25\nto 27).\nFig 25 A CAD/CAM zirconia abutment was produced\nand veneered using the e.max ZirPress technique\n(Ivoclar Vivadent). The incisal third was completed\nwith a thin layer of traditionally built-up feldspathic\nceramic\nto\nreproduce\nthe\ntranslucency\nand\ncharacteristics of the natural reference tooth.\n434"
  },
  {
    "page": 435,
    "content": "Fig 26 After insertion of the final directly screw-\nretained all -ceramic crown. The esthetic outcome was\nsatisfactory,\nincluding\nthe\nwell-positioned\ncervical\nmucosa with a distinctly convex profile on the facial\naspect and the return of a harmoniously scalloped\nmucosa.\n435"
  },
  {
    "page": 436,
    "content": "Fig 27 Frontal view of the patient’s unforced smile\nconfirming\nan\nacceptable\nintegration\nof\nthe\nnew\nrestoration, despite some minor differences in relative\ntooth dimensions, volume, and cervical emergence\ncontour between implant crown 12 and reference site\n22.\nFinal insertion of the directly screw-retained zirconia-\nbased\nall-ceramic\nimplant\ncrown\n12\ncomprised\ntightening of the occlusal screw to 35 Ncm, coverage\nwith condensed Teflon® tape, and closure of the access\nchannel\nwith\ncomposite\nresin\nusing\nan\nadhesive\nprotocol.\nThe post-insertion periapical radiograph documented\nprecise seating, an adequate flat cervical emergence\nprofile, and stable osseointegration (Fig 28). In fact, the\nmost coronal bone-to-implant contact was located at the\nimplant shoulder mesially and distally, confirming the\nefficacy of the platform-switching concept implemented\nby the bone-level implant design. The favorable clinical\nand radiographic findings were confirmed at the five-\nyear\nfollow-up\n(Figs\n29a-c\nand\n30).\nThis\nwas\nparticularly true in terms of crestal bone stability and\nesthetic integration of the implant-crown complex at\nsite 12.\n436"
  },
  {
    "page": 437,
    "content": "Fig 28 The periapical radiograph taken at insertion of\nthe final all-ceramic crown shows a well-integrated\nbone-level implant.\n437"
  },
  {
    "page": 438,
    "content": "Fig\n29a\nThe\nfive-year\nexamination\ndemonstrated\nsymmetric and healthy peri-implant soft tissues, in\nharmony with the adjacent dentition.\nFig 29b Lateral view showing complete tissue closure\nof the mesial and distal embrasure areas.\nFig 29c Minor recession was still present at the distal\naspect of tooth 11.\n438"
  },
  {
    "page": 439,
    "content": "Fig 30 Periapical radiograph at the five-year follow-up\nshowing excellent stability of the crestal bone levels.\nThe 4 × 4 cm CBCT image showed a thick facial bone\nwall established by contour augmentation using GBR\n(Figs 31a-b).\n439"
  },
  {
    "page": 440,
    "content": "Fig 31a Horizontal CBCT confirming a thick and intact\nfacial bone wall at the five-year follow-up. The lateral\nincisor implant is positioned about 2 mm palatally of\nthe facial emergence contour of the clinical crown.\n440"
  },
  {
    "page": 441,
    "content": "Fig 31b Orofacial CBCT showing a thick and intact\nfacial bone wall. The bone wall extends coronally to the\nimplant shoulder.\nDiscussion\nIn the present case, an implant had been inserted too far\nfacially alio loco to replace an extracted upper lateral\nincisor. Despite simultaneous bone augmentation with\nGBR, no facial bone wall was present at reentry,\nalthough this bone wall is an important prerequisite for\na long-lasting functional and esthetic result (Buser and\ncoworkers 2004). Following referral to the clinic, the\n3D CBCT examination confirmed that a facial bone\nwall was indeed missing.\nIn this situation, the clinician has three options to\nconsider as outlined at the beginning of this case report.\nRegrafting an implant without a facial bone wall is only\nan option if (a) the implant is located in a correct\norofacial position, with the exposed implant surface\ninside the alveolar crest; and (b) the exposed implant\nsurface has not been contaminated by an acute peri-\nimplant infection. In the present case, the intraoperative\nview confirmed a facial malposition, which is often the\ncause of esthetic complications (Chen and Buser 2010).\nThe implant was therefore carefully removed with a\nspecial removal instrument and a ratchet using a\ncounterclockwise rotational torque. This technique was\nintroduced about six years ago by several manufacturers\nto loosen an osseointegrated implant by fracturing the\nbone-implant interface (Froum and coworkers 2011). It\nrepresents significant progress, as it allows implant\n441"
  },
  {
    "page": 442,
    "content": "removal without damage to surrounding bone. The use\nof a trephine for implant removal must now be\nconsidered outdated—it destroys too much peri-implant\nbone.\nIn\nthe\npresent\ncase,\nthe\noriginal\nremoval\ninstrument\nby\nStraumann\nwas\nused,\ncalled\nthe\n“explantation tool.” Generic removal instruments are\nalso available, for example the BTI Implant Extraction\nKit (Anitua and Orive 2012; Biotechnology Institute\nBTI, Vitoria-Gasteiz, Spain).\nFollowing implant removal, the local anatomy allowed\nthe immediate insertion of a new implant. The implant\nwas prepared slightly further palatally, keeping a palatal\nbone wall of 1 mm intact. This allowed implant\nplacement in a correct 3D position, positioning the\nimplant platform in the comfort zones (Buser and\ncoworkers 2004). The resulting facial bone defect had a\nfavorable\ntwo-wall\nmorphology,\nan\nimportant\nprerequisite for predictable bone regeneration.\nAn experimental study by Schenk and coworkers\n(1994) demonstrated that new bone formation originates\nfrom bony walls, since the essential cells for creating\nnew bone—angioblasts and osteoblasts—are located in\nthe bone marrow. In consequence, the morphology of\nthe defect is an important factor in predicting a\nsuccessful regenerative outcome. A bone defect with a\nnarrow but deep two-wall morphology is much easier to\nregenerate than a wide and shallow one-wall defect\n(Buser 2009). Another factor is the bone filler applied\nto the defect. The bone filler should have osteogenic\ncharacteristics, meaning that should be able to promote\n442"
  },
  {
    "page": 443,
    "content": "new\nbone\nformation\nduring\ninitial\npostoperative\nhealing.\nSince 1998, our group has preferred bioabsorbable,\nnon-crosslinked\ncollagen\nmembranes\nfor\nGBR\nprocedures, since they are easy to handle during surgery\nand do not require a reentry procedure. In addition, the\nrisk of complications—soft-tissue dehiscence following\nGBR procedures—is low (von Arx and Buser 2006).\nHowever, these collagen membranes only offer a barrier\nfunction for four to eight weeks (von Arx and\ncoworkers 2005). These resorbable membranes must\ntherefore be combined with appropriate bone fillers to\ncompensate for the short-term barrier function.\nSo in 1998, based on preclinical data, we started using a\ncombination of two bone fillers, autologous bone chips\nand xenogeneic DBBM particles (Buser and coworkers\n2004; Buser and coworkers 2008b). This combination\noffers synergistic optimized regenerative outcomes with\nthe GBR technique. Autologous bone grafts accelerate\nthe formation of new bone—not only at the implant\nsurface to establish rapid osseointegration, but also\nwithin the superficial layer of bone substitute to\nproduce DBBM particles embedded in bone. The\nsuperiority of autograft bone chips has been confirmed\nin\nseveral\nhistomorphometric\nexperimental\nstudies\n(Buser and coworkers 1998; Jensen and coworkers\n2006;\nJensen\nand\ncoworkers\n2007;\nJensen\nand\ncoworkers 2009).\nIt is believed that these osteogenic properties of\nautograft\nbone\nchips\nare\ndue\nto\nnon-collagenous\n443"
  },
  {
    "page": 444,
    "content": "proteins and growth factors entrapped in the bone\nmatrix (Bosshardt and Schenk 2009). It is also possible\nthat entrapped osteocytes have a positive impact on\nosteogenic cells (Bonewald 2011). Recent in-vitro\nstudies using osteoblast cultures have demonstrated that\nthe harvesting technique also influences the osteogenic\npotential of autograft chips (Miron and coworkers 2011;\nMiron and coworkers 2013). Of four tested harvesting\ntechniques, bone grafts harvested with a bone mill or a\nbone scraper showed the highest osteogenic potential.\nDBBM particles are routinely used to cover the applied\nlayer of autograft chips and improve the contour of the\nalveolar\ncrest\naround\ndental\nimplants.\nThis\ntechnique—called contour augmentation—is intended\nto\noptimize\nthe\nesthetic\noutcomes\naround\ndental\nimplants\n(Buser\nand\ncoworkers\n2008b).\nDBBM\nparticles are characterized by a low-substitution rate as\ndemonstrated by several preclinical studies (Jensen and\ncoworkers 2006; Jensen and coworkers 2007; Jensen\nand coworkers 2009). However, there is increasing\nevidence that only DBBM particles embedded in bone\nhave a low substitution rate. These fillers show\nevidence of severe resorption in fibrous tissues, as\nrecently\ndemonstrated\nin\na\npreclinical\nstudy\n(Busenlechner\nand\ncoworkers\n2012).\nThe\ncellular\nmechanism of this resorption is not understood yet and\nneeds\nfurther\ninvestigation.\nThis\nunderlines\nthe\nimportance of the first layer of autologous bone grafts\nto stimulate the ingrowth of bone into the superficial\nlayer of DBBM particles.\n444"
  },
  {
    "page": 445,
    "content": "This has been confirmed by stable and favorable\nesthetic outcomes in two case series examining single-\ntooth rehabilitation with early implant placement and\nsimultaneous contour augmentation using GBR (Buser\nand coworkers 2008a; Buser and coworkers 2009). Both\ngroup of patients were prospectively examined by\nCBCT for the status of their facial bone wall (Buser and\ncoworkers 2013a; Buser and coworkers 2013b). Both\nstudies demonstrated intact facial bone wall in 95% of\nthe\npatients.\nIn\naddition,\na\nvery\nrecent\nhistomorphometric study with 12 human biopsies in 10\npatients confirmed the low substitution rate of DBBM\nparticles with a mean percentage of 32% at 14 to 80\nmonths\npost-augmentation\n(Jensen\nand\ncoworkers\n2014).\nThe favorable results of these case series studies were\nconfirmed in the present case report, since the five-year\nfollow-up demonstrated not only a very pleasing\nesthetic outcome, but also the presence of thick facial\nbone wall, as documented by CBCT (Figs 29a-c to 31a-\nb).\n445"
  },
  {
    "page": 446,
    "content": "9.2.2 Oral Lichen Planus Associated with the Peri-\nimplant Mucosa\nA. Frydrych\nThis case describes the ongoing management of a\n64-year-old healthy, non-smoking female patient with\nerosive oral lichen planus (OLP) affecting the gingivae\nand the buccal and lingual mucosa. The peri-implant\nmucosa\nwas\nalso\naffected\nsubsequent\nto\nimplant\nplacement.\nThe patient had osseointegrated implants (four in the\nmaxilla,\nfour\nin\nthe\nmandible)\nplaced\nfollowing\nextraction of hopeless teeth and a healing period. The\npatient had a history of OLP prior to implant placement\nand had been referred to an oral-medicine specialist for\ndefinitive\ndiagnosis\nand\ntreatment.\nShe\nexhibited\ngeneralized oral mucosal involvement. Following a\nclinical assessment, biopsy, and blood tests, she was\ntreated\nwith\ntopical\ncorticosteroids.\nSystemic\nprednisolone\nwas\nreserved\nfor\nsevere\nflare-ups.\nAmphotericin lozenges were used in combination with\ncorticosteroid treatment to prevent the development of\noral candidiasis.\nFollowing\nrestoration\nof\nthe\nimplants\n(full-arch\nmaxillary fixed prosthesis supported by four implants\nand two fixed prostheses each supported by two\nimplants in the right and left posterior mandible), the\npatient received regular maintenance care, including\n446"
  },
  {
    "page": 447,
    "content": "professional prophylaxis (removal of biofilm) and oral-\nhygiene instruction on a six-monthly basis.\nDuring the three years following implant placement and\nrestoration,\nthe\npatient\nexperienced\nperiodic\nexacerbations of her OLP, with gingival, peri-implant,\nand buccal and lingual mucosal involvement. This was\nnot\nunexpected\ngiven\nthe\nchronic\nnature\nof\nthe\ncondition.\nExacerbations\nwere\nassociated\nwith\nincreasing mucosal erythema and with the presence of\nerosive and ulcerated lesions and increasing mucosal\ndiscomfort. Management of these exacerbations varied\ndepending on disease severity. Figures 1 to 4 illustrate\nthe presence of OLP at the peri-implant mucosa.\nFig 1 OLP, gingivae, and peri-implant mucosa.\n447"
  },
  {
    "page": 448,
    "content": "Fig 2 OLP, buccal mucosa, and peri-implant mucosa.\nFig 3 OLP, buccal peri-implant mucosa.\n448"
  },
  {
    "page": 449,
    "content": "Fig 4 OLP, palatal peri-implant mucosa.\nFig 5 OPG.\nThe first line of treatment involved the use of two\nsprays of beclomethasone dipropionate spray (50 µg/\ndose) on the oral mucosal lesions four times daily in\ncombination with 10 mg of amphotericin lozenges\ntwice daily. Localized non-responsive ulcerated lesions\n449"
  },
  {
    "page": 450,
    "content": "were treated with intra-lesion injections of 1 mg\nbetamethasone solution (5.7 mg/ml). Severe generalized\nflare-ups\nwere\nmanaged\nwith\nshort-term\nsystemic\nprednisolone\nin\ncombination\nwith\namphotericin\nlozenges.\nAt all follow-up visits the patient had good oral hygiene\nwith stable peri-implant probing depths within a normal\nrange (2 – 4 mm). Radiographic evaluation showed\nstable marginal peri-implant bone levels.\nDiscussion\nThis case demonstrates the placement of implants in a\npatient with erosive OLP with generalized oral mucosal\ninvolvement, including persistent involvement of the\nperi-implant\nmucosa.\nA\nteam\nof\nspecialists\nwas\ninvolved in treating the patient. A correct diagnosis of\nOLP is important and requires an adequate patient\nhistory, clinical examination, and biopsy. Optimal oral\nhygiene is considered important for peri-implant tissue\nhealth and for the management of OLP. Patients should\nbe instructed in correct tooth-brushing and flossing\ntechniques and advised to use a toothpaste that does not\nirritate\nthe\nmucosa.\nThe\nfocus\nshould\nbe\non\nmanagement of the OLP and optimal plaque control.\nDespite the chronic nature of the condition and periodic\ndisease exacerbations, the OLP in this patient could be\nmanaged without significant adverse outcomes over the\nthree-year follow-up period.\n450"
  },
  {
    "page": 451,
    "content": "Oral\nlichen\nplanus\nis\na\nchronic,\nsystemic,\nimmunologically mediated disease of unknown etiology\nthat commonly affects the oral mucosa (Au and\ncoworkers 2013). It is one of the most common non-\ninfectious oral mucosal diseases, affecting about 2% of\nthe\nworld’s\nadult\npopulation\n(Roopashree\nand\ncoworkers 2010). Various forms of clinical presentation\nare\nencountered,\nincluding\nreticular,\nerosive,\nand\natrophic forms. Oral lichen planus may sometimes\nresemble other chronic mucosal inflammatory diseases,\nhence a biopsy is essential to ensure an accurate\ndiagnosis (Parashar 2011). The treatment of OLP is\nsupportive and palliative only, with corticosteroids\n(with or without concomitant antimycotics) forming the\nfirst line of treatment (Al-Hashimi and coworkers\n2007). Oral lichen planus is currently considered a\npotentially\nmalignant\ndisorder;\nlong-term—at\nleast\nannual—follow-up is recommended (van der Waal\n2009),\nAcknowledgments\nSurgical procedures\nDr. Brent Allan, oral and maxillofacial surgeon – West\nLeederville, Australia\nProsthetic procedures\nDr. Rick Lazar, prosthodontist – West Perth, Australia\nPeriodontal procedures\n451"
  },
  {
    "page": 452,
    "content": "Dr. Albert Tan, periodontist – Perth, Australia\nOral-medicine procedures\nDr. Agnieszka Frydrych, oral-medicine specialist –\nWest Perth, Australia\n452"
  },
  {
    "page": 453,
    "content": "9.2.3 Peri-implant Carcinoma\nM. Moergel, P. W. Kämmerer, B. Al-Nawas\nOral implants are highly successful and offer long-term\nbenefits, especially in the rehabilitation of edentulous\npatients or patients with oral defects following ablative\ntumor surgery (Albrektsson and coworkers 1986), and\nalso after radiation therapy (Schiegnitz and coworkers\n2014). With the number of implants placed globally\ngoing into the millions, implant dentists have observed\nsome rare adverse events. Although carcinogenesis\naround implants is an exceedingly rare phenomenon, we\nrecently\nreported\nabout\n15\npatients\ntreated\nfor\ncarcinomas\nadjacent\nto\nimplants\nat\nour\nclinical\ndepartment over a period of fifteen years (Moergel and\ncoworkers 2014). The following case represents a\npatient of this cohort; it discusses possible risk factors\nand makes suggestions for a recall schedule.\nA 70-year-old woman was referred to our outpatient\ndepartment\nfor\nevaluation\nof\na\nrapidly\ngrowing\nmacroscopic alteration of the mucosa in the left\nmandible. Her general health status was good, except\nfor\nmild\nhypertension\ntreated\nby\na\nbeta-blocker\n(atenolol 25 mg/d) and age-related arthritis suppressed\nby a non-steroidal antiphlogistic (ibuprofen 300 mg) as\nneeded. A history of smoking or ingestion of alcohol\nwas denied. Intriguingly, a small carcinoma of the right\nlower lip following an actinic keratosis had been\ncompletely resected in local anesthesia by an ENT\nspecialist seven weeks previously.\n453"
  },
  {
    "page": 454,
    "content": "The patient presented a partly ulcerous and partly\nexophytic lesion of the crestal and vestibular mucosa\nnext to the implant at site 34. It was highly sensitive to\nmechanical\nalteration\nand was surrounded by an\nerythroleukoplakia (Fig 1). In addition, signs of oral\nlichen planus (OLP) were found on the left buccal\nsurface. The dental orthopantomograph revealed slight\nsigns of crestal osteolysis and loss of marginal bone. No\nfurther indications of any invasion of the mandibular\nbone\nwere\ninitially\napparent\n(Fig\n2).\nThe\nright\nmandibular implants exhibited additional osteolysis,\nsuggesting\nan\nactive\nperi-implantitis,\nbut\nwithout\nfurther affecting the surrounding mucosa. Histologic\nevaluation confirmed the presence of an oral carcinoma\nat site 34. The patient was prepared for radical\nresection.\nFig 1 Macroscopic presence of the peri-implant mucosa.\nAn ulcerous lesion, highly sensitive to mechanic\nalteration, next to the implant.\n454"
  },
  {
    "page": 455,
    "content": "Fig 2 Preoperative orthopantomograph. Crestal osseous\nlesions are present at nearly every implant. Osteolysis\nmay mimic peri-implantitis, so a tumor cannot be\ndistinguished from a benign lesion by radiological\nmeans.\nAn anterolateral neck dissection was performed on the\nleft side, including the lymph tissue in Robbins levels\nI–IV. Intraoperative frozen sections were negative for\ncervical metastases, so levels V and VI were left intact\n(Robbins and coworkers 2002). In the oral cavity, the\ntumor was marked for resection with a safety margin\nand the bridgework was divided to preserve the distal\nimplant. The mesial implant was resected in two steps:\na small part of the surrounding soft and hard tissues\nwere\nremoved\nfor\nhistological\nand\nradiological\nevaluation, followed by a more extended resection of\nthe surrounding mucosa and crestal mandible to provide\na safety margin (Fig 3). The remaining bone was\nsmoothed (Fig 4) and the defect covered with an\n455"
  },
  {
    "page": 456,
    "content": "extraoral transpositional flap from the left nasolabial\nfold.\nFig 3 Resection specimen containing the peri-implant\nmucosa and bone.\n456"
  },
  {
    "page": 457,
    "content": "Fig 4 Postoperative orthopantomograph.\nPerioperative anti-infective prophylaxis was performed\nwith cephalosporin for three days and the patient\nrecovered\nwell\nfrom\nthe\noperation.\nHistological\nexamination\nrevealed\nan\ninvasive\nperi-implant\ncarcinoma that had invaded the bone but not spread\nfurther into locoregional lymph nodes or produced\ndistant metastases. The carcinoma was resected with\nample safety margins: pT4a, pN0, pM0, pR0. Due to\nthe invasion of the cancellous bone, the patient was\noffered radiotherapy as an adjuvant treatment option\n(Figs 5a-c and 6a-c).\nFig 5a-c Micro-CT scans rendered graphically and as\noriginals showing the peri-implant loss of bone. The\ncomb-like structure may be of importance in case the\ncancellous boneis invaded (Schache and coworkers\n2008).\n457"
  },
  {
    "page": 458,
    "content": "458"
  },
  {
    "page": 459,
    "content": "Figs 6a-c At the histological examination the tumor was\nfound to be in direct contact with the implant, and first\nsigns of an invasion of the cortical bone are apparent.\nToluidineblue, original magnifications ×100 (a, c) and\n×200 (b).\nDiscussion\nOral\nsquamous-cell\ncarcinomas\n(OSCC)\nnext\nto\nimplants are rare. There have been only a few case\nreports and two observational studies (Abu El-Naaj and\ncoworkers\n2007;\nBhatavadekar\n2012;\nBlock\nand\nScheufler\n2001;\nChimenos-Küstner\nand\ncoworkers\n2008; Clapp and coworkers 1996; Cuesta-Gil and\ncoworkers 2009; Czerninski and coworkers 2006; De\nCeulaer and coworkers 2010; Eguia del Valle and\ncoworkers 2008; Gallego and coworkers 2008; Gallego\nand coworkers 2009; Gulati and coworkers 2009; Kwok\nand coworkers 2008; McGuff and coworkers 2008;\nMeijer and coworkers 2010; Moergel and coworkers\n459"
  },
  {
    "page": 460,
    "content": "2014; Moxley and coworkers 1997; Schache and\ncoworkers 2008).\nYet as implants are used ever more widely, even those\nimplant-related\ncomplications\nwhose\nincidence\nis\nextremely low may be seen more frequently in clinical\npractice, simply because of the large numbers involved.\nTo identify patients at risk, we investigated all implant-\nrelated carcinomas in a retrospective study for risk\nfactors. We had treated 15 implant-related carcinomas\nat our clinical department in fifteen years. As 9 patients\nhad a prev\nious history of an oral carcinoma, no cause-and-effect\nmodel could be postulated. Intriguingly, an extended\nlatency from the time of implant insertion to the time\nthe carcinoma became manifest was seen both in our\npatients (53.4 months) and in the patients in the\navailable literature (51.6 months). Since the gender\nratio was nearly balanced, these findings underline the\nclinical\nrelevance\nof\nimplants\nfor\nthe\norofacial\nrehabilitation of patients with oral carcinomas (Korfage\nand coworkers 2010; Nelson and coworkers 2007; Tang\nand coworkers 2008; Schiegnitz and coworkers 2014).\nThe most likely manifestations were an exophytic mass\nadjacent to the implant and a radiotranslucency. Both of\nthese are findings that may mimic a harmless peri-\nimplantitis.\nThe woman whose case is presented here had not had a\nprevious oral carcinoma and denied important habits\ngenerally viewed as carcinogenic triggers, such as\nalcohol\nand\ncigarette\nuse.\nFurthermore,\nshe\nhad\n460"
  },
  {
    "page": 461,
    "content": "presented with signs of peri-implantitis with marginal\nbone loss around the implants in the contralateral\nquadrant that may have been additionally misleading.\nThe\nmacroscopic\npresence\nof\nulcerous\nerythroleukoplakia was an important clinical sign and\ncharacterized the lesion as high-risk, since ulcerous\nerythroleukoplakia has a high potential for malignant\ntransformation (Reichart and Philipsen 2005). As our\npatient collective revealed, patients with a history of\noral carcinoma are at risk for developing a secondary\ncarcinoma and should therefore be carefully examined\nfor\nmacroscopic\nmucosal\nchanges.\nSince\nchronic\nperiodontitis as a chronic inflammatory process has\nbeen described as independent risk factor for the\ndevelopment\nof\nan\noral\ncarcinoma,\npatients\nmay\nadditionally benefit from histological examination by\nscalpel biopsy if the peri-implantitis does not respond to\nlocal treatment (Moergel and coworkers 2013; Tezal\nand coworkers 2007).\nAs a clinical consequence, patients with a history of\nhead-and-neck\ncancer\nare\nat\nrisk\nfor\ndeveloping\nsecondary carcinomas. In these patients, persistent peri-\nimplant infections that are atypically restricted to a\nsingle implant site, a biopsy should be performed to rule\nout a secondary carcinoma.\n461"
  },
  {
    "page": 462,
    "content": "9.2.4 Peripheral Giant-cell Granuloma Associated with\nPeri-implant Tissues\nM. M. Bornstein\nGiant-cell granulomas (GCG) of the jaws are benign\nreactive lesions of unknown etiology, unrelated to\ngiant-cell tumors (osteoclastomas), which are defined as\nbenign but locally destructive and aggressive neoplasms\n(Jundt and coworkers 2005). Depending on their\nlocalization at the initial diagnosis, GCG are dived into\ncentral (CGCG) and peripheral (PGCG) types. CGCGs\noccur within the jawbones and appear as unilocular or\nmultilocular radiolucent lesions. The incidence in the\ngeneral\npopulation\nis\nvery\nlow.\nThey\nare\nmore\ncommonly found in the mandible, mainly in children\nand young adults—patients are generally younger than\n30 years—and have a greater incidence in females\n(Heithersay and coworkers 2002). The clinical behavior\nof CGCGs varies from slowly growing asymptomatic\nswellings to aggressive lesions that may result in pain,\ncortical perforation of the affected jaw site, and root\nresorption (de Lange and coworkers 2007). Surgical\ncurettage or, in aggressive lesions, resection, are the\nmost common therapy modalities reported in the\nliterature. When using surgical curettage, damage to the\njawbone, neighboring teeth or tooth germs is often\nunavoidable; recurrences are frequent. In recent years,\nless\ninvasive\ntreatment\napproaches\nsuch\nas\nthe\nintralesional injection of corticosteroids have been\nreported (Ferretti and Muthray 2011).\n462"
  },
  {
    "page": 463,
    "content": "The PGCG is a rare exophytic lesion that develops on\nthe gingiva and alveolar ridge, and is more frequently\nencountered than the CGCG type (Motamedi and\ncoworkers 2007). The PGCG is also more frequently\ndiagnosed in younger patients, located in the mandible,\nbut exhibits an equal gender distribution, and has a\nlower tendency to recur. Although the precise etiology\nof PGCGs is unknown, it has been speculated that these\nlesions originate from the mucoperiosteum or the\nperiodontal ligament and represent a local reaction to\ntrauma or irritation such as tooth extraction, poor dental\nrestorations, ill-fitting dentures, plaque or calculus\nformation, and food impaction (Mannem and Chava\n2012). Management requires a surgical excision of the\nlesion and regular recall examinations due to possible\nrecurrence (Banthia and coworkers 2013).\nThe\npresent\ncase\nreport\ndescribes\nthe\nclinical,\nradiological, and histopathological features of a PGCG\nassociated with an implant and discusses possible\netiological factors and sequelae.\nCase report\nA 77-year-old female patient was referred to the\nDepartment of Oral Surgery and Stomatology at the\nUniversity\nof\nBern\nfor\ntherapy\nof\na\nrecurring\nhyperplasia at the peri-implant mucosa of an implant\ninserted in the region of the mandibular left lateral\nincisor. The patient was a former smoker (approx.\n15–20 pack-years) and was under oral medication for\nhypertonia\nand\nhypothyroidism.\nThe\npatient\nhad\nreceived a fixed restoration on natural teeth in the left\n463"
  },
  {
    "page": 464,
    "content": "maxilla and fixed partial dentures on implants in the\nmandible several years previously. These restorations\nwere\nmaintained\nwithout\ncomplications\nuntil\nthe\nimplant at site 32 had exhibited signs of peri-implantitis\nsix months previously. Shortly afterwards, the peri-\nimplant mucosa had enlarged, and the hyperplasia\nmentioned had developed.\nThe hyperplastic lesion had already been removed three\ntimes alio loco over the course of the six months prior\nto the referral, but had always recurred immediately.\nThe initial specimen excised had not been sent in for\nhistopathological examination, but the second and third\nwere evaluated by the pathologist. In the initial report,\nthe mucosal mass was not found to be conclusive and\nwas tentatively diagnosed as a fibrous hyperplasia with\nsigns\nof\nosseous\nmetaplasia.\nThe\nsecond\nspecimen—sent in and evaluated less than three months\nafter the first—exhibited the presence of numerous\nmultinucleated giant cells. Thus, the diagnosis of a\nPGCG in the peri-implant mucosa of 32 had already\nbeen established upon referral.\nAt the initial presentation, the lesion was located on the\nbuccal, but also lingual aspect of implant 32, measured\n1 × 1.5 cm, exhibited a reddish color, and was partially\ncovered with fibrin (Fig 1). The implant was part of a\nfixed restoration from site 42 to site 32. The mandibular\ncanines were still in place. Implant 32 exhibited clinical\nand radiological signs of peri-implantitis (Figs 2 and 3).\nFurthermore, tooth 33 showed progressive attachment\nloss and was clinically mobile. The patient did not\nexperience pain from the growing mass, but felt\n464"
  },
  {
    "page": 465,
    "content": "discomfort from the lesion upon chewing and when\nperforming oral hygiene.\nFig 1 Initial examination. (a) Buccal view. (b) Occlusal\nview showing the extension of the lesion to the lingual\naspect of the alveolar process.\n465"
  },
  {
    "page": 466,
    "content": "Fig 2 Initial panoramic radiograph.\nFig 3 Initial periapical radiograph. Crestal bone loss\naround implant 32.\n466"
  },
  {
    "page": 467,
    "content": "The initial surgical step included excision of the PGCG\nand debridement of the implant surface using a scalpel\nand a CO2laser under local anesthesia (Fig 4). The\nremoved specimen was sent in for histopathological\nevaluation, where the clinical diagnosis of PGCG was\nconfirmed (Fig 5).\n467"
  },
  {
    "page": 468,
    "content": "Fig 4 After the first removal of the lesion with the CO2\nlaser. (a) Buccal view. (b) Occlusal view.\nFig 5 Histopathological aspect of the excised specimen.\n(a) The overview exhibits a thin epithelial layer with\nparakeratosis.\nImmediately\nbelow\nthe\nepithelium:\nhighly vascularized connective tissue including multiple\nfibroblasts and histiocytes is visible (hematoxylin-eosin\n468"
  },
  {
    "page": 469,
    "content": "staining/HE; original magnification ×10). (b) Detailed\nview demonstrated the presence of multinucleated giant\ncells in the highly cellular connective tissue (HE;\noriginal magnification ×20).\nInitial healing was uneventful, but the lesion recurred\none month after surgery, thusresulting in the fourth\nrecurrence of the lesion since the initial removal seven\nmonths earlier (Figure 6). After consultations with the\nDepartment of Periodontology, it was decided to extract\ntooth 33 and excise the lesion more aggressively,\nincluding a circular revision of the peri-implant bone\n(Fig 7). Again, histopathology confirmed the initial\ndiagnosis (PGCG). Unfortunately, the lesion recurred\nyet again, for the fifth time, three weeks after the\nsurgical intervention (Fig 8).\nFig 6 Recurrence of the PGCG one month after removal\n(fourth recurrence).\n469"
  },
  {
    "page": 470,
    "content": "Fig 7 Periapical radiograph after renewed removal of\nthe lesion and extraction of tooth 33. Further crestal\nbone loss around implant 32.\nFig 8 Recurrence of the PGCG one month a\n470"
  },
  {
    "page": 471,
    "content": "fter removal (fifth recurrence) and extraction of tooth\n33.\nAfter\nrenewed\ninterdisciplinary\nconsultations,\nthe\nfollowing procedure was decided on: Removal of\nimplant 32; provisional fixed restoration from site\nimplant 42 to site 34. The patient agreed to that\nprocedure. After removing implant 32 (Fig 9), a\nprovisional fixed restoration was fabricated alio loco.\nThe patient has had no recurrence since then (4.5 years\nsince explantation).\nFig 9 After removal of implant 32 and before insertion\nof the provisional fixed restoration (42–34).\nTable 1 Overview of the cases with a PGCG in\nassociation with implant(s) reported in the literature up\nto 2014\n471"
  },
  {
    "page": 472,
    "content": "Authors\nAge/\nsex\nLocation\nTreatment (initial)\nRelapse Implant\nsurvival\nHirshberg and\ncoworkers\n2003\n31/m\n69/m\n44/f\nMandible\nMaxilla\nMandible\nCurettage/excision\nCurettage/excision\nCurettage/excision\nYes\nYes\nYes\nYes\nNo/\nexplantation\nNo/\nexplantation\nBischof\nand\ncoworkers\n2004\n56/f\nMandible Curettage/excision\nNo\nYes\nCloutier\nand\ncoworkers\n2007\n21/m Mandible Excision/explantation No\nNo\nScarano\nand\ncoworkers\n2008\n48/f\nMaxilla\nExcision/soft-tissue\ngraft\nNo\nYes\nÖzden\nand\ncoworkers2009 60/f\nMandible Curettage/excision\nNo\nYes\nHernández and\ncoworkers\n2009\n45/f\n36/f\n62/f\nMandible\nMaxilla\nMandible\nCurettage/excision\nCurettage/excision\nExcision\nYes\nYes\nNo\nNo/\nexplantation\nNo/\nexplantation\n472"
  },
  {
    "page": 473,
    "content": "Yes\nOlmedo\nand\ncoworkers\n2010\n64/f\nMandible Excision\nNo\nYes\nHanselaer and\ncoworkers\n2010\n33/f\nMaxilla\nCurettage/excision\nNo\nYes\nPeñarrocha-\nDiago\nand\ncoworkers\n2012\n54/f\nMandible Curettage/excision\nNo\nYes\nGalindo-\nMoreno\nand\ncoworkers\n2013\n74/m Maxilla\nExcision\nNo\nYes\nPresent\ncase\n2014\n77/f\nMandible Excision\nYes\nNo/\nexplantation\nm = male; f = female.\nDiscussion\nIn the literature, case series of PGCGs include up to\nseveral hundred cases (Giansanti and Waldron 1969;\n473"
  },
  {
    "page": 474,
    "content": "Katsikeris and coworkers 1988; Mighell and coworkers\n1995; Buchner and coworkers 2010), but lesions\nassociated with the peri-implant mucosa are rare. Only\n14 cases of PGCGs located around implants have been\ndocumented in the literature to date (Table 1). Similar\nto PGCGs diagnosed around natural teeth, they seem to\nbe related to chronic local irritation and inflammation.\nThese irritating factors may include the accumulation of\nplaque or calculus and the presence of foreign matter\nsuch as traces of dental cement (Peñarrocha-Diago and\ncoworkers 2012). PGCGs have also been associated\nwith trauma from the extraction of teeth prior to implant\nplacement (Hirshberg and coworkers 2003).\nIn the present case, trauma and chronic tissue irritation\nas a sequela of tooth extraction seem rather unlikely, as\nthe implants had already been in function for several\nyears. Peri-implant mucositis and subsequently peri-\nimplantitis could have been the stimulating factors for\nthe formation and growth of the PGCG around implant\n32. Exposure of the rough surface of implants in the\ncourse of inflammatory disease, such as peri-implantitis\nresulting in plaque accumulation and chronic local\nirritation, has also been mentioned as a possible\netiological factor for PGCG (Cloutier and coworkers\n2007). Furthermore, restorations with ill-fitting margins\nhave been reported as a potential cause for PGCG\naround implants, resulting in plaque accumulation and\nchronic soft-tissue irritation (Özden and coworkers\n2009).\nRecurrences of PGCG around implants after surgical\nremoval have been reported in 5 of the 14 cases in the\n474"
  },
  {
    "page": 475,
    "content": "literature (Table 1). Therefore, relapses seem more\nfrequent in PGCGs associated with implants than with\nnatural teeth, where recurrences are seen in up to 10%\nof cases (Mighell and coworkers 1995). This may also\nexplain the high incidence of implants lost/explanted\ndue to progressive bone loss in the reports mentioned.\nBone loss around the affected implant in the present\ncase was most likely already present initially, given the\nperi-implantitis reported by the patient and referring\ndentist, but progressed further and rather quickly due to\nrepeated surgical interventions, including osteoplasty\n(four interventions before explantation and excision of\nthe PGCG).\nRegarding the diagnostic workflow in cases with\nrapidly proliferating tissue on keratinized mucosa, it\nseems mandatory to stress the need for a proper\nhistopathologic examination of the removed tissue to\nensure an accurate diagnosis. Potential differential\ndiagnoses of PGCGs around implants include lesions\nsimilar to those found in fully dentate patients, such as a\nperforating CGCG that may mimic a PGCG, pyogenic\ngranulomas,\nfibromas\nor\nfibrous\nhyperplasias,\nperipheral ossifying fibromas, metastatic carcinomas of\ndifferent origins (breast, lung, prostate), or Kaposi’s\nsarcoma (Cloutier and coworkers 2007; Ferrazzini\nPozzi and coworkers 2008). Furthermore, radiographic\nfeatures may help determine whether a lesion is of\ngingival origin or has arisen centrally from the bone,\nwith perforation of the cortex and spreading towards the\nsoft-tissue surface (Frei and coworkers 2012). For cases\nwith a suspected origin within the jawbone, three-\ndimensional\nimaging\nusing\ncone-beam\ncomputed\n475"
  },
  {
    "page": 476,
    "content": "tomography has been documented as adding diagnostic\nvalue, especially when differentiating benign from\nmalignant pathoses (Bornstein and coworkers 2008).\nAcknowledgments\nThe author would like to thank Professor Hans Jörg\nAltermatt, Pathology Länggasse, Bern, Switzerland, for\nhis\nhelp\nin\nestablishing\na\nsolid\nhistopathological\ndiagnosis and for preparing the relevant respective\nfigures for the manuscript.\n476"
  },
  {
    "page": 477,
    "content": "9.2.5 Peri-implantitis\nResulting\nin\nBisphosphonate-\nrelated Osteonecrosis of the Jaw\nM. M. Bornstein\nIntroduction\nBisphosphonates are used to treat malignoma-related\nosteolysis (such as bone metastases of prostate or\nmammary\ncarcinomas,\nmultiple\nmyelomas),\nhypercalcemia caused by hyperparathyroidism, Paget’s\ndisease, or osteoporosis (Migliorati 2003; Hubner and\nHouston 2005). Other treatments, such as for giant-cell\nlesions of the jaws, osteogenesis imperfecta, fibrous\ndysplasia, Gaucher’s disease, or chronic recurrent\nmultifocal osteomyelitis, have also been described in\nthe literature (Landesberg and coworkers 2009). A\nmajor complication in patients using oral or intravenous\n(i.v.) bisphosphonates is osteonecrosis of the jaw.\nBisphosphonate-related\nosteonecrosis\nof\nthe\njaw\n(BRONJ) was first described in 2003 as a side effect in\npatients taking pamidronate or zoledronate (zoledronic\nacid), which are bisphosphonates prescribed i.v. to\ncontrol bone metastases in patients with breast and\nprostate cancer or multiple myelomas (Marx 2003;\nMigliorati\n2003;\nRuggerio\nand\ncoworkers\n2009).\nAlthough there are some differences between clinicians\nwhen diagnosing BRONJ, the common features of a\nmanifest BRONJ include the following characteristics\n(Ruggerio and coworkers 2009): current or previous\ntreatment with a bisphosphonate (oral or i.v.); exposed\nbone in the maxillofacial region that has persisted for\n477"
  },
  {
    "page": 478,
    "content": "more than eight weeks and exhibits no or poor tendency\nto heal; no history of radiation therapy to the jaws.\nRisk factors for BRONJ include the length of exposure\nto bisphosphonates (Bamias and coworkers 2005) and\nthe type of bisphosphonate, with a significantly higher\ncumulative hazard for zoledronic acid (Boonyapakorn\nand coworkers 2008; Walter and coworkers 2008).\nIntravenous\nadministration\nincreases\nthe\nrisk\nof\ndeveloping BRONJ as much as 4.4 times (Cartsos and\ncoworkers 2008). Trauma to the oral mucosa and bone,\nsuch as tooth extractions and oral surgical procedures\nincluding the placement of oral implants, is another\nimportant\nrisk\nfactor\nand\ntrigger\nfor\nBRONJ\ndevelopment\n(Badros\nand\ncoworkers\n2006;\nBoonyapakorn and coworkers 2008; Bornstein and\ncoworkers 2009; Madrid and Sanz 2009).\nThis case report describes the development of BRONJ\nnear implants with peri-implantitis in the maxilla and\nmandible in a patient diagnosed with multiple myeloma\nand under long-term treatment with i.v. zoledronate and\npamidronate. Furthermore, the clinical and radiological\nfeatures, risk factors for BRONJ development in long-\nstanding implants, and therapeutic concepts in patients\nwith such systemic risk factors will be critically\ndiscussed.\nCase report\nA 82-year-old female patient was referred to the\nDepartment of Oral Surgery and Stomatology at the\nUniversity of Bern, Switzerland, for further diagnosis\n478"
  },
  {
    "page": 479,
    "content": "and treatment of growing discomfort in the right\nmandible (implant 45) and left maxilla (implant 23).\nThe patient had had implants of various types inserted\nin the mandible and maxilla over the course of the\nprevious three decades (in the 1980s and 1990s). The\npatient had received removable partial dentures on\nimplants in the maxilla and on natural teeth in the\nmandible. The implants in the posterior right mandible\nhad been restored with two splinted single crowns. The\nlower partial denture was not well tolerated by the\npatient and therefore had not been worn for over ten\nyears. After insertion of the implants, there had been no\ncomplications for many years, but implants 45 and 46\nas well as 23 had begun to exhibit signs of peri-\nimplantitis\nwith\nlimited\nbone\nloss\nseveral\nyears\npreviously. The infection had been treated by the\nprivate practitioner, and bone loss around the three\nimplants had not progressed until about half a year\npreviously (Figs 1 to 3).\nFig 1 Panoramic view of the patient about six\n479"
  },
  {
    "page": 480,
    "content": "months\nprior\nto\nthe\ninitial\nexamination\nat\nthe\ndepartment. At this time, the multiple myeloma had\nprogressed and worsened, and the medication was\nswitched to i.v. pamidronate (Aredia) using a high dose\nprotocol. The implants at sites 45, 46, and 23 exhibited\nbone loss in the crestal area (peri-implantitis). The\ninfection had been treated by the private practitioner\nand was under control.\n480"
  },
  {
    "page": 481,
    "content": "Figs\n2a-b\nPeriapical\nradiographs\nof\nthe\nimplants\ninserted and restored with splinted crowns at sites 45\nand 46 in 1994 (a) and 2005 (b), before deterioration of\nthe health status and a switch to pamidronate (Aredia)\nusing a high-dose protocol.\n481"
  },
  {
    "page": 482,
    "content": "Fig 3 Periapical radiograph of implant 23 splinted with\nimplant 21 half a year before deterioration of the health\nstatus and a switch to i.v. pamidronate (Aredia) using a\nhigh-dose protocol.\nThe patient had been diagnosed with multiple myeloma\n(stage III according to the Durie-Salmon classification;\nSailer and coworkers 1995) eight years previously and\ntreated by chemotherapy, including melphalan and\nprednisone, after establishing the diagnosis. Thereafter,\ni.v. bisphosphonates were given, initially pamidronate\n(pamidronic acid, Aredia; Novartis, Basel, Switzerland)\nfor four years, followed by zoledronate (zoledronic\nacid, Zometa; Novartis) over the following 3.5 years.\nUnder this therapy, the progression of the neoplasia was\narrested, and there was even some remission; the patient\nhad been without symptoms during this time. About\n482"
  },
  {
    "page": 483,
    "content": "half a year prior to the initial visit at the department, the\nmyeloma had progressed and deteriorated, so the\nmedication had again been switched to i.v. pamidronate\n(Aredia) at a higher dose. Shortly after the deterioration\nand the medication switch, the patient began to\ncomplain\nabout\ngrowing\ndiscomfort\nin\nthe\nright\nmandible (implant 45) and left maxilla (implant 23).\nAt the initial visit in our department, pain was more\npronounced in the maxilla. Clinically, both implants (45\nand 23) were stable, probably also as a result of being\nsplinted with implants 46 and 21. The peri-implant\nmucosa did not exhibit clear signs of inflammation, and\nthere was no marked bleeding or discharge upon\nprobing. Nevertheless, probing depths were clearly\nincreased around both implants, to up to 10 mm. The\npanoramic and periapical radiographs (Figs 4 and 5a-b)\nexhibited progressive bone loss around implants 45 and\n23 when compared to previous radiographs, including\nsigns of sequestration. The bony sequesters around the\nimplants seemed attached to the implant surface, and\nthe bone surrounding the implants exhibited signs of\nosseous\nsclerosis—presenting\nthemselves\nvery\ndifferently from the classic radiographic features for\nperi-implantitis. Based on the anamnestic data, clinical\nsymptoms, and the radiographs, a diagnosis of BRONJ\naround implants 45 and 23 was made.\n483"
  },
  {
    "page": 484,
    "content": "Fig 4 Panoramic radiograph of the patient at the initial\nexamination at the department. Implants 45 and 23\nexhibited progressive bone loss, including signs of\nsequestration. The bony sequesters around the implants\nseemed attached to the implant surfaces.\n484"
  },
  {
    "page": 485,
    "content": "Figs 5a-b Periapical radiographs exhibiting the status of\nthe bone disease around the affected implants at sites 45\n(a) and 23 (n) in more detail.\nThe initial treatment concept chosen was a conservative\napproach that included regular visits to the dental\nhygienist every six to eight weeks and local disinfection\nof implants 45 and 23 with chlorhexidine and peroxide\nrinses. Subjective symptoms initially decreased, but half\na year after the initial visit, the patient reported growing\npain in the lower right mandible. The treating dentist\nseparated implants 45 and 46, and removed implant 45\nduring\na\nfollow-up\nvisit.\nAfter\nexplantation,\nthe\nsituation worsened for the patient including growing\npain in the posterior right mandible and increasing\nnumbness in the chin area (hypoesthesia).\n485"
  },
  {
    "page": 486,
    "content": "At the following visit to our department, explantation\nsite 45 did not exhibit any clear signs of inflammation,\nbut exposed bone was detected on probing all along the\nformer\nimplant\nsocket\n(Fig\n6).\nThe\ncone-beam\ncomputed tomography (CBCT; Figs 7a-e) exhibited\nosseous sclerosis in the area of the former implant 45\nand the implant still integrated at site 46. The sclerosis\nhad enclosed the mandibular canal, and periosteal bone\nformation was noted on the buccal aspect of the\nmandible. An extended osteolytic area and suspected\nsequesters had formed at explantation site 45. In the\nregions mesially and distally of the suspected BRONJ,\nthe radiologic characteristics of the mandible were\nmarkedly different, with a cortical lining of the bone in\nthe outer aspects, a trabecular network in the bone\nmarrow, and a mandibular canal delineated by a thin\ncortical bone structure.\n486"
  },
  {
    "page": 487,
    "content": "Fig 6 Following explantation of implant 45 two weeks\npreviously, the area exhibited no signs of inflammation,\nbut exposed bone was detected upon probing.\n487"
  },
  {
    "page": 488,
    "content": "488"
  },
  {
    "page": 489,
    "content": "Figs 7a-e CBCT exhibited osseous sclerosis at the site\nof the former implant 45 (* = mandibular canal) and the\nimplant still integrated at site 46 (b, c). The sclerosis\nalso was enclosing the mandibular canal in this region,\nand on the buccal aspect of the mandible periosteal\nbone formation was visible (a, d; + = mental foramen).\nIn the explantation site 45, an extended osteolytic area\nand suspected sequestra formation were visible (a, c). In\nthe region distal to the suspected BRONJ, a regular\ncortical lining of the bone in the outer aspects, a\ntrabecular network in the bone marrow part and a\nmandibular canal delineated by a thin cortical bone\nstructure was visible (d, e).\nBased on these findings, progressive BRONJ in the\nmandible was suspected that required further surgical\ntreatment. The patient was referred to the Department\nof Cranio-Maxillofacial\nSurgery at the University\n489"
  },
  {
    "page": 490,
    "content": "Hospital in Bern, where the BRONJ was surgically\ntreated by sequestrotomy, decortication of the mandible,\nand lateralization of the inferior alveolar nerve. Wound\nhealing\nwas\nuneventful,\nand\nthe\nneurosensory\ndisturbance in the area of the right mental nerve\nregressed. Following this procedure, surgical treatment\nof the peri-implantitis and suspected BRONJ in the left\nanterior maxilla (23) was planned, which the patient\nrefused. She was referred to the dental hygienist for\ntreatment every six to eight weeks, including local\ndisinfection of implant 23 with chlorhexidine and\nperoxide rinses. Control visits at the Department of\nCranio-Maxillofacial Surgery were scheduled at six-\nmonth intervals. The patient has remained stable under\nthis therapeutic regime for more than six years (Fig 8).\nFig 8 Panoramic view of the patient six years after\nsurgical revision of the BRONJ at sites 45 and 46. The\nbone in the posterior right mandible has regenerated,\nand the radiologic situation around the remaining\n490"
  },
  {
    "page": 491,
    "content": "implants in the mandible and maxilla seems to be\nstable.\nDiscussion\nGenerally, clinical manifestations of BRONJ include\nexposed bone, which may be painful in up to 69% of\ncases (Ruggerio and Woo 2008). Radiographically,\nBRONJ presents with thickening of the lamina dura,\nwidening of the periodontal ligament space, osteolysis,\ndiffuse sclerosis, and poor or non-healing in extraction\nsockets (Phal and coworkers 2007; Arce and coworkers\n2009). In the present case report, there was no visible\nexposure of necrotic bone, but the patient experienced\nvariable episodes of pain, and the radiological features\nobserved in the CBCT scan were typical for BRONJ as\ndescribed in the literature (Stockmann and coworkers\n2010). Overlapping clinical and radiographic features\nsometimes make it difficult to differentiate BRONJ\nfrom osteolysis due to neoplasias in patients with an\nunderlying or metastatic or malignant bone disease\n(Arce and coworkers 2009; Frei and coworkers 2010).\nThe presence of actinomyces and other bacteria in the\naffected jaws is a characteristic feature in patients with\nBRONJ and demonstrates that bacterial infection plays\na significant role in the pathogenesis of BRONJ\n(Hansen and coworkers 2007).\nThere is a clear risk for implant failure related to oral or\ni.v. intake of bisphosphonates. Failure may occur\nfollowing placement in patients taking bisphosphonates,\nor in existing and well osseointegrated implants when a\npatient begins taking bisphosphonates for either bone\n491"
  },
  {
    "page": 492,
    "content": "cancer or osteoporosis. In a large sample of 16,000\npatients with 28,000 implants, Goss and coworkers\n(2010) identified 7 cases of implant failures associated\nwith oral bisphosphonate intake due to osteoporosis\nwith 3 cases of failures after surgery, and 4 cases of\nimplants that had been successful before patients were\ndiagnosed as having osteoporosis and commencement\nof bisphosphonate use, resulting in subsequent loss of\nintegration. The authors calculated that—based on the\nassumption that 5% of the patients were taking oral\nbisphosphonates—1 out of 114 treated patients (0.89%)\nwould exhibit implant failure including BRONJ.\nBRONJ that develops in the first weeks or months after\nthe placement of implants is regarded as a surgical\ncomplication (Kwon and coworkers 2014). If BRONJ\noccurs more than six months after surgery, implant\nplacement (surgery) is not considered an etiological\nfactor. Interestingly, a case series of implant-related\nBRONJ showed that the average time between implant\nplacement and the onset of bone necrosis was 20.9\nmonths (Jacobsen and coworkers 2012). Furthermore,\nonly one case of BRONJ out of 14 clearly triggered by\nsurgery was identified: a female patient after sinus floor\nelevation with simultaneous implant placement. The\nauthors also stated that the location of the implant could\nbe an influencing factor for BRONJ development and\nloss of the implant. Most cases were diagnosed in\nposterior regions, and no patient exhibited BRONJ in an\nimplant placed in the anterior maxilla. The authors\nspeculated that posterior implants were more difficult\nfor patients to clean and therefore there were at risk for\nperi-implantitis development and initiation of BRONJ.\n492"
  },
  {
    "page": 493,
    "content": "The present case report showed two implant failures in\na patient with a known history of peri-implantitis and\nlong-term\nbisphosphonate\nintake\ndue\nto\nmultiple\nmyeloma. The situation was exacerbated following\ndeterioration of the health status and a switch in the\ntype of i.v. bisphosphonate including an increase in the\ndose. Both implants (45 and 23) exhibited a bone\ndestruction pattern recently described and termed as\n“en-bloc type” of sequestration (Kwon and coworkers\n2014), where a considerable amount of bone-to-implant\ncontact is actually maintained and bone destruction\ncontinues\nperipherally\nto\nthe\nbone\nimmediately\nsurrounding the implant. Sometimes the implant and\nattached bone become sequestrated as a block (Figs\n5a-b). This pattern of BRONJ around implants has also\nbeen described in other case reports (Shirota and\ncoworkers 2009; Favia and coworkers 2011; Sverzut\nand coworkers 2012) and case series (Lazarovici and\ncoworkers 2010; López-Cedrún and coworkers 2013;\nKwon and coworkers 2014).\nBased on the findings of the present case and also the\ndata from the literature, not only the placement of\nimplants, but also long-standing implants and especially\nthe condition of peri-implant tissues appear to be pose a\ncontinuous risk factor for BRONJ development in\npatients under oral or i.v. bisphosphonate therapy\n(Shirota and coworkers 2009; Jacobsen and coworkers\n2013; Kim and Kwon 2014; Kwon and coworkers\n2014). Thus, in patients receiving either oral or i.v.\nbisphosphonates, implants must be planned and inserted\ncarefully, ideally using a minimally invasive approach.\nFurthermore, in patients with implants already in\n493"
  },
  {
    "page": 494,
    "content": "function, the intake of bisphosphonates increases the\nrisk for peri-implant infections potentially resulting in\nBRONJ with subsequent loss of the implant. Therefore,\nthese\npatients\nshould\nget\nregular\nfollow-ups\nand\nmaintenance at short intervals (every three to six\nmonths).\nAcknowledgments\nThe author would like to thank Professor Tateyuki\nIizuka, Department of Cranio-Maxillofacial Surgery,\nUniversity Hospital of Bern, Switzerland, for his help in\nestablishing the diagnosis and treatment of the patient.\n494"
  },
  {
    "page": 495,
    "content": "9.2.6 Metal Allergy\nD. Wismeijer, D. Kruger, J. Muris\nIn 2004, the patient, a smoker, began dental treatment at\nthe ACTA graduate clinic. She was a TV producer\nexposed to a lot of stress in her job and had a sick\nhusband. Her maxillary teeth had been extracted, as had\nthe mandibular canines, premolars, and molars, with the\nexception of tooth 34.\nShe received a complete maxillary denture and a\nmandibular skeleton denture. In October 2007, her\nmaxilla was augmented by an oral and maxillofacial\nsurgeon; in March 2008, implants (Biomet 3i, Palm\nBeach, Florida, USA) were inserted at that same clinic.\nIn 2008, the patient was presented at the Department of\nOral Implantology and Prosthetic Dentistry to request\nrestorations for her implants. An implant-supported\noverdenture was planned. She also asked if we could\nrestore her occlusion with fixed prosthetics. To that end,\nwe\ninserted\nfour\nmandibular\nimplants\n(35,\n44:\nStraumann SP, diameter 4.1 mm, length 10 mm; 36, 46:\nStraumann SPWN, diameter 4.8 mm, length 10 mm;\nInstitut Straumann AG, Basel, Switzerland) and fit\nthese with a three-unit fixed partial denture and two\nsingle crowns.\nThe mandibular implants were inserted at the ACTA\npostgraduate implant clinic in August 2008. To prepare\nfor\nthe\nprosthetic\nphase\nand\nto\nevaluate\nthe\n495"
  },
  {
    "page": 496,
    "content": "augmentation of the maxilla, the second-stage surgery\nwas carried out by the oral and maxillofacial surgeon.\nIn October 2008, the patient reported pain and irritation\naround the healing caps in the maxilla. The soft tissue\naround the healing caps had begun to show symptoms\nof inflammation (Fig 1a). The soft tissue was resected\nbut the inflammation and proliferation returned (Fig\n1b). The patient had also started to develop signs and\nsymptoms of an allergy. Her hands and face developed\nskin problems (Figs 2a-b).\nFig 1a The soft tissue around the healing caps showing\nsigns of inflammation.\n496"
  },
  {
    "page": 497,
    "content": "Fig 1b It was resected but the inflammation and\nproliferation returned.\n497"
  },
  {
    "page": 498,
    "content": "Figs 2a-b Skin problems on the face and both hands.\nWe replaced the healing caps with titanium healing caps\n(Figs\n3a-b).\nOne\nweek\nlater,\nthe\nproblems\nhad\ndisappeared.\nDifferential\ndiagnosis\npointed\nto\nhypersensitivity to the metal of the healing caps. The\nmaterial\nwas\nexamined\nby\nour\nmaterial\nsciences\ndepartment.\n498"
  },
  {
    "page": 499,
    "content": "Figs 3a-b The healing caps were replaced with caps\nmade of titanium.\nSeveral samples were taken of the healing abutments\nusing an Arkansas stone and analyzed by energy-\ndispersive X-ray spectroscopy (EDX). The analysis\nshowed that the healing caps contained palladium. A\nsuperstructure (Fig 4) and a resin-based denture (Figs\n5a-b) were inserted. The mandibular implants were\nrestored with metal-ceramic crowns and a bridge.\n499"
  },
  {
    "page": 500,
    "content": "Fig 4 Superstructure on eight 3i implants.\n500"
  },
  {
    "page": 501,
    "content": "Figs 5a-b Three-unit fixed partial denture (44–46) (a)\nand 2 single crowns (35–36) (b).\nTable 1 ADX analysis, new restorations (% w/w).\nAu Pt\nCu Zn Ag Pd Cr Mo Co\nSuperstructure\n86\n11 2\n1\nClips\n68\n4\n12\n3\n10\n3\nMaxillary denture, metal\npart\n28 10\n62\nMetal-ceramic crown 35\n96\n1\n2\n2\n501"
  },
  {
    "page": 502,
    "content": "Metal-ceramic crown 36\n84\n11 1\n2\nMetal-ceramic crowns 45/\n46\n83\n14 2\n1\nAfter the maxillary superstructure, the mandibular\ncrowns, and the overdenture had been inserted, some\nirritation reoccurred in the maxilla. We analyzed the\nmaterials used in the dental restorations and found that\nthe clips used in the overdenture contained a small\namount of palladium. Once the clips were removed and\nreplaced with a nickel-free and palladium-free alloy, the\ncomplaints disappeared.\nDiscussion\nThe anamnesis of this patient contained several “red\nflags.”\nShe\nreported\nbeing\nallergic\nto\nadhesive\nbandages,\nplastic\nwatch\nstraps,\nsome\nbrands\nof\ndeodorant, bell pepper, nickel, and other metals but not\nto silver and gold. She also wore an intrauterine\ncontraceptive device made of copper, to which she\nreported no allergic reactions; she did report additional\nallergi\nes to ammonia and several brands of detergents.\nGiven the patient’s known allergy to nickel, we\nconsidered this the probable explanation for her specific\nreaction when exchanged the primary healing caps for\ntitanium caps. On the other hand, it would seem\nadvisable for a patient with multiple signs of allergy to\n502"
  },
  {
    "page": 503,
    "content": "undergo comprehensive allergy testing. It was not until\nafter specific allergy testing that we discovered her\nhypersensitivity to palladium and found that the initial\nhealing caps had also contained palladium.\n503"
  },
  {
    "page": 504,
    "content": "9.3\nHardware Complications\n9.3.1 Management of a Fractured Implant Supporting a\nScrew-retained Metal-ceramic Restoration\nH. P. Weber, A. Grous\nThe fracture of an\nimplant after it has been restored is one of the most\nsevere complications. It most frequently occurs in\npartially\nedentulous\njaws\n(1.5%).\nMost\nimplant\nfractures involve implants with a diameter of 3.75 mm\nmade of commercially pure titanium (Eckert 2010).\nUnfortunately,\nmany\ncases\nare\nnot\nreported\nor\ndocumented by the clinicians involved in resolving the\nproblems created by the fracture.\nThis case report describes the management of an\nimplant fracture at site 36 in a middle-aged male\npatient. The implant had been restored with a screw-\nretained metal-ceramic crown (Fig 1).\n504"
  },
  {
    "page": 505,
    "content": "Fig 1 Panoramic radiograph. Fractured rough-surfaced\nexternal-hex implant, diameter 3.75 mm, length 11 mm.\nFig 2 CT scan of site 36. Bone loss around the fractured\nimplant.\n505"
  },
  {
    "page": 506,
    "content": "Fig 3 CT scan of site 36. Buccolingual orientation and\nrelation of the implant to the mental nerve.\nAn external-hex rough-surface implant (diameter 3.75\nmm, length 11 mm) had been immediately placed in\n2000, following the extraction of the fractured natural\ntooth 36. After twelve years of service (February 2012),\nthe patient presented with slight mobility of the implant\nand\ndiscomfort\nupon\nmastication.\nThe\nperiapical\nradiograph revealed signs of bone loss advancing past\nthe engagement of the abutment screw at the distal\naspect of the implant (Fig 4). This area seems to be\nmost vulnerable to cyclic fatigue, as it is the thinnest\nportion of the implant. The titanium alloy may undergo\nfatigue and ultimately failure under the bending forces.\nMicrostructural\nanalysis\nhas\ndemonstrated\nthat\nfragments from fractured implant showed patterns\ncompatible with failure due to fatigue (Rangert and\ncoworkers 1995).\n506"
  },
  {
    "page": 507,
    "content": "Fig 4 Periapical radiograph. Implant 36 with signs of\nbone loss on the distal aspect.\nThe\nfractured\nimplant\nwas\nexposed\nunder\nlocal\nanesthesia using a conservative mucoperiostal flap to\nfacilitate the application of a 4-mm trephine drill to\nretrieve the fractured apical part (Froum and coworkers\n2011; Anitua 2010).\nFigure 5 shows the bony attachment around the implant\nbelow the fracture level. The fracture line is located\nbetween the third and fourth threads and coincides with\nthe end of the prosthetic retention screw.\n507"
  },
  {
    "page": 508,
    "content": "Fig 5 Coronal part of the fractured implant with the\nscrew-retained metal-ceramic crown. The retrieved\napical portion of the implant shows the remaining\nattached bone.\nThe fractographic analysis of the two pieces at the\nfracture line (Figs 6a-b) documented the strain induced\nby bending forces. A lack of osseointegration or peri-\nimplantitis were excluded as causes of this implant\nfailure. The fracture resulted from problems related to\nprosthesis cantilever and the implant’s design and\ndimensions (diameter 3.75 mm).\n508"
  },
  {
    "page": 509,
    "content": "Figs 6a-b Stereomicroscopic imaging of the fracture\narea.\nThe implant fracture may have a multifactorial etiology.\n509"
  },
  {
    "page": 510,
    "content": "The fracture presumably occurred gradually, starting\nwith cracks developing when some bone was lost\naround the neck of the implant. This resulted in a\nfatigue-induced fracture of the implant body, which\nmight have been enhanced by corrosion (Reclaru and\ncoworkers 1994; Olmedo and coworkers 2009; Adya\nand\ncoworkers\n2005)\nand\noverload\ndue\nto\nthe\nunfavorable implant position distal to the center of site\n36 with an evident mesial cantilever effect (Pjetursson\nand coworkers 2004; Romeo and Storelli 2012).\nAlthough the removal of an implant with a trephine drill\nis somewhat invasive, the surrounding bone in this\nparticular case was intact for at least two-thirds of the\nheight of the implant. Taking into consideration the\npatient’s desire for immediate replacement of the\nimplant and subsequent restoration, the treatment plan\ncalled for placing of an implant with a wider diameter\nof 5 mm and a length of 11.5 mm immediately after\nremoving the fractured implant. This new implant was\nof the tapered type with a microrough surface and an\nexternal hex (NanoTite; Biomet 3iPalm Beach Gardens,\nFlorida, USA).\nFour months after surgery, a new screw-retained metal-\nceramic crown was connected and tightened to 32 Ncm\nusing a titanium hex screw (Figs 7a-d).\n510"
  },
  {
    "page": 511,
    "content": "Figs 7a-b New metal-ceramic crown, occlusal view, on\nthe master cast (a) and in situ (b).\n511"
  },
  {
    "page": 512,
    "content": "Figs 7c-d New metal-ceramic crown, buccal view, on\nthe master cast (c) and in situ (d).\n512"
  },
  {
    "page": 513,
    "content": "Fig\n8\nTwelve-month\npostoperative\npanoramic\nradiograph of the replacement implant and restoration.\nFig 9 Twelve-month postoperative occlusal view.\n513"
  },
  {
    "page": 514,
    "content": "Fig 10 Two-year postoperative periapical radiograph.\nOsseous steady state around the implant.\nFig 11 Two-year postoperative clinical follow-up with\nimplant-supported restoration in centric occlusion.\n514"
  },
  {
    "page": 515,
    "content": "Discussion\nThe etiology of implant fractures is multifactorial, and\nmany of the factors leading up to them are “interactive.”\nThe evidence-based literature related to the etiology of\nimplant fractures is inconclusive. From the limited\nstudies available, it appears that implant fractures occur\nmore frequently in partially dentate than in edentulous\npatients. Most fractures occur below the level of\nengagement of the abutment screw. In this area, where\nstress is concentrated, implants are generally hollow.\nDanger signs such as screw loosening and bone\nresorption should be taken seriously during follow-up\nvisits. Unsupported cantilever extensions in molar areas\nshould be avoided. Patients with parafunctional habits\nshould be provided with occlusal guards and strongly\nadvised\nto\nwear\nthem.\nClinicians\nmust\ncarefully\nconsider the prosthetic design and the choice of\nimplants in terms of diameter and length, especially in\nareas of high masticatory loads.\nConclusion\nThe fracture of an osseointegrated implant is a severe\ncomplication that often requires the removal of the\nimplant fragments. This procedure calls for extreme\ncaution, as there is substantial risk for further damage.\nAction should be taken in accordance with evidence-\nbased methods of treatment and material selection,\naiming\nat\nperfection\nthrough\ncareful\nclinical\nimplementation and including the necessary recall and\nfollow-up.\n515"
  },
  {
    "page": 516,
    "content": "9.3.2 Retreatment of a Patient with Multiple Biological\nand Technical Complications and Failures\nS. Hicklin, S. Tettamanti, U. Brägger\nA 66-year-old patient presented because of retention\nloss of the tooth-supported FDP in the right maxilla\n(x-13-x-11).\nThe\nmandibular\nfull-arch\nimplant-\nsupported reconstruction (x-i34-i33-x-x-x-x-i43-i44-x)\nhad suffered extreme wear.\nHis medical history revealed high blood pressure,\ncontrolled\nwith\nanti-hypertensive\nmedication.\nThe\npatient was a light smoker (2 to 3 cigarettes per day).\nThe existing reconstructions had been performed alio\nloco about five years previously. That treatment had\ntaken an extensive amount of time, and as early as\nduring the fabrication of the reconstructions, multiple\ncomplications had occurred with the provisionals.\nClinical diagnoses and findings\nA comprehensive clinical and radiographic examination\nrevealed the following findings and diagnoses (Figs 1a-\nb to 3):\n516"
  },
  {
    "page": 517,
    "content": "Fig 1a Pretreatment occlusal view of the maxilla.\nFig 1b Pretreatment occlusal view of the mandible.\n517"
  },
  {
    "page": 518,
    "content": "Fig 2 Pretreatment frontal view.\nFig 3 Pretreatment panoramic radiograph.\nIntraoral conditions\n•\nMultiple missing teeth\n•\nRoot tips 13, 11, and 25\n518"
  },
  {
    "page": 519,
    "content": "•\nTooth 26 with a deep carious lesion and periapical\nradiolucency (non-vital)\n•\nFDP on implants 21 and 23, single crown on implant\n24\n•\nSevere wear of the fixed mandibular implant-\nsupported acrylic prosthesis with a metal framework\ndue to a parafunctional habit\nFunction and occlusion\n•\nReduced occlusal vertical dimension due to attrition\nand pronounced wear of the mandibular prosthesis\nPeriodontal/peri-implant condition\n•\nPoor oral hygiene\n•\nPeri-implant mucositis at implant 21, 24, 34, 33, 43,\nand 44\n•\nPeri-implantitis at implant 23 with a bone defect\nCompromised esthetics\n•\nInadequate vertical dimensions and facial height\n•\nSeveral missing teeth in the maxilla\nTreatment plan\n519"
  },
  {
    "page": 520,
    "content": "General considerations\nDue to caries in the root canal and only minimal tooth\nsubstance remaining, the extraction of teeth 13, 11, and\n25\nwas\nunavoidable.\nA\nremovable\nmaxillary\nreconstruction was planned. The existing implants 21,\n23, and 24 were to be incorporated into the new\nreconstruction.\nTo\nobtain\nan\nadequate\nvertical\ndimension of occlusion, a new prosthesis was planned\non the existing mandibular implants. Tooth length in the\nmaxilla was adequate, so the bite had to be raised in the\nmandible (Fig 4). For a less expensive alternative\ncompared to a new reconstruction, the repair of the\nexisting\nfixed\nimplant-supported\nprosthesis\nwas\nproposed.\n520"
  },
  {
    "page": 521,
    "content": "Fig 4 The smile line before the loss of the FDP in the\nright maxilla revealed that the maxillary teeth had been\nappealingly visible.\nThe prosthodontic rehabilitation was planned with an\nincreased vertical dimension of occlusion of 4 mm. This\napproach was necessary to provide adequate interarch\nspace, an ideal occlusal plane, and correct facial\nproportions.\n521"
  },
  {
    "page": 522,
    "content": "Hygienic phase\n•\nDelivery of a provisional removable prosthesis in the\nmaxilla\n•\nExtraction of root tips 13, 11, 25 and tooth 26;\nestablishing\nan\noptimized\nlevel\nof\noral\nhygiene\n(instruction and motivation)\n•\nRemoval of deposits at the implants by a dental\nhygienist\nand\nregular\napplication\nof\ndisinfectants\n(chlorhexidine)\nSurgical phase\n•\nPresurgical\nassessments:\ncentric\nmounting\nand\ndiagnostic set-up/mock-up at an increased occlusal\nvertical dimension\n•\nPeri-implant GBR at implant 23 by a periodontist or\nexplantation\n•\nImplant placement according to the set-up in the\nright maxilla at sites 12 and 14\nReconstructive phase\n•\nReconstruction with a maxillary removable bar-\nsupported acrylic prosthesis with metal framework on\nfour implants (14, 12, 21, 24)\n•\nRepair of the existing mandibular full-arch fixed\nimplant-supported metal-acrylic prosthesis using the\n522"
  },
  {
    "page": 523,
    "content": "existing\nframework;\nincreased\nocclusal\nvertical\ndimension by modification of the reconstruction in the\nmandible\nMaintenance phase\n•\nSupportive periodontal care and maintenance at\nthree-months intervals\nTreatment\nHygienic phase\nTwo alginate impressions and a bite registration in\nhabitual\nocclusion\nwere\ntaken\nduring\nthe\nfirst\nemergency treatment. To rapidly establish function and\nesthetics, a provisional partial denture was made (Figs\n5a-b).\n523"
  },
  {
    "page": 524,
    "content": "Figs 5a-b Provisional partial denture.\nAfter this immediate provisional rehabilitation, the\npatient\nunderwent\na\ncomprehensive\nclinical\nand\nradiographic examination. The hygienic phase included\nmotivation and instruction in tooth-brushing techniques\nand the use of interdental brushes (mandible) to\nestablish adequate oral hygiene. The patient was\ninstructed to rinse with a chlorhexidine solution twice a\nday for one minute. Plaque and calculus were removed\nby a dental hygienist.\nRoot tips 13, 11, and 25 were extracted. Tooth 26 was\nextracted during the hygienic phase because of the large\ncavity, periapical lesion, and poor prognosis.\nAfter soft-tissue healing at sites 13, 11, 15, and 26, the\ncemented implant-supported FDP (i21-x-i23) and the\nsingle crown on implant 24 were removed using the\nCORONAflex® device (KaVo, Biberach, Germany).\nSpherical attachments were inserted on implants 21, 23,\n524"
  },
  {
    "page": 525,
    "content": "and 24 (Fig 6a) and a polyether impression was taken\nwith\nthe\nprovisional\ndenture\nin\nocclusion.\nThe\nremovable prosthesis was relined and modified to an\noverdenture with retention on the three ball attachments\n(Fig 6b).\nFigs 6a-b After soft-tissue healing and modification of\nthe provisional prosthesis.\n525"
  },
  {
    "page": 526,
    "content": "Surgical phase\nA wax wall was adapted on an acrylic record base and a\nbite registration in centric occlusion was performed.\nAcrylic teeth were selected and arranged on the record\nbase for a trial arrangement. After the try-in, the set-up\nwas duplicated and a radiographic stent was produced\nfor a CBCT to evaluate the ideal implant sites in the\nfirst quadrant.\nHaving obtained the CBCT data, the patient was\nreferred to a periodontist for evaluation of implant 23.\nAccording to the specialist, a guided bone regeneration\n(GBR) procedure around that implant was impossible\nbecause of the large bone defect and missing buccal\nbone wall. Therefore, implant 23 had to be explanted\nprior to implant placement in the right maxilla.\nAccording to the prosthetic planning and the CBCT,\ntwo implants (RN; Institut Straumann AG, Basel,\nSwitzerland) were placed at sites 12 and 14. After ten\nweeks of healing, the abutments were connected (Fig\n7).\n526"
  },
  {
    "page": 527,
    "content": "Fig 7 Occlusal view of the maxilla after abutment\nconnection.\nReconstructive phase\nFour weeks later, a polyether impression (Impregum®;\n3M ESPE, Seefeld, Germany) was taken at the implant\nlevel using an open custom impression tray. To check\nthe accuracy of the master cast, a verification jig was\nused intraorally to ensure the passive fit of the planned\ntitanium bar (Figs 8a-b).\n527"
  },
  {
    "page": 528,
    "content": "Figs 8a-b Verification jig on the master cast and the\nintraoral try-in.\nA composite-resin record base with a wax occlusion rim\nwas used to determine the occlusal vertical dimension\nand to record the maxillomandibular relationship. A set-\nup for the maxilla and a mock-up on the mandibular\nprosthesis was constructed. Several try-ins with an\n528"
  },
  {
    "page": 529,
    "content": "increased\nvertical\ndimension\nof\nocclusion\n(group\nfunction in lateral movements), phonetics, esthetics, the\nocclusal plane, and the facial height were performed\n(Figs 9a-d).\nFigs 9a-b Try-in of the maxillary set-up with the mock-\nup in the mandible to increase the vertical dimension of\nocclusion (freeway space and centric relation).\n529"
  },
  {
    "page": 530,
    "content": "530"
  },
  {
    "page": 531,
    "content": "Figs 9c-d Smile line and facial height with the set-up/\nmock-up.\nThe implant-supported titanium bar was CAD/CAM-\ndesigned and milled based on the set-up/mock-up. The\npassive fit of the bar was examined on the master cast\nas well as intraorally using the Sheffield test. After\nverifying the fit of the CAD/CAM bar, the maxillary\ndenture was produced in the dental lab with a cobalt-\nchromium framework.\n531"
  },
  {
    "page": 532,
    "content": "The maxillary prosthesis was tried in when the denture\nbase was still in its raw phase t\no confirm esthetics, the occlusal plane, phonetics, and\nfunction. The mock-up was bonded to the existing\nmandibular prosthesis with composite and a bite\nregistration was taken in centric relation (Figs 10a-b).\n532"
  },
  {
    "page": 533,
    "content": "Figs 10a-b Bite registration with the new removable\nprosthesis in the maxilla and the mock-up bonded to the\nexisting mandibular prosthesis.\nThe maxillary prosthesis was finished at the dental\nlaboratory, including characterization of the buccal\nacrylics (Figs 11a-c).\n533"
  },
  {
    "page": 534,
    "content": "534"
  },
  {
    "page": 535,
    "content": "Figs 11a-c Final reconstructions in the articulator.\nThe\nteeth\nand\nacrylic\nwere\nremoved\nfrom\nthe\nmandibular\nframework.\nIt\nhad\nbeen\ndesigned\nas\ncleansable with all pontics convex and showed adequate\ncontact to the oral mucosa, so there was no need for any\nmodifications. With this bite registration (Fig 10), the\nocclusion and the mandibular denture were rebuilt with\nnew denture teeth and acrylic (Figs 12a-j).\n535"
  },
  {
    "page": 536,
    "content": "Figs 12a-b Final maxillary prosthesis and titanium\nCAD/CAM bar.\n536"
  },
  {
    "page": 537,
    "content": "Figs 12c-d Repaired mandibular prosthesis.\n537"
  },
  {
    "page": 538,
    "content": "Fig 12e CAD/CAM bar.\nFig 12f Maxillary bar and final mandibular prosthesis.\n538"
  },
  {
    "page": 539,
    "content": "Fig 12g Final Maxillary and mandibular prostheses.\n539"
  },
  {
    "page": 540,
    "content": "Figs 12h-i Lateral view of final prostheses.\n540"
  },
  {
    "page": 541,
    "content": "Fig 12j Smile line and facial height with final\nprostheses.\nMaintenance phase\nSupportive periodontal care and maintenance was\nplanned at three-month intervals. To prevent attrition,\nthe patient was provided with a night guard.\nAcknowledgments\n541"
  },
  {
    "page": 542,
    "content": "Dental laboratory procedures\nElias\nBühler\n–\nBühler\nDental\nAesthetik,\nZurich,\nSwitzerland\n542"
  },
  {
    "page": 543,
    "content": "9.3.3 Management of a Technical Complication Caused\nby a Fractured Zirconia Abutment\nT. Joda, U. Brägger\nA 24-year-old female patient was treated with an\nimplant-supported crown for single-tooth replacement\nat site 11. A Straumann Bone Level RC implant\n(Institut Straumann AG, Basel, Switzerland) was placed\nwith simultaneous bone augmentation (Fig 1), and the\nperi-implant emergence profile was conditioned with a\nfixed\nimplant-supported\nprovisional\ncrown.\nAfter\nfinalization of the mucosal architecture, the clinical\nsituation was transferred by means of a custom\nimpression post for fabrication of an implant-supported\nscrew-retained\none-piece\ncrown\nconsisting\nof\na\nCARES® zirconia abutment (Straumann) with a direct\nceramic veneer.\n543"
  },
  {
    "page": 544,
    "content": "Fig 1 Periapical x-ray after surgical placement of a\nStraumann Bone Level RC implant at site 11.\nDuring the first clinical try-in of the final restoration, a\nfracture in the apical portion of the pristine CARES®\nzirconia\nabutment\nbecame\nevident.\nThe\nzirconia\nremnant was trapped in the implant and could not be\nremoved (Figs 2a-b).\n544"
  },
  {
    "page": 545,
    "content": "Fig 2 (a) Fractured CARES® zirconia abutment. (b)\nOcclusal view of the clinical situation with a zirconia\nremnant trapped in the implant at site 11.\nComplication management aimed at removing the ring-\nlike\nshaped\nzirconia\nremnant\nwithout\nsurgical\nintervention\nand\nwithout\ndamaging\nthe\ninternal\nconfiguration of the implant. Due to its ring shape,\n545"
  },
  {
    "page": 546,
    "content": "however, the zirconia remnant could not be removed\nwith the classical manufacturer’s service set, which\ncontains drills designed to remove components trapped\nin the central screw-access canal (Luterbacher and\ncoworkers 2000).\nA compatible extraction bolt was used to detach the\nfractured component. Despite meticulous caution, the\napex of the extraction bolt fractured within the zirconia\nring and blocked the screw access hole (Fig 3).\nFig 3 Fractured extraction bolt.\nFurthermore, neither the provisional implant crown nor\nthe fractured crown could be placed in their intended\nposition\nand\nconnected\nto\nthe\nimplant\nfor\nprovisionalization.\nTherefore,\na\ncustom\nwire\nconstruction was used to bond the crown to the adjacent\nteeth, so that the shape of the mucosa around the\nimplant could be maintained (Figs 4a-c).\n546"
  },
  {
    "page": 547,
    "content": "547"
  },
  {
    "page": 548,
    "content": "Figs\n4a-c\nModified\nfractured\nimplant\ncrown\n(a)\nprovisionally bonded to the adjacent teeth to maintain\nthe mucosal architecture around the implant (b-c).\nIn a first attempt, the double-fractured zirconia ring plus\nthe fragment of the extraction bolt was meant to be\nremoved with the manufacturer’s service set. Once\nagain, however, the blocked implant could not be\nreleased.\nUltimately, a custom-made tungsten carbide round bur\nhad to be manufactured (Jota AG, Rüthi, Switzerland).\nTungsten\ncarbide\nis\ncharacterized\nby\na\nYoung’s\nmodulus of approximately 550 GPa and a stiffness two\ntimes higher than steel. The custom round bur had the\nsame shaft design as the drills of the manufacturer’s\nservice set (Figs 5a-c). This was necessary to determine\nthe shaft’s length for the protection of the internal\nconfiguration of the implant. The tip of the custom\nsmall-diameter round bur created a centralized access to\nthe fractured extraction bolt.\n548"
  },
  {
    "page": 549,
    "content": "Figs 5a-b (a) Detailed view of a customized small-\ndiameter round bur (Jota AG, Rüthi, Switzerland). (b)\nBur\nplaced\nin\nthe\nappropriate\nbracket\nof\nthe\nmanufacturer’s service set.\nDuring intermediate drilling combined with permanent\nwater-cooling, the custom round bur could be placed in\nthe implant axis with the specific drilling guide for\n549"
  },
  {
    "page": 550,
    "content": "Straumann\nBone\nLevel\nimplants\n(Brägger\nand\ncoworkers 1995). After repeated drilling, the round bur\nwas able to engage the trapped remnant and remove it\nfrom the screw canal (Figs 6a-c).\n550"
  },
  {
    "page": 551,
    "content": "Figs 6a-c (a) The first treatment sequence with the\ninserted system-specific drilling guide in the screw\ncanal. (b) Custom round bur. (c) The bur was used\nunder irrigation.\nIn the second step, the drill of the manufacturer’s\nservice set was able to reach the defined insertion depth.\nContinuous\nrinsing\nwith\nchlorhexidine\ndigluconate\nsolution helped remove the last remnants of the trapped\ncomponents (Figs 7a-c).\n551"
  },
  {
    "page": 552,
    "content": "552"
  },
  {
    "page": 553,
    "content": "Figs 7a-c Second treatment sequence with intermediate\nuse of the Straumann-specific drills until the final depth\nwas reached.\nAs a final step, the implant screw thread was re-tapped\nwith the Straumann tap guides I to III; followed by\nthorough\nrinsing\nwith\nchlorhexidine\ndigluconate\nsolution (Figs 8a-c).\n553"
  },
  {
    "page": 554,
    "content": "Figs 8a-c Third treatment sequence with re-tapping the\nimplant screw thread (guides I–III).\nThe fractured remnants of the CARES® zirconia\nabutment and extraction bolt could thus be removed\nsuccessfully without requiring a surgical intervention.\nNeither the implant connection nor the bone-to-implant\ninterface was damaged (Fig 9).\n554"
  },
  {
    "page": 555,
    "content": "Figs 9a-b Screw canal and persisting peri-implant\nmucosal architecture after minimally invasive removal\nof all fractured remnants.\nThe incremental approach using a customized round bur\nand the system-specific drills of the manufacturer’s\nservice set saved the blocked implant, so that it could be\n555"
  },
  {
    "page": 556,
    "content": "successfully restored with a new crown (Figs 10a-c and\n11).\n556"
  },
  {
    "page": 557,
    "content": "Figs 10a-c (a) New implant-supported crown with\nCARES® zirconia abutment and direct veneer. (b)\nRehabilitated patient with crown at site 11, buccal view.\n(c) Occlusal view.\n557"
  },
  {
    "page": 558,
    "content": "Fig 11 Final periapical x-ray of the new implant-\nsupported crown at site 11.\n558"
  },
  {
    "page": 559,
    "content": "9.3.4 Repeated Acrylic Fractures on a MandibularFixed\nFull-arch Implant-supported Metal/Acrylic Prosthesis\nJ. Kan\nA 77-year-old male patient was referred for the\nmanagement of frequent and repeated acrylic fracture of\nhis\nexisting\nmandibular\nfixed\nfull-arch\nimplant-\nsupported metal/acrylic prosthesis. He also complained\nabout soft-tissue soreness and the lack of retention and\nstability of his maxillary removable partial metal/acrylic\nprosthesis. Both prostheses had been delivered two\nyears previously as part of his full-mouth rehabilitation\n(caries, tooth wear, tooth fracture).\nHis medical history revealed high blood pressure,\ncontrolled with the use of antihypertensive medication.\nClinical diagnoses and findings\nA comprehensive clinical (extraoral and intraoral) and\nradiographic examination yielded the following clinical\nfindings and diagnoses (Figs 1 and 2a-c):\nFig 1 Pre-treatment dental charting.\n559"
  },
  {
    "page": 560,
    "content": "Fig 2a Pre-treatment occlusal view of the maxillary\narch.\nFig 2b Pre-treatment occlusal view of the mandibular\narch.\n560"
  },
  {
    "page": 561,
    "content": "Fig\n2c\nPre-treatment\nfrontal\nview\nin\nmaximum\nintercuspation.\nFunctional and restorative challenges\n•\nMultiple missing teeth. Maxillary teeth 13, 12, 11,\n21, 23, 27 remaining.\n•\nSevere tooth attrition leading to reduced clinical\ncrown lengths of teeth 13, 12, 11, 21\n•\nSevere wear and fractures on the acrylic teeth of the\nmaxillary removable prosthesis and the mandibular\nfixed prosthesis\n•\nPotential etiological factors: Parafunctional habits,\nacid erosion of extrinsic dietary genesis\nOcclusal challenges\n•\nReduced interarch space\n561"
  },
  {
    "page": 562,
    "content": "•\nCompromised length and curvature of the maxillary\nincisal plane\n•\nCompromised vertical dimension of the mandibular\nprosthesis\n•\nCrossbites in the maxillary and mandibular right\nquadrants\nPeriodontal/peri-implant challenges\n•\nAttachment loss\n•\nGeneralized moderate to advanced periodontitis\n•\nClinical mobility grade I (teeth 13, 12, 11, 21, 23)\nand grade II (tooth 27)\n•\nPeri-implant tissue mucositis at sites 36, 33, 43, 46\nand the midline\n•\nPoor oral hygiene\nEsthetic challenges\n•\nInadequate tooth dimension, contour, symmetry, and\ndiscoloration\nOther\n•\nMaxillary\ndental\narch:\nAcceptable\narch\nshape,\nmoderate ridge resorption, normal palatal vault and\nnormal vestibular depth\n562"
  },
  {
    "page": 563,
    "content": "•\nMandibular dental arch: Acceptable arch shape,\nmoderate ridge resorption, normal vestibular depth\nTreatment considerations and treatment planning\nPatient preferences. Based on the patient’s wishes to\nretain all his remaining teeth despite poor to guarded\nprognoses and to address his primary concern of\nmechanical wear and fracture, several treatment options\nwere considered with the intention to provide a short-\nterm solution for his maxillary restoration and a long-\nterm result for his mandibular restoration. It was agreed\nthat\na\nmaxillary\nremovable\nimplant-retained\noverdenture or a fixed full-arch implant-supported\nprosthesis would be considered should his maxillary\ndentition fail.\nRehabilitation at an increased vertical dimension of\nocclusion.\nThe\nprosthodontic\nrehabilitation\nwas\nperformed\nat\nan\nincreased\nvertical\ndimension\nof\nocclusion (VDO) of 4 mm (interincisal distance). This\nwas necessary to provide adequate interarch space for\nan ideal occlusal plane as well as adequate soft-tissue\nclearance and dimension to ensure a strong metal\nframework and acrylic base for the mandibular fixed\nprosthesis. The dentofacial effect of the VDO increase\nwas acceptable in terms of facial height, proportion, and\nprofile and the establishment of a class I occlusal\nrelationship.\nThe following treatment plan was outlined:\nControl and holding phases\n563"
  },
  {
    "page": 564,
    "content": "•\nDietary analysis and formulation of a preventive\noral-hygiene regime\n•\nPeriodontal and peri-implant tissue management\nwith a periodontist\n•\nCentric mounting and diagnostic wax-up at an\nincreased occlusal vertical dimension\n•\nComposite core build-up for teeth 13, 12, 11, 21 and\nacrylic modifications to the occlusion of the existing\nprostheses\n•\nProsthodontic\nassessment:\nMonitoring\nof\nthe\npatient’s functional adaptation (mastication, phonetics),\nesthetics, and comfort\nReconstructive phase\n•\nConstruction of a maxillary removable partial metal/\nacrylic prosthesis\n•\nConstruction\nof\na\nmandibular\nfixed\nfull-arch\nimplant-supported metal/acrylic prosthesis\nMaintenance phase\n•\nContinued periodontal and prosthodontic recall and\nmaintenance\nProsthetic design and configuration\n564"
  },
  {
    "page": 565,
    "content": "Maxillary removable metal/acrylic partial prosthesis.\nThe framework design of the existing maxillary partial\nprosthesis had involved the use of a horseshoe-shaped\nmajor connector. Thus, support was derived from the\nalveolar ridge as the primary load-bearing area. Under\nhigh functional and parafunctional loads, this had\nresulted in soft-tissue trauma on the alveolar ridge,\nespecially the edentulous site 22 and the palatal gingiva\nof the remaining abutment teeth 13, 12, 11, 21, 23. The\nexisting cobalt-chrome metal framework design had to\nbe modified to improve support for the new prosthesis,\nwhich was achieved by adding occlusal or cingulum\nrests on teeth 13, 23, 27 and a posterior palatal strap\nmade of metal (Fig 3a).\nFig 3a Maxillary dental arch restored with a removable\npartial metal/acrylic prosthesis. Post-treatment occlusal\nview.\nIt\nwas\naccepted\nthat\nthe\nstability\nof\nthe\nVDO\ncontributed by the maxillary restoration, being a short-\n565"
  },
  {
    "page": 566,
    "content": "term solution, was questionable due to the poor\nprognosis of abutment 27, anticipated continued ridge\nresorption, and the wear on composite restorations\n(Filtek™\nSupreme\nXTE;\n3M\nESPE,\nSt.\nPaul,\nMinnesota, USA) and acrylic teeth (SR Phonares® II;\nIvoclar Vivadent, Schaan, Liechtenstein).\nMandibular full-arch fixed hybrid implant-supported\nmetal/acrylic prosthesis. Implants placed at sites 36, 33,\n43, 46 and midline (Neoss Dental Implants, North\nYorkshire, UK) had previously been restored with a\nfull-arch fixed metal/acrylic prosthesis retained by\ndirect-to-fixture\nabutment\nscrews.\nThe\nvertical\ndimension of the existing prosthetic design was limited\nand did not allow adequate soft-tissue clearance for oral\nhygiene. The height and width of the metal framework\nwere also minimal, and the framework was visible\nthrough the thin and fractured acrylic. Hence, a decision\nwas made to make modifications to address these\nfundamental issues in the new prosthesis.\nFor soft-tissue clearance, the framework was designed\nto allow light tissue contact on the edentulous ridge,\nwhilst having embrasure areas around implants for oral\nhygiene maintenance (Fig 3b).\n566"
  },
  {
    "page": 567,
    "content": "Fig 3b Gingival contours of the mandibular fixed full-\narch implant-supported metal/acrylic prosthesis.\nTo maximize the stability of the VDO contributed by\nthe mandibular restoration, the posterior occlusion was\ndesigned in metal as part of the implant-supported\ntitanium-vanadium-aluminum-milled framework (Nobel\nProcera;\nNobel\nBiocare,\nQuebec,\nCanada).\nThe\nmandibular anterior segment and the buccal aspect of\nthe posterior segments were realized with acrylic teeth\n(SR Phonares® II; Ivoclar Vivadent) secured to the\nframework with tooth-colored polymethyl methacrylate\n(Telio Lab; Ivoclar Vivadent) and pink polymethyl\nmethacrylate (IvoBase High Impact; Ivoclar Vivadent)\n(Fig 3c).\n567"
  },
  {
    "page": 568,
    "content": "Fig 3c Mandibular arch restored with a fixed full-arch\nimplant-supported\nmetal/acrylic\nprosthesis,\nPost-\ntreatment occlusal view.\nProsthetic phase\nAfter the diagnostic wax-up in centric occlusion at the\nchosen\nVDO,\ncomposite-core\nrestorations\nwere\nprovided for teeth 13, 12, 11, 21, temporary acrylic was\nadded to improve the occlusal plane of the existing\nmandibular prosthesis, and a new maxillary removable\npartial metal/acrylic prosthesis was fabricated.\nConstruction of the new mandibular prosthesis began\nwith implant-level impressions using splinted open-tray\nimpression\ncopings\nand\nlight-\nand\nheavy-body\npolyvinylsiloxane impression materials (ImprintTM 3\nVPS; 3M ESPE) in a custom tray.\nA lab-processed verification jig was used intraorally to\nverify the accuracy of the working cast. A maxillary\n568"
  },
  {
    "page": 569,
    "content": "cast with the newly constructed maxillary removable\nmetal/acrylic partial prosthesis in place was mounted in\na semi-adjustable articulator using a facebow record\n(Whip Mix 2000 series; Whip Mix, Louisville, USA).\nUsing the existing mandibular prosthesis, which had\nbeen modified to the ideal vertical dimension, the\nworking cast was mounted against the maxillary\nworking model at chairside. At an acrylic try-in, aided\nby temporary titanium cylinders, the accuracy of the\ntooth set-up in centric occlusion, the planned group\nfunction in lateral excursive movements, as well as\nesthetics and phonetics were verified. This was then\nprovided to the laboratory for the copymilling process\n(Jemt\nand\ncoworkers\n1999)\nfor\ndesigning\nand\nfabricating an implant-supported framework using the\nCAD/CAM scanning and milling method.\nAt the framework try-in and the insertion of the finished\nmandibular fixed full-arch metal/acrylic prosthesis (Fig\n3d), direct vision, tactile sensation, and alternative\nfinger\npressure\ntesting\non\nalternating\nterminal\nabutments helped investigate any misfit that may\nmanifest itself as a mechanical fulcrum or in the form of\nsaliva movement at the framework-implant interface\n(Kan and coworkers 1999). Parallel-view radiographic\nevaluation complemented the clinical assessment (Figs\n4a-c).\n569"
  },
  {
    "page": 570,
    "content": "Fig\n3d\nPost-treatment\nfrontal\nview\nin\nmaximum\nintercuspation.\n570"
  },
  {
    "page": 571,
    "content": "Figs 4a-c Parallel-view radiographs of implants 36, 33,\n43, 46, and midline.\nCAD/CAM titanium frameworks have shown a superior\nand consistent passive fit across many studies thanks to\nthe omission of conventional casting steps (Torsello and\n571"
  },
  {
    "page": 572,
    "content": "coworkers 2008; Örtorp and coworkers 2003; Al-Fadda\nand coworkers 2007).\nAt the one-year review, the patient continued to report\ncomplete satisfaction with the functional and esthetic\noutcome. The mandibular restoration presented no\nbiological or mechanical complications. The patient\nwas reminded to consider long-term treatment options\navailable for the restoration of his failing dentition in\nthe maxillary arch.\nAcknowledgments\nLaboratory procedures\nMichael\nStandish\n–\nMichael\nStandish\nDental\nLaboratory, Perth, WA, Australia\n572"
  },
  {
    "page": 573,
    "content": "Table\n1\npresents\na\ncomprehensive\noverview\nsummarizing\nthe\ntopics\nconcerning\nhardware\ncomplications and failures with implant supported\nreconstructions, which were discussed in the previous\nchapters.\nThe table is structured by the site of origin of hardware-\nrelated problems. The key biomechanical parameters\ninvolved in the etiology are listed along with the\nresulting\nobserved\ncomplication/failure,\nits\nmanagement, and preventive measures to be taken.\nThe locations of the observed problems start with the\nimplant, proceed from the apical to occlusal aspect, and\nend with the superstructure, as indicated in Chapter 4.1\n(Figs 1a-f).\nThe table presents guidelines related to management\nand prevention of hardware-related complications and\nfailures and attempts to structure the complexity of\nclinical findings in patients with implant-supported\nreconstructions.\nTable 1 Hardware-related failures and complications in\ndifferent\npositions\nalong\nan\nimplant/abutment/\nreconstruction complex, key biomechanical parameters\ninvolved, management, and prevention.\n573"
  },
  {
    "page": 574,
    "content": "Implant/\nreconstruction\ncomplex\nKey\nparameters\nComplication/\nfailure\nManagement\nPrevention\n574"
  },
  {
    "page": 575,
    "content": "•\nDeformation\n•\nRemove\nimplant\nMaterials’\nphysical\nproperties\nSmall diameter\nDesign\nof\nplatform, neck\n•\nFracture:\n–\nFatigue\nfracture\n–\nDisruption\n(trauma)\n•\nRemove\nimplant\nfragment\n•\nLeave\nfragment\nsleeping\n•\nOptimized\nphysical material\nand\ndesign\nproperties\n•\nResistant\nmaterials\nfor\nsmall\ndiameter\nimplants\n•\nCorrect\nindication\n•\nSufficient\ndimensions\n•\nReduce stress\npeaks\nby\noptimized design\nachieved\nby\nsimulation,\ntesting,\ne.g.\nFinite-Element\nAnalysis (FEA)\n•\nScratches, pits\n•\nTraces\nfrom\ninstrumentation\n•\nPolish\n•\nSmoothen\n•\nAvoid\ndamage\nwhen\nhandling\ncomponents\n•\nAvoid\ndamage\nduring\nmaintenance\nprocedures\n1.\nImplant\nbody\nSurface\n•\nDamage\nto\nplatform, neck\n•\nExplantation\n•\nUse adequate\ninstruments\n•\nAvoid\ndamage\nwhen\nremoving\nold\nreconstructions\n575"
  },
  {
    "page": 576,
    "content": "Osseointegration\n•\nSpinner\n•\nStop\nmanipulation\n•\nWait\n•\nIf persistent,\nremove\n•\nGive enough\ntime for healing\n•\nSlow\nincrease\nof\ntorque\nwhen\nremoving\nhealing\nabutments\n•\nObserve\npatient reaction\n•\nUse ISQ as\nindicator\n3D position of\nplatform\n•\nMalpositioned\nplatform\n•\nProsthetic\ncompromise\n•\nRemove\nor\nleave\nthe\nimplant\nsleeping\n•\nProsthetically\ndriven\nplanning\nand\nimplant\nplacement\nImplant/\nreconstruction\ncomplex\nKey\nparameters\nComplication/\nfailure\nManagement\nPrevention\n576"
  },
  {
    "page": 577,
    "content": "•\nLoosening\nof\nabutment/\nabutment screw\n•\nRemove,\nclean\ncomponents,\nrinse,\nretorque\n•\nFracture\nof\nabutment base\n•\nRemove,\nrinse, use new\ncomponent,\nretorque\nMaterials’\nphysical\nproperties\nand design\nClamping,\nsettling,\ntolerance\n•\nFragment\nblocks access to\nbore\nin\nthe\nimplant\n•\nRemove\nfragment,\nretap,\nrinse,\nuse\nnew\ncomponent,\ntorque\n•\nUse\nwell-\ndocumented\nsystems\n•\nCorrect\ntorque\n•\nMatching\ncomponents\n•\nUse original\nabutments\nIndex\n•\nMisfit\nof\nposition (index)\n•\nGap\n•\nFind\ncorrect\nposition\n•\nRetake\nimpression\n•\nNew\nreconstruction\n•\nClean\nthe\ninterface\n•\nNo\nforeign\nbodies\nwhile\ninserting\nabutments\n•\nCorrect\nindexing\n•\nRadiographic\ncontrol\nof\nposition\nbefore\ndefinitive torque\n2.\nImplant\nbody/\nAbutment\ninterface\n(connection)\nTribology\n•\nWear\nof\nimplant\nmaterial\ncausing\na\ntitanium tattoo\n•\nRemove\nabutment\ncausing wear\n•\nReplace\n•\nUse\noptimized\ncomponents\n577"
  },
  {
    "page": 578,
    "content": "Bore\n•\nDamage\nby\nnon-guided\nattempt\nto\nremove\nfragments\n•\nUse\nservice set\n•\nRetap\n•\nAvoid\ndamage\nwhen\nremoving\nfragments\nSeal\n•\nColonization\nby\nbacterial\nplaque\n•\nFistulas\n•\nTreat\ninfection\n•\nInsert\nperfectly\nfitting\nabutments\nand\nreconstruction\n•\nUse\ncorrect\ncomponents,\ntorque, index\n•\nPrecision\nof\ncomponents\nImplant/\nreconstruction\ncomplex\nKey\nparameters\nComplication/\nfailure\nManagement\nPrevention\n578"
  },
  {
    "page": 579,
    "content": "Materials’\nphysical\nproperties,\ndimensions\nand design\n•\nLoosening\n•\nFracture\n•\nRemove\nscrew\nor\nfragment,\nclean,\nrinse,\nuse\nnew\nscrew,\nretorque\n•\nUse\ncorrect\nabutment\nscrew\n•\nApply\ncorrect\ntorque\n•\nUse\noriginal\nabutment\nscrew\nand\noriginal\nscrewdriver\nAccess\nto\ninsert\nfor\nscrewdriver\n•\nInsert\ndamaged\ndue\nto handling of\nthe\nscrewdriver or\nwhile\ndrilling\nout\ncovering\nrestoration\n•\nClean\nwith probe\n•\nApply\naxial pressure\non\nscrewdriver\nwhile\ndetorqueing\n•\nApply\nultrasound\n•\nFreeze\n•\nRemove\nwith\nservice\nset\nif\ninsert\ndamaged\n•\nClean\nabutment\nscrew\n•\nClean\ninsert before\nuse of intact\nscrew driver\n•\nProtect\nscrew\nhead\nwith Teflon\nand\na\ncovering\nrestoration\n3.\nAbutment\nscrew\nScrew-head\nseating\non\nabutment\nbody\n(clamping)\n•\nE.g.\nfracture\nof\nceramic\nabutment\nbecause\nof\nwrong\n•\nRemove\nfractured\ncomponent\nwith\nservice\nset\n•\nUse\ncorrect\nabutment\nscrew\nfrom\nthe\nbeginning\n579"
  },
  {
    "page": 580,
    "content": "abutment\nscrew\n•\nRemake\nwith\ncorrect\nscrew\n•\nNo\ninadvertent\nexchange of\nscrews\nFracture\nmode\n•\nFracture\noccurring\nat\ndifferent levels\n•\nEasy\nor\ncomplicated\nremoval\nof\nscrew\nfragment\n•\nSystems\nwith built-in\npredictable\nfracture\nmode\nfor\neasy\nremoval\nof\nfragments\nImplant/\nreconstruction\ncomplex\nKey\nparameters\nComplication/\nfailure\nManagement\nPrevention\n580"
  },
  {
    "page": 581,
    "content": "Materials’\nphysical\nproperties\n•\nDeformation\n•\nFracture\n•\nRemove\nand\nreplace\ncomponent\n•\nCorrect\nindications\n•\nCorrect\nhandling\n•\nOriginal\ncomponent\nDesign: wide\nchoice\nof\nprefabricated\ncomponents\nor\ncustom\nCAD/CAM\ncomponents,\ndimensions,\nheight\n•\nLoss\nof\nretention\n(cementable)\n•\nRecement\n•\nIf\nrepeatedly,\nremake\nbut\nchange\nconcept\n•\nUse\nplan\nabutment\n•\nEnough\nretention\nfor\ncementation\nAntirotationaI\nstop\n•\nRotation\n(“spinning\ncrown”)\n•\nNew\nabutment\n•\nNew\ncrown\n•\nUse\nrotational stop\n•\nUse\ncorrect\ncopings\nAccess\nfor\nscrew, axis\n•\nAccess\ntoo\nlabialy\nfor\nscrew-retained\nreconstructions\n•\nChange\nabutment\nor\nchange\nto\ncementation\n•\nUse\nplan\nabutments\n•\nProsthetically\ndriven\nimplant\nplacement\n4.\nAbutment\nbody\nSurface\nof\nemergence\nprofile aspect\n•\nScratches,\npits\n•\nTraces from\ninstrumentation\n•\nPolish\n•\nSmoothen\n•\nChange\nabutment\n•\nAvoid\ndamage\nduring\nmaintenance\nprocedures\n•\nUse adequate\ninstruments\n581"
  },
  {
    "page": 582,
    "content": "Implant/\nreconstruction\ncomplex\nKey\nparameters\nComplication/\nfailure\nManagement\nPrevention\n582"
  },
  {
    "page": 583,
    "content": "Retention\nby\ncementation\n•\nLoss\nof\nretention\n•\nRecementation\n•\nUse\ncorrect\nheight\nof\ncomponents\n•\nChoose\namong more or\nless\nretentive\ncements\nCement\nresidue\n•\nCementing\nerror\n•\nCement\nresidue\n•\nRemove\ncement residues\n•\nCareful\ncementation\n•\nRemove\ncement residues\n•\nRadiographic\ncontrol\n•\nPlace implant\nat\nfavorable\ndepth\n•\nNo\ncementation\nif\nsubmucosal\ncement margin is\nnot accessible\n•\nRemove\nimmediately\nif\ncement\nmistake\nhas occurred\n5.\nInterface\nbetween\nreconstruction\nand abutment\nInterface\nbetween\nimplant\nplatform\nand\ncemented\nor\nscrew-\nretained\nreconstruction\nIndex\nfor\nsingle\ncrowns\nand\ntolerance\nfor\nmultiunit\nreconstructions\nPrecision\n•\nMisfit\n•\nGap\n•\nLeakage\n•\nCement\nresidue\n•\nFind index\n•\nRepositioning\nof abutment\n•\nRemake\n•\nControlled\ntransfer/index\n•\nPrecise\nlaboratory\nprocedures\n•\nCorrect try-in\nprocedure\n583"
  },
  {
    "page": 584,
    "content": "•\nFistula\n•\nMucositis/\nperi-\nimplantitis\n•\nRadiographic\ncontrol\n•\nTransfer aid\nTorque,\npreload,\nclamping with\nocclusal screw\n•\nLoosening\n•\nRemove, clean\ncomponent, rinse,\nretorque\n•\nCorrect screw\n•\nOriginal\nscrew\n•\nNo lab screw\nMaterials\nphysical\nproperties\nof\nocclusal screw\n•\nFracture\n•\nRemove,\nrinse,\nuse\nnew\nscrews\n•\nCorrect\nhandling\nof\nscrew\ndriver,\napply\ncorrect\ntorque at correct\nposition (index)\nInsert\nof\nocclusal screw\n•\nInsert\ndamaged\nby\nincorrect\nhandling\nof\nscrewdriver,\nby wear, or by\nprevious\ndrilling\n•\nRemove\nwith\nservice set\n•\nProtect\nocclusal\nscrew\nhead with teflon\nand\na\ncover\nrestoration\nAccess\nfor\nocclusal screw\n•\nScrew does\nnot engage\n•\nSoft-tissue\npressure\n•\nAccess for\nscrewdriver\nblocked\n•\nPosition\nwith\ncorrect indexing\n•\nRemove\nexcessive tissue\n•\nProsthetically\ndriven\nimplant\nplanning\nand\nplacement\n•\nProvide\nsufficiently wide\naccess channel\n584"
  },
  {
    "page": 585,
    "content": "•\nAccess\nwith\nscrewdriver\nnot\nmanageable\n•\nUse angulated\nabutment\n•\nAccess\nlocated too far\nlabially\n•\nUse\ncustomized\nabutment\nScrew-retained\nversus\ncemented\n•\nEsthetics\n•\nNon-\nretrievability\nof\nsuperstructure\n•\nScrew-access\ncover restauration\n•\nUse\nprovisional\ncement\n•\nConsider pros\nand\ncons\nfrom\nthe\nITI\nConsensus\nConference 2013\nrelated\nto\nrecommendations\nfor cementation/\nscrew retention\nImplant/\nreconstruction\ncomplex\nKey\nparameters\nComplication/\nfailure\nManagement\nPrevention\n585"
  },
  {
    "page": 586,
    "content": "•\nComponent\ncovered\nby\nbone/graft\n•\nSurgical\nremoval\nof\ngraft/bone\n•\nProvide\naccess\nto\nimplant\n•\nChoose\noptimal\nabutment\n•\nOvergrowth\nof soft tissue\n•\nReplace\nwith\ncomponent\nwith optimal\nconfiguration\n•\nSurgical\nsoft-tissue\ncorrection\n•\nSoft-\ntissue\nmanagement\nat\nsecond-\nstage\nsurgery\n•\nSoft-\ntissue\ngraft\nin cases with\nthin mucosa\nMaterials’\nphysical\nproperties\nDesign,\nheight,\nwidth\n•\nMucosal\nrecession\n•\nChange to\nsmaller\ncomponent in\ncase of thin\nmucosa\n•\nAvoid\nlong-lasting\nblanching\nInsert\n•\nInsert filled\nwith deposits\n•\nClean\ninsert\n•\nInstruct\npatient\nfor\ncleaning\n•\nRemove\ndeposits\nbefore using\nscrewdriver\n6.\nClosure\nscrew, healing\nabutment,\nmucosa\nformer\n•\nDamaged\ninsert\n•\nUse\nservice set\n•\nCareful\nhandling\nof\nscrewdriver\n586"
  },
  {
    "page": 587,
    "content": "and\nratchet\n(axis)\nImplant/\nreconstruction\ncomplex\nKey\nparameters\nComplication/\nfailure\nManagement\nPrevention\n587"
  },
  {
    "page": 588,
    "content": "•\nLoosening\n•\nRemove,\nclean\ncomponent,\nrinse,\nretorque\n•\nUse\ncorrect\ncomponent\n•\nCorrect\ntorque\nMaterials’\nphysical\nproperties,\ntorque,\nclamping\n•\nFracture\n•\nRemove\nfragment\nwith\nservice\nset,\nclean,\nrinse\n•\nReplace\nfractured\ncomponent\n•\nEstablished\nsystems\nAttrition\n•\nWear\nof\ninserts\nand/or\nabutments\n•\nReplace\nworn parts\n•\nProtective\nsplint\n•\nImplant axes\nnot too divergent\n7. Attachment\nsystem\nfor\noverdentures\nReduction\nof retention\n•\nLoose\nfit\nand\nreduced\nfunction\n•\nReplace\nwith\ninserts\nwith\nbetter\nretention\n•\nChange to\ncomponents\nwith\nbetter\nretention\n•\nRespect\ntissue height\n•\nRespect\nprosthetic\nprinciples\nfor\noverdentures\nsuch as distances\nbetween\nimplants, axes\n•\nProsthetically\ndriven\nimplant\nplacement\n588"
  },
  {
    "page": 589,
    "content": "Activation\n•\nPatient\ncannot handle\ninsertion\nor\nremoval\nof\noverdenture\n•\nUse\ninserts\nwith\nless retention\n•\nStart\nwith\nlow retention\n•\nAdapt\nretention\nindividually\n•\nInstruct\nhandling\nMaintenance\nservice\nneeds\n•\nRepeated\nservice need\n•\nHardware-\nrelated\nmucositis,\nperi-\nimplantitis,\nhyperplasia\n•\nChange\nattachment\nsystem,\nconcept\n•\nImprove\ndomestic oral\nhygiene\n•\nTreat\ninfection\n•\nCorrect\nsurgically\n•\nCorrect\nprosthetic\nposition\n•\nSupport\npolygon,\naxes,\nrequired space\n•\nPrefer\ndurable\nmaterials,\neasy\nreplacement\n•\nInstruct\non\ncareful insertion\nof overdenture\n•\nRegular\nmaintenance\nImplant/\nreconstruction\ncomplex\nKey\nparameters\nComplication/\nfailure\nManagement\nPrevention\n589"
  },
  {
    "page": 590,
    "content": "Materials’\nphysical\nproperties of\nprefabricated\nor\ncustom-\nmade\ncomponents\n•\nFracture\n•\nLoosening\nof\nsubstructure\n(abutment)\n•\nRemove\ncemented\nreconstruction\n•\nIf\nsuccessful,\nrecement\nafter cleaning\nand\nretightening\n•\nRemake\n•\nChoose\nresistant\nmaterials\nand\nmaterial\ncombinations\n•\nRetrievable\nfinal\nreconstruction\n•\nOvercontouring\n•\nNo access for\ncleaning\n•\nReduce\novercontour\n8.\nMesostructure\nCorrection\nof\naxes\nor\nvertical\nlevels\n•\nPlaque\naccumulation\n•\nCalculus\n•\nBiological\ncomplications\n•\nInstruct in\noral hygiene\n•\nAvoid\nthe\nneed\nfor\nmesostructures\nwith\nprosthetically\ndriven implant\nplacement\n•\nAvoid\novercontour\nand\nconcave\nsurfaces\nblocking\nthe\naccess\nfor\nhygiene\nImplant/\nreconstruction\ncomplex\nKey\nparameters\nComplication/\nfailure\nManagement\nPrevention\n590"
  },
  {
    "page": 591,
    "content": "Materials’\nphysical\nproperties/\nDimension\nfor\nframework/\nveneer\n•\nAging\nof\nmaterials\n•\nDifferent\ndegrees\nof\nwear\n•\nChange\nin\ncolor\n•\nPolish\nrough\nsurfaces\n•\nRemove\nstain, deposits\n•\nReduce\nknown\nrisk\nfactors\nas\ndescribed\nin\nChapter 8\n•\nOptimize\nlaboratory\nprocedures\nChairside\ncorrections\n•\nDifferent\nseverity\nof\nceramic\nfractures\n•\nPolish\n•\nRepair\n•\nRemake\n•\nMeticulous\npolishing\nafter\ncorrections\nto\navoid\ncrack\nformation\n•\nAvoid\ncrack\nformation in the\nlaboratory\n•\nRetrievability\nConnector\ndimension\n•\nFramework\nfractures\n•\nRemake\n•\nChoose\nsufficient\ndimensions\nParafunction\n•\nWear\n•\nRepair\n•\nRemake\n•\nSplint\nprotection\n9.\nReconstruction\nAccess\nfor\nhygiene\n•\nMucositis/\nperi-\nimplantitis\n•\nModify\naccess\n•\nRemake\n•\nDesign\nleaves access for\nhygiene\nand\nmaintenance\n591"
  },
  {
    "page": 592,
    "content": "Maintenance\nservice\nneeds\n•\nCombined\nand/or\nrepeated\ncomplications/\nfailures\n•\nRemake\nbut\nchange\nconcept\n•\nApply\na\nreasonable\nocclusal concept\n•\nRegular\nsupportive\ncare\nfor\nearly\ndiagnosis\nAllergenic\npotential\n•\nAllergic\nreaction\n•\nFibrotic\nlung disease of\ndental\ntechnician\n•\nRemake\nwith\nbiocompatible\nmaterial\n•\nAvoid Ni and\nPd\n•\nProtection by\nexhaust\nventilation\n592"
  },
  {
    "page": 593,
    "content": "10 Etiology, Management, and Prevention of Hardware\nComplications with Implant-supported Reconstructions\nU. Brägger, S. Hicklin\n593"
  },
  {
    "page": 594,
    "content": "This volume of the ITI Treatment Guide series has\npresented the etiology, risk factors, and strategies for\nthe treatment and prevention of biological and hardware\ncomplications in implant dentistry.\nAs more implants are placed throughout the world by\nan increasing number of practitioners with varying\nlevels of expertise, it is likely that the cumulative\nnumber of patients who experience complications will\nalso increase. Hence, the skills for an accurate diagnosis\nand management plan are important.\nWith careful treatment planning and patient assessment,\nin order to identify systemic, local or site-related, and\nlifestyle-related\nrisk\nfactors,\nthe\noccurrence\nof\ncomplications can be minimized.\nMeticulous preparation of the patient and the implant-\nrecipient site, followed by precision in both implant\nplacement and restorative aspects of treatment, will also\nminimize the risks for future complications.\nCareful\nselection\nof\nappropriate\nmaterials\nand\ntechniques, which have all been tested and well\ndocumented, can reduce the incidence of complications.\nA thorough understanding of the technical requirements\nof the restorative components used is important, as well\nas good communication between the implant surgeon,\nthe restorative clinician, and the laboratory technician.\nPatients should be informed of the possibility of future\ncomplications arising at the outset of treatment during\n594"
  },
  {
    "page": 595,
    "content": "the\ntreatment\nplanning\nstage.\nFurthermore,\nthe\nimportance of regular maintenance care and monitoring\nshould be reinforced. An individualized supportive-care\nprogram for each patient should be planned and\nimplemented, in order to maintain healthy peri-implant\ntissues.\nFinally, clinicians should be aware of their own\nexperience level and limitations and adopt a team\napproach to patient care where appropriate.\n595"
  },
  {
    "page": 596,
    "content": "11 Conclusions\nL. J. A. Heitz-Mayfield, U. Brägger\n596"
  },
  {
    "page": 597,
    "content": "597"
  },
  {
    "page": 598,
    "content": "12 References\nReferences have been listed in the order of (1) the first\nor only author’s last name and (2) the year of\npublication. Identical short references are distinguished\nin the text by lowercase letters, which if used are given\nin parentheses at the end of the respective entry in this\nlist of references.\nAbi Nader S, Eimar H, Momani M, Shang K, Daniel\nNG, Tamimi F. Plaque accumulation beneath maxillary\nall-on-4™implant-supported prostheses. Clin Implant\nDent Relat Res. 2014 Jan 27. doi: 10.1111/cid.12199.\n[Epub ahead of print]\nAbu El-Naaj I, Trost O, Tagger-Green N, Trouilloud P,\nRobe N, Malka G, Peled M. [Peri-implantitis or\nsquamous cell carcinoma?] [Article in French.] Rev\nStomatol Chir Maxillofac. 2007 Nov; 108(5): 458–460.\nAdya N, Alam M, Ravindranath T, Mubeen A, Saluja\nB. Corrosion in titanium dental implants: literature\nreview. Journal Indian Prosthodont Soc. 2005 Jul: 5(3):\n126–131.\nAgar JR, Cameron SM, Hughbanks JC, Parker MH.\nCement removal from restorations luted to titanium\nabutments\nwith\nsimulated\nsubgingival\nmargins.\nJ\nProsthet Dent. 1997 Jul; 78(1): 43–47.\nAglietta M, Siciliano VI, Zwahlen M, Brägger U,\nPjetursson BE, Lang NP, Salvi GE. A systematic\n598"
  },
  {
    "page": 599,
    "content": "review of the survival and complication rates of implant\nsupported\nfixed\ndental\nprostheses\nwith\ncantilever\nextensions after an observation period of at least 5\nyears. Clin Oral Implants Res. 2009 May; 20(5):\n441–451.\nAlbrektsson T, Zarb G, Worthington P, Eriksson AR.\nThe\nlong-term\nefficacy\nof\ncurrently\nused\ndental\nimplants: a review and proposed criteria of success. Int\nJ Oral Maxillofac Implants. 1986 Summer; 1(1): 11–25.\nAlbrektsson T, Isidor F. Consensus report of session\nIV. In: Lang NP, Karring T (eds): Proceedings of the\nFirst European Workshop on Periodontology. London:\nQuintessence; 2009: 365–369.\nAlbrektsson T, Dahlin C, Jemt T, Sennerby L, Turri A,\nWennerberg A. Is marginal bone loss around oral\nimplants the result of a provoked foreign body reaction?\nClin Implant Dent Relat Res. 2013 Sep 4. doi: 10.1111/\ncid.12142. [Epub ahead of print]\nAl-Fadda SA, Zarb GA, Finer Y. A comparison of the\naccuracy of fit of 2 methods for fabricating implant-\nprosthodontic frameworks. Int J Prosthodont. 2007\nMay–Apr; 20(2): 125–131.\nAl-Hashimi I. Schifter M. Lockhart PB. Wray D.\nBrennan M. Migliorati CA. Axell T. Bruce AJ.\nCarpenter W. Eisenberg E. Epstein JB. Holmstrup P.\nJontell M. Lozada-Nur F. Nair R. Silverman B.\nThongprasom K. Thornhill M. Warnakulasuriya S. van\nder Waal I. Oral lichen planus and oral lichenoid\n599"
  },
  {
    "page": 600,
    "content": "lesions: diagnostic and therapeutic considerations. Oral\nSurg Oral Med Oral Pathol Oral Radiol Endod. 2007\nMar; 103 Suppl: S25.e1–12.\nAllum SR, Tomlinson RA, Joshi R. The impact of loads\non standard diameter, small diameter and mini implants:\na comparative laboratory study. Clin Oral Implants Res.\n2008 Jun; 19(6): 553–559.\nAl-Nawas B, Brägger U, Meijer HJ, Naert I, Persson R,\nPerucchi A, Quirynen M, Raghoebar GM, Reichert TE,\nRomeo E, Santing HJ, Schimmel M, Storelli S, ten\nBruggenkate\nC,\nVandekerckhove\nB,\nWagner\nW,\nWismeijer D, Müller F. A double-blind randomized\ncontrolled trial (RCT) of titanium-13zirconium versus\ntitanium grade IV small-diameter bone level implants in\nedentulous\nmandiblesw—results\nfrom\na\n1-year\nobservation period. Clin Implant Dent Relat Res. 2012\nDec; 14(6): 896–904.\nAnitua E. Can osseointegration be reversed? Dental\nDialogue 2010; 1: 1–13.\nArce K, Assael LA, Weissman JL, Markiewicz MR.\nImaging\nfindings\nin\nbisphosphonate-related\nosteonecrosis of jaws. J Oral Maxillofac Surg. 2009\nMay; 67(5 Suppl): 75–84.\nAtieh MA, Alsabeeha NH, Faggion CM Jr, Duncan WJ.\nThe frequency of peri-implant diseases: a systematic\nreview and meta-analysis. J Periodontol. 2013 Nov; 84\n(11): 1586–1598.\n600"
  },
  {
    "page": 601,
    "content": "Au J, Patel D, Campbell JH. Oral lichen planus. Oral\nMaxillofac Surg Clinics of North Am. 2013 Feb; 25(1):\n93–100.\nBadros A, Weikel D, Salama A, Goloubeva O,\nSchneider A, Rapoport A, Fenton R, Gahres N,\nSausville E, Ord R, Meiller T. Osteonecrosis of the jaw\nin multiple myeloma patients: clinical features and risk\nfactors. J Clin Oncol. 2006 Feb 20; 24(6): 945–952.\nBamias A, Kastritis E, Bamia C, Moulopoulos LA,\nMelakopoulos I, Bozas G, Koutsoukou V, Gika D,\nAnagnostopoulos\nA,\nPapadimitriou\nC,\nTerpos\nE,\nDimopoulos MA. Osteonecrosis of the jaw in cancer\nafter treatment with bisphosphonates: oncidence and\nrisk factors. J Clin Oncol. 2005 Dec 1; 23(34):\n8580–8587.\nBanthia R, Maheshwari S, Banthia P, Mantri K:\nPeripheral giant cell granuloma: a case report. Gen\nDent. 2013 Jan–Feb;61(1): e12–e14.\nBarter S, Stone P, Brägger U. A pilot study to evaluate\nthe success and survival rate of titanium-zirconium\nimplants in partially edentulous patients: results after 24\nmonths of follow-up. Clin Oral Implants Res. 2012 Jul;\n23(7): 873–381.\nBerglundh T, Persson L, Klinge B. A systematic\nreview of the incidence of biological and technical\ncomplications\nin\nimplant\ndentistry\nreported\nin\nprospective longitudinal studies of at least 5 years. J\nClin Periodontol. 2002; 29 Suppl 3: 197–212.\n601"
  },
  {
    "page": 602,
    "content": "Bhatavadekar\nNB.\nSquamous\ncell\ncarcinoma\nin\nassociation with dental implants: An assessment of\npreviously hypothesized carcinogenic mechanisms and\na case report. J Oral Implantol. 2012 Dec; 38(6):\n792–798.\nBidra AS, Almas K. Mini implants for definitive\nprosthodontic treatment: a systematic review. J Prosthet\nDent. 2012 Mar; 109(3): 156–164.\nBischof M, Nedir R, Lombardi T: Peripheral giant cell\ngranuloma associated with a dental implant.Int J Oral\nMaxillofac Implants. 2004 Mar–Apr; 19(2): 295–299.\nBlock MS, Scheufler E. Squamous cell carcinoma\nappearing as peri-implant bone loss: a case report. J\nOral Maxillofac Surg. 2001 Nov; 59(11): 1349–1352.\nBoonyapakorn T, Schirmer I, Reichart PA, Sturm I,\nMassenkeil G. Bisphosphonate-induced osteonecrosis\nof the jaws: prospective study of 80 patients with\nmultiple myeloma and other malignancies. Oral Oncol.\n2008 Sep; 44(9): 857–869.\nBormann KH, Gellrich NC, Kniha H, Dard M,\nWieland M, Gahlert M. Biomechanical evaluation of a\nmicrostructured zirconia implant by a removal torque\ncomparison with a standard Ti-SLA implant. Clin Oral\nImplants Res. 2012 Oct; 23(10): 1210–1216.\nBornstein MM, von Arx T, Altermatt HJ: Loss of pulp\nsensitivity and pain as the first symptoms of a Ewing’s\nsarcoma in the right maxillary sinus and alveolar\n602"
  },
  {
    "page": 603,
    "content": "process: Report of a case. J Endod. 2008 Dec; 34(12):\n1549–1553.\nBornstein MM, Cionca N, Mombelli A. Systemic\nconditions and treatments as risks for implant therapy.\nInt J Oral Maxillofac Implants. 2009; 24 Suppl: 12–27.\nBosshardt\nDD,\nSchenk\nRK.\nBone\nregeneration:\nbiologic basis. In: Buser D (ed). 20 years of guided\nbone regeneration in implant dentistry. 2nd Edition.\nChicago: Quintessence; 2009: 14–45.\nBrägger U, Wermuth W, Török E. Heat generated\nduring preparation of titanium implants of the ITI\nDental Implant System: an in vitro study. Clin Oral\nImpl Res. 1995 Dec; 6(4): 254–259.\nBrito C, Tenenbaum HC, Wong BK, Schmitt C,\nNogueira-Filho G. Is keratinized mucosa indispensable\nto maintain peri-implant health? A systematic review of\nthe literature. J Biomed Mater Res B Appl Biomater.\n2014 Apr; 102(3): 643–650.\nBuchner\nA,\nShnaiderman-Shapiro\nA,\nVered\nM:\nRelative frequency of localized reactive hyperplastic\nlesions of the gingiva: a retrospective study of 1675\ncases from Israel. J Oral Pathol Med. 2010 Sep; 39(8):\n631–638.\nBusenlechner D, Tangl S, Arnhart C, Redl H, Schuh C,\nWatzek G, Gruber R. Resorption of deproteinized\nbovine bone mineral in a porcine calvaria augmentation\nmodel. Clin Oral Implants Res. 2012 Jan; 23(1): 95–99.\n603"
  },
  {
    "page": 604,
    "content": "Buser D, Hoffmann B, Bernard JP, Lussi A, Mettler D,\nSchenk\nRK.\nEvaluation\nof\nfilling\nmaterials\nin\nmembrane-protected\nbone\ndefects.\nA\ncomparative\nhistomorphometric study in the mandible of miniature\npigs. Clin Oral Implants Res. 1998 Jun; 9(3): 137–150.\nBuser D, Martin W, Belser UC. Optimizing esthetics\nfor\nimplant\nrestorations\nin\nthe\nanterior\nmaxilla:\nanatomic\nand\nsurgical\nconsiderations.\nInt\nJ\nOral\nMaxillofac Implants. 2004; 19 Suppl: 43–61.\nBuser D, Bornstein MM, Weber HP, Grütter L, Schmid\nB,\nBelser\nUC.\nEarly\nimplant\nplacement\nwith\nsimultaneous GBR following single tooth extraction in\nthe esthetic zone: A cross-sectional, retrospective study\nin 45 patients with a 2–4-year follow-up. J Periodontol.\n2008 Sep; 79(9): 1773–1781. (a)\nBuser D, Chen ST, Weber HP, Belser UC. Early\nimplant placement following single-tooth extraction in\nthe esthetic zone: biologic rationale and surgical\nprocedures. Int J Periodontics Restorative Dent. 2008\nOct; 28(5): 441–451. (b)\nBuser D, Halbritter S, Hart C, Bornstein MM, Grütter\nL, Chappuis V, Belser UC. Early implant placement\nwith\nsimultaneous\nGBR\nfollowing\nsingle\ntooth\nextraction in the esthetic zone: 12-months results of a\nprosthetic\nstudy\nwith\n20\nconsecutive\npatients.\nJ\nPeriodontol. 2009 Jan; 80(1): 152–162.\nBuser D. Implant placement with simultaneous guided\nbone\nregeneration:\nSelection\nof\nbiomaterials\nand\n604"
  },
  {
    "page": 605,
    "content": "surgical principles. In: Buser D (ed): 20 years of guided\nbone regeneration in implant dentistry. 2nd edition.\nChicago: Quintessence; 2009: 123–152.\nBuser D, Janner SF, Wittneben JG, Brägger U,\nRamseier CA, Salvi GE. 10-year survival and success\nrates of 511 titanium implants with a sandblasted and\nacid-etched surface: a retrospective study in 303\npartially edentulous patients. Clin Implant Dent Relat\nRes. 2012 Dec; 14(6): 839–851.\nBuser D, Chappuis V, Bornstein MM, Wittneben JG,\nFrei M, Belser UC. Long-term Stability of Contour\nAugmentation with Early Implant Placement Following\nSingle\nTooth\nExtraction\nin\nthe\nEsthetic\nZoneA\nProspective, Cross-sectional Study in 41 Patients with a\n5- to 9-year Follow-up. J Periodontol. 2013 Nov;\n84(11): 1517–1527. (a)\nBuser D, Chappuis V, Kuchler U, Bornstein MM,\nWittneben JG, Buser R, Cavusoglu Y, Belser UC.\nLong-term stabilty of early implant placement with\ncontour augmentation. J Dent Res. 2013 Dez; 92(12\nSuppl): 176S–182S. (b)\nCarlsson GE. Dental occlusion: modern concepts and\ntheir application in implant prosthodontics. Odontology.\n2009 Jan; 97(1): 8–17.\nCartsos VM, Zhu S, Zavras AI. Bisphosphonate use\nand the risk of adverse jaw outcomes: a medical claims\nstudy of 714,217 people. J Am Dent Assoc. 2008 Jan;\n139(1): 23–30.\n605"
  },
  {
    "page": 606,
    "content": "Casado P L, Otazu I B, Balduino A, de Mello W,\nBarboza E P, Duarte M E. Identification of periodontal\npathogens in healthy periimplant sites. Implant Dent\n2011 Jun; 20(3): 226–235.\nCecchinato\nD,\nParpaiola\nA,\nLindhe\nJ.\nMucosal\ninflammation and incidence of crestal bone loss among\nimplant patients: a 10-year study. Clin Oral Implants\nRes. 2013 Jun 14. doi: 10.1111/clr.12209. [Epub ahead\nof print]\nCehreli MC, Karasoy D, Kokat AM, Akca K, Eckert\nSE.\nSystematic\nreview\nof\nprosthetic\nmaintenance\nrequirements for implant-supported overdentures. Int J\nOral\nMaxillofac\nImplants.\n2010\nJan–Feb;\n25(1):\n163–180.\nChan HL, Oh WS, Ong HS, Fu JH, Steigmann M,\nSierraalta M, Wang HL. Impact of implantoplasty on\nstrength of the implant-abutment complex. Int J Oral\nMaxillofac\nImplants.\n2013\nNov–Dec;\n28(6):\n1530–1535.\nChang M, Chronopoulos V, Mattheos N. Impact of\nexcessive occlusal load on successfully-osseointegrated\ndental implants: a literature review. J Investig Clin\nDent. 2013 Aug; 4(3): 142–150.\nChee WW, Duncan J, Afshar M, Moshaverinia A.\nEvaluation of the amount of excess cement around the\nmargins of cement-retained dental implant restorations:\nthe effect of the cement application method. J Prosthet\nDent. 2013 Apr; 109(4): 216–221.\n606"
  },
  {
    "page": 607,
    "content": "Chen H, Liu N, Xu X, Qu X, Lu E. Smoking,\nradiotherapy, diabetes and osteoporosis as risk factors\nfor dental implant failure: a meta-analysis. PLoS One.\n2013\nAug\n5;\n8(8):\ne71955.\ndoi:\n10.1371/\njournal.pone.0071955. Print 2013.\nChen ST, Buser D. Esthetic complications due to\nimplant\nmalpositions:\netiology,\nprevention,\nand\ntreatment.\nIn:\nFroum\nSJ\n(ed):\nDental\nimplant\ncomplications. Etiology, prevention, and treatment.\nWiley-Blackwell; 2010; 134–155.\nChiapasco M, Casentini P, Zaniboni M, Corsi E,\nAnello T. Titanium-zirconium alloy narrow-diameter\nimplants (Straumann Roxolid®) for the rehabilitation of\nhorizontally deficient edentulous ridges: prospective\nstudy on 18 consecutive patients. Clin Oral Implants\nRes. 2012 Oct; 23(10): 1136–1141.\nChimenos-Küstner\nE,\nLópez-López\nJ,\nFinestres-\nZubeldia F. Squamous carcinoma after dental implants:\na clinical case. Rev Port Estomatol Med Dent Cir\nMaxilofac. 2008; 49(2): 97–100.\nChongcharoen N, Lulic M, Lang NP. Effectiveness of\ndifferent\ninterdental\nbrushes\non\ncleaning\nthe\ninterproximal\nsurfaces\nof\nteeth\nand\nimplants:\na\nrandomized controlled, double-blind cross-over study.\nClin Oral Implants Res. 2012 May; 23(5): 635–640.\nClapp C, Wheeler JC, Martof AB, Levine, PA. Oral\nsquamous cell carcinoma in association with dental\nosseointegrated implants. An unusual occurrence. Arch\n607"
  },
  {
    "page": 608,
    "content": "Otolaryngol Head Neck Surg. 1996 Dec; 122(12):\n1402–1403.\nClementini M, Rossetti PH, Penarrocha D, Micarelli C,\nBonachela WC, Canullo L. Systemic risk factors for\nperi-implant bone loss: a systematic review and meta-\nanalysis.Int J Oral Maxillofac Surg. 2014 Mar; 43(3):\n323–334.\nCloutier M, Charles M, Carmichael RP, Sándor GK:\nAn\nanalysis\nof\nperipheral\ngiant\ncell\ngranuloma\nassociated with dental implant treatment.Oral Surg Oral\nMed Oral Pathol Oral Radiol Endod. 2007 May; 103(5):\n618–622.\nCochran DL, Schou S, Heitz-Mayfield LJ, Bornstein\nMM, Salvi GE, Martin WC. Consensus statements and\nrecommended clinical procedures regarding risk factors\nin implant therapy. Int J Oral Maxillofac Implants.\n2009; 24 Suppl: 86–89.\nCosta FO, Takenaka-Martinez S, Cota LO, Ferreira SD,\nSilva GL, Costa JE. Peri-implant disease in subjects\nwith and without preventive maintenance: a 5-year\nfollow-up.\nJ\nClin\nPeriodontol.\n2012\nFeb;\n39(2):\n173–181.\nCuesta-Gil M, Ochandiano Caicoya S, Riba-García F,\nDuarte Ruiz B, Navarro Cuéllar C, Navarro Vila C.\nOral rehabilitation with osseointegrated implants in\noncologic patients. J Oral Maxillofac Surg. 2009 Nov;\n67(11): 2485–2096.\n608"
  },
  {
    "page": 609,
    "content": "Czerninski R, Kaplan I, Almoznino G, Maly A, Regev\nE.\nOral\nsquamous\ncell\ncarcinoma\naround\ndental\nimplants. Quintessence Int. 2006 Oct; 37(9): 707–711.\nDe\nCeulaer\nJ,\nMagremanne\nM,\nvan\nVeen\nA,\nScheerlinck J. Squamous cell carcinoma recurrence\naround dental implants. J Oral Maxillofac Surg. 2010\nOct; 68(10): 2507–2012.\nde Lange J, van den Akker HP, van den Berg H:\nCentral giant cell granuloma of the jaw: a review of the\nliterature with emphasis on therapy options.Oral Surg\nOral Med Oral Pathol Oral Radiol Endod. 2007 Nov;\n104(5): 603–615.\nDixon DL, Breeding LC, Sadler JP McKay ML.\nComparison of screw loosening, rotation, and deflection\namong three implant designs. J Prosthet Dent. 1995\nSep; 74(3): 270–278.\nEckert S, Salinas T. Implant fractures: etiology,\nprevention and treatment. In: Froum S (ed): Dental\nimplant\ncomplications.\nHoboken:\nWiley-Blackwell;\n2010: 100–109.\nEguia del Valle A, Martínez-Conde Llamosas R, López\nVicente J, Uribarri Etxebarria A, Aguirre Urizar JM.\nPrimary oral squamous cell carcinoma arising around\ndental\nosseointegrated\nimplants\nmimicking\nperi-\nimplantitis. Med Oral Patol Oral Cir Bucal. 2008 Aug\n1; 13(8): E489–491.\n609"
  },
  {
    "page": 610,
    "content": "Esposito\nM\n,\nGrusovin\nMG,\nWorthington\nHV.\nTreatment of peri-implantitis: what interventions are\neffective? A Cochrane systematic review. Eur J Oral\nImplantol. 2012; 5 Suppl: S21–S41.\nFavia G, Piattelli A, Sportelli P, Capodiferro S, Iezzi G.\nOsteonecrosis of the posterior mandible after implant\ninsertion: a clinical and histological case report. Clin\nImplant Dent Relat Res. 2011 Mar; 13(1): 58–63.\nFerrario VF, Sforza C, Zanotti G, Tartaglia GM.\nMaximal bite forces in healthy young adults as\npredicted by surface electromyography. J Dent. 2004\nAug; 32(6): 451–457.\nFerrazzini Pozzi EC, Altermatt HJ, Rees TD, Bornstein\nMM: Exophytic mass of the gingiva as exclusive sign\nof a pulmonary adenocarcinoma: Report of a case. J\nPeriodontol. 2008 Jan; 79(1): 187–191.\nFerreira SD, Silva GL, Cortelli JR, Costa JE, Costa\nFO. Prevalence and risk variables for peri-implant\ndisease in Brazilian subjects. J Clin Periodontol. 2006\nDec; 33(12): 929–935.\nFerretti C, Muthray E: Management of central giant\ncell\ngranuloma\nof\nmandible\nusing\nintralesional\ncorticosteroids: case report and review of literature.J\nOral Maxillofac Surg. 2011 Nov; 69(11): 2824–2829.\nFrei M, Bornstein MM, Schaller B, Reichart PA,\nWeimann\nR,\nIizuka\nT.\nBisphosphonate-related\nosteonecrosis of the jaw combined with jaw metastasis\n610"
  },
  {
    "page": 611,
    "content": "of prostate adenocarcinoma: report of a case.J Oral\nMaxillofac Surg. 2010 Apr; 68(4): 863–867.\nFrei M, Dubach P, Reichart PA, Schmitt AM, Mueller-\nGaramvölgyi E, Bornstein MM: Diffuse swelling of the\nbuccal\nmucosa\nand\npalate\nas\nfirst\nand\nonly\nmanifestation of an extranodal non-Hodgkin “double-\nhit” lymphoma: report of a case. Oral Maxillofac Surg.\n2012 Mar; 16(1): 69–74.\nFrisch E, Ziebolz D, Vach K, Ratka-Krüger P. The\neffect of keratinized mucosa width on peri-implant\noutcome under supportive postimplant therapy. Clin\nImplant Dent Relat Res. 2013 Dec 16. doi: 10.1111/\ncid.12187. [Epub ahead of print]\nFroum S, Yamanaka T, Cho SC, Kelly R, St James S,\nElian N.. Techniques to remove a Failed Integrated\nImplant, Compend Contin Educ Dent. 2011 Sep; 32(7):\n22–26, 28–30.\nFürst MM, Salvi GE, Lang NP, Persson GR. Bacterial\ncolonization immediately after installation on oral\ntitanium implants. Clin Oral Implants Res. 2007 Aug;\n18(4): 501–508.\nGahlert M, Röhling S, Wieland M, Sprecher CM,\nKniha H, Milz S. Osseointegration of zirconia and\ntitanium\ndental\nimplants:\na\nhistological\nand\nhistomorphometrical study in the maxilla of pigs. Clin\nOral Implants Res. 2009 Nov; 20(11): 1247–1253.\n611"
  },
  {
    "page": 612,
    "content": "Gahlert\nM.\nBurtscher\nD,\nGrunert\nI,\nKniha\nH,\nSteinhauser E. Failure analysis of fractured dental\nzirconia implants. Clin Oral Implants Res. 2012 Mar;\n23(3): 287–293.\nGalindo-Moreno P, Hernández-Cortes P, Rios R,\nSanchez-Fernández\nE,\nCamara\nM,\nO\nValle\nF.\nImmunophenotype\nof\nDental\nImplant-Associated\nPeripheral Giant Cell Reparative Granuloma in a\nrepresentative case report. J Oral Implantol. 2013 Sep\n23. [Epub ahead of print]\nGalindo-Moreno P, Hernández-Cortes P, Rios R,\nSanchez-Fernández\nE,\nCamara\nM,\nO\nValle\nF:\nImmunophenotype\nof\nDental\nImplant-Associated\nPeripheral Giant Cell Reparative Granuloma in a\nrepresentative case report.J Oral Implantol. 2013 Sep\n23. [Epub ahead of print]\nGallego, L, Junquera L, Baladrón J, Villarreal P. Oral\nsquamous cell carcinoma associated with symphyseal\ndental implants: An unusual case report. J Am Dent\nAssoc. 2008 Aug; 139(8): 1061–1065.\nGallego L, Junquera L, Llorente S. Oral carcinoma\nassociated with implant-supported overdenture trauma:\nA case report. Dent Traumatol. 2009 Feb; 25(1): e3–4.\nGallucci GO, Grütter L, Chuang SK, Belser UC.\nDimensional changes of peri-implant soft tissue over 2\nyears\nwith\nsingle-implant\ncrowns\nin\nthe\nanterior\nmaxilla. J Clin Periodontol. 2011 Mar; 38(3): 293–299.\n612"
  },
  {
    "page": 613,
    "content": "Giansanti JS, Waldron CA: Peripheral giant cell\ngranuloma: review of 720 cases. J Oral Surg. 1969 Oct;\n27(10): 787–791.\nGigandet M, Bigolin G, Faoro F, Burgin W, Brägger\nU. Implants with original and non-original abutment\nconnections. Clin Implant Dent Relat Res. 2014 Apr;\n16(2): 303–311.\nGoss A, Bartold M, Sambrook P, Hawker P:The nature\nand\nfrequency\nof\nbisphosphonate-associated\nosteonecrosis of the jaws in dental implant patients: a\nSouth Australian case series. J Oral Maxillofac Surg.\n2010 Feb; 68(2): 337–343.\nGottlow J, Dard M, Kjellson F, Obrecht M, Sennerby\nL. Evaluation of a new titanium-zirconium dental\nimplant: a biomechanical and histological comparative\nstudy in the mini pig. Clin Implant Dent Relat Res.\n2012 Aug; 14(4): 538–545\nGratton DG, Aquilino SA, Stanford CM. (2001).\nMicromotion and dynamic fatigue properties of the\ndental implant-abutment interface. J Prosthet Dent.\n2001 Jan; 85(1): 47–52.\nGraves\nDT,\nLiu\nR,\nAlikhani\nM,\nAl-Mashat\nH,\nTrackman PC. Diabetes-enhanced inflammation and\napoptosis—impact on periodontal pathology. J Dent\nRes. 2006 Jan; 85(1): 15–21.\n613"
  },
  {
    "page": 614,
    "content": "Grusovin MG, Coulthard P, Worthington HV, George\nP, Esposito M. Interventions for replacing missing\nteeth: maintaining and recovering soft tissue health\naround dental implants. Cochrane Database Syst Rev.\n2010 Aug 4; (8): CD003069.\nGulati A, Puthussery, FJ, Downie IP, Flood TR.\nSquamous cell carcinoma presenting as peri-implantitis:\nA case report. Ann R Coll Surg Engl. 2009 Oct; 91(7):\nW8–10.\nHallström H, Persson GR, Lindgren S, Olofsson M,\nRenvert S. Systemic antibiotics and debridement of\nperi-implant mucositis. A randomized clinical trial. J\nClin Periodontol. 2012 Jun; 39(6): 574–581.\nHämmerle CH, Wagner D, Brägger U, Lussi A,\nKarayiannis A, Joss A, Lang NP. Threshold of tactile\nsensitivity perceived with dental endosseous implants\nand natural teeth. Clin Oral implants Res. 1995 Jun;\n6(2): 83–90.\nHanselaer L, Cosyn J, Browaeys H, De Bruyn H:\n[Giant cell peripheral granuloma surrounding a dental\nimplant: case report.] [Article in French.] Rev Belge\nMed Dent (1984). 2010 Oct–Dec; 65(4): 152–158.\nHansen T, Kunkel M, Springer E, Walter C, Weber A,\nSiegel E, Kirkpatrick CJ. Actinomycosis of the jaws -\nhistopathological study of 45 patients shows significant\ninvolvement\nin\nbisphosphonate-associated\nosteonecrosis\nand\ninfected\nosteoradionecrosis.\nVirchows Arch. 2007 Dec; 451(6): 1009–1017.\n614"
  },
  {
    "page": 615,
    "content": "Haraldson T, Karlsson U, Carlsson GE. Bite force and\noral function in complete denture wearers. J Oral\nRehabil. 1979 Jan; 6(1): 41–48.\nHarder S, Kern M. Survival and complications of\ncomputer\naided-designing\nand\ncomputer-aided\nmanufacturing vs. conventionally fabricated implant-\nsupported reconstructions: a systematic review. Clin\nOral Implants Res. 2009 Sep; 20 Suppl 4: 48–54.\nHeithersay GS, Cohn SA, Parkins DJ: Central giant\ncell granuloma. Aust Endod J 2002 Apr; 28(1): 18–23.\nHeitz F, Heitz-Mayfield LJ, Lang NP. Effects of post-\nsurgical cleansing protocols on early plaque control in\nperiodontal and/or periimplant wound healing. J Clin\nPeriodontol. 2004 Nov; 31(11): 1012–1018.\nHeitz-Mayfield LJ, Huynh-Ba G. History of treated\nperiodontitis and smoking as risks for implant therapy.\nInt J Oral Maxillofac Implants. 2009; 24 Suppl: 39–68.\nHeitz-Mayfield LJ, Salvi GE, Botticelli D, Mombelli\nA, Faddy M, Lang NP; Implant Complication Research\nGroup.\nAnti-infective\ntreatment\nof\nperi-implant\nmucositis: a randomised controlled clinical trial. Clin\nOral Implants Res. 2011 Mar; 22(3): 237–241.\nHeitz-Mayfield LJ, Salvi GE, Mombelli A, Faddy M,\nLang NP. Implant Complication Research Group. Anti-\ninfective\nsurgical\ntherapy\nof\nperi-implantitis.\nA\n12-month prospective clinical study. Clin Oral Implants\nRes. 2012 Feb; 23(2): 205–210.\n615"
  },
  {
    "page": 616,
    "content": "Heitz-Mayfield LJ, Mombelli A. The therapy of peri-\nimplantitis: a systematic review.Int J Oral Maxillofac\nImplants. 2014; 29 Suppl: 325–345.\nHeitz-Mayfield LJ, Needleman I, Salvi GE, Pjetursson\nBE.\nConsensus\nstatements\nand\nclinical\nrecommendations for prevention and management of\nbiologic and technical implant complications.Int J Oral\nMaxillofac Implants. 2014; 29 Suppl: 346–350.\nHelkimo E, Carlsson GE, Helkimo M. Bite force and\nstate of dentition. Acta Odontol Scand. 1977; 35(6):\n297–303.\nHernández G, Lopez-Pintor RM, Torres J, de Vicente\nJC: Clinical outcomes of peri-implant peripheral giant\ncell granuloma: a report of three cases.J Periodontol.\n2009 Jul; 80(7): 1184–1191.\nHeydecke G, Zwahlen M, Nicol A, Nisand D, Payer M,\nRenouard F, Grohmann P, Mühlemann S, Joda T. What\nis\nthe\noptimal\nnumber\nof\nimplants\nfor\nfixed\nreconstructions: a systematic review. Clin Oral Implants\nRes. 2012 Oct; 23 Suppl 6: 217–228.\nHirshberg\nA,\nKozlovsky\nA,\nSchwartz-Arad\nD,\nMardinger O, Kaplan I: Peripheral giant cell granuloma\nassociated with dental implants.J Periodontol. 2003\nSep; 74(9): 1381–1384.\nHsu\nYT,\nFu\nJH,\nAl-Hezaimi\nK,\nWang\nHL.\nBiomechanical\nimplant\ntreatment\ncomplications:\na\nsystematic review of clinical studies of implants with at\n616"
  },
  {
    "page": 617,
    "content": "least 1 year of functional loading. Int J Oral Maxillofac\nImplants. 2012 Jul–Aug; 27(4): 894–904.\nHubner RA, Houston SJ. Bisphosphonates’ use in\nmetastatic bone disease. Hosp Med. 2005 Jul; 66(7):\n414–419.\nJacobsen C, Metzler P, Rössle M, Obwegeser J,\nZemann W, Grätz KW. Osteopathology induced by\nbisphosphonates\nand\ndental\nimplants:\nclinical\nobservations.Clin\nOral\nInvestig.\n2013\nJan;\n17(1):\n167–175.\nJaved F, Al-Hezaimi K, Almas K, Romanos GE. Is\ntitanium sensitivity associated with allergic reactions in\npatients with dental implants? A systematic review.\nClin Implant Dent Relat Res. 2013 Feb; 15(1): 47–52.\nJemt T, Back T, Petersson. Precision of CNC-milled\ntitanium frameworks for implant treatment in the\nedentulous jaw. Int J Prosthodont. 1999 May–Jun;\n12(3): 209–215.\nJensen SS, Broggini N, Hjørting-Hansen E, Schenk R,\nBuser D. Bone healing and graft resorption of autograft,\nanorganic bovine bone and beta-tricalcium phosphate.\nA histologic and histomorphometric study in the\nmandibles of minipigs. Clin Oral Implants Res, 2006\nJun; 17 (3): 237–243.\nJensen SS, Yeo A, Dard M, Hunziker E, Schenk R,\nBuser D. Evaluation of a novel biphasic calcium\nphosphate in standardized bone defects. A histologic\n617"
  },
  {
    "page": 618,
    "content": "and histomorphometric study in the mandibles of\nminipigs. Clin Oral Implants Res. 2007 Dec; 18(6):\n752–760.\nJensen SS, Bornstein MM, Dard M, Bosshardt DD,\nBuser D. Comparative study of biphasic calcium\nphosphates with different HA/TCP ratios in mandibular\nbone defects. A long-term histomorphometric study in\nminipigs. J Biomed Mater Res B Appl Biomater. 2009\nJul; 90(1): 171–181.\nJensen SS, Bosshardt DD, Gruber R, Buser D. Long-\nterm stability of contour augmentation in the esthetic\nzone. Histologic and histomorphometric evaluation of\n12 human biopsies 14 to 80 months after augmentation.\nJ Periodontol 2014 .\nJoda T, Wittneben JG, Brägger U. A novel cryo-\nmechanical approach for the removal of blocked\nnonretrievable\nimplant\ncomponents.\nInt\nJ\nOral\nMaxillofac Implants. 2013 Jan–Feb; 28(1): e45–e47.\nJundt G, Bertoni F, Unni KK, Saito K, Dehner LP:\nBenign tumors of bone and cartilage. In: Barnes L,\nEveson JW, Reichart P, Sidransky D (eds): World\nHealth\nOrganization\nClassification\nof\nTumours,\nPathology and Genetics of Head and Neck Tumors.\nLyon: IARC Press; 2005: 53–57.\nJung RE, Pjetursson BE, Glauser R, Zembic A,\nZwahlen M, Lang NP. A systematic review of the\n5-year survival and complication rates of implant-\n618"
  },
  {
    "page": 619,
    "content": "supported single crowns.Clin Oral Implants Res. 2008\nFeb; 19(2): 119–130.\nJung RE, Zembic A, Pjetursson BE, Zwahlen M,\nThoma DS. Systematic review of the survival rate and\nthe incidence of biological, technical, and aesthetic\ncomplications of single crowns on implants reported in\nlongitudinal studies with a mean follow-up of 5 years.\nClin Oral Implants Res. 2012 Oct; 23 Suppl 6: 2–21.\nKaiser M, Wasserman A, Strub JR. [Long-term clinical\nresults of VITA In-Ceram Classic: a systematic review.]\n[Article in German.] Schweiz Monatsschr Zahnmed.\n2006; 116(2): 120–128.\nKan JY, Rungcharassaeng K, Bohsali K, Goodacre CJ,\nLang BR. Clinical methods for evaluating implant\nframework fit. J Prosthet Dent. 1999 Jan; 81(1): 7–13.\nKapos T, Evans C. CAD/CAM technology for implant\nabutments, crowns, and superstructures. Int J Oral\nMaxillofac Implants. 2o014; 29 Suppl: 117–136.\nKatsikeris\nN,\nKakarantza-Angelopoulou\nE,\nAngelopoulos AP: Peripheral giant cell granuloma.\nClinicopathologic study of 224 new cases and review of\n956 reported cases. Int J Oral Maxillofac Surg. 1988\nApr; 17(2): 94–99.\nKeith SE, Miller BH, Woody RD, Higginbottom FL.\n(1999). Marginal discrepancy of screw-retained and\ncemented metal-ceramic crowns on implants abutments.\n619"
  },
  {
    "page": 620,
    "content": "Int J Oral Maxillofac Implants. 1999 May–Jun; 14(3):\n369–378.\nKeller W, Brägger U, Mombelli A. Peri-implant\nmicroflora of implants with cemented and screw\nretained suprastructures. Clin Oral Implants Res. 1998\nAug; 9(4): 209–217.\nKhraisat A, Stegaroiu R, Nomura S, Miyakawa O.\nFatigue\nresistance\nof\ntwo\nimplant/abutment\njoint\ndesigns. J Prosthet Dent. 2002 Dec; 88(6): 604–610.\nKim SS, Yeo IS, Lee SJ, Kim DJ, Jang BM, Kim SH,\nHan JS. Clinical use of alumina-toughened zirconia\nabutments\nfor\nimplant-supported\nrestoration:\nprospective cohort study of survival analysis. Clin Oral\nImplants Res. 2013 May; 24(5): 517–522.\nKim\nJW,\nKwon\nTG:\nBisphosphonate-related\nosteonecrosis of the jaw at a previously grafted\nsinus.Implant Dent. 2014 Feb; 23(1): 18–21.\nKoldsland OC, Scheie AA, Aass AM. Prevalence of\nperi-implantitis related to severity of the disease with\ndifferent degrees of bone loss. J Periodontol. 2010 Feb;\n81(2): 231–238.\nKoller B, Att W, Strub JR. Survival rates of teeth,\nimplants, and double crown-retained removable dental\nprostheses:\na\nsystematic\nliterature\nreview.\nInt\nJ\nProsthodont. 2011 Mar–Apr; 24: 109–117.\n620"
  },
  {
    "page": 621,
    "content": "Korfage A, Schoen PJ, Raghoebar GM, Roodenburg\nJL, Vissink A, Reintsema H. Benefits of dental implants\ninstalled during ablative tumour surgery in oral cancer\npatients: a prospective 5-year clinical trial. Clin Oral\nImplants Res. 2010 Sep; 21(9): 971–979.\nKorsch M, Obst U, Walther W: Cement-associated\nperi-implantitis: a retrospective clinical observational\nstudy of fixed implant-supported restorations using a\nmethacrylate cement. Clin Oral Implants Res. 2014 Jul;\n25(7): 797–805.\nKwok J, Eyeson J, Thompson I, McGurk M. Dental\nimplants and squamous cell carcinoma in the at risk\npatient—report of three cases. Br Dent J. 2008 Nov 22;\n205(10): 543–545.\nKwon TG, Lee CO, Park JW, Choi SY, Rijal G, Shin\nHI. Osteonecrosis associated with dental implants in\npatients undergoing bisphosphonate treatment. Clin\nOral\nImplants\nRes.\n2012 Dec\n26. doi:\n10.1111/\nclr.12088. [Epub ahead of print]\nKwon TG, Lee CO, Park JW, Choi SY, Rijal G, Shin\nHI. Osteonecrosis associated with dental implants in\npatients undergoing bisphosphonate treatment.Clin Oral\nImplants Res. 2014 May; 25(5): 632–640.\nLandesberg R, Eisig S, Fennoy I, Siris E. Alternative\nindications\nfor\nbisphosphonate\ntherapy.\nJ\nOral\nMaxillofac Surg. 2009 May; 67 (5 Suppl): 27–34.\n621"
  },
  {
    "page": 622,
    "content": "Lang NP, Tonetti MS. Periodontal risk assessment\n(PRA) for patients in supportive periodontal therapy\n(SPT). Oral Health Prev Dent 2003 1: 7–16.\nLang NP, Pjetursson BE, Tan K, Brägger U, Egger M,\nZwahlen M. A systematic review of the survival and\ncomplication rates of fixed partial dentures (FPDs) after\nan observation period of at least 5 years. II. Combined\ntooth/implant-supported FPDs. Clin Oral Implants Res.\n2004 Dec; 15(6): 643–653.\nLang NP, Berglundh T; Working Group 4 of Seventh\nEuropean Workshop on Periodontology. Periimplant\ndiseases: where are we now? Consensus of the Seventh\nEuropean\nWorkshop\non\nPeriodontology.J\nClin\nPeriodontol. 2011 Mar; 38 Suppl 11: 178–181.\nLazarovici TS, Yahalom R, Taicher S, Schwartz-Arad\nD,\nPeleg\nO,\nYarom\nN.\nBisphosphonate-related\nosteonecrosis\nof\nthe\njaw\nassociated\nwith\ndental\nimplants.J Oral Maxillofac Surg. 2010 Apr; 68(4):\n790–796.\nLee FK, Tan KB, Nicholls JI. Critical bending moment\nof four implant-abutment interface designs. Int J Oral\nMaxillofac Implants. 2010 Jul–Aug; 25(4): 744–751.\nLeonhardt A, Bergström C, Lekholm U. Microbiologic\ndiagnostics at titanium implants. Clin Implant Dent\nRelat Res. 2003; 5(4): 226–232.\n622"
  },
  {
    "page": 623,
    "content": "Lin GH, Chan HL, Wang HL. The significance of\nkeratinized mucosa on implant health: a systematic\nreview. J Periodontol. 2013 Dec; 84(12): 1755–1967.\nLindquist LW, Carlsson GE, Jemt T. Association\nbetween marginal bone loss around osseointegrated\nmandibular implants and smoking habits: a 10-year\nfollow-up study. J Dent Res. 1997 Oct; 76(10):\n1667–1674.\nLinkevicius T, Vindasiute E, Puisys A, Peciuliene V.\nThe influence of margin location on the amount of\nundetected cement excess after delivery of cement-\nretained implant restorations. Clin Oral Implants Res.\n2011 Dec; 22(12): 1379–1384.\nLinkevicius T, Vindasiute E, Puisys A, Linkeviciene L,\nMaslova\nN,\nPuriene\nA.\nThe\ninfluence\nof\nthe\ncementation\nmargin\nposition\non\nthe\namount\nof\nundetected cement. A prospective clinical study. Clin\nOral Implants Res. 2012 Jan; 24(1): 71–76.\nLinkevicius T, Puisys A, Vindasiute E, Linkeviciene L,\nApse\nP.\nDoes\nresidual\ncement\naround\nimplant-\nsupported restorations cause peri-implant disease? A\nretrospective case analysis. Clin Oral Implants Res.\n2013 Nov; 24(11): 1179–1184.\nLópez-Cedrún JL, Sanromán JF, García A, Peñarrocha\nM, Feijoo JF, Limeres J, Diz P. Oral bisphosphonate-\nrelated osteonecrosis of the jaws in dental implant\npatients: a case series. Br J Oral Maxillofac Surg. 2013\nDec; 51(8): 874–879.\n623"
  },
  {
    "page": 624,
    "content": "López-Jornet P, Camacho-Alonso F, Sánchez-Siles M.\nDental implants in patients with oral lichen planus: a\ncross-sectional study. Clin Implant Dent Relat Res.\n2014 Feb; 16(1): 107–115.\nLujan-Climent M, Martinez-Gomis J, Palau S, Ayuso-\nMontero R, Salsench J, Peraire M. Influence of static\nand dynamic occlusal characteristics and muscle force\non masticatory performance in dentate adults. Eur J\nOral Sci. 2008 Jun; 116(3): 229–236.\nLulic M, Brägger U, Lang NP, Zwahlen M, Salvi GE.\nAnte’s (1926) law revisited: a systematic review on\nsurvival\nrates\nand\ncomplications\nof\nfixed\ndental\nprostheses (FDPs) on severely reduced periodontal\ntissue support. Clin Oral Implants Res. 2007 Jun; 18\nSuppl 3: 63–72.\nLuterbacher S, Fourmousis I, Lang NP, Brägger U.\nFractured\nprosthetic\nabutments\nin\nosseointegrated\nimplants: a technical complication to cope with. Clin\nOral Impl Res. 2000 Apr; 11(2): 163–170.\nMadrid C, Sanz M. What impact do systemically\nadministrated bisphosphonates have on oral implant\ntherapy? A systematic review. Clin Oral Implants Res.\n2009 Sep; 20 Suppl: 87–95.\nMaló P, Rigolizzo M, Nobre MD, Lopes A, Agliardi E.\nClinical outcomes in the presence and absence of\nkeratinized mucosa in mandibular guided implant\nsurgeries: a pilot study with a proposal for the\n624"
  },
  {
    "page": 625,
    "content": "modification of the technique. Quintessence Int. 2013\nFeb; 44(2): 149–157.\nMannem S, Chava VK: Management of an unusual\nperipheral giant cell granuloma: A diagnostic dilemma.\nContemp Clin Dent. 2012 Jan; 3(1): 93–96.\nMarsh PD, Devine DA. How is the development of\ndental\nbiofilms\ninfluenced\nby\nthe\nhost?\nJ\nClin\nPeriodontol. 2011 Mar; 38(11 Suppl): 28–35.\nMarx\nRE.\nPamidronate\n(Aredia)\nand\nzoledronate\n(Zometa) induced avascular necrosis of the jaws: a\ngrowing epidemic. J Oral Maxillofac Surg. 2003 Sep;\n61 (9): 1115–1117.\nMáximo MB, de Mendonça AC, Renata Santos V,\nFigueiredo LC, Feres M, Duarte PM. Short-term\nclinical and microbiological evaluations of peri-implant\ndiseases before and after mechanical anti-infective\ntherapies. Clin Oral Implants Res. 2009 Jan; 20(1):\n99–108.\nMcGuff HS, Heim-Hall J, Holsinger FC, Jones AA,\nO’Dell DS, Hafemeister AC. Maxillary osteosarcoma\nassociated with a dental implant: Report of a case and\nreview\nof\nthe\nliterature\nregarding\nimplant-related\nsarcomas. J Am Dent Assoc. 2008 Aug; 139(8):\n1052–1059.\nMeijer GJ, Dieleman FJ, Bergé SJ, Merkx MA.\nRemoval of an oral squamous cell carcinoma including\nparts of osseointegrated implants in the marginal\n625"
  },
  {
    "page": 626,
    "content": "mandibulectomy. A case report. Oral Maxillofac Surg.\n2010 Dec; 14(4): 253–256.\nMeng JC, Everts JE, Qian F, Gratton DG. Influence of\nconnection geometry on dynamic micromotion at the\nimplant-abutment interface. Int J Prosthodont. 2007\nNov–Dec; 20(6): 623–625.\nMighell AJ, Robinson PA, Hume WJ: Peripheral giant\ncell granuloma: a clinical study of 77 cases from 62\npatients, and literature review. Oral Dis. 1995 Mar;\n1(1): 12–19.\nMigliorati\nC.\nBisphosphonates\nand\noral\ncavity\navascular bone necrosis. J Clin Oncol. 2003 Nov;\n21(22): 4253–4254.\nMiron RJ, Hedbom E, Saulacic N, Zhang Y, Sculean A,\nBosshardt DD, Buser D. Osteogenic potential of\nautogenous bone grafts harvested with four different\nsurgical techniques. J Dent Res. 2011 Dec; 90(12):\n1428–1433.\nMiron RJ, Gruber R, Hedbom E, Saulacic N, Zhang Y,\nSculean A, Bosshardt DD, Buser D. Impact of bone\nharvesting techniques on cell viability and the release of\ngrowth factors of autografts. Clin Impl Dent Rel Res.\n2013 Aug; 15(4): 481–489.\nMisch CE, Goodacre CJ, Finley JM, Misch CM,\nMarinbach M, Dabrowsky T, English CE, Kois JC,\nCronin JR Jr. Consensus conference panel report:\ncrown-height\nspace\nguidelines\nfor\nimplant\n626"
  },
  {
    "page": 627,
    "content": "dentistry—part 2. Implant Dent. 2006 Jun; 15(2):\n113–121.\nMoergel M, Kämmerer P, Kasaj A, Armouti E, Alshihri\nA, Weyer V, Al-Nawas B. Chronic periodontitis and its\npossible\nassociation\nwith\noral\nsquamous\ncell\ncarcinoma—a retrospective case control study. Head\nFace Med. 2013 Dec 9; 9: 39.\nMoergel M, Karbach J, Kunkel M, Wagner W. Oral\nsquamous cell carcinoma in the vicinity of dental\nimplants. Clin Oral Investig. 2014 Jan; 18(1): 277–284.\nMombelli\nA,\nDécaillet\nF.\nThe\ncharacteristics\nof\nbiofilms in peri-implant disease. J Clin Periodontol.\n2011 Mar; 38(11 Suppl): 203–213.\nMombelli A, Müller N, Cionca N. The epidemiology of\nperi-implantitis. Clin Oral Implants Res. 2012 Oct; 23(6\nSuppl): 67–76.\nMoráguez\nOD,\nBelser\nUC.\nThe\nuse\nof\npolytetrafluoroethylene tape for the management of\nscrew access channels in implant-supported prostheses.\nJ Prosthet Dent. 2010 Mar; 103(3): 189–191.\nMotamedi MH, Eshghyar N, Jafari SM, Lassemi E,\nNavi\nF,\nAbbas\nFM,\nKhalifeh\nS,\nEshkevari\nPS:\nPeripheral and central giant cell granulomas of the jaws:\na demographic study. Oral Surg Oral Med Oral Pathol\nOral Radiol Endod. 2007 Jun; 103(6): e39–e43.\n627"
  },
  {
    "page": 628,
    "content": "Moxley\nJE,\nStoelinga\nPJ.\nBlijdorp\nPA.\n(1997)\nSquamous cell carcinoma associated with a mandibular\nstaple implant. J Oral Maxillofac Surg. 1997 Sep; 55(9):\n1020–1022.\nNeldam CA, Pinholt EM. State of the art of short dental\nimplants: a systematic review of the literature. Clin\nImplant Dent Relat Res. 2012 Aug; 14(4): 622–632.\nNelson K, Heberer S, Glatzer C. Survival analysis and\nclinical evaluation of implant-retained prostheses in oral\ncancer resection patients over a mean follow-up period\nof 10 years. J Prosthet Dent. 2007 Nov; 98(5): 405–410.\nO’Leary\nTJ,\nStandish\nSM,\nBloomer\nRS.\nSevere\nperiodontal\ndestruction\nfollowing\nimpression\nprocedures. J Periodontol. 1973 Jan; 44(1): 43–48.\nOlmedo DG, Tasat DR, Duffó G, Guglielmotti MB,\nCabrini RL. The issue of corrosion in dental implants: a\nreview, Acta Odontol Latinoam. 2009; 22(1): 3–9.\nOlmedo DG, Paparella ML, Brandizzi D, Cabrini RL:\nReactive lesions of peri-implant mucosa associated with\ntitanium dental implants: a report of 2 cases. Int J Oral\nMaxillofac Surg. 2010 May; 39(5): 503–507.\nÖrtorp A, Jemt T, Bäck T, Jälevik T. Comparisons of\nPrecision\nof\nFit\nBetween\nCast\nand\nCNC-Milled\nTitanium Implant Frameworks for the Edentulous\nMandible. Int J Prosthodont. 2003 Mar–Apr; 16(2):\n194–200.\n628"
  },
  {
    "page": 629,
    "content": "Osman\nRB,\nPayne\nAG,\nMa\nS.\nProsthodontic\nmaintenance of maxillary implant overdentures: a\nsystematic literature review. Int J Prosthodont. 2012\nJul–Aug; 25(4): 381–391.\nÖzden FO, Özden B, Kurt M, Gündüz K, Günhan O:\nPeripheral giant cell granuloma associated with dental\nimplants: a rare case report.Int J Oral Maxillofac\nImplants. 2009 Nov–Dec; 24(6): 1153–1156.\nPalmer RM, Wilson RF, Hasan AS, Scott DA.\nMechanisms\nof\naction\nof\nenvironmental\nfactors—tobacco smoking. J Clin Periodontol. 2005; 32\nSuppl 6: 180–195.\nPapaspyridakos P, Chen CJ, Chuang SK, Weber HP,\nGallucci GO. A systematic review of biologic and\ntechnical\ncomplications\nwith\nfixed\nimplant\nrehabilitations for edentulous patients. Int J Oral\nMaxillofac Implants. 2012 Jan–Feb; 27(1): 102–110.\nParashar P. Oral lichen planus. Otolaryngolog Clin\nNorth Am. 2011 Feb; 44(1): 89–107.\nPeñarrocha-Diago MA, Cervera-Ballester J, Maestre-\nFerrín L, Peñarrocha-Oltra D: Peripheral giant cell\ngranuloma associated with dental implants: clinical case\nand literature review.J Oral Implantol. 2012 Sep;\n38(Spec No): 527–532.\nPersson LG, Berglundh T, Lindhe J, Sennerby L. Re-\nosseointegration after treatment of peri-implantitis at\ndifferent implant surfaces. An experimental study in the\n629"
  },
  {
    "page": 630,
    "content": "dog.\nClin\nOral\nImplants\nRes.\n2001\nDec;\n12(6):\n595–603.\nPersson GR, Samuelsson E, Lindahl C, Renvert S.\nMechanical non-surgical treatment of peri-implantitis: a\nsingle-blinded randomized longitudinal clinical study.\nII. Microbiological results. J Clin Periodontol. 2010\nJun; 37(6): 563–573.\nPhal PM, Myall RW, Assael LA, Weissman JL.\nImaging\nfindings\nof\nbisphosphonate-associated\nosteonecrosis of the jaws.AJNR Am J Neuroradiol.\n2007 Jun–Jul; 28(6): 1139–1145.\nPiattelli A, Cosci F, Scarano A, Trisi P. Localized\nchronic suppurative bone infection as a sequel of peri-\nimplantitis\nin\na\nhydroxyapatite-coated\ndental\nimplant.Biomaterials. 1995 Aug; 16(12): 917–920.\nPiattelli A, Scarano A, Favero L, Iezzi G, Petrone G,\nFavero GA. Clinical and histologic aspects of dental\nimplants removed due to mobility. J Periodontol. 2003\nMar; 74(3): 385–390.\nPjetursson BE, Tan K, Lang NP, Brägger U, Egger M,\nZwahlen M. A systematic review of the survival and\ncomplication rates of fixed partial dentures (FPDs) after\nan observation period of at least 5 years IV. Cantilever\nor extension FPDs. Clin Oral Impl Res 2004 Dec;\n15(6): 667–676.\nPjetursson BE, Brägger U, Lang NP, Zwahlen M.\nComparison of survival and complication rates of tooth-\n630"
  },
  {
    "page": 631,
    "content": "supported fixed dental prostheses (FDPs) and implant-\nsupported FDPs and single crowns (SCs). Clin Oral\nImplants Res. 2007 Jun; 18(3 Suppl): 97–113.\nPjetursson BE, Tan WC, Tan K, Brägger U, Zwahlen\nM, Lang NP. A systematic review of the survival and\ncomplication rates of resin-bonded bridges after an\nobservation period of at least 5 years. Clin Oral\nImplants Res. 2008 Feb; 19(2): 131–141.\nPjetursson BE, Thoma D, Jung R, Zwahlen M, Zembic\nA.\nA\nsystematic\nreview\nof\nthe\nsurvival\nand\ncomplication rates of implant-supported fixed dental\nprostheses (FDPs) after a mean observation period of at\nleast 5 years. Clin Oral Implants Res. 2012 Oct; 23\nSuppl 6: 22–38.\nPjetursson BE, Asgeirsson AG, Zwahlen M, Sailer I.\nImprovements in implant dentistry over the last decade:\ncomparison of survival and complication rates in older\nand newer publications.Int J Oral Maxillofac Implants.\n2014; 29 Suppl: 308–324.\nPontoriero R, Tonelli MP, Carnevale G, Mombelli A,\nNyman SR, Lang NP. Experimentally induced peri-\nimplant mucositis. A clinical study in humans. Clin\nOral Implants Res. 1994 Dec; 5(4): 254–259.\nRamberg P, Lindhe J, Botticelli D, Botticelli A. The\neffect of a triclosan dentifrice on mucositis in subjects\nwith dental implants: a six-month clinical study. J Clin\nDent. 2009; 20(3): 103–107.\n631"
  },
  {
    "page": 632,
    "content": "Rangert B, Krogh PH, Langer B, Van Roekel N.\nBending overload and impact fracture: a retrospective\nclinical analysis. Int J Oral Maxillofac Implants 1996\nSep–Oct; 11(5): 575.\nRavald N, Hamp SE, Brikhed D. (1986). Long-term\nevaluation of root surface caries in periodontally treated\npatients. J Clin Periodontol. 1986 Sep; 13(8): 758–767.\nReclaru L, Meyer JM. Study of corrosion between a\ntitanium implant and dental alloys. J Dent. 1994 Jun;\n22(3): 159–168.\nRee MH. An unusual swelling following endodontic\nand prosthodontic treatment of a mandibular molar due\nto a foreign body reaction. Int Endod J; 2001 Oct;\n34(7): 562–567.\nReichart PA, Philipsen HP. Oral erythroplakia—a\nreview. Oral Oncol. 2005 Jul; 41(6): 551–561.\nRobbins KT, Clayman G, Levine PA, Medina J,\nSessions R, Shaha A, Som P, Wolf GT; American Head\nand\nNeck\nSociety;\nAmerican\nAcademy\nof\nOtolaryngology—Head\nand\nNeck\nSurgery.\nNeck\ndissection classification update: Revisions proposed by\nthe American Head and Neck Society and the American\nAcademy of Otolaryngology—Head and Neck Surgery.\nArch Otolaryngol Head Neck Surg. 2002 Jul; 128(7):\n751–758.\nRoccuzzo M, Bonino F, Aglietta M, Dalmasso P. Ten-\nyear results of a three arms prospective cohort study on\n632"
  },
  {
    "page": 633,
    "content": "implants in periodontally compromised patients. Part 2:\nclinical results.Clin Oral Implants Res. 2012 Apr;\n23(4): 389–395.\nRohlin M, Nilner K, Davidson T, Gynther G, Hultin M,\nJemt T, Lekholm U, Nordenram G, Norlund A,\nSunnegardh-Gronberg K, Tranaeus S. Treatment of\nadult patients with edentulous arches: a systematic\nreview. Int J Prosthodont. 2012 Nov–Dec; 25(6):\n553–567.\nRomanos GE, Gupta B, Eckert SE. Distal cantilevers\nand implant dentistry. Int J Oral Maxillofac Implants.\n2012 Sep–Oct; 27(5): 1131–1136.\nRomeo E, Storelli S. Systematic review of the survival\nrate\nand\nthe\nbiological,\ntechnical,\nand\naesthetic\ncomplications\nof\nfixed\ndental\nprostheses\nwith\ncantilevers on implants reported in longitudinal studies\nwith a mean of 5 years follow-up.Clin Oral Implants\nRes. 2012 Oct; 23 (Suppl 6): 39–49.\nRoopashree MR, Gondhalekar RV, Shashikanth MC.\nGeorge J, Thippeswamy SH, Shukla A. Pathogenesis of\noral lichen planus—a review. J Oral Pathol Med. 2010\nNov; 39(10): 729–734.\nRosling B, Nyman S, Lindhe J. The effect of systematic\nplaque control on bone regeneration in infrabony\npockets. J Clin Periodontol. 1976 Feb; 3(1): 38–53.\n633"
  },
  {
    "page": 634,
    "content": "Ruggiero\nSL,\nWoo\nSB.\nBiophosphonate-related\nosteonecrosis of the jaws. Dent Clin North Am. 2008\nJan; 52(1): 111–128.\nRuggiero SL, Dodson TB, Assael LA, Landesberg R,\nMarx RE, Mehrotra B. American Association of Oral\nand\nMaxillofacial\nSurgeons\nposition\npaper\non\nbisphosphonate-related osteonecrosis of the jaws—2009\nupdate. J Oral Maxillofac Surg. 2009 May; 67(5 Suppl):\n2–12.\nSailer M, Vykoupil KF, Peest D, Coldewey R, Deicher\nH, Georgii A. Prognostic relevance of a histologic\nclassification system applied in bone marrow biopsies\nfrom\npatients\nwith\nmultiple\nmyeloma:\na\nhistopathological evaluation of biopsies from 153\nuntreated patients. Eur J Haematol. 1995 Mar; 54(4):\n137–146.\nSailer I, Pjetursson BE, Zwahlen M, Hämmerle CH. A\nsystematic review of the survival and complication rates\nof all-ceramic and metal-ceramic reconstructions after\nan observation period of at least 3 years. Part II: Fixed\ndental prostheses. Clin Oral Implants Res. 2007 Jun; 18\nSuppl 3: 86–96.\nSailer I, Mühlemann S, Zwahlen M, Hämmerle CH,\nSchneider D. Cemented and screw-retained implant\nreconstructions: a systematic review of the survival and\ncomplication rates. Clin Oral Implants Res. 2012 Oct;\n23 Suppl 6: 163–201.\n634"
  },
  {
    "page": 635,
    "content": "Sakaguchi RL, Borgersen SE. Nonlinear finite element\ncontact analysis of dental implant components. The Int\nJ Oral Maxillofac Implants. 1993; 8(6): 655–661.\nSakaguchi\nRL,\nBorgersen\nSE.\nNonlinear\ncontact\nanalysis of preload in dental implant screws. Int J Oral\nMaxillofac Implants. 1995 May–Jun; 10(3): 295–302.\nSalinas T, Eckert S. Implant-supported single crowns\npredictably\nsurvive\nto\nfive\nyears\nwith\nlimited\ncomplications. J Evid Based Dent Pract. 2012 Sep; 12(3\nSuppl): 213–214.\nSalvi\nGE,\nLang\nNP.\nDiagnostic\nparameters\nfor\nmonitoring\nperi-implant\nconditions.\nInt\nJ\nOral\nMaxillofac Implants. 2004; 19 Suppl: 116–127.\nSalvi GE, Brägger U. Mechanical and technical risks in\nimplant therapy. Int J Oral Maxillofac Implants. 2009;\n24 Suppl: 69–85.\nSalvi GE, Aglietta M, Eick S, Sculean A, Lang NP,\nRamseier\nCA.\nReversibility\nof\nexperimental\nperi-\nimplant mucositis compared with experimental in\ngingivitis in humans. Clin Oral Implants Res. 2012 Feb;\n23(2): 182–190.\nSalvi GE, Zitzmann NU. The effects of anti-infective\npreventive measures on the occurrence of biologic\nimplant complications and implant loss: a systematic\nreview.Int J Oral Maxillofac Implants. 2014; 29 Suppl:\n292–307.\n635"
  },
  {
    "page": 636,
    "content": "Scarano A, Iezzi G, Artese L, Cimorelli E, Piattelli A:\nPeripheral giant cell granuloma associated with a dental\nimplant. A case report. Minerva Stomatol. 2008 Oct;\n57(10): 529–534.\nSchache A, Thavaraj S, Kalavrezos N. Osseointegrated\nimplants: A potential route of entry for squamous cell\ncarcinoma of the mandible. Br J Oral Maxillofac Surg.\n2008 Jul; 46(5): 397–399.\nSchenk RK, Buser D, Hardwick WR, Dahlin C.\nHealing pattern of bone regeneration in membrane-\nprotected defects. A histologic study in the canine\nmandible.\nInt\nJ\nOral\nMaxillofac\nImplants.\n1994\nJan–Feb; 9: 13–29.\nSchiegnitz E, Al-Nawas B, Kammerer PW, Grotz KA.\nOral rehabilitation with dental implants in irradiated\npatients: a meta-analysis on implant survival. Clin Oral\nInvestig. 2014 Apr; 18(3): 687–698.\nSchley JS, Heussen N, Reich S, Fischer J, Haselhuhn K,\nWolfart S. Survival probability of zirconia-based fixed\ndental prostheses up to 5 yr: a systematic review of the\nliterature. Eur J Oral Sci. 2010 Oct; 118(5): 443–450.\nSchroeder A, Sutter F, Krekeler G. Oral Implantology.\nStuttgart: Georg Thieme Verlag; 1988 .\nSchrott AR, Jimenez M, Hwang JW, Fiorellini J,\nWeber HP. Five-year evaluation of the influence of\nkeratinized mucosa on peri-implant soft-tissue health\nand stability around implants supporting full-arch\n636"
  },
  {
    "page": 637,
    "content": "mandibular fixed prostheses. Clin Oral Implants Res.\n2009 Oct; 20(10): 1170–1177.\nSchwarz F, Sahm N, Becker J. Combined surgical\ntherapy\nof\nadvanced\nperi-implantitis\nlesions\nwith\nconcomitant soft tissue volume augmentation. A case\nseries. Clin Oral Implants Res. 2014 Jan; 25(1):\n132–136.\nSerino\nG,\nStröm\nC.\nPeri-implantitis\nin\npartially\nedentulous patients: association with inadequate plaque\ncontrol. Clin Oral Implants Res. 2009 Feb; 20(2):\n169–174.\nShirota\nT,\nNakamura\nA,\nMatsui\nY,\nHatori\nM,\nNakamura\nM,\nShintani\nS.\nBisphosphonate-related\nosteonecrosis of the jaw around dental implants in the\nmaxilla: report of a case.Clin Oral Implants Res. 2009\nDec; 20(12): 1402–1408.\nSicilia A, Cuesta S, Coma G, Arregui I, Guisasola C,\nRuiz E, Maestro A. Titanium allergy in dental implant\npatients: a clinical study on 1500 consecutive patients.\nClin Oral Implants Res. 2008 Aug; 19(8): 823–835.\nSohrabi K, Mushantat A, Esfandiari S, Feine J. How\nsuccessful are small-diameter implants? A literature\nreview. Clin Oral Implants Res. 2012 May; 23(5):\n515–525.\nSrinivasan M, L, Rieder P, Moraguez O, Bernard JP,\nBelser UC. Efficacy and predictability of short dental\nimplants (< 8 mm): a critical appraisal of the recent\n637"
  },
  {
    "page": 638,
    "content": "literature.\nInt\nJ\nOral\nMaxillofac\nImplants.\n2012\nNov–Dec; 27(6): 1429–1437.\nStavropoulou AF, Koidis PT. A systematic review of\nsingle crowns on endodontically treated teeth. J Dent.\n2007 Oct; 35(10): 761–767.\nSteinemann SG. Titanium—the material of choice?\nPeriodontol 2000. 1998 Jun; 17: 7–21.\nStimmelmayr M, Edelhoff D, Güth JF, Erdelt K, Happe\nA, Beuer F. Wear at the titanium-titanium and the\ntitanium-zirconia\nimplant-abutment\ninterface:\na\ncomparative in vitro study. Dent Mater. 2012 Dec;\n28(12): 1215–1220.\nStockmann P, Hinkmann FM, Lell MM, Fenner M,\nVairaktaris E, Neukam FW, Nkenke E. Panoramic\nradiograph,\ncomputed\ntomography\nor\nmagnetic\nresonance imaging. Which imaging technique should be\npreferred in bisphosphonate-associated osteonecrosis of\nthe jaw? A prospective clinical study.Clin Oral Investig.\n2010 Jun; 14(3): 311–317.\nSunnegardh-Gronberg K, Davidson T, Gynther G,\nJemt T, Lekholm U, Nilner K, Nordenram G, Norlund\nA, Rohlin M, Tranaeus S, Hultin M. Treatment of adult\npatients with partial edentulism: a systematic review.\nInt J Prosthodont. 2012 Nov–Dec; 25(6): 568–581.\nSverzut CE, Sverzut AT, de Matos FP, Kato RB,\nTrivellato\nAE,\nde\nOliveira\nPT.\nMandibular\nbisphosphonate-related\nosteonecrosis\nafter\ndental\n638"
  },
  {
    "page": 639,
    "content": "implant rehabilitation: a case report.Implant Dent. 2012\nDec; 21(6): 449–453.\nSwierkot K, Brusius M, Leismann D, Nonnenmacher\nC, Nüsing R, Lubbe D, Schade-Brittinger C, Mengel R.\nEur J Oral Implantol. Manual versus sonic-powered\ntoothbrushing for plaque reduction in patients with\ndental implants: an explanatory randomised controlled\ntrial. 2013 Summer; 6(2): 133–144.\nTan K, Pjetursson BE, Lang NP, Chan ES. A\nsystematic review of the survival and complication rates\nof fixed partial dentures (FPDs) after an observation\nperiod of at least 5 years. III. Clin Oral Implants Res.\n2004 Dec; 15(6): 654–666.\nTang JA, Rieger JM, Wolfaardt JF. A review of\nfunctional outcomes related to prosthetic treatment after\nmaxillary and mandibular reconstruction in patients\nwith head and neck cancer. Int J Prosthodont. 2008\nJul–Aug; 21(4): 337–354.\nten Bruggenkate CM, Sutter F, van den Berg JP,\nOosterbeek HS. . Explanation procedure with special\nemphasis on the ITI implant system. Int J Oral\nMaxillofac Implants. 1994 Mar–Apr; 9(2): 223–229.\nTezal M, Sullivan MA, Reid ME, Marshall JR, Hyland\nA, Loree T, Lillis C, Hauck L, Wactawski-Wende J,\nScannapieco FA. (2007) Chronic periodontitis and the\nrisk of tongue cancer. Arch Otolaryngol Head Neck\nSurg. 2007 May; 133(5): 450–454.\n639"
  },
  {
    "page": 640,
    "content": "Theoharidou A, Petridis HP, Tzannas K, Garefis P.\nAbutment\nscrew\nloosening\nin\nsingle-implant\nrestorations: a systematic review. Int J Oral Maxillofac\nImplants. 2008 Jul–Aug; 23(4): 681–690.\nThoma DS, Jones AA, Dard M, Grize L, Obrecht M,\nCochran DL. Tissue integration of a new titanium-\nzirconium dental implant: a comparative histologic and\nradiographic study in the canine. J Periodontol. 2012\nOct; 82(10): 1453–1461.\nTimmerman R, Stoker GT, Wismeijer D et al: Patient\nsatisfaction\nwith\nimplant-supported\nmandibular\noverdentures: a comparison of three different treatment\nstrategies with ITI-dental implants in a randomized\ncontrolled clinical trial 8 years after treatment. J Dent\nRes 2004; 83: 630–633.\nTorsello F, di Torresanto VM, Ercoli C, Cordaro L.\nEvaluation of the marginal precision of one-piece\ncomplete arch titanium frameworks fabricated using\nfive\ndifferent\nmethods\nfor\nimplant-supported\nrestorations. Clin Oral Implants Res. 2008 Aug; 19(8):\n772–779.\nTosches NA, Brägger U, Lang NP. Marginal fit of\ncemented and screw-retained crowns incorporated on\nthe Straumann (ITI) Dental Implant System: an in vitro\nstudy. Clin Oral Implants Res. 2009 Jan; 20(1): 79–86.\nTrombelli L, Farina R. Efficacy of triclosan-based\ntoothpastes in the prevention and treatment of plaque-\n640"
  },
  {
    "page": 641,
    "content": "induced periodontal and peri-implant diseases. Minerva\nStomatol. 2013 Mar; 62(3): 71–88.\nvan der Waal I. Potentially malignant disorders of the\noral\nand\noropharyngeal\nmucosa;\nterminology,\nclassification and present concepts of management.\nOral Oncol. 2009 Apr–May; 45(4–5): 317–323.\nvan Heumen CC, Kreulen CM, Creugers NH. Clinical\nstudies of fiber-reinforced resin-bonded fixed partial\ndentures: a systematic review. Eur J Oral Sci. 2009 Feb;\n117(1): 1–6.\nVervaeke S, Collaert B, Cosyn J, Deschepper E, De\nBruyn\nH.\nA\nMultifactorial\nAnalysis\nto\nIdentify\nPredictors of Implant Failure and Peri-Implant Bone\nLoss.Clin Implant Dent Relat Res. 2013 Sep 4. doi:\n10.1111/cid.12149. [Epub ahead of print]\nvon Arx T, Broggini N, Jensen SS, Schenk RK, Buser\nD. Membrane durability and tissue response of different\nbioresorbable barrier membranes: a histologic study in\nthe rabbit calvarium. Int J Oral Maxillofac Implants.\n2005 Nov–Dec; 20(6): 843–853.\nvon Arx T, Buser D. Horizontal ridge augmentation\nusing autogenous block grafts and the guided bone\nregeneration technique with collagen membranes: a\nclinical study with 42 patients. Clin Oral Implants Res.\n2006 Aug; 17(4): 359–366.\n641"
  },
  {
    "page": 642,
    "content": "Wadhwani CP, Chung KH. The role of cements in\ndental implant success, Part 2. Dent Today. 2013 Jun;\n32(6): 46, 48–51.\nWalterC, Al-Nawas B, Grötz KA, Thomas C, Thüroff\nJW, Zinser V, Gamm H, Beck J, Wagner W. Prevalence\nand\nrisk\nfactors\nof\nbisphosphonate-associated\nosteonecrosis of the jaw in prostate cancer patients with\nadvanced disease treated with zoledronate. Eur Urol.\n2008 Nov; 54(5): 1066–1072.\nWalton JN, Huizinga SC, Peck CC. Implant angulation:\na\nmeasurement\ntechnique,\nimplant\noverdenture\nmaintenance, and the influence of surgical experience.\nInt J Prosthodont. 2001 Nov–Dec; 14(6): 523–530.\nWilson TG Jr. The positive relationship between excess\ncement and peri-implant disease: a prospective clinical\nendoscopic study. J Periodontol. 2009 Sep; 80(9):\n1388–1392.\nWiskott HWA. Fixed prosthodontics: principles and\nclinics. London: Quintessence; 2011.\nWismeijer D, Brägger U, Evans C, Kapos T, Kelly R,\nMillen\nC,\nWittneben\nJ,\nZembic\nA,\nTaylor\nTD.\nConsensus\nStatements\nand\nRecommended\nClinical\nProcedures\nRegarding\nRestorative\nMaterials\nand\nTechniques for Implant Dentistry. Int J Oral Maxillofac\nImplants. 2013 Aug 15; 28 Suppl; 137–140\n.\n642"
  },
  {
    "page": 643,
    "content": "Wismeijer\nD,\nVermeeren\nJI,\nvan\nWaas\nMA.\nOverdentures supported by ITI implants: a 6.5-year\nevaluation\nof\npatient\nsatisfaction\nand\nprosthetic\naftercare. Int J Oral Maxillofac Implants. 1995 Nov-\nDec; 10(6): 744–749.\nWittneben JG, Wright RF, Weber HP, Gallucci GO. A\nsystematic review of the clinical performance of CAD/\nCAM single-tooth restorations. Int J Prosthodont. 2009\nSep–Oct; 22: 466–471.\nWittneben JG, Buser D, Belser UC, Brägger U. Peri-\nimplant\nsoft\ntissue\nconditioning\nwith\nprovisional\nrestorations\nin\nthe\nesthetic\nzone:\nthe\ndynamic\ncompression technique. Int J Periodontics Restorative\nDent. 2013 Jul–Aug. 33(4): 447–455. (a)\nWittneben JG, Buser D, Salvi GE, Bürgin W, Hicklin S,\nBrägger U. Complication and failure rates with implant-\nsupported fixed dental prostheses and single crowns: a\n10-year retrospective study. Clin Implant Dent Relat\nRes. 2013 Apr 2. doi: 10.1111/cid.12066. [Epub ahead\nof print]. (b)\nWittneben JG, Millen C. Clinical performance of\nscrew-versus cement-retained fixed implant supported\nreconstructions—a\nsystematic\nreview.\nInt\nJ\nOral\nMaxillofac Implants. 2014; 29 Suppl: 84–98.\nYuan J, SukotjoC. Occlusion for implant-supported\nfixed dental prostheses in partially edentulous patients:\na literature review and current concepts. J Periodontal\nImplant Sci. 2013 Apr; 43(2): 51–57.\n643"
  },
  {
    "page": 644,
    "content": "Zembic A, Kim S, Zwahlen M, Kelly JR. Systematic\nreview of the survival rate and incidence of biologic,\ntechnical, and esthetic complications of single implant\nabutments supporting fixed prostheses. Int J Oral\nMaxillofac Implants. 2014; 29 Suppl: 99–116.\nZinsli B, Sägesser T, Mericske E, Mericske-Stern R.\nClinical evaluation of small-diameter ITI implants: a\nprospective study. Int J Oral Maxillofac Implants. 2004\nJan–Feb; (1): 92–99.\nZitzmann NU, Berglundh T, Marinello CP, Lindhe J.\nExperimental peri-implant mucositis in man. J Clin\nPeriodontol. 2001 Jun; 28(6): 517–523.\nZitzmann NU, Berglundh T. Definition and prevalence\nof peri-implant diseases. J Clin Periodontol. 2008 Sep;\n35(8 Suppl): 286–291.\nZurdo J, Romão C, Wennström JL. Survival and\ncomplication rates of implant-supported fixed partial\ndentures with cantilevers: a systematic review. Clin\nOral Implants Res. 2009; 20 Suppl 4: 59–66.\n644"
  }
]